
<html lang="en"     class="pb-page"  data-request-id="272cb102-9df7-41de-aab4-5c9791fdd5ca"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2015.58.issue-20;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b00874"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain" /></meta><meta name="dc.Creator" content="Emmanuel  Deau" /></meta><meta name="dc.Creator" content="Elodie  Robin" /></meta><meta name="dc.Creator" content="Raluca  Voinea" /></meta><meta name="dc.Creator" content="Nathalie  Percina" /></meta><meta name="dc.Creator" content="Grzegorz  Satała" /></meta><meta name="dc.Creator" content="Adriana-Luminita  Finaru" /></meta><meta name="dc.Creator" content="Agnès  Chartier" /></meta><meta name="dc.Creator" content="Gilles  Tamagnan" /></meta><meta name="dc.Creator" content="David  Alagille" /></meta><meta name="dc.Creator" content="Andrzej J.  Bojarski" /></meta><meta name="dc.Creator" content="Séverine  Morisset-Lopez" /></meta><meta name="dc.Creator" content="Franck  Suzenet" /></meta><meta name="dc.Creator" content="Gérald  Guillaumet" /></meta><meta name="dc.Description" content="We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo[d]imidazol-2(3H)-ones, imidazo[4,5-b]pyridin-2(3H)-ones, imidazo[4,5-c]pyridin-2(3H)-ones, benzo[d]oxazol-2(3H)-ones, oxazolo[..." /></meta><meta name="Description" content="We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo[d]imidazol-2(3H)-ones, imidazo[4,5-b]pyridin-2(3H)-ones, imidazo[4,5-c]pyridin-2(3H)-ones, benzo[d]oxazol-2(3H)-ones, oxazolo[..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 5, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00874" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00874" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00874" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00874" /></link>
        
    
    

<title>Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00874" /></meta><meta property="og:title" content="Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0026.jpeg" /></meta><meta property="og:description" content="We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo[d]imidazol-2(3H)-ones, imidazo[4,5-b]pyridin-2(3H)-ones, imidazo[4,5-c]pyridin-2(3H)-ones, benzo[d]oxazol-2(3H)-ones, oxazolo[4,5-b]pyridin-2(3H)-ones and N,N′-dialkylated benzo[d]imidazol-2(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1H-benzo[d]imidazol-2(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)piperidin-1-yl)hexyl)-1H-benzo[d]imidazol-2(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, KB = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, KB = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluated with [18F] radiolabeled compounds [18F]79 and [18F]81 in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT7R and 5-HT2AR in the CNS." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00874"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00874">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00874&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00874&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00874&amp;href=/doi/10.1021/acs.jmedchem.5b00874" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8066-8096</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00851" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00912" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT<sub>7</sub>)/5-Hydroxytryptamine 2A (5-HT<sub>2A</sub>) Receptor Antagonists and Evaluation by [<sup>18</sup>F]-PET Imaging in a Primate Brain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel++Deau">Emmanuel Deau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elodie++Robin">Elodie Robin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raluca++Voinea">Raluca Voinea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathalie++Percina">Nathalie Percina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grzegorz++Sata%C5%82a">Grzegorz Satała</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥∞\</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adriana-Luminita++Finaru">Adriana-Luminita Finaru</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agn%C3%A8s++Chartier">Agnès Chartier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gilles++Tamagnan">Gilles Tamagnan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Alagille">David Alagille</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrzej+J.++Bojarski">Andrzej J. Bojarski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥∞\</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9verine++Morisset-Lopez">Séverine Morisset-Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Franck++Suzenet">Franck Suzenet</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%A9rald++Guillaumet">Gérald Guillaumet</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institut de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Centrul de Cercetare ‘Chimie Aplicată şi Inginerie de Proces’, Universitatea din Bacău, Calea Mărăşesti, nr. 157, 600115 Bacău, Romania</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Centre de Biophysique Moléculaire, Centre National de la Recherche Scientifique (CNRS), UPR 4301, Université d’Orléans et INSERM, rue Charles Sadron, 45071 Orléans Cedex 2, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Molecular NeuroImaging, 60 Temple Street, New Haven, Connecticut 06510, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥∞\</span> <span class="aff-text">Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, Kraków 31-343, Poland</span></div><div class="corresp-info"><strong>*</strong>For G.G.: phone, +33 2 38 41 70 73; fax, +33 2 38 41 72 81; E-mail, <a href="/cdn-cgi/l/email-protection#accbc9decdc0c882cbd9c5c0c0cdd9c1c9d8ecd9c2c5da81c3dec0c9cdc2df82cade"><span class="__cf_email__" data-cfemail="5c3b392e3d3038723b293530303d293139281c2932352a71332e30393d322f723a2e">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For F.S.: phone, +33 2 38 49 45 80; fax, +33 2 38 41 72 81; E-mail, <a href="/cdn-cgi/l/email-protection#197f6b78777a72376a6c637c777c6d596c77706f34766b757c78776a377f6b"><span class="__cf_email__" data-cfemail="ef899d8e818c84c19c9a958a818a9baf9a818699c2809d838a8e819cc1899d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00874&amp;href=/doi/10.1021%2Facs.jmedchem.5b00874" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8066–8096</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 8, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 June 2015</li><li><span class="item_label"><b>Published</b> online</span>5 October 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 October 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00874" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00874</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8066%26pageCount%3D31%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEmmanuel%2BDeau%252C%2BElodie%2BRobin%252C%2BRaluca%2BVoinea%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D20%26contentID%3Dacs.jmedchem.5b00874%26title%3DRational%2BDesign%252C%2BPharmacomodulation%252C%2Band%2BSynthesis%2Bof%2BDual%2B5-Hydroxytryptamine%2B7%2B%25285-HT7%2529%252F5-Hydroxytryptamine%2B2A%2B%25285-HT2A%2529%2BReceptor%2BAntagonists%2Band%2BEvaluation%2Bby%2B%255B18F%255D-PET%2BImaging%2Bin%2Ba%2BPrimate%2BBrain%26numPages%3D31%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8096%26publicationDate%3DOctober%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00874"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2925</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00874" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [18F]-PET Imaging in a Primate Brain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;Deau&quot;},{&quot;first_name&quot;:&quot;Elodie&quot;,&quot;last_name&quot;:&quot;Robin&quot;},{&quot;first_name&quot;:&quot;Raluca&quot;,&quot;last_name&quot;:&quot;Voinea&quot;},{&quot;first_name&quot;:&quot;Nathalie&quot;,&quot;last_name&quot;:&quot;Percina&quot;},{&quot;first_name&quot;:&quot;Grzegorz&quot;,&quot;last_name&quot;:&quot;Satała&quot;},{&quot;first_name&quot;:&quot;Adriana-Luminita&quot;,&quot;last_name&quot;:&quot;Finaru&quot;},{&quot;first_name&quot;:&quot;Agnès&quot;,&quot;last_name&quot;:&quot;Chartier&quot;},{&quot;first_name&quot;:&quot;Gilles&quot;,&quot;last_name&quot;:&quot;Tamagnan&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Alagille&quot;},{&quot;first_name&quot;:&quot;Andrzej&quot;,&quot;last_name&quot;:&quot;J. Bojarski&quot;},{&quot;first_name&quot;:&quot;Séverine&quot;,&quot;last_name&quot;:&quot;Morisset-Lopez&quot;},{&quot;first_name&quot;:&quot;Franck&quot;,&quot;last_name&quot;:&quot;Suzenet&quot;},{&quot;first_name&quot;:&quot;Gérald&quot;,&quot;last_name&quot;:&quot;Guillaumet&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8066-8096&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00874&quot;},&quot;abstract&quot;:&quot;We report the synthesis of 46 tertiary amine-bearing N-alkylated benzo[d]imidazol-2(3H)-ones, imidazo[4,5-b]pyridin-2(3H)-ones, imidazo[4,5-c]pyridin-2(3H)-ones, benzo[d]oxazol-2(3H)-ones, oxazolo[4,5-b]pyridin-2(3H)-ones and N,N′-dialkylated benzo[d]imidazol-2(3H)-ones. These compounds were evaluated against 5-HT7R, 5-HT2AR, 5-HT1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1H-benzo[d]imidazol-2(3H)-one (79) and 1-(6-(4-(4-fluorobenzoyl)piperidin-1-yl)hexyl)-1H-benzo[d]imidazol-2(3H)-one (81) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, KB = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, KB = 0.6 and 16 nM, respectively) signaling pathways of 5-HT7R and 5-HT2AR. Both antagonists crossed the blood–brain barrier as evaluate&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00874&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00874" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00874&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00874" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00874&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00874" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00874&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00874&amp;href=/doi/10.1021/acs.jmedchem.5b00874" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00874" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00874" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00874%26sid%3Dliteratum%253Aachs%26pmid%3D26348247%26genre%3Darticle%26aulast%3DDeau%26date%3D2015%26atitle%3DRational%2BDesign%252C%2BPharmacomodulation%252C%2Band%2BSynthesis%2Bof%2BDual%2B5-Hydroxytryptamine%2B7%2B%25285-HT7%2529%252F5-Hydroxytryptamine%2B2A%2B%25285-HT2A%2529%2BReceptor%2BAntagonists%2Band%2BEvaluation%2Bby%2B%255B18F%255D-PET%2BImaging%2Bin%2Ba%2BPrimate%2BBrain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D20%26spage%3D8066%26epage%3D8096%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/jmcmar.2015.58.issue-20/20151022/jmcmar.2015.58.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report the synthesis of 46 tertiary amine-bearing <i>N</i>-alkylated benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones and <i>N</i>,<i>N</i>′-dialkylated benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones. These compounds were evaluated against 5-HT<sub>7</sub>R, 5-HT<sub>2A</sub>R, 5-HT<sub>1A</sub>R, and 5-HT<sub>6</sub>R as potent dual 5-HT<sub>7</sub>/5-HT<sub>2A</sub> serotonin receptors ligands. A thorough study of the structure–activity relationship of the aromatic rings and their substituents, the alkyl chain length and the tertiary amine was conducted. 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>79</b>) and 1-(6-(4-(4-fluorobenzoyl)piperidin-1-yl)hexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>81</b>) were identified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, <i>K</i><sub>B</sub> = 4.9 and 5.9 nM, respectively) and inositol monophosphate (IP1, <i>K</i><sub>B</sub> = 0.6 and 16 nM, respectively) signaling pathways of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Both antagonists crossed the blood–brain barrier as evaluated with [<sup>18</sup>F] radiolabeled compounds <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> in a primate’s central nervous system using positron emission tomography. Both radioligands showed standard uptake values ranging from 0.8 to 1.1, a good plasmatic stability, and a distribution consistent with 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R in the CNS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since its discovery in the early 1990s,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> serotonin-activated cell-surface receptor 5-hydroxytryptamine 7 (5-HT<sub>7</sub>R) has become a subject of interest for numerous research groups and industries specialized in organic and medicinal chemistry, molecular biology, neurology, neurochemistry, and nuclear medicine. 5-HT<sub>7</sub>R is the last of the serotonin receptors families. This family is divided into seven types (5-HT<sub>1</sub>R to 5-HT<sub>7</sub>R), all of which count no less than 14 subtypes. 5-HT<sub>7</sub>R is a G<sub>αs</sub>-protein-coupled receptor (GPCR), a heptameric transmembrane domain which is positively linked to adenylate cyclase. When studied in 5-HT<sub>7</sub> transfected cells, two potent agonists, 5-carboxytryptamine (5-CT) and 5-hydroxytryptamine (serotonin, 5-HT), induced a rapid increase in the formation of an intracellular second messenger, 3′-5′-cyclic adenosine monophosphate (cAMP).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> With the exception of 5-HT<sub>3</sub>R, a Cys-loop ligand-gated ion channel (LGIC) receptor,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> the high amino-acid sequence homology between all 5-HT receptors makes it relatively difficult to synthesize highly selective ligands. In recent years, major progress has been made with selective 5-HT<sub>7</sub>R agonists/antagonists (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and knockout mice strains that lack the 5-HT<sub>7</sub>R, unveiling the multiple roles of this receptor in the central nervous system (CNS). Several agonists and antagonists including pyridines, long chain arylpiperazines (LCAP: LP 44, LP 211),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> triazines,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> arylsulfonamides (SB-269970, SB-656104),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> benzimidazol-2-ones (SB-691673),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> tetrahydrobenzindolones (DR 4485),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and pyrazoles (AS-19, E-55888)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> were reported as selective 5-HT<sub>7</sub>R ligands (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). 5-HT<sub>7</sub>R is believed to play major regulatory functions in the human CNS, but the full scope of its physiological, pathophysiological, and neurological roles remains unraveled. In addition to its association with psychiatric disorders,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> treatment of neurodevelopmental disorders,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> deregulation of the circadian rhythm,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> sleep disturbance,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> thermoregulation,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> inflammatory processes,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> pain and control of nociception,<a onclick="showRef(event, 'cit12b'); return false;" href="javascript:void(0);" class="ref cit12b">(12b)</a> learning, and memory<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>, various studies recently underpinned the pivotal role of 5-HT<sub>7</sub>R in neuronal modeling and brain circuitry reshaping.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected examples of selective 5-HT<sub>7</sub>R antagonists (left) and agonists (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected examples of selective 5-HT<sub>2A</sub>R antagonists (left) and agonists (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unlike 5-HT<sub>7</sub>R, 5-H<sub>2A</sub>R is a G<sub>αq</sub>-protein-coupled heptameric transmembrane domain receptor. When triggered by an agonist, 5-HT<sub>2A</sub>R activates the phospholipase C pathway, which consequently stimulates the production of diacylglycerol (DAG) and inositol triphosphate (IP3)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Various 5-HT<sub>2A</sub>R antagonists (Fananserin,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Altanserin,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Nefazodone,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Melperone,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> MDL100907,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and Ketanserin<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>) and agonists (DOI (2,5-dimethoxy-4-iodoamphetamine),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> 25CN-NBOH,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> PNU 22394,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and TCB-2<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) were studied in clinical trials and approved as psychotropic drugs (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><div class="NLM_p">Pathologies associated with 5-HT<sub>7</sub>R<a onclick="showRef(event, 'ref1 ref10 ref15'); return false;" href="javascript:void(0);" class="ref ref1 ref10 ref15">(1, 10, 15)</a> are commonly correlated with 5-HT<sub>2A</sub>R diseases.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Altogether, implications in mood disorders, schizophrenia, and CNS-related diseases support that 5-HT<sub>7</sub>R is also a highly important therapeutic target in the treatment of cognitive disorders. Therefore, synthesizing dual ligands of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R could constitute a highly significant strategy and a potential therapeutic advance for patients suffering of CNS diseases and psychiatric disorders.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Our research groups previously demonstrated that 1-(4-chlorophenyl)piperazine linked to benzimidazol-2-one with a <i>n</i>-pentyl spacer (product <b>I</b>) constitutes an excellent, high-affinity 5-HT<sub>7</sub>R ligand (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 7 nM) with an appreciable activity against 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 79 nM).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This manuscript describes our efforts in the development, optimization, and pharmacomodulation of dual ligands that specifically target 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Upon in vitro evaluation on 5-HT<sub>7</sub>R, 5-HT<sub>2A</sub>R, 5-HT<sub>1A</sub>R, and 5-HT<sub>6</sub>R, the best dual ligands were selected and evaluated to determine their agonistic or antagonistic properties. The most promising compounds bearing a fluorine atom were radiolabeled with [<sup>18</sup>F]fluoride and evaluated in nonhuman primates to estimate their propensity to cross the blood–brain barrier (BBB) by positron emission tomography (PET) imaging (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Previous work and current work on the synthesis of dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands and brain penetration study by PET imaging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To increase its affinity for 5-HT<sub>2A</sub>R and maintain its affinity for 5-HT<sub>7</sub>R, various pharmacomodulations of the previously identified compound <b>I</b> were undertaken. The effects of the aromatic rings, the length of the alkyl chain, the simple or double substitution of the urea function, and the nature of the tertiary amine on the affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R were investigated. This structure–activity relationship study and radiolabeling were achieved according to the following retrosynthetic pathway: the brain permeability of radiolabeled compound (<b>II</b>) would be studied after in vitro evaluation and radiolabeling of the target compounds (<b>III</b>). Compounds (<b>III</b>) would be synthesized after a substitution reaction on various bromoalkyl intermediates (<b>IV</b>) obtained by different synthetic routes from simple aromatic compounds (<b>V</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This general retrosynthetic pathway would provide access to <i>N</i>-alkylated or <i>N</i>,<i>N</i>′-dialkylated benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, or oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Pathway and Access to Novel <i>N</i>-Alkylated or <i>N</i>,<i>N</i>′-Dialkylated 1<i>H</i>-Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, 1<i>H</i>-Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, 1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones and Radiosynthesis of a Dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R Radioligand for the Evaluation of the Blood–Brain Barrier Permeability</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To optimize the synthesis of dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands, we first focused on the potential modulations of the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one moiety and its side chains.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Commercially available benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> was initially monoprotected and converted into <i>tert</i>-butylcarbamate <b>2</b>, which was alkylated with various 1,<i>n</i>-dibromoalkanes (from ethyl (<i>n</i> = 2) to <i>n</i>-heptyl (<i>n</i> = 7)) under microwave irradiation in phase transfer-catalyzed conditions to yield intermediates <b>3</b>–<b>8</b>. The latter were finally deprotected to yield a first set of bromoalkylbenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones intermediates <b>9</b>–<b>14</b>. In addition to <i>N</i>-alkylated series, the synthesis <i>N</i>,<i>N</i>′-dialkylated analogues bearing an <i>n</i>-butyl side chain was investigated as the addition of an alkyl moiety could increase the brain permeability due to its higher lipophilicity. Because the direct alkylation of compounds <b>9</b>–<b>14</b> may be problematic, the <i>n</i>-butyl side chain should be inserted prior to the bromoalkyl side chain. Accordingly, <i>tert</i>-butylcarbamate <b>2</b> was alkylated in the same conditions as described above with <i>n</i>-bromobutane to isolate alkylcarbamate <b>15</b>, which was deprotected into <b>16</b> and subsequently alkylated with 1,4-dibromobutane or 1,5-dibromopentane to yield intermediates <b>17</b>–<b>18</b>.</div><div class="NLM_p">Because of their potentially high pharmacological impact, the effect of halogenated substituents on the aromatic ring was also explored.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Different synthetic strategies were implemented to synthesize monohalo-substituted bromoalkylbenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones precursors. However, benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> cannot be directly and regioselectively desymmetrized by monohalogenation without appropriately deactivating one of the nitrogen atoms of the urea moiety. Therefore, <b>1</b> was initially converted into ethylcarbamate derivative <b>19</b> using ethylpyridin-2-yl carbonate <b>20</b>, itself prepared from 2-hydroxypyridine and ethyl chloroformate. Monohalogenation of <b>19</b> was achieved regioselectively when performed in acetic acid at 65–70 °C with bromine or iodine monochloride to yield products <b>21</b> and <b>22</b>, respectively. In this reaction, the temperature proved to be a critical parameter: lower temperatures gave incomplete conversions while higher temperatures provoked the partial deprotection of <b>19</b> into <b>1</b> which rapidly underwent polyhalogenation reactions. Phase transfer-catalyzed alkylation of ethylcarbamates <b>21</b> and <b>22</b> gave products <b>23</b> and <b>24</b>, which protective group was conveniently removed with isopropylamine in THF to yield monohalo-substituted bromoalkylbenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones <b>25</b> and <b>26</b>, respectively. Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> was also efficiently converted into 5,6-dichlorobenzimidazol-2(3<i>H</i>)-one <b>27</b> using two equivalents of <i>N</i>-chlorosuccimide. Monoprotection of <b>27</b> into <i>tert</i>-butylcarbamate <b>28</b> followed by alkylation and deprotection gave 5,6-dichlorobromoalkylbenzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>30</b>. Addition of another aliphatic chain on the <i>n</i>-butyl dichloro derivative was conducted in the same manner as for compounds <b>17</b>–<b>18</b> starting from the dichlorocarbamate derivative <b>28</b>. It was alkylated with <i>n</i>-bromobutane to give intermediate <b>31</b>, which was deprotected into <b>32</b> to finally yield product <b>33</b> after a second alkylation with 1,4-dibromobutane.</div><div class="NLM_p">Among the possible pharmacomodulations, we wished to synthesize a dissymmetric dichlorobenzo[<i>d</i>]imidazol-2(3<i>H</i>)-one. 4,6-Dichlorobenzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>35</b> was conveniently synthesized by a Curtius rearrangement-mediated cyclization of commercially available 2-amino-4,6-dichlorobenzoic acid <b>34</b> with diphenylphosphoryl azide (DPPA). Unlike other intermediates, monoprotection of <b>35</b> into <i>tert</i>-buylcarbamate <b>36</b> was achieved with dimethylaminopyridine (DMAP) and di-<i>tert</i>-butyl dicarbonate (Boc<sub>2</sub>O) with perfect regioselectivity in position 1 of 4,6-dichlorobenzo[<i>d</i>]imidazol-2(3<i>H</i>)-one.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Alkylation of <b>36</b> into intermediate <b>37</b> followed by TFA-mediated deprotection yielded intermediate <b>38</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Alkylated, <i>N</i>,<i>N</i>′-Dialkylated, Monohalo-, and Dihalobenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH (1.1 equiv), Boc<sub>2</sub>O (1 equiv), DMF, rt, 24 h. (b) TBAB (0.05 equiv), K<sub>2</sub>CO<sub>3</sub> (5 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br or <i>n</i>BuBr (5 equiv), H<sub>2</sub>O, 80 °C (μw), 1 h. (c) TFA (3 equiv), DCM, rt, 3 h. (d) ethylpyridin-2-yl carbonate (<b>20</b>) (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), ACN, reflux, 2 h. Note: <b>20</b> was prepared using a modified protocol. For details, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Sections">Experimental Sections</a>. (e) Br<sub>2</sub> (1.2 equiv) or ICl (2 equiv), AcOH, 65 °C, 3 h. (f) TBAB (0.05 equiv), K<sub>2</sub>CO<sub>3</sub> (5 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (5 equiv) or <i>n</i>BuBr (5 equiv), H<sub>2</sub>O, 60 °C (μw), 1 h. (g) <i>i</i>PrNH<sub>2</sub> (1.2 equiv), THF, rt, 12 h. (h) NCS (2 equiv), DMF, rt, 6 h. (i) DPPA (1.1 equiv), TEA (1 equiv), dioxane, reflux, 12 h. (j) DMAP (0.1 equiv), Boc<sub>2</sub>O (1.025 equiv), THF, reflux, 2 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><div class="NLM_p">Because of their potentially high pharmacological effect, the influence of new pyridine analogues on the selectivity and affinity against 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R was also studied. Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one <b>41</b> and imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one <b>48</b> are not commercially available, and required to be prepared from simple aromatic precursors: diaminopyridines <b>39</b> and <b>47</b>, or 2-aminonicotinic acid <b>40</b>. The global strategy was to access all four <i>N</i>-monoalkylated imidazopyridin-2(3<i>H</i>)-ones, all of which would bear a nitrogen atom at a different position of the aromatic cycle upon regioselective protection of <b>41</b> or <b>48</b>.</div><div class="NLM_p">Accordingly, imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one <b>41</b> was prepared from 2,3-diaminopyridine which was cyclized using carbonyldiimidazole (CDI) or from 2-aminonicotinic acid <b>40</b> by Curtius rearrangement-mediated cyclization with DPPA, similarly to compound <b>35</b>. Although the isolated yield was somewhat lower with the second method, it had the advantage of avoiding the laborious chromatographic purification step of this highly polar pyridine precursor. Monoprotection of imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one <b>41</b> into <i>tert</i>-butylcarbamate <b>42</b> was efficiently and regioselectively achieved with sodium hydride and Boc<sub>2</sub>O.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Carbamate <b>42</b> was directly converted into 3-(4-bromobutyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one <b>43</b> in a one-pot reaction without isolating the pH-sensitive alkylcarbamate intermediate. The second bromobutyl isomer <b>46</b> was synthesized from <b>41</b> using a differential protection sequence. First, <b>41</b> was regioselectively converted into ethylcarbamate <b>44</b> using ethylpyridin-2-yl carbonate <b>20</b>. An orthogonal protection of the remaining free NH function with Boc<sub>2</sub>O in the presence of DMAP followed by deprotection of the ethylcarbamate moiety with isopropylamine gave <i>tert</i>-butylcarbamate <b>45</b> in an overall good yield. Again, <b>45</b> was converted into monoalkylated isomer <b>46</b> using the same one-pot sequence as forementioned. Synthesis of the third pyridine isomer was achieved from 3,4-diaminopyridine <b>47</b>. Starting material <b>47</b> was cyclized into imidazo[4,5-<i>c</i>]pyridin-2-one <b>48</b> with CDI, which was selectively protected into <i>tert</i>-butylcarbamate <b>49</b> followed by an alkylation-deprotection sequence, which yielded 1-(4-bromobutyl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-one <b>50</b>. Attempt to use 3-aminoisonicotinic acid and cyclize it into <b>48</b> using DPPA (same conditions as <b>40</b>) only provided an inseparable mixture of starting material and <b>48</b>. Despite our efforts and regardless of the synthetic sequence or protective group, we were not able to isolate the last isomer but a complex mixture of unidentified compounds.</div><div class="NLM_p">Finally, the synthesis of <i>N</i>-alkylated benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones and oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones was achieved. Replacement of the NH function by an oxygen atom may help to assess the importance of the urea function on the affinity and selectivity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Commercial benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one <b>51</b> was treated with 1,<i>n</i>-dibromoalkanes (<i>n</i> = 4, 5) to yield <i>N</i>-alkylated products <b>52</b> and <b>53</b>. Pyridine isomers <b>56</b> and <b>57</b> were isolated in a similar way: 2-aminopyridin-3-ol <b>54</b> was initially cyclized into oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one <b>55</b> with CDI and alkylated to give <b>56</b> and <b>57</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Alkylated Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CDI, THF, 66 °C (μw), 2 h. (b) DPPA (1.1 equiv), TEA (1 equiv), dioxane, reflux, 12 h. (c) NaH (1.1 equiv), Boc<sub>2</sub>O (1 equiv), DMF, rt, 24 h. (d) K<sub>2</sub>CO<sub>3</sub> (1 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (2 equiv), DMF, rt, 2 h, then TFA (5 equiv), DCM, rt, 3 h. (e) ethylpyridin-2-yl carbonate (<b>20</b>) (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), ACN, reflux, 2 h. Note: <b>20</b> was prepared using a modified protocol. For details, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>. (f) DMAP (0.1 equiv), Boc<sub>2</sub>O (1.2 equiv), THF, rt, 2 h, then <i>i</i>PrNH<sub>2</sub> (1.2 equiv). (g) K<sub>2</sub>CO<sub>3</sub> (3 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (5 equiv), DMF, 60 °C (μw), 3 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><div class="NLM_p">At this stage, 20 precursors were synthesized to perform a thorough evaluation of the effect of aromatic core and its substituents as well as the length of the alkyl chain on the selectivity and affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. To measure the effect of the nature of the amine, the brominated precursors were reacted with a series of 15 substituted piperazines and substituted piperidines. The reason for choosing substituted piperazines (series <b>A</b>) and substituted piperidines (series <b>B</b>–<b>E</b>) was directly driven by previous results of numerous research groups; long-chain arylpiperazines and structurally related moieties have been long known for being one of the most important classes of serotonin receptor ligands.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> All final products were isolated after a nucleophilic substitution of the brominated precursors with the appropriate piperazines and piperidines in acetonitrile and DIPEA at 90 °C to yield products <b>58</b>–<b>102</b> and <b>103</b>, a phthalimide analogue, in moderate to excellent yields varying from 42 to 99% (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Series <b>A</b>–<b>E</b>: Tertiary Amine-Bearing <i>N</i>-Alkylated Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, and <i>N</i>,<i>N</i>′-Dialkylated Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: RNHR (or ·HCl or ·HBr) (1.2 equiv), DIPEA (2.5 equiv), ACN, 90 °C, sealed tube, 12 h. For detailed experimental protocols, spectroscopic data, HPLC chromatograms of final products, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">In Vitro Assays: Biological Evaluation and Functional Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Radioligand binding assays were used to determine the affinity of the synthesized compounds for primary targets 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R, stably expressed in human embryonic kidney 293 cells (HEK 293) and Chinese hamster ovary cells (CHO), respectively. Because long-chain arylpiperazine or piperidine derivatives were often reported as 5-HT<sub>1A</sub>R and 5-HT<sub>6</sub>R ligands, affinity for these receptors was also determined.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">A first series of compounds <b>58</b>–<b>76</b> (series <b>A</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was studied in order to evaluate the effect of heterocyclic core, the spacer length, and the substituents of the phenylpiperazine. Previous results demonstrated that the optimum spacer providing affinity and selectivity for 5-HT<sub>7</sub>R is a pentyl chain as shown in the case of ligand <b>I</b>.<a onclick="showRef(event, 'ref30 ref4'); return false;" href="javascript:void(0);" class="ref ref30 ref4">(30, 4)</a> A butyl spacer was also reported as an optimal spacer for similar series of compounds<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and was therefore screened to potentially improve the selectivity and the affinity against 5-HT<sub>2A</sub>R and 5-HT<sub>7</sub>R. In accordance with results from Volk et al., changing the chlorine atom in position 4 with a methoxy group in compound <b>58</b> resulted in a complete loss of affinity for 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 282 nM).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Also, compound LP-44, a selective 5-HT<sub>7</sub>R agonist bearing a 1-(2-(methylthio)phenyl)piperazine moiety, was used as a template to synthesize thiomethylated compound <b>59</b>.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Because both products share a 1-(2-(methylthio)phenyl)piperazine, similar biological results could be anticipated. Changing the position of the substituent and using a thiomethyl group instead of a chlorine substituent resulted in a similar affinity for 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 7.7 nM) compared to product <b>I</b>. However, a complete loss of selectivity was observed because product <b>59</b> also exhibits a high affinity for 5-HT<sub>1A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>1A</sub>R) = 9.3 nM), unlike LP-44, which shows a selectivity fold above 200 between 5-HT<sub>7</sub>R and 5-HT<sub>1A</sub>R. This result points out the crucial role of the amide-bearing tetrahydronaphthalene moiety of LP-44 versus the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle to conserve a high selectivity for 5-HT<sub>7</sub>R against 5-HT<sub>1A</sub>R when they are associated with substituted phenylpiperazines.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Series <b>A</b>: In Vitro Evaluation, Selectivity, and Physicochemical Properties of <i>N</i>-Substituted or <i>N</i>,<i>N</i>′-Substituted Phenylpiperazinyl-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones (X = NH, W = CH), −Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones (X = O, W = CH), and −Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones (X = O, W = N) <b>58</b>–<b>76</b> as Serotonin Receptor Ligands; Effects of the Heteroaryl Ring, the Alkyl Chain Length, and the Phenylpiperazine Substituent on the Affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0019.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are means of three experiments run in triplicate, SEM ≤ 12%. Most relevant results are presented in bold.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Calculations were run on calculator plugins to predict Log <i>D</i> and PSA values, Marvin 6.0.3, 2013, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Isolated yield (last reaction step).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Log <i>D</i> was chosen instead of Log <i>P</i> to better estimate the propensity of products to pass through the blood–brain barrier at a physiological pH = 7.4.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">PSA = polar surface area.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Undetermined.</p></div></div><div></div></div><div class="NLM_p">The in vitro study of new 4-halosubstituted products <b>60</b>–<b>62</b> was also carried out. Halogenated products <b>60</b> and <b>61</b>, and more particularly the fluorinated derivative <b>62</b>, proved to be highly active 5-HT<sub>7</sub>R ligands, with inhibition constants of 8, 17, and 6.2 nM, respectively. Product <b>62</b> showed much better selectivities of 73- and 197-fold for 5-HT<sub>7</sub>R versus 5-HT<sub>1A</sub>R and HT<sub>6</sub>R, respectively, and a good inhibition constant against 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 19 nM). Among the most active compounds, <i>para</i>-hydroxylated product <b>63</b> was also identified with an inhibition constant of 3.6 nM against 5-HT<sub>7</sub>R and excellent 712 and 587 selectivity folds for 5-HT<sub>7</sub>R versus 5-HT<sub>1A</sub>R and HT<sub>6</sub>R, respectively, but a much lower affinity for 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 188 nM) compared to fluorinated product <b>62</b>. In an effort to assess the effect of the free NH function of the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle of the most active ligands, the <i>N</i>-butyl analogue <b>64</b> of <i>para</i>-hydroxylated product <b>63</b> was examined. Functionalization of the free NH function resulted in a partial loss of affinity (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 149 nM), indicating that functionalization of the NH function most likely results in a depleted biological activity. Taking into account the fact that compounds with the highest affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R bear a 4-fluorophenyl or 4-hydroxyphenylpiperazinyl moiety, the evaluation of products <b>65</b>–<b>76</b> bearing a benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one or oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one heterocyclic core was considered to appreciate the effect of the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle on the affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Results presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> demonstrate that interchanging the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one cycle with a benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one moiety induced a partial loss of selectivity and affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. Higher inhibition constants of products <b>65</b>–<b>70</b> thus indicate that the benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one heterocycle is not adapted to the synthesis of dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands when it is combined to 4-fluorophenyl or 4-hydroxyphenylpiperazine. However, in the case of product <b>69</b>, substitution with a hydroxyl group at position 4 partially restored the selectivity for 5-HT<sub>7</sub>R versus 5-HT<sub>1A</sub>R and 5-HT<sub>6</sub>R, which is consistent with the previous results obtained with product <b>63</b>. Aza-analogues <b>71</b>–<b>76</b> of products <b>65</b>–<b>70</b> displayed a completely different affinity profile with a biological activity oriented toward 5-HT<sub>1A</sub>R. Products <b>71</b> and <b>74</b>, which only differ by the dimension of the spacer, <i>n</i>-butyl versus <i>n</i>-pentyl chain, respectively, present inhibition constants of 15 and 24 nM against 5-HT<sub>1A</sub>R. Compounds <b>71</b> and <b>74</b> also demonstrate that the optimum spacer length is no longer a <i>n</i>-pentyl, but a <i>n</i>-butyl chain if one wishes to optimize the affinity against 5-HT<sub>1A</sub>R. With regards to the affinity against 5-HT<sub>1A</sub>R, aza-analogues <b>71</b>–<b>76</b> interestingly prove that substitution of the para-position of the phenylpiperazine induced a loss of affinity and selectivity against 5-HT<sub>1A</sub>R. This unexpected result highly contrasts with our previous observation: substitution in the para position of the phenylpiperazine was essential to conserve or enhance the activity against 5-HT<sub>7</sub>R in the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one series.</div><div class="NLM_p">With the initial intention of synthesizing new 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R dual ligands, evaluation of the most active compounds of series <b>A</b> as potent 5-HT<sub>2A</sub>R ligands was investigated. With the exception of compound <b>62</b>, all products were insufficiently active against 5-HT<sub>2A</sub>R as previously shown. Affinity constants are limited to the double-digit nanomolar to micromolar range, which might signify that substituted phenylpiperazines may not be the most adequate moiety to provide 5-HT<sub>2A</sub>R affinity. At this stage of our study, the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle bearing a <i>n</i>-butyl or <i>n</i>-pentyl spacer seemed to be the most adequate to provide inhibition against 5-HT<sub>7</sub>R, but phenylpiperazine moieties were discarded due to insufficiently high affinities for 5-HT<sub>2A</sub>R in this series.</div><div class="NLM_p">With the aim of circumventing these results and isolate pharmacophores with better inhibitory constants against 5-HT<sub>2A</sub>R, the use of new tertiary amines was envisaged. 4-Fluorobenzoylpiperidine was knowingly chosen as a potential pharmacophoric moiety not only due to the high structural similarity with the previous series and hence conserve the initial 5-HT<sub>7</sub>R activity, but also because previous studies demonstrated that compounds bearing this pharmacophoric core have high affinities for 5-HT<sub>2A</sub>R.<a onclick="showRef(event, 'ref19 ref21 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref21 ref23">(19, 21, 23)</a> Additionally, this fluorinated scaffold constitutes an ideal partner for an effective radiolabeling and evaluation of brain penetration by PET imaging.</div><div class="NLM_p">As a result, another set of ligands <b>77</b>–<b>82</b> (series <b>B</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) bearing a 4-fluorobenzoylpiperidine and a benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle attached together with <i>n</i>-alkyl spacers was also investigated. The structural differences between arylpiperazines and 4-fluorobenzoylpiperidine incited us to reevaluate the effect of the alkyl spacer length, using ethyl to <i>n</i>-heptyl chains. In this series, biological results indicate that the optimum chain length is no longer a <i>n</i>-pentyl chain, as in arylpiperazine series, but surprisingly a <i>n</i>-butyl or <i>n</i>-hexyl chain. Products <b>79</b> and <b>81</b> proved to have a high affinity for 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 2 nM for both products) with excellent selectivities against 5-HT<sub>6</sub>R and 5-HT<sub>1A</sub>R. Evaluation of the affinity of compounds of series B against 5-HT<sub>2A</sub>R demonstrated that choosing 4-fluorobenzoylpiperidine as a tertiary amine was the right choice because both products <b>79</b> and <b>81</b> also have a high affinity for 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 4 and 27 nM, respectively).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Series <b>B</b>: In Vitro Evaluation, Selectivity, and Physicochemical Properties of 1-(<i>n</i>-(4-(4-Fluorobenzoyl)piperidin-1-yl)alkyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones <b>77</b>–<b>82</b> as Serotonin Receptor Ligands; Effect of the <i>n</i>-Alkyl Spacer on the Affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0020.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are means of three experiments run in triplicate, SEM ≤ 12%. Most relevant results are presented in bold.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Calculations were run on calculator plugins to predict Log <i>D</i> and PSA values, Marvin 6.0.3, 2013, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Isolated yield (last reaction step).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Log <i>D</i> was chosen instead of Log <i>P</i> to better estimate the propensity of products to pass through the blood–brain barrier at a physiological pH = 7.4.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">PSA = polar surface area.</p></div></div><div></div></div><div class="NLM_p">In an effort to better understand this complete shift of affinity and possibly enhance the biological activities of these dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands, various structural changes were accomplished on the core structures of products <b>79</b> and <b>81</b>: position and number of fluorine atoms (series <b>C</b>), role of the methyne and carbonyl functions of the 4-fluorobenzoylpiperidine (series <b>D</b>), and finally, addition of substituents or replacement of aromatic sp<sup>2</sup> carbon atoms by an aromatic nitrogen atom on the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one core (series <b>E</b>).</div><div class="NLM_p">Ligands <b>83</b>–<b>86</b> (series <b>C</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) demonstrate that the position of the fluorine atom on the benzoylpiperidine is essential. Substitution in the para position by a fluorine atom is the best position to maintain a selective ligand with high affinity for 5-HT<sub>7</sub>R. Any other substitution in ortho or meta positions or disubstitutions induced a partial loss of affinity for 5-HT<sub>7</sub>R.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Series <b>C</b>: In Vitro Evaluation, Selectivity, and Physicochemical Properties of Mono- and Difluorinated 1-(4-(4-Benzoylpiperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones <b>83</b>–<b>86</b> as Serotonin Receptor Ligands; Effect of the Fluorine Atoms Position on the Affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0021.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values are means of three experiments run in triplicate, SEM ≤ 12%. Most relevant results are presented in bold.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Calculations were run on calculator plugins to predict Log <i>D</i> and PSA values, Marvin 6.0.3, 2013, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Isolated yield (last reaction step).</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Log <i>D</i> was chosen instead of Log <i>P</i> to better estimate the propensity of products to pass through the blood–brain barrier at a physiological pH = 7.4.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">PSA = polar surface area.</p></div></div><div></div></div><div class="NLM_p">Taking in account the high affinity of products <b>79</b> and <b>81</b>, the effect of the carbonyl group and the tertiary carbon in position 4 of 4-fluorobenzoylpiperidine was investigated and ligands <b>87</b>–<b>89</b> were studied in that sense (series <b>D</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Replacement of the tertiary carbon by a nitrogen atom using 4-fluorobenzoylpiperazine lowered the affinity for 5-HT<sub>7</sub>R as demonstrated with product <b>87</b> (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 81 nM), indicating that the ketone function of 4-fluorobenzoylpiperidine rather than an amide function is essential to preserve the biological activity. In accordance with this observation, replacement of the carbonyl function by a methylene or a sulfonyl group with products <b>88</b> and <b>89</b>, respectively, induced a partial loss of affinity and selectivity against 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 127 and 334 nM, respectively).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Series <b>D</b>: In Vitro Evaluation, Selectivity, and Physicochemical Properties of <i>N</i>-Butyl 1<i>H</i>-Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones as Serotonin Receptor Ligands; Effect of the Nature of the Tertiary Amine on the Affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0022.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Values are means of three experiments run in triplicate, SEM ≤ 12%. Most relevant results are presented in bold.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Calculations were run on calculator plugins to predict Log <i>D</i> and PSA values, Marvin 6.0.3, 2013, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Isolated yield (last reaction step).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Log <i>D</i> was chosen instead of Log <i>P</i> to better estimate the propensity of products to pass through the blood–brain barrier at a physiological pH = 7.4.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">PSA = polar surface area.</p></div></div><div></div></div><div class="NLM_p">At this point of the study, products <b>79</b> and <b>81</b> constitute the best dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands and also the best candidates for radiolabeling. Keeping in mind that 4-fluorobenzoylpiperidine constitute a highly potent substructure for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R inhibition, the effect and importance of the benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one heterocycle remained to be studied.</div><div class="NLM_p">Consequently, the effect of the heteroaromatic ring and its substituents was examined and the in vitro evaluation of <b>90</b>–<b>103</b> (series <b>E</b>, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) was carried out. As shown with product <b>90</b>, addition of the <i>n</i>-butyl side chain on the remaining free NH function expectedly gave a lower affinity for 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 30 nM). This result is in accordance with biological evaluation of <i>N</i>-alkylated product <b>64</b> compared to the nonalkylated product <b>63</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Monobrominated, monoiodinated, dichlorinated, and <i>N</i>-alkyldichlorinated products <b>91</b>–<b>95</b> were also evaluated to assess the effect of substituents on the aromatic ring. Biological evaluation of products <b>91</b>–<b>95</b> indicates that all the substitutions on the aromatic ring were detrimental for the affinity for 5-HT<sub>7</sub>R although ligand <b>93</b> remained quite active against 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 27 nM) and 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 26 nM). It is noteworthy that adding halogen atoms noticeably enhances the affinity for the 5-HT<sub>6</sub>R for products <b>91</b>–<b>93</b>. In the same manner, pyridine derivatives <b>96</b>–<b>98</b> were evaluated. Regardless of the position of the aromatic nitrogen atom, affinities were lower than the reference compounds <b>79</b> and <b>81</b>. Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one and oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one derivatives <b>99</b>–<b>102</b> were also synthesized and evaluated. Attempts to change the free NH function of benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one by an oxygen atom or adding a nitrogen atom to the heterocyclic ring resulted in a partial loss of affinity and selectivity against 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R although compound <b>99</b> still had an acceptable inhibition constant against 5-HT<sub>7</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>7</sub>R) = 13 nM) and 5-HT<sub>2A</sub>R (<i>K</i><sub>i</sub> (5-HT<sub>2A</sub>R) = 18 nM). It is noteworthy that compound <b>103</b>, a phthalimide analogue of product <b>79</b>, demonstrated that the NHCONH sequence of the urea function is also essential to conserve the activity against 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R. The most important SARs are summarized in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Also, lipophilicities (Log <i>D</i>) and polar surface areas (PSA), two critical factors for brain penetration, were calculated for compounds <b>58</b>–<b>103</b>. Values in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> indicate that all products are in the commonly accepted range needed for a proper brain penetration (2 < Log <i>D</i> < 4 and PSA < 80 Å<sup>2</sup>).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Series <b>E</b>: In Vitro Evaluation, Selectivity, and Physicochemical Properties of <i>N</i>-Butyl- and <i>N</i>-Pentyl-4-fluorobenzoylpiperidines as Serotonin Receptor Ligands; Effect of the Heteroaromatic Ring and Its Substituents on the Affinity for 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0023.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Values are means of three experiments run in triplicate, SEM ≤ 12%. Most relevant results are presented in bold.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Calculations were run on calculator plugins to predict Log <i>D</i> and PSA values, Marvin 6.0.3, 2013, ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Isolated yield (last reaction step).</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Log <i>D</i> was chosen instead of Log <i>P</i> to better estimate the propensity of products to pass through the blood–brain barrier at a physiological pH = 7.4.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">PSA = polar surface area.</p></div><div class="footnote" id="t5fn6"><sup>Table f</sup><p class="last"><b>103</b> was synthesized from commercially available 2-(4-bromobutyl)isoindoline-1,3-dione using operating conditions described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</p></div></div><div></div></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of the main SAR results.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the agonistic or antagonistic properties of products <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b> on 5-HT<sub>7</sub>R, the effect of all five ligands was investigated on cyclic adenosine monophosphate (cAMP) production in response to 5-HT<sub>7</sub>R stimulation by 5-carboxamidotryptamine (5-CT), a full and nonselective 5-hydroxytryptamine receptor agonist (initial concentration: 10 nM). cAMP measurements were determined using homogeneous time-resolved fluorescence resonance energy transfer LANCE assay. cAMP accumulations were measured in HEK 293 cells (HEK 293 mock) as control and in transfected HEK 293 cells stably expressing 5-HT<sub>7</sub>R. In HEK 293 mock cells, 5-CT did not induce cAMP accumulation, and ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b> did not modify the cAMP production. (2<i>R</i>)-1-((3-Hydroxyphenyl)sulfonyl)-2-(2-(4-methyl-1-piperidinyl)ethyl)pyrrolidine (SB-269970),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> a full and selective 5-HT<sub>7</sub>R antagonist, was used as a control. Upon pharmacological evaluation, products <b>I</b>, <b>62</b>, <b>63</b>,<b>79</b>, and <b>81</b> proved to significantly induce a dose-dependent decrease of 5-CT-induced cAMP accumulation in transfected HEK cells expressing 5-HT<sub>7</sub>R (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). The concentration values that produce half of the effect IC<sub>50</sub>, calculated dissociation constants, antagonist potencies (<i>K</i><sub>B</sub>), and maximum inhibitory effects (<i>I</i><sub>max</sub>) were also calculated using GraphPad Prism software. The lowest <i>K</i><sub>B</sub> values were obtained for ligands <b>62</b> and <b>79</b> (1.7 nM and 4.9 nM, respectively), whereas compound <b>I</b> had a higher <i>K</i><sub>B</sub> (20.3 nM). Moreover, the maximum inhibitory effects (<i>I</i><sub>max</sub>) were above 98% for most of the tested compounds, similar to the full antagonist SB-269970 (100%). Thus, ligands <b>I</b>, <b>62</b>, <b>63</b>, and <b>81</b> behave as potent and full antagonist of 5-HT<sub>7</sub>R, and compound <b>79</b> can be considered as a partial antagonist (<i>I</i><sub>max</sub> = 81.5%; <i>p</i> < 0.05) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Functional assays of 5-HT<sub>7</sub>R agonist 5-CT, antagonist SB-269970, and ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b>. Inhibition of 5-CT induced cAMP accumulation was determined using HEK-293 cells stably expressing 5-HT<sub>7</sub>R. Cells were incubated with 10 nM 5-CT and increasing concentrations of products. cAMP accumulation was measured with a LANCE cAMP detection kit (PerkinElmer). Data are means ± SEM from three to six independent experiments. The IC<sub>50</sub> for each drug was determined using GraphPad prism software and indicated in the <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. For detailed experimental protocols of functional characterization, negative controls of 5-CT, SB-26970, and ligands, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Antagonist Potencies (<i>K</i><sub>B</sub>) of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R Ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b>; Comparison to SB-269970 and Ketanserin<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0024.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Data plotted in <a class="ref internalNav" href="#fig5" aria-label="Figures 5">Figures 5</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> were analyzed by nonlinear regression using GraphPad Prism (GraphPad Software) to yield IC<sub>50</sub> values. Antagonist potency (<i>K</i><sub>B</sub> values) for inhibition of agonist action were calculated from <i>K</i><sub>B</sub> = IC<sub>50</sub>/(1 + [agonist]/EC<sub>50</sub>), where IC<sub>50</sub> = inhibitory concentration<sub>50</sub> of antagonist, [agonist] = concentration of 5-CT(10 nM), and EC<sub>50</sub> = effective concentration<sub>50</sub> of 5-CT (4 nM).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Not applicable.</p></div></div><div></div></div><div class="NLM_p">The antagonistic properties of products <b>62</b>, <b>79</b>, and <b>81</b> on 5-HT<sub>2A</sub>R were also determined. The effect of the three ligands was investigated on inositol monophosphate (IP1) production in response to 5-HT<sub>2A</sub>R stimulation by serotonin, a full and nonselective serotonin receptor agonist. IP1 measurements were determined using homogeneous time-resolved fluorescence assays. IP1 accumulation was measured in HEK 293 cells stably expressing human 5-HT<sub>2A</sub>R. Ketanserin, a full and selective 5-HT<sub>2A</sub>R antagonist, was used as control. Products <b>62</b>, <b>79</b>, and <b>81</b> induced a significant dose-dependent decrease of serotonin-induced IP1 accumulation in HEK 293 cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The concentration values that produce half of the effect (IC<sub>50</sub>), antagonist potencies (<i>K</i><sub>B</sub>), and maximum inhibitory effects (<i>I</i><sub>max</sub>) were also determined. The lowest <i>K</i><sub>B</sub> value was obtained for ligand <b>79</b> (0.6 nM), whereas compounds <b>62</b> and <b>81</b> had a higher <i>K</i><sub>B</sub> (15 and 16 nM, respectively). Moreover, the maximum inhibitory effects (<i>I</i><sub>max</sub>) were 91.7%, 93.6%, and 99%, respectively, for compounds <b>62</b>, <b>81</b>, and <b>79</b>, similar to the full antagonist ketanserin (100%). Thus, ligands <b>62</b>, <b>79</b>, and <b>81</b> also behave as potent and full antagonist of 5-HT<sub>2A</sub>R (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Functional assays of 5-HT<sub>2A</sub>R antagonists <b>62</b>, <b>79</b>, and <b>81</b>. Inositol monophosphate (IP1) accumulation was measured with HTRF assay by CEREP. HEK 293 cells were stimulated with serotonin (100 nM) and then with the different drugs (compounds <b>62</b>, <b>79</b>, and <b>81</b>, concentration range from 1.10<sup>–11</sup> M to 1.10<sup>–6</sup> M). Data are means ± SEM from one representative experiment performed in duplicate. Concentration/response curves were analyzed using Prism 4 software. The <i>K</i><sub>B</sub> value of the different drugs as antagonist and the IC<sub>50</sub> (the inhibitory concentration50) of antagonist were determined by CEREP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Radiosynthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With the intention to evaluate the brain penetration of the most active compounds (<b>79</b> and <b>81</b>) as a preliminary result, in vivo PET imaging was considered as the most effective technique.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> To carry out the radiosynthesis, a classical synthetic strategy of nucleophilic aromatic substitution from nitro precursors was conceived. The synthesis of the nitro derivatives and the radiolabeled compounds would then be achieved according to the retrosynthetic pathway described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> starting from the ethyl isonipecotate <b>104</b>.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Retrosynthetic Pathway and Access to (4-Nitrophenyl)(piperidin-4-yl)methanone <b>110</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Accordingly, an optimized synthesis of (4-nitrophenyl)(piperidin-4-yl)methanone <b>110</b> was initially performed.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Because the free secondary amine may be problematic during the synthesis of <b>110</b>, ethyl isonipecotate <b>104</b> was protected as benzamide <b>105</b> before the ethyl ester was hydrolyzed in alkaline conditions to yield carboxylic acid <b>106</b>. The latter was then converted into an acyl chloride and directly engaged in a Friedel–Crafts reaction with bromobenzene to give intermediate <b>107</b>. A direct copper-catalyzed amination of aryl bromide <b>107</b> with aqueous ammoniac provided benzoylamine <b>108</b> in good yield. The latter was oxidized with <i>meta</i>-chloroperbenzoic acid (<i>m</i>-CPBA) and converted into nitro intermediate <b>109</b>, which was finally freed from its benzoyl protective group in acidic conditions to furnish (4-nitrophenyl) (piperidin-4-yl)methanone <b>110</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0017.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (4-Nitrophenyl)(piperidin-4-yl)methanone <b>110</b> from Ethyl Isonipecotate <b>104</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N (1.5 equiv), BzCl (1 equiv), DCM, rt, 20 h; (b) NaOH (2.5 equiv), aqueous EtOH (70%), rt, 18 h; (c) (COCl)<sub>2</sub> (1.1 equiv), DCM, rt, 15 h; (d) PhBr, AlCl<sub>3</sub> (1.5 equiv), 90 °C, 6.5 h; (e) CuI (10 mol %), K<sub>3</sub>PO<sub>4</sub> (2 equiv), NH<sub>4</sub>OH (28%), DMF, sealed tube, 90 °C, 27 h; (f) <i>m</i>-CPBA (4 equiv), CHCl<sub>3</sub>, reflux, 45 min; (g) EtOH 70%, 12 M HCl, reflux, 24 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><div class="NLM_p">4-Nitrobenzoylpiperidine <b>110</b> was then condensed with bromoalkylbenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones <b>11</b> and <b>13</b> using the same experimental conditions as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> and yielded precursors <b>111</b> and <b>112</b>, bearing an <i>n</i>-butyl- and <i>n</i>-hexyl spacer, respectively.</div><div class="NLM_p">Radiolabeling of both precursors with fluorine-18 was achieved using a commercial GE TRACERlab FXFN module by displacement of the nitro precursor with dry [<sup>18</sup>F]fluoride in DMSO with potassium carbonate and Kryptofix-222. The crude reaction material was purified with a semipreparative reversed phase HPLC (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). The fraction containing the radiolabeled product was isolated on a tC18 light Sep-Pak, eluted with ethanol, and formulated into normal saline containing ascorbic acid and polysorbate-80. <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> were obtained in overall decay corrected radiochemical yields of 25.4 ± 6.8% and 23.0 ± 5.1%, respectively, in a synthesis time of approximately 60 min (<i>n</i> = 3). Both preparations showed a radiochemical purity exceeding 99% and a specific activity above 3000 mCi/μmol (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Log <i>D</i> of both compounds was measured experimentally between <i>n</i>-octanol and phosphate buffer (pH = 7.4) and found to be 1.98 ± 0.06 (<b>[</b><sup><b>18</b></sup><b>F]79</b>, <i>n</i> = 3) and 1.92 ± 0.08 (<b>[</b><sup><b>18</b></sup><b>F]81</b>, <i>n</i> = 3) within the commonly accepted range for good brain penetration.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> It should be noted that the lower experimental values compared to the computational estimates is a well-described phenomenon, inherent to the underestimation of hydrogen bonding and ionization contributions of the fragment-based computational method.<a onclick="showRef(event, 'cit36b'); return false;" href="javascript:void(0);" class="ref cit36b">(36b)</a> Polar surface areas (PSA) were also calculated and found to be 58.85 Å<sup>2</sup> for both <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b>, a value below the critical 80 Å<sup>2</sup> needed for a proper brain entry.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0018.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Nitro Precursors <b>111</b> and <b>112</b> and Radiosynthesis of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> by Nucleophilic Aromatic Substitution</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Specifications of Radiotracers <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0025.gif" alt="" id="fx7" /></img><div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">In Vivo Assays: Pet Scan Imaging</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All experiments were conducted in accordance with institutional animal care protocols in compliance with Federal regulations. <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> were evaluated in three adult rhesus monkeys, one male and two females (Macaca mulatta; mean weight ± SD, 7.0 ± 2.6 kg). Brain PET imaging was used to quantify brain uptake, kinetics, and binding properties of the radiolabeled compounds. Both radiotracers were injected intravenously as a bolus and entered the primates’ brains rapidly. Average images acquired over 120 min for both radiotracers are presented in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a> (<b>[</b><sup><b>18</b></sup><b>F]79</b>) and <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> (<b>[</b><sup><b>18</b></sup><b>F]81</b>), respectively. Higher radiotracer uptakes were observed in the thalamus, hippocampus regions, and brain stem for <b>[</b><sup><b>18</b></sup><b>F]79</b> as well as in the anterior cingulate and frontal cortex for <b>[</b><sup><b>18</b></sup><b>F]81</b>.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Average image of <b>[</b><sup><b>18</b></sup><b>F]79</b> over 120 min. A = brain stem; B = thalamus; C = hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Average image of <b>[</b><sup><b>18</b></sup><b>F]81</b> over 120 min. A = anterior cingulate; B = thalamus; C = hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Time–activity curves (TACs) from several brain regions are given in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>. <b>[</b><sup><b>18</b></sup><b>F]79</b> overall uptake in the brain was moderate (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), with a maximum standard uptake value (SUV) of approximately 0.4 and up to 0.6 in the thalamus, followed by a moderate washout over 240 min which reduced the radiotracer’s concentration by half after 240 min. The cerebellum had the lowest uptake, in agreement with the lowest density of 5-HT<sub>2a</sub>R and 5-HT<sub>7</sub>R in that region.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> For <b>[</b><sup><b>18</b></sup><b>F]81</b>, overall uptake was higher with a maximum SUV around 0.8–1.0 (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), with the cerebellum exhibiting again the lowest uptake. The washout out phase was slower compared to <b>[</b><sup><b>18</b></sup><b>F]79</b>, with a peak uptake happening late into the imaging, around 90–120 min.</div><figure id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0009.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Time–activity curves over 240 min in a Rhesus macaque post intravenous administration of <b>[</b><sup><b>18</b></sup><b>F]79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0010.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Time–activity curves over 240 min at baseline condition in a Rhesus macaque post intravenous administration of <b>[</b><sup><b>18</b></sup><b>F]81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the parent profile in plasma of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> was determined in vivo. Both radioligands showed moderate metabolism, with about 20% and 40% intact parent remaining at 120 min post administration for <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b>, respectively (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). For both radiolabeled products, the detected metabolites were much more polar than the parent compound and deemed unlikely to cross the blood–brain barrier. The free fraction in plasma (not protein bound) was measured by ultrafiltration and found to be low for <b>[</b><sup><b>18</b></sup><b>F]79</b>, around 4% but much higher <b>[</b><sup><b>18</b></sup><b>F]81</b>, around 24%. These results indicate that both radiotracers were more stable in vivo than the previously described radiolabeled [<sup>11</sup>C] long-chain arylpiperazines,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> which were rapidly metabolized and eliminated from the bloodstream by P-glycoproteins, a brain efflux transporter which is highly present at the BBB and able to metabolize radiotracers.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The full validation of these new radioligands in nonhuman primate (signal specificity, selectivity and individual 5-HT<sub>2A</sub>/5-HT<sub>7</sub> contribution) is currently under investigation and will be reported in due time.</div><figure id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0011.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Parent fraction profile in plasma of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> post administration in Rhesus macaques.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">To conclude, we carried out the synthesis of 46 piperidine or piperazine-derived compounds as potential ligands of 5-HT<sub>7</sub>R and 5-HT<sub>2A</sub>R, two neuronal receptors known for their important implications in brain-related, psychiatric, and neurodevelopmental diseases. Various synthetic strategies were implemented to study the structure–activity relationship of these compounds. In vitro evaluation of all potential pharmacophores led to the discovery of seven new products (<b>I</b>, <b>60</b>–<b>63</b>, <b>79</b>, and <b>81</b>) identified as new lead compounds with affinity in the nanomolar range for 5-HT<sub>2A</sub>R and/or 5-HT<sub>7</sub>R. Functional assays on the most active compounds helped to determine the effect of ligands on the brain receptors. Ligands <b>I</b> and <b>62</b> are antagonists of 5-HT<sub>7</sub>R, and <b>62</b>, <b>79</b>, and <b>81</b> are dual antagonists of 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R. Compounds <b>79</b> and <b>81</b> were also identified as potential radiolabeled molecules to evaluate the passage of the blood–brain barrier and locate the accumulation of both radioactive ligands in primates’ brains by PET imaging. Radiolabeled compounds <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> were isolated after nucleophilic aromatic substitution of the corresponding nitrated aromatic precursors and injected intravenously in nonhuman primates. PET imaging demonstrated a moderate uptake of both radiotracers with an important accumulation in specific brain regions, the brain stem, the thalamus, the hippocampus, and the anterior cingulate, indicating an important presence of 5-HT<sub>7</sub>R and/or 5-HT<sub>2A</sub>R in those brain tissues. Analysis of the parent fractions of both radiolabeled molecules in plasma indicated that both ligands present a good metabolic stability. Further in vivo investigations are currently underway to identify the potential therapeutic solutions compounds <b>I</b>, <b>60</b>–<b>63</b>, <b>79</b>, and <b>81</b> may bring to patients suffering from brain-related diseases.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Synthetic Methods</h3><div class="NLM_p last">All reactions were carried out under inert atmosphere of argon or nitrogen and monitored by thin-layer chromatography with silica gel 60 F<sub>254</sub> precoated aluminum plates (0.25 mm). Glassware was oven-dried or flame-dried prior to use. Visualization was performed with a UV light at 254 and 365 nm. All reagents were purchased from commercial suppliers and were used without further purification. Solvents were dried and distilled according to known procedures.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Purifications were performed on AIT France prepacked flash chromatography cartridges (simply, irregular silica, 4–96 g, 20–40 μm or 40–60 μm) equipped with a Büchi pump module C-601. Melting points of solid products were measured in capillary tubes with an Electrothermal Thermo Scientific IA9200 apparatus and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with a Bruker DXP250 spectrometer at 250 and 62 MHz, respectively, or with a Bruker Advance II spectrometer at 400 and 101 MHz, respectively. <sup>19</sup>F NMR spectra were recorded with a Bruker DXP250 spectrometer at 235 MHz. Samples were solubilized in the appropriate deuterated solvent, and 5 μL of α,α,α-trifluorotoluene (TFT) were added and used as an internal standard (δ = −63.72 ppm) to assign the fluorine atom chemical shift. Abbreviations used for peak multiplicities are as follows: s, singlet; bs, broad singlet; d, doublet; t, triplet; q, quartet; p, pentuplet; m, multiplet. Coupling constants (<i>J</i>) are given in hertz (Hz), chemical shifts are given in parts per million (ppm), and calibrated with DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> residual peak. Microwave experiments were conducted in a RotosynthTM (Milestone Srl Italy) with a power delivery system ranging from 0 to 1200 W. Reactions were carried out in round-bottom flasks equipped with a reflux condenser. Temperature was monitored by a contactless IR pyrometer (IRT) and a fiber-optic contact thermometer (FO). Temperature and power profiles were controlled and monitored through the EASY-control software provided with the microwave. High-resolution mass spectra (HRMS) were performed on a Bruker maXis mass spectrometer. Chromatographic purities of the final compounds were determined using a Shimadzu HPLC system equipped with a C18 column (Agilent ZORBAX Eclipse Plus, 5 μm, 2.1 mm × 150 mm) operating at 30 °C. Elution was carried out with acetonitrile containing 0.1% formic acid as mobile phase A and water containing 0.1% formic acid as mobile phase B. Elution and gradient conditions: from <i>t</i> = 0 min, 10% phase A + 90% phase B to <i>t</i> = 15 min, 100% phase A. The flow rate of the mobile phase was 0.25 mL/min, and the injection volume of the sample was 2 μL. Purities of all final products were found to be superior to 95% and determined by integration of the chromatogram after subtraction of the background using Labsolutions LCMS software at wavelengths (typically two wavelengths) giving the maximum absorbance (the highest of the two purities was always discarded).</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General in Vitro Evaluation Methods</h3><div id="sec7_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> In Vitro Pharmacology on 5-HT<sub>7</sub>R, 5-HT<sub>2A</sub>R, 5-HT<sub>1A</sub>R, and 5-HT<sub>6</sub>R</h4><div id="sec7_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Cell Culture and Preparation of Cell Membranes</h5><div class="NLM_p last">HEK 293 cells with stable expression of human serotonin 5-HT<sub>7b</sub>R, 5-HT<sub>1A</sub>R, or 5-HT<sub>6</sub>R and CHO cells with 5-HT<sub>2A</sub>R (prepared with the use of Lipofectamine 2000) were maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub> and were grown in Dulbecco’s Modified Eagle Medium containing 10% dialyzed fetal bovine serum and 500 μg/mL G418 sulfate. For membrane preparations, cells were subcultured in 10 cm diameter dishes, grown to 90% confluence, washed twice with phosphate buffered saline (PBS), prewarmed to 37 °C, and pelleted by centrifugation (200<i>g</i>) in PBS containing 0.1 mM EDTA and 1 mM dithiothreitol. Prior to membrane preparations, the pellets were stored at −80 °C.</div></div><div id="sec7_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Radioligand Binding Assays</h5><div class="NLM_p last">Cell pellets were thawed and homogenized in 20 volumes of assay buffer using an Ultra Turrax tissue homogenizer and centrifuged twice at 35000<i>g</i> for 20 min at 4 °C, with incubation for 15 min at 37 °C in between rounds of centrifugation. The composition of the assay buffers was as follows: for 5-HT<sub>7b</sub>R, 50 mM Tris–HCl, 4 mM MgCl<sub>2</sub>, 10 μM pargyline, and 0.1% ascorbate; for 5-HT<sub>2A</sub>R, 50 mM Tris–HCl, 0.1 mM EDTA, 4 mM MgCl<sub>2</sub>, and 0.1% ascorbate; for 5-HT<sub>1A</sub>R, 50 mM Tris–HCl, 0.1 mM EDTA, 4 mM MgCl<sub>2</sub>, 10 μM pargyline, and 0.1% ascorbate; for 5-HT<sub>6</sub>R, 50 mM Tris–HCl, 0.5 mM EDTA, and 4 mM MgCl<sub>2</sub>. All assays were incubated in a total volume of 200 μL in 96-well microtiter plates for 1 h at 37 °C, except for 5-HT<sub>1A</sub>R and 5-HT<sub>2A</sub>R, which were incubated at room temperature for 1 and 1.5 h, respectively. The process of equilibration was terminated by rapid filtration through Unifilter plates with a 96-well cell harvester (PerkinElmer), and the radioactivity retained on the filters was quantified on a Microbeta plate reader (PerkinElmer). For displacement studies, the assay samples contained the following as radioligands: 0.6 nM [<sup>3</sup>H]-5-CT (39.2 Ci/mmol) for 5-HT<sub>7b</sub>R, [<sup>3</sup>H]-Ketanserin (53.4 Ci/mmol) for 5-HT<sub>2A</sub>R, 1.5 nM [<sup>3</sup>H]-8-OH-DPAT (187 Ci/mmol) for 5-HT<sub>1A</sub>R, or 2 nM [<sup>3</sup>H]-LSD (85.2 Ci/mmol) for 5-HT<sub>6</sub>R. Nonspecific binding was defined with 10 μM of 5-HT in 5-HT<sub>7b</sub>R and 5-HT<sub>1A</sub>R binding experiments, whereas 10 μM of chlorpromazine or 10 μM of methiothepine were used in the 5-HT<sub>2A</sub>R and 5-HT<sub>6</sub>R assays, respectively. Each compound was tested in triplicate at 7–8 different concentrations (10<sup>–11</sup>–10<sup>–4</sup> M). The inhibition constants (<i>K</i><sub>i</sub>) were calculated from the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The results are expressed as the means of at least two separate experiments.</div></div><div id="sec7_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> cAMP Accumulation and Functional Assays</h5><div class="NLM_p last">cAMP accumulation was measured with a LANCE cAMP detection kit (PerkinElmer). Twelve hours before experiment, cells were starved. Then, cells were harvested in Hank’s Balanced Salt Solution (HBSS) containing HEPES pH 7.4, 1 mM isobutylmethylxanthine (IBMX), 1 mg/mL BSA. After centrifugation (1000<i>g</i>, 5 min), cells were resuspended in the same buffer (2 × 10<sup>6</sup> per mL). The ALEXA fluor 647 anti-cAMP antibody solution (1 μL) was added to the cell suspension (100 μL), and 5 μL aliquots of the mixture were dispensed in white 384-well microtiter plates (Optiplate, PerkinElmer). The cells were then stimulated with 5 μL aliquots of 5-CT or 5-CT (10 nM) with different drugs (SB-269970, compounds <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b>). After 1 h incubation at room temperature in the dark, lysis buffer (0.35% Triton X-100, 10 mM CaCl<sub>2</sub>, 50 mM HEPES) containing LANCE EU-W8044 labeled streptavidin and biotinylated-cAMP was added to the cells (10 μL per well). After 2 h incubation at room temperature in the dark, the plates were read on an EnVision microplate reader (PerkinElmer). Concentration/response curves were analyzed using Prism 4 software. The <i>K</i><sub>b</sub> value of the different drugs as antagonist was calculated according to the equation <i>K</i><sub>b</sub> = IC<sub>50</sub>/(1 + (S/EC<sub>50</sub>) where IC<sub>50</sub> is the inhibitory concentration<sub>50</sub> of antagonist, S is the concentration of 5-CT (10 nM), and EC<sub>50</sub> is the effective concentration<sub>50</sub> of 5-CT.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Radiosynthesis, in Vivo Evaluation, PET Scan Imaging, Measurement of Log <i>D</i></h3><div id="sec7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Radiosynthesis and Purification</h4><div class="NLM_p">Radiochemical labeling was performed using a GE TRACERlab FX<sub>FN</sub> module using helium pressure or vacuum for fluid transfers. [<sup>18</sup>F]Fluoride was purchased from Cardinal Health (Hartford, CT) or PETNet (Hackensack, NJ). Analytical HPLC testing of radiotracers <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> was performed with a Waters HPLC system (1525 or e2695), using a water XBridge C18 column (5 μm, 4.6 mm × 250 mm) eluted with a 40/60 and 45/55 v/v mixture of methanol/water containing 0.1% phosphoric acid at a flow rate of 1 mL/min, respectively. Monitoring of the column effluent was achieved with ultraviolet (Waters 2489, λ = 254 nM) and radioactivity detectors (Bioscan FC-200). The data were analyzed with Waters Empower software. Radioactivity was measured with a Capintec CRC-25 dose calibrator.</div><div id="sec7_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Radiolabeling</h5><div class="NLM_p last">A GE TRACERlab FX<sub>FN</sub> synthesis module was operated in the following sequence: The [<sup>18</sup>F]fluoride in target water (0.5–3 mL) was transferred from the shipping vial and trapped on a short ion-exchange solid phase extraction (SPE) cartridge (ORTG, TN). The cartridge was eluted into the preheated (60 °C) reactor vial with a solution of cryptand-222 (7.1 mg, 19 μmol) and potassium carbonate (0.75 mg, 5.4 μmol) dissolved in a mixture of acetonitrile (0.7 mL) and water (0.3 mL). The reactor was heated to 95 °C under vacuum with a stream of helium for 4 min before addition of acetonitrile (1 mL), and evaporation continued for 2 min. A second portion of acetonitrile (1 mL) was added, and drying was continued for a further 2 min before the reactor was cooled to 60 °C. A solution of nitro precursor <b>111</b> or <b>112</b> (1 mg) in anhydrous DMSO (1.0 mL) was added to the reactor vial, which was then sealed and heated to 160 °C for 10 min. The reactor vial was cooled to 40 °C, and its contents were transferred to the HPLC loop-loading vial. The reactor vial was rinsed with 1.5 mL of HPLC mobile phase, and the rinse was also transferred to the HPLC loop-loading vial. The contents of the loop-loading vial was transferred to the HPLC loop, via a fluid detector, injected onto the prep-HPLC column (Waters XBridge C18, 5 μm, 9.4 mm × 250 mm), and eluted with a 65/35/0.1 v/v/v mixture of methanol/water/triethylamine at a flow rate of 5 mL/min. The eluent was monitored by ultraviolet (λ = 254 nm) and radioactive detectors connected in series. The product-containing fraction was collected in a flask containing water with ascorbic acid (15 mL), and the diluted product fraction was transferred onto a preconditioned solid-phase extraction cartridge (Waters Sep-Pak tC18 light, prerinsed with 6 mL of ethanol and 6 mL of water). The cartridge was washed with water with ascorbic acid (10 mL), and the product was eluted from the cartridge with ethanol (1 mL) into a second flask containing the drug product matrix (10 mL). The cartridge was rinsed with a further portion of the formulation matrix (4 mL), and the rinse was added to the second flask. The contents of the second flask were pushed through a sterilizing filter (Millex LG 0.22 μm, Millipore) into a vented final product vial, which had been assembled under aseptic conditions. The final drug product formulation had the following composition: 29 mL of normal saline, 1 mL of ethanol, 2.0 mg/mL of ascorbic acid, and 0.004 mL/mL of polysorbate-80.</div></div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Animal Preparation and in Vivo Evaluation</h4><div class="NLM_p last">Animals were fasted for up to 12 h prior to imaging. On the imaging day, the animal was anesthetized with intramuscular ketamine (10 mg/kg) and glycopyrrolate (0.1–0.2 mg/kg) at ∼2 h prior to radiotracer injection, transferred to the positron emission tomography (PET) camera, and immediately intubated with an endotracheal tube for continued anesthesia with 1.5–2.5% isoflurane administered through an air-breathing circuit. An intravenous (iv) line was established in a cephalic and/or saphenous vein for injection of fluids for hydration and radiotracer injection. Body temperature was maintained by heated water blanket and monitored by rectal thermometer. Vital signs, including end tidal CO2, SpO<sub>2</sub>, heart rate, respiration rate, and blood pressure, were monitored continuously and recorded at least every 15 min during the study.</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Image Acquisition and Reconstruction</h4><div class="NLM_p">Image acquisition and reconstruction: All PET data were acquired using a microPET Focus220 scanner (Siemens). A transmission scan was acquired, and then, immediately after radiotracer administration, a 180 min emission scan was obtained using three-dimensional mode. The dynamic PET sinograms were corrected for randoms, dead time, scatter, and attenuation. Subsequently, acquired frames were reconstructed using filtered backprojection with a Shepp–Logan filter and image size of 256 × 256.</div><div class="NLM_p">Reconstructed scans were imported into PMOD 3.308 software (PMOD Technologies, Zurich, Switzerland) and motion correction was performed by creating an average image of consecutive scans with absence of motion, which was then used as a reference for rigid matching of all scans in the study. An in-house developed baboon brain magnetic resonance imaging (MRI) template was used for image coregistration and placement of volumes of interest (VOIs) for quantification of radiotracer uptake. The T1-weighted MR images were acquired with a GE Signa unit (General Electric, Milwaukee, WI, USA) at 1.5 T with a spoiled gradient recall sequence with the following settings: TR = 25 ms, TE = 5 ms, NEX = 2, matrix = 256 × 256, field of view = 16 cm. The MR images were reduced from an initial matrix of 256 × 256 with 240 axial slices (axial slice thickness = 0.7 mm) to a 128 × 128 matrix with 120 axial slices (axial slice thickness = 1.4 mm). The following brain regions were manually drawn on the MRI: striatum, caudate, putamen, frontal cortex, temporal cortex, parietal cortex, occipital cortex, cerebellum, and whole brain. Average images were generated by averaging the scans presenting the highest uptake. Then, the generated average image was coregistered to the MRI template using an automatic rigid matching tool. The transformation matrix was saved and subsequently applied to the dynamic PET series. Finally, MRI derived VOIs were applied to the coregistered PET images for image quantification.</div><div class="NLM_p last">Standardized uptake values (SUV) were calculated as concentration in the VOI divided by the injected dose divided by the animal weight. In addition, the SUV values obtained for each brain region were divided by the SUV values determined in the cerebellum, the selected reference region, to generate SUV ratios (SUVr). Both SUV and SUVr values were then plotted against time.</div></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Measurement of Log <i>D</i></h4><div class="NLM_p last">The value for the partition coefficient of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> between <i>n</i>-octanol and sodium phosphate buffer (0.15 M, pH 7.4) was determined according to the general method of Ding et al.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> An aliquot of radiotracer (5–10 μCi) was added to a vial containing 2.5 mL of <i>n</i>-octanol and 2.5 mL of 0.1 M phosphate buffer, pH = 7.4. The mixture was vortexed for 2 min and centrifuged at 5000 rpm for 2 min. A sample of the <i>n</i>-octanol (0.1 mL) and buffer (1 mL) layers was counted in a c counter. The radioactivity counts were corrected for decay, and the partition coefficient (P) was calculated as counts in <i>n</i>-octanol/counts in buffer. The major portion of the <i>n</i>-octanol layer (2.0 mL) was diluted with 0.5 mL of <i>n</i>-octanol and mixed with a fresh portion of 2.5 mL phosphate buffer. The equilibration procedure described above was repeated until a constant value of Log <i>P</i> was obtained.</div></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Experimental Procedures and Characterization Data</h3><div id="sec7_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 2-Oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>2</b>)</h4><div class="NLM_p last">Sodium hydride (60% w/w, 3.280 g, 82.01 mmol, 1.1 equiv) was added portionwise to a stirred solution of 1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> (10 g, 74.55 mmol, 1 equiv) in dry DMF (180 mL) at room temperature. The solution was vigorously stirred for 1 h, and a solution of Boc<sub>2</sub>O (16.270 g, 74.55 mmol, 1 equiv) in dry DMF (37 mL) was added dropwise. The resulting mixture was stirred for 24 h and concentrated in vacuo. The crude mixture was partitioned between AcOEt and water. The aqueous layer was extracted three times with AcOEt. The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The oily residue was purified by chromatography on silica gel using PE/AcOEt (1:0 to 0:1) to afford monoprotected benzimidazolone <b>2</b>. Yield 89% (15.542 g), colorless solid, mp = 324–326 °C (lit. 313–315 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.20 (bs, 1H), 7.67–7.60 (m, 1H), 7.18–6.96 (m, 3H), 1.58 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.7, 148.4, 128.5, 126.7, 123.7, 121.2, 113.7, 109.0, 83.6, 27.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3272, 2979, 1769, 1479, 1341, 1299, 1149, 1116, 838, 754. HRMS calcd for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 235.1077, found 235.1079.</div></div><div id="sec7_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl 2-Oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>19</b>)</h4><div class="NLM_p last">A stirred suspension of 1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> (10.941 g, 81.57 mmol, 1 equiv), potassium carbonate (12.402 g, 89.73 mmol, 1.1 equiv), and ethylpyridin-2-yl carbonate <b>20</b> (15 g, 89.73 mmol, 1.1 equiv) in dry acetonitrile (330 mL) was refluxed for 2 h. A white precipitate rapidly evolved, and the heterogeneous mixture was concentrated in vacuo. The solid residue was solubilized in a minimum amount of water. The solution was slowly acidified by addition of aqueous 1 M HCl to pH 6 until a white precipitate appeared. The solid was filtered off on a Büchner funnel to yield the monoprotected benzimidazolone in analytically pure form. In case trace amounts of aromatic impurities remained, the solid was recrystallized from an AcOEt/MeOH (95:5) mixture. Yield 87% (14.633 g), off-white solid, mp = 149–151 °C (lit. 149–151 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.26 (bs, 1H), 7.73–7.67 (m, 1H), 7.19–6.96 (m, 3H), 4.39 (q, <i>J</i> = 7.1 Hz, 2H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.5, 150.1, 128.6, 126.6, 124.0, 121.4, 113.9, 109.1, 62.9, 14.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3262, 2981, 2915, 1774, 1482, 1446, 1374, 1341, 1285, 1242, 1127, 1114, 1017, 739. HRMS calcd for C<sub>10</sub>H<sub>11</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 207.0764, found 207.0766.</div></div><div id="sec7_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethylpyridin-2-yl Carbonate (<b>20</b>)</h4><div class="NLM_p last">Sodium hydride (60% w/w, 9.239 g, 0.231 mol, 1.1 equiv) was added portionwise to a stirred solution of 2-hydroxypyridine (20 g, 0.210 mol, 1 equiv) in THF (700 mL) at room temperature. The mixture was vigorously stirred for 90 min, then ethyl chloroformate (24.1 mL, 0.231 mol, 1.1 equiv) was slowly added dropwise over a period of 30 min. The resulting mixture was stirred for 12 h and filtered off onto a diatomaceous silica pad. The filtrate was concentrated in vacuo. The oily crude was dissolved in AcOEt, washed three times with water, and dried over MgSO<sub>4</sub>. The oily residue was purified by chromatography on silica gel using PE/AcOEt (1:0 to 1:1) to afford carbonate <b>20</b>. Yield 46% (16.304 g), colorless oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.39 (ddd, <i>J</i> = 4.9, 2.0, 0.8 Hz, 1H), 7.79 (ddd, <i>J</i> = 8.1, 7.4, 2.0 Hz, 1H), 7.27–7.20 (m, 1H), 7.11 (dt, <i>J</i> = 8.1, 0.8 Hz, 1H), 4.33 (q, <i>J</i> = 7.1 Hz, 1H), 1.38 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 157.9, 152.9, 148.5, 139.9, 122.3, 115.6, 65.1, 14.2. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2985, 1758, 1591, 1469; 1434, 1196; 992, 775. HRMS calcd for C<sub>8</sub>H<sub>10</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 168.0655, found 168.0658.</div></div><div id="sec7_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5,6-Dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last">At room temperature, a solution of <i>N</i>-chlorosuccinimide (12.543 g, 93.93 mmol, 2.1 equiv) in DMF (44 mL) was slowly added dropwise to a stirred solution of 1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>1</b> (6 g, 44.73 mmol, 1 equiv) in DMF (44 mL). The resulting solution was stirred for 6 h. Addition of water led to the precipitation of the product, which was isolated by filtration on a Büchner funnel. The off-white cake was further washed with water and diethyl ether and dried in vacuo to yield the desired product in analytically pure form. Yield 97% (8.819 g), off-white solid, mp >360 °C (lit. > 360 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.91 (bs, 2H), 7.10 (s, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.3, 129.9, 122.5, 109.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3155, 3063, 2846, 2746, 2742, 1689, 1486, 1457, 1362, 1362, 1022, 967, 727. HRMS calcd for C<sub>7</sub>H<sub>5</sub>Cl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 202.9773, found 202.9774.</div></div><div id="sec7_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>tert</i>-Butyl 5,6-Dichloro-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>28</b>)</h4><div class="NLM_p last">Sodium hydride (60% w/w, 650 mg, 16.25 mmol, 1.1 equiv) was added portionwise to a stirred solution of 5,6-dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one <b>27</b> (3 g, 14.77 mmol, 1 equiv) in dry DMF (49 mL) at room temperature. The solution was vigorously stirred for 1 h, and a solution of Boc<sub>2</sub>O (3.224 g, 14.77 mmol, 1 equiv) in dry DMF (7 mL) was added dropwise. The resulting mixture was stirred for 24 h and concentrated in vacuo. The crude mixture was partitioned between AcOEt and water. The aqueous layer was extracted three times with AcOEt. The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The solid residue was purified by chromatography on silica gel using PE/AcOEt (1:0 to 0:1) to afford monoprotected benzimidazolone <b>28</b>. Yield 91% (4.074 g), colorless solid, mp ≥ 360 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.53 (bs, 1H), 7.76 (s, 1H), 7.18 (s, 1H), 1.58 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.3, 147.9, 128.7, 126.7, 125.8, 123.0, 115.1, 110.3, 84.5, 27.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3178, 3130, 2986, 2972, 2928, 1742, 1732, 1487, 1336, 1293, 1124, 1017, 846, 768. HRMS calcd for C<sub>12</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 303.0298, found 303.0298.</div></div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Protocol for the DPPA-Mediated Curtius Rearrangement of Aminobenzoic Acids and 2-Aminonicotinic Acid (Products <b>35</b> and <b>41</b>)</h3><div class="NLM_p">At room temperature, DPPA (4.74 mL, 22 mmol, 1.1 equiv) was added dropwise to a stirred solution of the appropriate amino acid (20 mmol, 1 equiv) in dioxane (100 mL) and triethylamine (2.78 mL, 20 mmol, 1 equiv). The mixture was slowly brought to reflux, and N<sub>2</sub> gas started to evolve. Reflux was maintained for 12 h. The cooled solution was concentrated in vacuo. The residual oily solid was agitated in a minimum amount of methanol. Filtration of the solid followed by washing with a minimum amount of methanol and diethyl ether yielded the title compound in analytically pure form.</div><div id="sec7_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4,6-Dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>35</b>)</h4><div class="NLM_p last">Yield 93% (3.776 g), beige solid, mp >360 °C (lit. 360–361 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.33 (bs, 1H, NH), 11.06 (bs, 1H, NH), 7.08 (d, <i>J</i> = 1.7 Hz, 1H), 6.92 (d, <i>J</i> = 1.7 Hz, 1H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.9, 131.6, 126.6, 125.0, 119.6, 113.1, 107.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3099, 3009, 2809, 1732, 1708, 1662, 1640, 1483, 1362, 1307, 1179, 1006, 895, 710. HRMS calcd for C<sub>7</sub>H<sub>5</sub>Cl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 202.9773, found 202.9774.</div></div><div id="sec7_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1<i>H</i>-Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>41</b>)</h4><div class="NLM_p last">Yield 77% (2.081 g), off-white solid, mp =274–276 °C (lit. 275–276 °C<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.27 (bs, 1H), 10.79 (bs, 1H), 7.85 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H), 7.21 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 6.93 (dd, <i>J</i> = 7.7, 5.2 Hz, 1H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.9, 145.3, 140.0, 124.1, 117.1, 114.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3072, 2977, 2902, 2790, 2691, 1678, 1443, 1430, 1386, 1230, 1186, 996, 959, 863, 802. HRMS calcd for C<sub>6</sub>H<sub>6</sub>N<sub>3</sub>O [M + H]<sup>+</sup> 136.0505, found 136.0506. (For protocol using CDI, please see ref <a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">49</a>).</div></div><div id="sec7_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl 4,6-Dichloro-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>36</b>)</h4><div class="NLM_p last">Boc<sub>2</sub>O (3.306 g, 15.15 mmol, 1.025 equiv) was added portionwise to a stirred solution of <b>35</b> (3 g, 14.78 mmol, 1 equiv) and DMAP (181 mg, 1.48 mmol, 0.1 equiv) in dry THF (50 mL). The solution was refluxed for 2 h. The cooled mixture was concentrated in vacuo. The solid residue was solubilized in AcOEt. The organic layer was washed with aqueous 0.5 M HCl, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield the desired product in analytically pure form. Yield 97% (4.346 g), beige solid, mp ≥ 360 °C (lit. > 360 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.92 (bs, 1H), 7.60 (d, <i>J</i> = 1.9 Hz, 1H), 7.37 (d, <i>J</i> = 1.9 Hz, 1H), 1.58 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.3, 147.8, 128.4, 125.8, 125.5, 122.8, 113.7, 112.6, 84.6, 27.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3160, 3077, 2989, 1739, 1476, 1341, 1296, 1136, 744, 686. HRMS calcd for C<sub>12</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 303.0298, found 303.0298.</div></div><div id="sec7_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-1-carboxylate (<b>42</b>)</h4><div class="NLM_p last">At room temperature, sodium hydride (60% w/w, 651 mg, 16.28 mmol, 1.1 equiv) was added portionwise to a stirred solution of <b>41</b> (2g, 14.8 mmol, 1 equiv) in dry DMF (37 mL). The mixture was vigorously stirred for 1 h, and a solution of Boc<sub>2</sub>O (3.280 g, 14.80 mmol, 1 equiv) in DMF (15 mL) was added dropwise. The solution was stirred for 24 h. The reaction mixture was concentrated in vacuo, and traces of DMF were removed by coevaporation with heptane. The solid residue was dissolved in AcOEt, and the organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, filtered off, and concentrated in vacuo. The colorless solid was stirred in diethyl ether and filtered off on a Büchner funnel to yield monocarbamate <b>42</b> in analytically pure form. Yield 80% (2.756 g), colorless solid, mp = 138–140 °C (lit. 156–157 °C<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (bs, 1H), 8.02 (dd, <i>J</i> = 5.2, 1.5 Hz, 1H), 7.82 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.07 (dd, <i>J</i> = 7.9, 5.2 Hz, 1H), 1.58 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.2, 148.0, 143.7, 142.7, 121.1, 120.1, 117.2, 84.1, 27.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3003, 2895, 2755, 1785, 1720, 1618, 1299, 1127, 993, 803, 765. HRMS calcd for C<sub>11</sub>H<sub>14</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 236.1030, found 236.1029.</div></div><div id="sec7_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Ethyl 2-Oxo-2,3-dihydro-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-1-carboxylate (<b>44</b>)</h4><div class="NLM_p last">A stirred suspension of <b>41</b> (1.780 g, 13.17 mmol, 1 equiv), potassium carbonate (2.002 g, 14.49 mmol, 1.1 equiv), and ethylpyridin-2-yl carbonate (2.422 g, 14.49 mmol, 1.1 equiv) in dry acetonitrile (52 mL) was refluxed for 2 h. The reaction mixture was concentrated in vacuo. The solid residue was dissolved in a minimum amount of water, and the resulting homogeneous solution was acidified to pH 3 with an aqueous solution of 1 M HCl. The precipitated solid was filtered off to yield monoprotected imidazopyridin-2-one <b>44</b> in analytically pure form. Yield 91% (2.486 g), colorless solid, mp = 203–205 °C (lit. 204–206 °C<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>). <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.94 (bs, 1H), 8.05 (dd, <i>J</i> = 5.2, 1.0 Hz, 1H), 7.89 (dd, <i>J</i> = 7.9, 1.0 Hz, 1H), 7.09 (dd, <i>J</i> = 7.9, 5.2 Hz, 1H), 4.40 (q, <i>J</i> = 7.1 Hz, 2H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.8, 149.7, 143.6, 142.9, 121.1, 120.4, 117.4, 63.2, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2985, 2894, 2816, 2748, 2684, 1770, 1720, 1614, 1424, 1263, 798, 743. HRMS calcd for C<sub>9</sub>H<sub>10</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 208.0717, found 208.0719.</div></div><div id="sec7_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 2-Oxo-1,2-dihydro-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-3-carboxylate (<b>45</b>)</h4><div class="NLM_p last">DMAP (59 mg, 483 μmol, 0.1 equiv) and Boc<sub>2</sub>O (1.263 g, 5.79 mmol, 1.2 equiv) were successively added to a stirred solution of <b>44</b> (1 g, 4.83 mmol, 1 equiv) in dry THF (16 mL) at room temperature. The mixture was stirred for 2 h, and isopropylamine (470 μL, 5.79 mmol, 1.2 equiv) was added dropwise. The solution was stirred another 45 min, and a white precipitate evolved. The solution was concentrated in vacuo. The solid residue was stirred in a minimum amount of Et<sub>2</sub>O and filtered off on a Büchner funnel to yield <i>tert</i>-butylcarbamate <b>45</b> in analytically pure form. Yield 76% (863 mg), colorless solid, mp = 259–261 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.39 (bs, 1H), 8.02 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.34 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.13 (dd, <i>J</i> = 7.8, 5.1 Hz, 1H), 1.56 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.0, 146.8, 141.5, 140.3, 122.9, 119.5, 115.8, 83.7, 27.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3071, 3001, 2981, 2894, 1782, 1732, 1442, 1337, 1256, 1149, 1133, 787. HRMS calcd for C<sub>11</sub>H<sub>14</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 236.1030, found 236.1030.</div></div><div id="sec7_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one (<b>48</b>)</h4><div class="NLM_p last">Protocol, results, and analytical data identical to ref <a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">49</a>.</div></div><div id="sec7_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 2-Oxo-1,2-dihydro-3<i>H</i>-imidazo[4,5-<i>c</i>]pyridine-3-carboxylate (<b>49</b>)</h4><div class="NLM_p last">Protocol, results, and analytical data identical to ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</div></div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Protocol for the Halogenation of Monoprotected Benzimidazolones (Products <b>21</b>–<b>22</b>)</h3><div class="NLM_p">At room temperature, bromine (3.3 mL, 34.9 mmol, 1.2 equiv) or iodine chloride (9.449 g, 58.2 mmol, 2 equiv) were slowly added to a stirred solution of ethylcarbamate <b>19</b> (6 g, 29.1 mmol, 1 equiv) in acetic acid (97 mL). The resulting mixture was stirred at room temperature for 1 h, gradually brought to 65–70 °C, and stirred another 4 h. Upon completion followed by <sup>1</sup>H NMR of the crude, the cooled mixture was poured onto iced water. The precipitated product was filtered off onto a Büchner funnel and washed with diethyl ether. Trace amounts of starting material were removed by recrystallization (for compound <b>21</b> only) from an AcOEt/MeOH (95:5) mixture to yield the desired monohalogenated carbamate.</div><div id="sec7_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Ethyl 6-Bromo-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>21</b>)</h4><div class="NLM_p last">Yield 89% (7.384 g), off-white solid, mp = 214–216 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (bs, 1H), 7.78 (d, <i>J</i> = 2.0 Hz, 1H), 7.30 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 4.39 (q, <i>J</i> = 7.1 Hz, 2H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.1, 149.8, 128.0, 127.9, 126.5, 116.4, 112.8, 110.7, 63.2, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3235, 3011, 2987, 1777, 1477, 1396, 1285, 1234, 1180, 998. HRMS calcd for C<sub>10</sub>H<sub>10</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 284.9869, found 284.9870.</div></div><div id="sec7_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Ethyl 6-Iodo-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>22</b>)</h4><div class="NLM_p last">Yield 91% (8.794 g), light-yellow solid, mp = 183–185 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 7.94 (d, <i>J</i> = 1.7 Hz, 1H), 7.43 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 6.80 (d, <i>J</i> = 8.2 Hz, 1H), 4.35 (q, <i>J</i> = 7.1 Hz, 2H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 132.3, 128.4, 128.1, 121.8, 111.2, 83.8, 63.2, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3239, 2986, 1775, 1716, 1688, 1474, 1337, 1285, 1235, 1180, 1128, 997. HRMS calcd for C<sub>10</sub>H<sub>10</sub>IN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 332.9731, found 332.9728.</div></div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> General Protocol for the Phase Transfer-Catalyzed Alkylation of Monoprotected Benzimidazolones (<b>3</b>–<b>8</b>, <b>15</b>, <b>17</b>–<b>18</b>, <b>23</b>–<b>24</b>, <b>29</b>, <b>31</b>, <b>33</b>, <b>37</b>)</h3><div class="NLM_p">A stirred solution of the appropriate monoprotected benzimidazolone (10 mmol, 1 equiv), TBAB (161 mg, 0.5 mmol, 0.05 equiv), potassium carbonate (6.910 g, 50 mmol, 5 equiv), and the appropriate dibromoalkane or butyl bromide (50 mmol, 5 equiv) in water (50 mL) was heated under microwave irradiation (ramp = 2 min, <i>P</i><sub>max</sub> = 300 W) at 80 °C for 1 h (with Boc as protective group) or 60 °C for 1 h (with COOEt as protective group). The resulting biphasic mixture was partitioned between water and AcOEt. The aqueous layer was extracted three times with AcOEt, and the combined organic layers were dried over MgSO<sub>4</sub> and evaporated in vacuo. The oily residue was purified by chromatography on silica gel using PE/AcOEt (1:0 to 7:3) to afford the corresponding alkylated product.</div><div id="sec7_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>tert</i>-Butyl 3-(2-Bromoethyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>3</b>)</h4><div class="NLM_p last">Yield 84% (2.866 g), colorless oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.72 (ddd, <i>J</i> = 7.8, 1.4, 0.5 Hz, 1H), 7.34 (ddd, <i>J</i> = 7.8, 1.4, 0.5 Hz, 1H), 7.28–7.08 (m, 2H), 4.25 (t, <i>J</i> = 6.3 Hz, 2H), 3.79 (d, <i>J</i> = 6.3 Hz, 2H), 1.60 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.4, 148.6, 129.5, 125.9, 124.3, 122.4, 114.2, 109.1, 84.6, 42.5, 30.2, 28.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2979, 2933, 1782, 1487, 1367, 1319, 1140, 1098, 747. HRMS calcd for C<sub>14</sub>H<sub>18</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 341.0495, found 341.0499.</div></div><div id="sec7_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>tert</i>-Butyl 3-(3-Bromopropyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>4</b>)</h4><div class="NLM_p last">Yield 72% (2.557 g), colorless solid, mp = 71–73 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.70–7.64 (m, 1H), 7.26–6.99 (m, 3H), 3.88 (t, <i>J</i> = 6.9 Hz, 2H), 3.52 (t, <i>J</i> = 6.6 Hz, 2H), 2.14 (p, <i>J</i> = 6.7 Hz, 2H), 1.55 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 148.2, 129.3, 125.6, 123.8, 121.7, 113.8, 108.0, 83.9, 39.1, 31.6, 30.7, 27.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2980, 2935, 1775, 1737, 1694, 1489, 1364, 1319, 1141, 1101, 744. HRMS calcd for C<sub>15</sub>H<sub>20</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 355.0652, found 355.0652.</div></div><div id="sec7_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl 3-(4-Bromobutyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>5</b>)</h4><div class="NLM_p last">Yield 73% (2.696 g), colorless oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.71 (ddd, <i>J</i> = 7.9, 1.2, 0.6 Hz, 1H), 7.32–7.07 (m, 3H), 3.84 (t, <i>J</i> = 6.5 Hz, 2H), 3.56 (t, <i>J</i> = 6.3 Hz, 2H), 1.92–1.69 (m, 4H), 1.59 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 148.2, 129.2, 125.5, 123.9, 121.7, 113.7, 108.2, 84.0, 39.5, 34.5, 29.4, 27.6, 26.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2977, 2935, 1782, 1741, 1487, 1366, 1320, 1248, 1139, 1100, 748. HRMS calcd for C<sub>16</sub>H<sub>22</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 369.0808, found 369.0808.</div></div><div id="sec7_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>tert</i>-Butyl 3-(5-Bromopentyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>6</b>)</h4><div class="NLM_p last">Yield 69% (2.644 g), colorless oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.73–7.68 (m, 1H), 7.29–7.05 (m, 3H), 3.81 (t, <i>J</i> = 7.0 Hz, 2H), 3.51 (t, <i>J</i> = 6.7 Hz, 2H), 1.90–1.76 (m, 2H), 1.74–1.61 (m, 2H), 1.59 (s, 9H), 1.48–1.32 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 148.2, 129.2, 125.5, 123.8, 121.6, 113.7, 108.2, 83.9, 40.2, 34.8, 31.8, 27.6, 26.4, 24.7. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2978, 2934, 1784, 1742, 1488, 1365, 1320, 1139, 1099, 841, 739. HRMS calcd for C<sub>17</sub>H<sub>24</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 383.0965, found 383.0967.</div></div><div id="sec7_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl 3-(6-Bromohexyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>7</b>)</h4><div class="NLM_p last">Yield 65% (2.582 g), colorless oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.28–7.04 (m, 3H), 3.79 (t, <i>J</i> = 7.1 Hz, 2H), 3.49 (t, <i>J</i> = 6.7 Hz, 2H), 1.87–1.62 (m, 4H), 1.59 (s, 9H), 1.49–1.23 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 148.2, 129.3, 125.5, 123.8, 121.6, 113.7, 108.2, 83.9, 40.2, 35.0, 32.1, 27.6, 27.1, 27.0, 25.2. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2977, 2933, 2860, 1784, 1742, 1488, 1365, 1321, 1150, 1008, 748. HRMS calcd for C<sub>18</sub>H<sub>26</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 397.1121, found 397.1122.</div></div><div id="sec7_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl 3-(7-Bromoheptyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>8</b>)</h4><div class="NLM_p last">Yield 61% (2.509 g), colorless oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.75–7.66 (m, 1H), 7.27–7.06 (m, 3H), 3.79 (t, <i>J</i> = 7.1 Hz, 2H), 3.50 (t, <i>J</i> = 6.7 Hz, 2H), 1.87–1.70 (m, 2H), 1.71–1.61 (m, 2H), 1.59 (s, 9H), 1.43–1.22 (m, 6H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.8, 148.2, 129.2, 125.5, 123.8, 121.5, 113.6, 108.1, 83.8, 40.2, 34.9, 32.1, 27.7, 27.6, 27.3, 27.2, 25.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2978, 2931, 2856, 1785, 1742, 1488, 1365, 1321, 1140, 1094, 748. HRMS calcd for C<sub>19</sub>H<sub>28</sub><sup>79</sup>BrN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 411.1278, found 411.1273.</div></div><div id="sec7_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 3-Butyl-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>15</b>)</h4><div class="NLM_p last">Yield 67% (1.945 g), colorless oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.86–7.80 (m, 1H), 7.19 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.11 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 6.99–6.93 (m, 1H), 3.84 (t, <i>J</i> = 7.3 Hz, 2H), 1.80–1.69 (m, 2H), 1.67 (s, 9H), 1.49–1.32 (m, 2H), 0.95 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 151.1, 149.1, 129.7, 126.4, 123.9, 122.0, 114.6, 107.7, 84.7, 41.0, 30.1, 28.3, 20.3, 13.9.</div></div><div id="sec7_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(4-Bromobutyl)-3-butyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">Yield 90% (2.927 g), colorless oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.13–7.04 (m, 2H), 7.04–6.95 (m, 2H), 4.05–3.74 (m, 4H), 3.56–3.27 (m, 2H), 2.00–1.84 (m, 4H), 1.82–1.63 (m, 2H), 1.39 (m, 2H), 0.95 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz CDCl<sub>3</sub>) δ 154.3, 129.6, 129.3, 121.2, 121.1, 107.8, 107.6, 41.0, 40.1, 33.2, 30.6, 29.8, 27.0, 20.2, 13.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2957, 2930, 2871, 1695, 1493, 1404, 1365, 1190, 750. HRMS calcd for [M + H]<sup>+</sup> C<sub>15</sub>H<sub>22</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 325.0910, found 325.0908.</div></div><div id="sec7_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(5-Bromopentyl)-3-butyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">Yield 92% (3.121 g), colorless oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.11–7.04 (m, 2H), 7.04–6.94 (m, 2H), 3.88 (td, <i>J</i> = 7.2, 3.1 Hz, 4H), 3.38 (t, <i>J</i> = 6.7 Hz, 2H), 2.02–1.64 (m, 6H), 1.60–1.29 (m, 4H), 0.95 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 154.3, 129.6, 129.4, 121.1, 121.0, 107.8, 107.6, 41.0, 40.9, 33.5, 32.4, 30.6, 27.7, 25.5, 20.2, 13.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2931, 2863, 1689, 1494, 1404, 1367, 1190, 751. HRMS calcd for C<sub>16</sub>H<sub>24</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 339.1067, found 339.1068.</div></div><div id="sec7_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Ethyl 6-Bromo-3-(4-bromobutyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>23</b>)</h4><div class="NLM_p last">Yield 62% (2.605 g), colorless solid, mp = 95–97 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.08 (d, <i>J</i> = 1.8 Hz, 1H), 7.36 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.86 (d, <i>J</i> = 8.4 Hz, 1H), 4.53 (q, <i>J</i> = 7.1 Hz, 2H), 3.90−3.85 (m, 2H), 3.53–3.33 (m, 2H), 1.92 (p, <i>J</i> = 3.2 Hz, 4H), 1.48 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 150.5, 150.4, 128.6, 127.2, 127.1, 118.0, 115.2, 108.9, 64.2, 40.4, 32.9, 29.6, 26.4, 14.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3133, 3073, 2974, 2872, 1486, 1699, 1615, 1486, 1369, 1142, 814. HRMS calcd for C<sub>14</sub>H<sub>17</sub><sup>79</sup>Br<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 418.9600, found 418.9598.</div></div><div id="sec7_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Ethyl 6-Iodo-3-(4-bromobutyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>24</b>)</h4><div class="NLM_p last">Yield 54% (2.522 g), colorless solid, mp = 104–106 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05 (d, <i>J</i> = 1.7 Hz, 1H), 7.58 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.14 (d, <i>J</i> = 8.3 Hz, 1H), 4.41 (q, <i>J</i> = 7.1 Hz, 2H), 3.89–3.79 (m, 2H), 3.55 (t, <i>J</i> = 6.2 Hz, 2H), 1.89–1.67 (m, 4H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.7, 149.2, 132.3, 129.3, 126.9, 121.8, 110.6, 84.4, 63.4, 39.7, 34.5, 29.3, 26.0, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3068, 2998, 2955, 2872, 1768, 1698, 1484, 1368, 1192, 1143, 1033, 764;. HRMS calcd for C<sub>14</sub>H<sub>17</sub><sup>79</sup>BrIN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 466.9462, found 466.9457.</div></div><div id="sec7_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl 3-(4-Bromobutyl)-5,6-dichloro-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>29</b>)</h4><div class="NLM_p last">Yield 65% (2.848 g), colorless solid, mp = 105–107 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.73 (s, 1H), 7.57 (s, 1H), 3.77 (t, <i>J</i> = 6.7 Hz, 2H), 3.51 (t, <i>J</i> = 6.3 Hz, 2H), 1.89–1.60 (m, 4H), 1.54 (s, 9H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.5, 147.7, 129.5, 126.2, 125.4, 123.4, 115.0, 109.8, 84.7, 39.9, 34.5, 29.3, 27.5, 26.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2980, 2931, 1754, 1735, 1616, 1489, 1359, 1316, 1148, 1131; 831. HRMS calcd for C<sub>16</sub>H<sub>20</sub><sup>79</sup>BrCl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 437.0029, found 437.0027.</div></div><div id="sec7_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl 3-Butyl-5,6-dichloro-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>31</b>)</h4><div class="NLM_p last">Yield 63% (2.263 g), colorless oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.88 (s, 1H), 6.95 (s, 1H), 3.74 (t, <i>J</i> = 7.3 Hz, 2H), 1.73–1.63 (m, 2H), 1.61 (s, 9H), 1.43–1.25 (m, 2H), 0.90 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 150.3, 148.4, 129.1, 127.5, 125.4, 125.4, 116.2, 108.9, 85.4, 41.2, 29.8, 28.0, 20.0, 13.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2960, 2933, 2873, 1794, 1750, 1489, 1354, 1306, 1150, 1104, 1023, 843. HRMS calcd for C<sub>16</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 381.0924, found 359.0924.</div></div><div id="sec7_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-(4-Bromobutyl)-3-butyl-5,6-dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>33</b>)</h4><div class="NLM_p last">Yield 84% (3.311 g), colorless solid, mp = 50–52 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.58 (s, 1H), 7.55 (s, 1H), 3.92–3.78 (m, 4H), 3.55 (t, <i>J</i> = 6.3 Hz, 2H), 1.87–1.69 (m, 4H), 1.59 (p, <i>J</i> = 7.2 Hz, 2H), 1.26 (d, <i>J</i> = 7.4 Hz, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.9, 129.5, 129.4, 123.5, 123.4, 110.0, 109.9, 40.8, 40.2, 34.9, 30.2, 29.8, 26.9, 19.8, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3056, 2930, 2871, 1731, 1500, 1458, 1406, 1371, 1276, 1106, 860, 747. HRMS calcd for C<sub>15</sub>H<sub>20</sub><sup>79</sup>BrCl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 393.0131, found 393.0130.</div></div><div id="sec7_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>tert</i>-Butyl 3-(4-Bromobutyl)-4,6-dichloro-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>37</b>)</h4><div class="NLM_p last">Yield 67% (2.936 g), colorless solid, mp = 82–84 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 2.0 Hz, 1H), 7.15 (d, <i>J</i> = 2.0 Hz, 1H), 4.30–4.14 (m, 2H), 3.51–3.38 (m, 2H), 1.93 (m, 4H), 1.66 (s, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 150.9, 148.3, 128.7, 127.9, 125.5, 124.6, 114.6, 113.8, 86.0, 41.6, 32.9, 29.7, 28.9, 28.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2985, 2973, 2922, 1755, 1741, 1478, 1360, 1309, 1251, 1124, 839. HRMS calcd for C<sub>16</sub>H<sub>20</sub><sup>79</sup>BrCl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 437.0029, found 437.0033.</div></div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> General Protocol for Isopropylamine-Mediated Deprotection of Ethylcarbamates (Products <b>25</b>–<b>26</b>)</h3><div class="NLM_p">Isopropylamine (350 μL, 4.28 mmol, 1.2 equiv) was added dropwise to a stirred solution of the appropriate ethylcarbamate <b>23</b> or <b>24</b> (3.57 mmol, 1 equiv) in dry THF (14 mL). The resulting solution was agitated for 12 h. Upon completion, the mixture was evaporated to dryness. The oily residue was purified by chromatography on silica gel using DCM/AcOEt (1:0 to 7:3) to afford the corresponding deprotected product.</div><div id="sec7_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-(4-Bromobutyl)-5-bromo-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">Yield 94% (1.167 g), colorless solid, mp = 160–162 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.20 (bs, 1H), 7.29 (d, <i>J</i> = 1.8 Hz, 1H), 7.22 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 3.99–3.85 (m, 2H), 3.54–3.40 (m, 2H), 2.03–1.86 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.7, 129.4, 129.3, 124.4, 114.4, 113.1, 109.1, 40.1, 33.0, 29.7, 27.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3164, 3095, 3003, 2939, 2861, 2813, 2716, 1685, 1621, 1605, 1487, 1459, 1403, 1203, 1140, 1109, 857, 794, 700. HRMS calcd for C<sub>11</sub>H<sub>13</sub><sup>79</sup>Br<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 346.9389, found 346.9386.</div></div><div id="sec7_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-(4-Bromobutyl)-5-iodo-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last">Yield 81% (1.142 g), colorless solid, mp = 184–186 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (bs, 1H), 7.33 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.25 (d, <i>J</i> = 1.6 Hz, 1H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 3.79 (t, <i>J</i> = 6.4 Hz, 2H), 3.55 (t, <i>J</i> = 6.2 Hz, 2H), 1.90–1.64 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.7, 130.0, 129.9, 128.8, 116.7, 110.0, 83.2, 39.0, 34.5, 29.4, 26.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3157, 3092, 3010, 2938, 2813, 1679, 1484, 1398, 1144, 1110, 794, 698. HRMS calcd for C<sub>11</sub>H<sub>13</sub><sup>79</sup>BrIN<sub>2</sub>O [M + H]<sup>+</sup> 394.9251, found 394.9246.</div></div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> General Protocol for TFA-Mediated Deprotection of <i>tert</i>-Butylcarbamates (Products <b>9</b>–<b>14</b>, <b>16</b>, <b>30</b>, <b>32</b>, <b>38</b>)</h3><div class="NLM_p">TFA (2.1. mL, 27.1 mmol, 5 equiv) was added dropwise to stirred solution of the appropriate <i>tert</i>-butyl carbamate (5.42 mmol, 1 equiv) in freshly distilled DCM (36 mL) at room temperature. The solution was stirred for 3 h at room temperature. The resulting mixture was concentrated in vacuo, dissolved in DCM, and quenched with a saturated solution of sodium hydrogenocarbonate. The aqueous layer was extracted three times with DCM. The combined organic layers were washed with water and brine and dried over MgSO<sub>4</sub>. Evaporation of the solvent in vacuo provided a crude residue, which was purified by chromatography on silica gel using DCM/AcOEt (1:1) to afford the corresponding deprotected product.</div><div id="sec7_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-(2-Bromoethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>9</b>)</h4><div class="NLM_p last">Yield 94% (1.228 g), colorless solid, mp = 164–166 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.66 (bs, 1H), 7.21–6.94 (m, 4H), 4.30 (t, <i>J</i> = 6.9 Hz, 2H), 3.67 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.7, 130.0, 128.1, 122.1, 121.6, 110.1, 108.0, 42.7, 28.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3130, 3075, 3051, 2965, 2919, 2899, 1688, 1673, 1626, 1486, 1425, 1396, 1135, 746, 735. HRMS calcd for C<sub>9</sub>H<sub>10</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 240.9971, found 240.9969.</div></div><div id="sec7_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(3-Bromopropyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">Yield 92% (1.272 g), colorless solid, mp = 124–126 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.22 (s, 1H), 7.21–6.98 (m, 4H), 4.07 (t, <i>J</i> = 6.8 Hz, 2H), 3.46 (t, <i>J</i> = 6.4 Hz, 2H), 2.36 (p, <i>J</i> = 6.5 Hz, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 156.0, 130.3, 128.2, 121.8, 121.5, 110.0, 107.9, 39.4, 31.7, 30.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3174, 3129, 3020, 2945, 2845, 2791, 1682, 1625, 1487, 1400, 1382, 1264, 1148, 723, 689. HRMS calcd for C<sub>10</sub>H<sub>12</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 255.0128, found 255.0127.</div></div><div id="sec7_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(4-Bromobutyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last">Yield 96% (1.4 g), off-white solid, mp = 82–84 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.87 (bs, 1H), 7.19–6.91 (m, 4H), 4.02–3.89 (m, 2H), 3.51–3.40 (m, 2H), 2.11–1.83 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.7, 130.3, 128.1, 121.8, 121.5, 109.9, 108.0, 39.9, 33.1, 29.8, 27.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3131, 3059, 2946, 2922, 2849, 1716, 1687, 1621, 1483, 1396, 773. HRMS calcd for C<sub>11</sub>H<sub>14</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 269.0284, found 269.0285.</div></div><div id="sec7_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(5-Bromopentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">Yield 95% (1.458 g), off-white solid, mp = 74–76 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (bs, 1H), 7.10 (d, <i>J</i> = 6.4 Hz, 1H), 6.98 (d, <i>J</i> = 6.7 Hz, 3H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 3.49 (t, <i>J</i> = 6.7 Hz, 2H), 1.82 (p, <i>J</i> = 6.8 Hz, 2H), 1.65 (p, <i>J</i> = 7.2 Hz, 2H), 1.38 (p, <i>J</i> = 7.6, 7.2 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.2, 130.2, 128.2, 120.7, 120.4, 108.7, 107.7, 34.9, 31.8, 27.0, 24.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3177, 3140, 3053, 2953, 2929, 2853, 1683, 1624, 1486, 1394, 1140, 720. HRMS calcd for C<sub>12</sub>H<sub>16</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 283.0440, found 283.0440.</div></div><div id="sec7_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(6-Bromohexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>13</b>)</h4><div class="NLM_p last">Yield 97% (1.562 g), colorless solid, mp = 105–107 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.71 (bs, 1H), 7.15–7.05 (m, 3H), 7.04–6.97 (m, 1H), 3.90 (t, <i>J</i> = 7.2 Hz, 2H), 3.39 (t, <i>J</i> = 6.7 Hz, 2H), 1.92–1.74 (m, 4H), 1.58–1.35 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.9, 130.4, 128.2, 121.6, 121.3, 109.9, 107.9, 40.8, 33.9, 32.7, 28.4, 27.9, 26.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3132, 3062, 2936, 2853, 1706, 1683, 1625, 1485, 1402, 1139, 748, 682. HRMS calcd for C<sub>13</sub>H<sub>18</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 297.0597, found 297.0597.</div></div><div id="sec7_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(7-Bromoheptyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">Yield 92% (1.551 g), colorless solid, mp = 85–87 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.17–6.96 (m, 4H), 3.90 (t, <i>J</i> = 7.2 Hz, 2H), 3.38 (t, <i>J</i> = 6.8 Hz, 2H), 1.94–1.72 (m, 4H), 1.49–1.33 (m, 6H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 156.1, 130.3, 128.3, 121.4, 121.1, 109.9, 107.9, 40.8, 33.9, 32.7, 28.5, 28.4, 28.1, 26.7. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3174, 3136, 3066, 2938, 2851, 1675, 1483, 1398, 1136, 740. HRMS calcd for C<sub>14</sub>H<sub>20</sub><sup>79</sup>BrN<sub>2</sub>O [M + H]<sup>+</sup> 311.0754, found 311.0754.</div></div><div id="sec7_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-Butyl-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one (<b>16</b>)</h4><div class="NLM_p last">Yield 95% (980 mg), colorless solid, mp = 99–101 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (bs, 1H), 7.15–7.06 (m, 1H), 7.04–6.91 (m, 3H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 1.61 (p, <i>J</i> = 7.3 Hz, 2H), 1.42–1.16 (m, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.7, 130.7, 128.7, 121.1, 120.9, 109.1, 108.1, 39.9, 30.4, 19.9, 14.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3138; 3065, 2952, 2923, 2870, 1713, 1685, 1624, 1399, 1135, 1094, 719, 680. HRMS calcd for C<sub>11</sub>H<sub>15</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 191.1179, found 191.1180.</div></div><div id="sec7_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-(4-Bromobutyl)-5,6-dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>30</b>)</h4><div class="NLM_p last">Yield 95% (1.740 g), off-white solid, mp = 197–199 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.16 (bs, 1H), 7.52 (s, 1H), 7.16 (s, 1H), 3.81 (t, <i>J</i> = 6.5 Hz, 2H), 3.56 (t, <i>J</i> = 6.3 Hz, 2H), 1.87–1.65 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.2, 130.3, 128.3, 122.8, 122.7, 110.0, 109.3, 39.2, 34.5, 29.4, 26.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3157, 2992, 2873, 1694, 1492, 1394, 1362, 1291, 1215, 1101, 856, 710. HRMS calcd for C<sub>11</sub>H<sub>12</sub><sup>79</sup>BrCl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 336.9505, found 336.9503.</div></div><div id="sec7_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-Butyl-5,6-dichloro-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one (<b>32</b>)</h4><div class="NLM_p last">Yield 96% (1.348 g), colorless solid, mp = 164–166 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (s, 1H), 7.47 (s, 1H), 7.15 (s, 1H), 3.77 (t, <i>J</i> = 7.1 Hz, 2H), 1.65–1.51 (m, 2H), 1.35–1.18 (m, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.2, 130.4, 128.3, 122.7, 122.6, 109.9, 109.3, 39.9, 29.8, 19.3, 13.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3151, 2928, 2870, 1694, 1632, 1490, 1397, 1328, 1098, 946, 852, 721. HRMS calcd for C<sub>11</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 259.0399, found 259.0400.</div></div><div id="sec7_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-(4-Bromobutyl)-5,7-dichloro-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>38</b>)</h4><div class="NLM_p last">Yield 92% (1.686 g), colorless solid, mp = 177–179 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.38 (bs, 1H), 7.07 (d, <i>J</i> = 1.9 Hz, 1H), 7.05 (d, <i>J</i> = 1.9 Hz, 1H), 4.21 (m, 2H), 3.52–3.42 (m, 2H), 1.96 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 156.0, 130.6, 127.6, 125.1, 123.1, 115.1, 109.1, 41.3, 33.0, 29.8, 29.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3158, 3059, 2994, 2873, 2764, 1694, 1633, 1601, 1492, 1394, 1362, 1318, 1101, 856, 783. HRMS calcd for C<sub>11</sub>H<sub>12</sub><sup>79</sup>BrCl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup> 336.9505, found 336.9504.</div></div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Protocol for the Synthesis of <i>N</i>-Alkylated Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, and Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one (Products <b>43</b>, <b>46</b>, <b>50</b>)</h3><div class="NLM_p">Potassium carbonate (176 mg, 1.28 mmol, 1 equiv) and 1,4-dibromobutane (553 mg, mmol, 2 equiv) were successively added to a stirred solution of the appropriate <i>tert</i>-butylcarbamate <b>42</b>, <b>45</b>, or <b>49</b> (300 mg, 1.28 mmol, 1 equiv) in DMF (2 mL) at room temperature, and the resulting solution was stirred for 1 h (attempt to run the reaction for a longer period resulted in the loss of the desired product). The mixture was partitioned between DCM and water. The aqueous layer was extracted three times with DCM, and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The resulting oily residue was dissolved in DCM (3 mL), and TFA (0.5 mL, 6.4 mmol; 5 equiv) was added dropwise to the solution. The mixture was stirred for 3 h and concentrated in vacuo. The oily residue was partitioned between DCM and an aqueous solution of saturated NaHCO<sub>3</sub>. The aqueous layer was extracted three times with DCM, and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. Purification of the oily residue by chromatography on silica gel using DCM/MeOH (1:0 to 95:5) yielded the corresponding monoalkylated imidazopyridin-2-one.</div><div id="sec7_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-(4-Bromobutyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>43</b>)</h4><div class="NLM_p last">Yield 43% (149 mg), colorless solid, mp = 110–112 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.55 (bs, 1H), 8.06 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H), 7.35 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.01 (dd, <i>J</i> = 7.8, 5.2 Hz, 1H), 4.06 (t, <i>J</i> = 6.5 Hz, 2H), 3.48 (t, <i>J</i> = 6.2 Hz, 2H), 2.10–1.87 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.5, 144.3, 141.1, 122.5, 117.6, 115.9, 38.9, 33.1, 29.9, 27.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3077, 3037, 2956, 2849, 1709, 1630, 1597, 1475, 1434, 1365, 1275, 776. HRMS calcd for C<sub>10</sub>H<sub>13</sub><sup>79</sup>BrN<sub>3</sub>O [M + H]<sup>+</sup> 270.0237, found 270.0231.</div></div><div id="sec7_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(4-Bromobutyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>46</b>)</h4><div class="NLM_p last">Yield 49% (169 mg), colorless solid, mp = 117–119 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.98 (bs, 1H), 8.10 (dd, <i>J</i> = 5.3, 1.4 Hz, 1H), 7.23 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.04 (dd, <i>J</i> = 7.8, 5.3 Hz, 1H), 3.94 (t, <i>J</i> = 6.4 Hz, 2H), 3.47 (t, <i>J</i> = 5.9 Hz, 2H), 2.07–1.78 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 154.4, 143.7, 140.3, 124.8, 117.1, 114.0, 39.8, 33.0, 29.6, 26.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3041, 2999, 2942, 2908, 2845, 2725, 1701, 1623, 1486, 1450, 1396, 1139, 785, 745, 683. HRMS calcd for C<sub>10</sub>H<sub>13</sub><sup>79</sup>BrN<sub>3</sub>O [M + H]<sup>+</sup> 270.0237, found 270.0236.</div></div><div id="sec7_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-(4-Bromobutyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one (<b>50</b>)</h4><div class="NLM_p last">Yield 41% (142 mg), colorless gummy oil. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.16 (bs, 1H), 8.20–8.16 (m, 2H), 7.24 (dd, <i>J</i> = 5.3, 0.6 Hz, 1H), 3.83 (t, <i>J</i> = 6.4 Hz, 2H), 3.59–3.51 (m, 2H), 1.88–1.69 (m, 4H). IR (cm<sup>–1</sup>) υ<sub>max</sub> 3350, 1666, 1558, 1518, 1190, 1130, 842, 721. HRMS calcd for C<sub>10</sub>H<sub>13</sub><sup>79</sup>BrN<sub>3</sub>O [M + H]<sup>+</sup> 270.0237, found 270.0232.</div></div><div id="sec7_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>55</b>)</h4><div class="NLM_p last">A stirred solution of 2-aminopyridin-3-ol (3 g, 27.24 mmol, 1 equiv) and CDI (5.301 g, 32.69 mmol, 1.2 equiv) in dry THF (45 mL) was heated under microwave irradiation (ramp = 2 min, <i>P</i><sub>max</sub> = 300 W) at 65 °C for 2 h. Upon completion, the mixture was concentrated in vacuo and the resulting solid was dissolved in DCM. The organic layer was extracted three times with aqueous 2 M NaOH. The organic layer was discarded, and the combined aqueous layers were acidified to pH = 6–7 with aqueous 1 M HCl until a precipitate appeared. The solid was filtered off on a Büchner funnel and dried in vacuo to yield the desired product in analytically pure form. Yield 80% (2.966 g), light-beige solid, mp = 212–214 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.41 (bs, 1H), 8.03 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.63 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.10 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.5, 146.3, 142.5, 137.5, 117.8, 115.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3107, 3067, 2995, 2887, 2739, 1789, 1766, 1738, 1633, 1478, 1434, 1264, 1218, 1145, 896, 788. HRMS calcd for C<sub>6</sub>H<sub>5</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 137.0346, found 137.0347.</div></div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> General Protocol for the Microwave-Assisted Alkylation of Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones (Products <b>52</b>–<b>53</b>, <b>56</b>–<b>57</b>)</h3><div class="NLM_p">A stirred solution of benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one or oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (22.2 mmol, 1 equiv), potassium carbonate (9.204 g, 66.6 mmol, 3 equiv), and the appropriate 1,<i>n</i>-dibromoalkane (111 mmol, 5 equiv) in dry DMF (30 mL) was heated under microwave irradiation (ramp = 2 min, <i>P</i><sub>max</sub> = 150 W) for 3 h at 60 °C. the resulting mixture was partitioned between DCM and water. The organic layer was extracted three times with DCM, and the combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification of the oily residue by chromatography on silica gel using EP/AcOEt (9:1 to 7:3) yielded the corresponding product.</div><div id="sec7_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 3-(4-Bromobutyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>52</b>)</h4><div class="NLM_p last">Yield 76% (4.556 g), colorless solid, mp = 43–45 °C. <sup>1</sup>H NMR (250 MHz,, DMSO-<i>d</i><sub>6</sub>) δ 7.30–7.24 (m, 2H), 7.17 (td, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.07 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 3.80 (t, <i>J</i> = 6.6 Hz, 2H), 3.56–3.46 (m, 2H), 1.89–1.68 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.8, 142.0, 130.9, 123.9, 122.2, 109.6, 109.1, 40.8, 34.3, 29.3, 26.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3077, 3035, 2956, 2847, 2707, 1709, 1630, 1597, 1475, 1434, 1365, 1246, 1110, 896, 727. HRMS calcd for C<sub>11</sub>H<sub>13</sub><sup>79</sup>BrNO<sub>2</sub> [M + H]<sup>+</sup> 270.0124, found 270.0124.</div></div><div id="sec7_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 3-(5-Bromopentyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>53</b>)</h4><div class="NLM_p last">Yield 73% (4.605 g), colorless solid, mp = 40–42 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.36–7.27 (m, 2H), 7.22 (td, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.12 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 3.82 (t, <i>J</i> = 7.0 Hz, 2H), 3.50 (t, <i>J</i> = 6.7 Hz, 2H), 1.90–1.65 (m, 4H), 1.49–1.34 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.7, 141.9, 130.9, 123.7, 122.0, 109.5, 109.0, 41.4, 34.6, 31.7, 26.3, 24.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3063, 2947, 2863, 1753, 1614, 1486, 1236, 1301, 1236, 921, 742. HRMS calcd for C<sub>12</sub>H<sub>15</sub><sup>79</sup>BrNO<sub>2</sub> [M + H]<sup>+</sup> 284.0281, found 284.0280.</div></div><div id="sec7_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 3-(4-Bromobutyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>56</b>)</h4><div class="NLM_p last">Yield 54% (3.250 g), colorless solid, mp = 45–47 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.11 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.40 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.06 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 3.98 (t, <i>J</i> = 6.7 Hz, 2H), 3.46 (t, <i>J</i> = 6.2 Hz, 2H), 2.11–1.88 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 153.4, 145.7, 143.3, 137.0, 118.2, 116.2, 40.3, 32.7, 29.6, 26.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3084, 3044, 2956, 2934, 1768, 1632, 1307, 1440, 1339, 802, 761. HRMS calcd for C<sub>10</sub>H<sub>12</sub><sup>79</sup>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 271.0077, found 271.0077.</div></div><div id="sec7_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-(4-Bromobutyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>57</b>)</h4><div class="NLM_p last">Yield 65% (4.115 g), colorless solid, mp = 57–59 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.10 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.39 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.04 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 3.95 (t, <i>J</i> = 7.2 Hz, 2H), 3.39 (t, <i>J</i> = 6.7 Hz, 2H), 2.00–1.81 (m, 4H), 1.66–1.46 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 153.3, 145.7, 143.1, 136.9, 118.1, 116.1, 40.9, 33.3, 32.1, 26.9, 25.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3097, 2951, 2863, 1762, 1628, 1594, 1474, 1454, 1430, 1347, 1264, 1033, 972, 793. HRMS calcd for C<sub>11</sub>H<sub>14</sub><sup>79</sup>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 285.0233, found 285.0233.</div></div></div><div id="sec7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> General Protocol for the Synthesis of Tertiary Amine-Bearing of <i>N</i>-Alkylated or <i>N</i>,<i>N</i>′-Dialkylated Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones (Products <b>58</b>–<b>102</b>, <b>111</b>–<b>112</b>) and Phthalimide Analogue <b>103</b></h3><div class="NLM_p">In a sealed tube, a stirred solution of the appropriate alkyl bromide (500 μmol, 1 equiv), the appropriate secondary amine (600 μmol, 1.2 equiv) in DIPEA (1.25 mmol, 213 μL, 2.5 equiv) in dry and degassed acetonitrile (4 mL) was heated in an oil bath at 90 °C for 12 h. The resulting solution was evaporated in vacuo, and the residue was partitioned between water and DCM. The aqueous layer was extracted three times with DCM, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo. The residue was purified by chromatography on silica gel using DCM/MeOH (piperazine series: 1:0 to 95:5; piperidine series 1:0 to 9:1) to afford the corresponding substituted product.</div><div id="sec7_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 1-(5-(4-(4-Methoxyphenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>58</b>)</h4><div class="NLM_p last">Yield 91% (180 mg), off-white solid, mp = 154–156 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.98 (bs, 1H), 7.13–6.97 (m, 4H), 6.92–6.79 (m, 4H), 3.90 (t, <i>J</i> = 7.2 Hz, 2H), 3.76 (s, 3H), 3.14–3.04 (m, 4H), 2.67–2.56 (m, 4H), 2.47–2.33 (m, 2H), 1.82 (p, <i>J</i> = 7.5 Hz, 2H), 1.71–1.53 (m, 2H), 1.52–1.36 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.9, 153.9, 145.7, 130.4, 128.2, 121.5, 121.2, 118.3, 114.5, 109.8, 107.9, 58.5, 55.7, 53.4, 50.6, 40.8, 28.4, 26.4, 24.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3131, 3063, 2925, 2817, 1707, 1687, 1514, 1486, 1401, 1250, 1239, 816, 799. HRMS calcd for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 395.2441, found 395.2439. <i>t</i><sub>R</sub>, 10.9 min; purity = 98.7%; λ<sub>max</sub>, 281 nm.</div></div><div id="sec7_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1-(5-(4-(2-(Methylthio)phenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>59</b>)</h4><div class="NLM_p last">Yield 73% (150 mg), off-white solid, mp = 128–130 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (bs, 1H), 7.22–6.77 (m, 8H), 3.74 (t, <i>J</i> = 7.0 Hz, 2H), 2.81 (s, 4H), 2.42 (s, 2H), 2.30 (s, 3H), 2.28–2.21 (m, 2H), 1.62 (p, <i>J</i> = 7.2 Hz, 2H), 1.43 (p, <i>J</i> = 7.6 Hz, 2H), 1.33–1.17 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.2, 149.1, 134.4, 130.2, 128.2, 124.7, 124.2, 120.6, 120.4, 119.4, 108.6, 107.7, 57.7, 53.1, 51.1, 39.7, 27.6, 25.8, 24.0, 13.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3019, 2933, 2808, 1691, 1490, 1470, 733. HRMS calcd for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 411.2213, found 411.2212. <i>t</i><sub>R</sub>, 11.8 min; purity = 99.4%; λ<sub>max</sub>, 280 nm.</div></div><div id="sec7_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1-(5-(4-(4-Bromophenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>60</b>)</h4><div class="NLM_p last">Yield 40% (89 mg), off-white solid, mp = 180–182 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.95 (bs, 1H), 7.32 (d, <i>J</i> = 9.1 Hz, 2H), 7.16–6.95 (m, 4H), 6.77 (d, <i>J</i> = 9.1 Hz, 2H), 3.89 (t, <i>J</i> = 7.2 Hz, 2H), 3.19–3.10 (m, 4H), 2.60–2.52 (m, 4H), 2.43–2.31 (m, 2H), 1.81 (p, <i>J</i> = 7.3 Hz, 2H), 1.63–1.51 (m, 2H), 1.51–1.35 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.6, 150.5, 132.0, 130.5, 128.1, 121.5, 121.4, 117.7, 111.8, 109.7, 108.0, 58.5, 53.2, 49.1, 40.9, 28.4, 26.6, 24.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3128, 2937, 2817, 1705, 1685,1484, 1400, 803. HRMS calcd for C<sub>22</sub>H<sub>28</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> 443.1441, found 443.1439. <i>t</i><sub>R</sub>, 11.9 min; purity = 99.0%; λ<sub>max</sub>, 251 nm.</div></div><div id="sec7_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 1-(5-(4-(4-Iodophenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>61</b>)</h4><div class="NLM_p last">Yield 62% (152 mg), light-yellow solid, mp = 213–215 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.13 (bs, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 2H), 7.15–6.96 (m, 4H), 6.65 (d, <i>J</i> = 9.0 Hz, 2H), 3.90 (t, <i>J</i> = 7.2 Hz, 2H), 3.21–3.10 (m, 4H), 2.62–2.52 (m, 4H), 2.44–2.32 (m, 2H), 1.81 (p, <i>J</i> = 7.4 Hz, 2H), 1.59 (p, <i>J</i> = 7.1 Hz, 2H), 1.52–1.34 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 155.8, 151.0, 137.9, 130.5, 128.1, 121.5, 121.3, 118.1, 109.8, 108.0, 81.4, 58.5, 53.1, 48.7, 40.8, 28.4, 26.5, 24.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3072, 3030, 2937, 28311707, 1667, 1488, 807, 726. HRMS calcd for C<sub>22</sub>H<sub>28</sub>IN<sub>4</sub>O [M + H]<sup>+</sup> 491.1302, found 491.1298. <i>t</i><sub>R</sub>, 12.2 min; purity = 98.1%; λ<sub>max</sub> = 255 nm.</div></div><div id="sec7_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 1-(5-(4-(4-Fluorophenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>62</b>)</h4><div class="NLM_p last">Yield 87% (166 mg), off-white solid, mp = 106–108 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.64 (bs, 1H), 7.17–6.75 (m, 8H), 3.90 (t, <i>J</i> = 7.2 Hz, 2H), 3.25–2.99 (m, 4H), 2.64–2.50 (m, 4H), 2.45–2.31 (m, 2H), 1.93–1.78 (m, 2H), 1.69–1.52 (m, 2H), 1.51–1.36 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 157.2 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 238.6 Hz), 155.9, 148.1 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.3 Hz), 130.4, 128.2, 121.5, 121.3, 117.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 115.6 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 22.0 Hz), 109.8, 108.0, 58.5, 53.4, 50.2, 40.9, 28.4, 26.6, 24.9. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −125.7. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3120, 3016, 2940, 2810, 1686, 1509, 1483, 1398, 1257, 1158, 816, 751. HRMS calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O [M + H]<sup>+</sup> 383.2242, found 383.2241. <i>t</i><sub>R</sub>, 11.2 min; purity = 99.4%; λ<sub>max1</sub>, 229 nm.</div></div><div id="sec7_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 1-(5-(4-(4-Hydroxyphenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>63</b>)</h4><div class="NLM_p last">Yield 100% (190 mg), beige solid, mp = 177–179 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (bs, 1H), 8.84 (bs, 1H), 7.14–7.06 (m, 1H), 7.04–6.92 (m, 3H), 6.74 (d, <i>J</i> = 9.0 Hz, 2H), 6.64 (d, <i>J</i> = 9.0 Hz, 2H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 2.99–2.84 (m, 4H), 2.48–2.40 (m, 4H), 2.26 (t, <i>J</i> = 7.2 Hz, 2H), 1.65 (p, <i>J</i> = 7.2 Hz, 2H), 1.54–1.38 (m, 2H), 1.36–1.20 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.2, 150.9, 144.1, 130.2, 128.3, 120.6, 120.4, 117.6, 115.4, 108.7, 107.7, 57.7, 52.9, 49.9, 39.7, 27.7, 25.8, 24.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3497, 3025, 2936, 2829, 1684, 1517, 1488, 1449; 1247, 815, 739. HRMS calcd for C<sub>22</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 381.2285, found 381.2284. <i>t</i><sub>R</sub> = 10.0 min; purity = 98.7%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 1-Butyl-3-(5-(4-(4-hydroxyphenyl)piperazin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>64</b>)</h4><div class="NLM_p last">Yield 88% (192 mg), visquous oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.76 (bs, 1H), 7.14–6.94 (m, 4H), 6.77 (s, 4H), 3.87 (t, <i>J</i> = 7.2 Hz, 4H), 3.09 (s, 4H), 2.69 (s, 4H), 2.54–2.38 (m, 2H), 1.84–1.55 (m, 6H), 1.46–1.28 (m, 4H), 0.93 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 154.4, 151.3, 144.5, 129.4, 129.3, 121.2, 118.9, 116.1, 107.9, 107.8, 58.2, 53.1, 50.2, 41.0, 40.9, 30.5, 28.1, 25.5, 24.6, 20.1, 13.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3185, 2931, 2860, 2818, 1703, 1667, 1571, 1494, 1446, 1407, 1372, 1259, 750, 731. HRMS calcd for C<sub>26</sub>H<sub>37</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 437.2911, found 437.2913. <i>t</i><sub>R</sub> = 12.0 min; purity = 98.2%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3-(4-(4-Phenylpiperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>65</b>)</h4><div class="NLM_p last">Yield 99% (174 mg), off-white solid, mp = 95–97 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.37–7.30 (m, 2H), 7.27–7.08 (m, 4H), 6.90 (dd, <i>J</i> = 8.9, 1.1 Hz, 2H), 6.82–6.70 (m, 1H), 3.85 (t, <i>J</i> = 7.0 Hz, 2H), 3.13–3.00 (m, 4H), 2.47–2.43 (m, 4H), 2.34 (t, <i>J</i> = 7.1 Hz, 2H), 1.74 (p, <i>J</i> = 7.3 Hz, 2H), 1.49 (p, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.8, 151.0, 141.9, 131.0, 128.9, 123.9, 122.1, 118.7, 115.3, 109.6, 109.2, 57.0, 52.7, 48.2, 41.5, 25.0, 23.2. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3061, 2943, 2919, 2811, 2779, 1748, 1600, 1487, 1358, 1239, 1137, 1077, 925, 749. HRMS calcd for C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 352.2020, found 352.2018. <i>t</i><sub>R</sub> = 11.4 min; purity = 99.4%; λ<sub>max</sub> = 229 nm.</div></div><div id="sec7_12_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 3-(4-(4-(4-Hydroxyphenyl)piperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>66</b>)</h4><div class="NLM_p last">Yield 76% (140 mg), off-white solid, mp = 118–120 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (bs, 1H), 7.40–7.29 (m, 2H), 7.22 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.12 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 6.75 (d, <i>J</i> = 9.0 Hz, 2H), 6.63 (d, <i>J</i> = 9.0 Hz, 2H), 3.84 (t, <i>J</i> = 7.0 Hz, 2H), 2.98–2.80 (m, 4H), 2.47–2.40 (m, 4H), 2.33 (t, <i>J</i> = 7.1 Hz, 2H), 1.73 (p, <i>J</i> = 7.2 Hz, 2H), 1.48 (d, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.8, 150.8, 144.2, 142.0, 131.0, 123.9, 122.2, 117.6, 115.4, 109.6, 109.2, 57.0, 52.9, 50.0, 41.6, 25.0, 23.2. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3475, 3122, 3068, 2955, 2879, 2825, 1749, 1515, 1485, 1371, 1234, 1134, 804, 749. HRMS calcd for C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 368.1969, found 368.1967. <i>t</i><sub>R</sub> = 10.1 min; purity = 99.7%; λ<sub>max</sub> = 229 nm.</div></div><div id="sec7_12_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 3-(4-(4-(4-Fluorophenyl)piperazin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>67</b>)</h4><div class="NLM_p last">Yield 89% (164 mg), colorless solid, mp = 130–132 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.39–7.26 (m, 2H), 7.22 (td, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.12 (td, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.02 (t, <i>J</i> = 8.9 Hz, 2H), 6.94–6.86 (m, 2H), 3.84 (t, <i>J</i> = 7.0 Hz, 2H), 3.08–2.93 (m, 4H), 2.48–2.41 (m, 4H), 2.33 (t, <i>J</i> = 7.1 Hz, 2H), 1.73 (p, <i>J</i> = 7.1 Hz, 2H), 1.49 (p, <i>J</i> = 7.1, 6.7 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 235.3 Hz), 153.8, 147.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.0 Hz), 141.9, 131.0, 123.9, 122.1, 117.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 115.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.6, 109.2, 56.9, 52.6, 49.0, 41.5, 25.0, 23.2. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −128.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3068, 2960, 2925, 2817, 2784, 1746, 1511, 1488, 1359, 1240, 1216, 1138, 818. HRMS calcd for C<sub>21</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 370.1925, found 370.1924. <i>t</i><sub>R</sub> = 11.6 min; purity = 100%; λ<sub>max</sub> = 254 nm.</div></div><div id="sec7_12_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 3-(5-(4-Phenylpiperazin-1-yl)pentyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>68</b>)</h4><div class="NLM_p last">Yield 80% (146 mg), off-white solid, mp = 85–87 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.33–7.23 (m, 2H), 7.23–7.02 (m, 4H), 6.85 (d, <i>J</i> = 7.9 Hz, 2H), 6.71 (t, <i>J</i> = 7.2 Hz, 1H), 3.78 (t, <i>J</i> = 7.0 Hz, 2H), 3.06–2.97 (m, 4H), 2.42–2.37 (m, 4H), 2.22 (t, <i>J</i> = 7.2 Hz, 2H), 1.68 (p, <i>J</i> = 7.1 Hz, 2H), 1.44 (p, <i>J</i> = 7.1 Hz, 2H), 1.35–1.18 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.7, 151.0, 141.9, 131.0, 128.8, 123.8, 122.1, 118.7, 115.2, 109.6, 109.1, 57.6, 52.7, 48.2, 41.6, 27.0, 25.7, 23.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2945, 2920, 2821, 2777, 1747, 1600, 1483, 1445, 1363, 1242, 1004, 752. HRMS calcd for C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 366.2176, found 366.2174. <i>t</i><sub>R</sub> = 11.8 min; purity = 99.0%; λ<sub>max</sub> = 229 nm.</div></div><div id="sec7_12_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 3-(5-(4-(4-Hydroxyphenyl)piperazin-1-yl)pentyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>69</b>)</h4><div class="NLM_p last">Yield 79% (151 mg), off-white solid, mp = 143–145 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (bs, 1H), 7.37–7.28 (m, 2H), 7.22 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.12 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 6.75 (d, <i>J</i> = 9.0 Hz, 2H), 6.63 (d, <i>J</i> = 9.0 Hz, 2H), 3.82 (t, <i>J</i> = 7.0 Hz, 2H), 2.98–2.82 (m, 4H), 2.48–2.40 (m, 4H), 2.26 (t, <i>J</i> = 7.1 Hz, 2H), 1.72 (p, <i>J</i> = 7.2 Hz, 2H), 1.48 (p, <i>J</i> = 7.4 Hz, 2H), 1.37–1.21 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.8, 150.8, 144.2, 141.9, 131.0, 123.9, 122.1, 117.6, 115.4, 109.6, 109.2, 57.6, 52.9, 49.9, 41.6, 27.0, 25.7, 23.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2939, 2822, 1770, 1512, 1485, 1524, 1228, 830, 749. HRMS calcd for C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 382.2125, found 382.2124. <i>t</i><sub>R</sub> = 10.7 min; purity = 98.7%; λ<sub>max</sub> = 274 nm.</div></div><div id="sec7_12_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 3-(5-(4-(4-Fluorophenyl)piperazin-1-yl)pentyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>70</b>)</h4><div class="NLM_p last">Yield 89% (171 mg), off-white solid, mp = 90–92 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.37–7.28 (m, 2H), 7.22 (td, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.12 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.07–6.98 (m, 2H), 6.94–6.86 (m, 2H), 3.82 (t, <i>J</i> = 7.0 Hz, 2H), 3.07–2.95 (m, 4H), 2.48–2.39 (m, 4H), 2.26 (t, <i>J</i> = 7.1 Hz, 2H), 1.72 (p, <i>J</i> = 7.2 Hz, 2H), 1.48 (p, <i>J</i> = 7.2 Hz, 2H), 1.41–1.21 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 235.5 Hz), 153.7, 147.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.0 Hz), 141.9, 131.0, 123.9, 122.1, 116.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.6 Hz), 115.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.6, 109.2, 57.5, 52.7, 48.9, 41.6, 26.9, 25.7, 23.8. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −128.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3064, 2931, 2861, 2818, 1781, 1749, 1512, 1487, 1361, 1236, 817, 732. HRMS calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 384.2081, found 384.2080. <i>t</i><sub>R</sub> = 11.9 min; purity = 99.7%; λ<sub>max</sub> = 229 nm.</div></div><div id="sec7_12_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 3-(4-(4-Phenylpiperazin-1-yl)butyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>71</b>)</h4><div class="NLM_p last">Yield 80% (141 mg), off-white solid, mp = 49–51 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.71 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.24–7.09 (m, 3H), 6.90 (d, <i>J</i> = 7.9 Hz, 2H), 6.75 (t, <i>J</i> = 7.4 Hz, 1H), 3.86 (t, <i>J</i> = 7.0 Hz, 2H), 3.16–3.03 (m, 4H), 2.48–2.42 (m, 4H), 2.34 (t, <i>J</i> = 7.1 Hz, 2H), 1.80 (p, <i>J</i> = 7.2 Hz, 2H), 1.50 (p, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.8, 151.0, 145.5, 142.7, 136.5, 128.8, 118.7, 118.2, 116.2, 115.2, 57.1, 52.7, 48.1, 40.7, 25.0, 23.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2947, 2809, 2765, 1768, 1598, 1476, 1455, 1358, 1266, 1214, 953, 756. HRMS calcd for C<sub>20</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 353.1972, found 353.1970. <i>t</i><sub>R</sub> = 10.5 min; purity = 99.4%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 3-(4-(4-(4-Hydroxyphenyl)piperazin-1-yl)butyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>72</b>)</h4><div class="NLM_p last">Yield 78% (144 mg), off-white solid, mp = 140–142 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (bs, 1H), 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.71 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.17 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 6.75 (d, <i>J</i> = 9.0 Hz, 2H), 6.63 (d, <i>J</i> = 9.0 Hz, 2H), 3.86 (t, <i>J</i> = 7.0 Hz, 2H), 2.98–2.85 (m, 4H), 2.47–2.41 (m, 4H), 2.33 (t, <i>J</i> = 7.2 Hz, 2H), 1.79 (p, <i>J</i> = 7.2 Hz, 2H), 1.49 (p, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.9, 150.8, 145.5, 144.2, 142.8, 136.5, 118.2, 117.6, 116.3, 115.4, 57.1, 52.9, 49.9, 40.7, 25.0, 23.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3101, 2946, 2885, 2825, 1777, 1513, 1481, 1445, 1359, 1262, 1240, 980, 925, 813, 747. HRMS calcd for C<sub>20</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 369.1921, found 369.1919. <i>t</i><sub>R</sub> = 8.7 min; purity = 99.6%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-(4-(4-(4-Fluorophenyl)piperazin-1-yl)butyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>73</b>)</h4><div class="NLM_p last">Yield 81% (150 mg), off-white solid, mp = 61–62 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.71 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.16 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 7.02 (t, <i>J</i> = 9 Hz, 2H), 6.95–6.87 (m, 2H), 3.86 (t, <i>J</i> = 7.0 Hz, 2H), 3.08–2.95 (m, 4H), 2.51–2.39 (m, 4H), 2.34 (t, <i>J</i> = 7.2 Hz, 2H), 1.79 (p, <i>J</i> = 7.2 Hz, 2H), 1.50 (p, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 235.5 Hz), 152.8, 147.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.0 Hz), 145.5, 142.7, 136.4, 118.2, 116.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 116.2, 115.1 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.7 Hz), 57.0, 52.6, 48.9, 40.6, 25.0, 23.3. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −128.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2943, 2821, 2786, 1785, 1510, 1478, 1451, 1361, 1235, 1207, 1136, 978, 816, 763. HRMS calcd for C<sub>20</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 371.1878, found 371.1875. <i>t</i><sub>R</sub> = 10.8 min; purity = 99.9%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 3-(5-(4-Phenylpiperazin-1-yl)pentyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>74</b>)</h4><div class="NLM_p last">Yield 81% (148 mg), off-white solid, mp = 102–104 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.70 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.23–7.12 (m, 3H), 6.96–6.85 (m, 2H), 6.75 (t, <i>J</i> = 7.2 Hz, 1H), 3.84 (t, <i>J</i> = 7.0 Hz, 2H), 3.12–3.03 (m, 4H), 2.49–2.40 (m, 4H), 2.28 (t, <i>J</i> = 7.1 Hz, 2H), 1.78 (p, <i>J</i> = 7.2 Hz, 2H), 1.49 (p, <i>J</i> = 7.2 Hz, 2H), 1.41–1.19 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.8, 151.0, 145.4, 142.7, 136.4, 128.8, 118.6, 118.2, 116.2, 115.2, 57.5, 52.7, 48.1, 40.6, 26.8, 25.6, 23.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2938, 2812, 2773, 1765, 1595, 1474, 1454, 1429, 1353, 1263, 1223, 930, 792, 762, 698. HRMS calcd for C<sub>21</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 367.2129, found 367.2127. <i>t</i><sub>R</sub> = 11.0 min; purity = 98.0%; λ<sub>max</sub> = 241 nm.</div></div><div id="sec7_12_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 3-(5-(4-(4-Hydroxyphenyl)piperazin-1-yl)pentyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>75</b>)</h4><div class="NLM_p last">Yield 70% (134 mg), colorless solid, mp = 131–133 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (bs, 1H, OH), 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.70 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.16 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 6.75 (d, <i>J</i> = 9.0 Hz, 2H), 6.63 (d, <i>J</i> = 8.9 Hz, 2H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 3.01–2.84 (m, 4H), 2.48–2.35 (m, 4H), 2.27 (t, <i>J</i> = 7.2 Hz, 2H), 1.78 (p, <i>J</i> = 7.0 Hz, 2H), 1.57–1.40 (m, 2H), 1.40–1.25 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.9, 150.8, 145.5, 144.2, 142.8, 136.5, 118.2, 117.6, 116.3, 115.4, 57.5, 52.9, 49.9, 40.6, 26.8, 25.6, 23.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2939, 2822, 1770, 1512, 1485, 1254, 1228, 830, 749. HRMS calcd for C<sub>21</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 383.2078, found 383.2077. <i>t</i><sub>R</sub> = 9.5 min; purity = 98.0%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 3-(5-(4-(4-Fluorophenyl)piperazin-1-yl)pentyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>76</b>)</h4><div class="NLM_p last">Yield 81% (156 mg), off-white solid, mp = 83–85 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.70 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.16 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 7.07–6.98 (m, 2H), 6.96–6.84 (m, 2H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 3.11–2.90 (m, 4H), 2.47–2.42 (m, 4H), 2.28 (t, <i>J</i> = 7.2 Hz, 2H), 1.78 (p, <i>J</i> = 7.5 Hz, 2H), 1.57–1.42 (m, 2H), 1.40–1.28 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 235.4 Hz), 152.8, 147.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.0 Hz), 145.4, 142.7, 136.4, 118.2, 116.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.5 Hz), 116.24, 115.1 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 57.4, 52.7, 48.9, 40.6, 26.8, 25.6, 23.8. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −128.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2939, 2811, 1767, 1507, 1475, 1455, 1429, 1361, 1220, 831, 761. HRMS calcd for C<sub>21</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 385.2034, found 385.2032. <i>t</i><sub>R</sub> = 11.2 min; purity = 99.5%; λ<sub>max</sub> = 283 nm.</div></div><div id="sec7_12_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 1-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>77</b>)</h4><div class="NLM_p last">Yield 74% (136 mg), off-white solid, mp = 169–171 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.89 (bs, 1H), 7.95 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.19–7.00 (m, 6H), 4.03 (t, <i>J</i> = 7.1 Hz, 2H), 3.30–3.15 (m, 1H), 3.13–3.02 (m, 2H), 2.74 (t, <i>J</i> = 7.0 Hz, 2H), 2.35–2.18 (m, 2H), 1.92–1.75 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.1, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.5 Hz), 155.2, 132.6 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.1 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.7, 127.9, 121.6, 121.6, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.9 Hz), 109.5, 108.2, 56.2, 53.6, 43.7, 39.0, 28.9. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3069, 2953, 2807, 2749, 1690, 1676, 1594, 1489, 1278, 1226, 1195, 1139, 971, 855, 730. HRMS calcd for C<sub>21</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 368.1769, found 368.1766. <i>t</i><sub>R</sub> = 10.6 min; purity = 99.9%; λ<sub>max</sub> = 248 nm.</div></div><div id="sec7_12_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 1-(3-(4-(4-Fluorobenzoyl)piperidin-1-yl)propyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>78</b>)</h4><div class="NLM_p last">Yield 66% (126 mg), off-white solid, mp = 163–165 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.18 (bs, 1H), 7.96 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.20–6.96 (m, 6H), 3.96 (t, <i>J</i> = 6.8 Hz, 2H), 3.18 (p, <i>J</i> = 7.6 Hz, 1H), 2.96 (dt, <i>J</i> = 11.1, 3.4 Hz, 2H), 2.42 (t, <i>J</i> = 6.9 Hz, 2H), 2.14–1.92 (m, 4H), 1.92–1.75 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.3, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.5 Hz), 155.4, 132.6 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.8, 127.9, 121.5, 121.4, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.5, 108.2, 55.5, 53.4, 43.9, 39.1, 28.9, 25.8. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3144, 3069, 2959, 2807, 2769, 1686, 1663, 1596, 1489, 1376, 1227, 1208, 1160, 854, 752, 684. HRMS calcd for C<sub>22</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 382.1925, found 382.1924. <i>t</i><sub>R</sub> = 10.8 min; purity = 99.1%; λ<sub>max</sub> = 278 nm.</div></div><div id="sec7_12_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>79</b>)</h4><div class="NLM_p last">Yield 73% (144 mg), off-white solid, mp = 173–175 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.46 (bs, 1H), 7.94 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.18–6.98 (m, 6H), 3.92 (t, <i>J</i> = 7.0 Hz, 2H), 3.32–3.15 (m, 1H), 3.01 (dt, <i>J</i> = 11.7, 3.7 Hz, 2H), 2.48 (t, <i>J</i> = 7.4 Hz, 2H), 2.26–2.14 (m, 2H), 1.97–1.75 (m, 6H), 1.65 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.0, 165.7 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.8 Hz), 155.8, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.1 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 130.3, 128.2, 121.5, 121.3, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.9 Hz), 109.8, 108.0, 58.0, 53.0, 43.2, 40.5, 28.3, 26.3, 23.8. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3125, 3066, 2933, 2807, 1710, 1677, 1597, 1487, 1404, 1203, 1155, 1142, 746, 680. HRMS calcd for C<sub>23</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 396.2082, found 396.2078. <i>t</i><sub>R</sub> = 11.1 min; purity = 98.8%; λ<sub>max</sub> = 278 nm.</div></div><div id="sec7_12_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 1-(5-(4-(4-Fluorobenzoyl)piperidin-1-yl)pentyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>80</b>)</h4><div class="NLM_p last">Yield 75% (154 mg), off-white solid, mp = 149–151 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.21 (bs, 1H), 7.95 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.19–6.96 (m, 6H), 3.89 (t, <i>J</i> = 7.1 Hz, 2H), 3.33–3.18 (m, 1H), 3.02 (dt, <i>J</i> = 11.7, 4.1 Hz, 2H), 2.49–2.38 (m, 2H), 2.32–2.16 (m, 2H), 2.01–1.74 (m, 6H), 1.71–1.56 (m, 2H), 1.48–1.33 (m, 2H). <sup>13</sup>C NMR (63 MHz CDCl<sub>3</sub>) δ 201.0, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.8 Hz), 155.8, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 130.4, 128.2, 121.5, 121.3, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.8, 107.9, 58.5, 52.9, 42.9, 40.8, 28.3, 28.2, 26.1, 24.8. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3137, 2943, 2917, 2859, 1685, 1671, 1592, 1482, 1399, 1171, 971, 739, 675. HRMS calcd for C<sub>24</sub>H<sub>29</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 410.2238, found 410.2236. <i>t</i><sub>R</sub> = 11.4 min; purity = 99.2%; λ<sub>max</sub> = 279 nm.</div></div><div id="sec7_12_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 1-(6-(4-(4-Fluorobenzoyl)piperidin-1-yl)hexyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>81</b>)</h4><div class="NLM_p last">Yield 89% (188 mg), off-white solid, mp = 126–128 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.70 (bs, 1H), 7.95 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.19–6.92 (m, 6H), 3.87 (t, <i>J</i> = 7.1 Hz, 2H), 3.46–3.33 (m, 1H), 3.16–3.02 (m, 2H), 2.67–2.45 (m, 4H), 2.20–1.87 (m, 4H), 1.86–1.56 (m, 4H), 1.47–1.30 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 200.6, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 255.1 Hz), 155.7, 132.1 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.3, 128.2, 121.5, 121.3, 116.0 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.9 Hz), 109.8, 107.9, 58.1, 52.2, 41.7, 40.7, 28.2, 27.3, 26.9, 26.5, 25.6. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3145, 2934, 2858, 1678, 1595, 1487, 1226, 1156, 753, 681. HRMS calcd for C<sub>25</sub>H<sub>31</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 424.2395, found 424.2391. <i>t</i><sub>R</sub> = 11.7 min; purity = 99.1%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 1-(7-(4-(4-Fluorobenzoyl)piperidin-1-yl)heptyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>82</b>)</h4><div class="NLM_p last">Yield 71% (155 mg), light-brown solid, mp = 55–58 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.93 (bs, 1H), 7.95 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.19–6.94 (m, 6H), 3.86 (t, <i>J</i> = 7.1 Hz, 2H), 3.45–3.32 (m, 1H), 3.16–3.03 (m, 2H), 2.63–2.46 (m, 4H), 2.18–1.85 (m, 4H), 1.83–1.53 (m, 4H), 1.43–1.26 (m, 6H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 200.7, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 255.2 Hz), 155.7, 132.1 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 130.4, 128.2, 121.5, 121.3, 116.0 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.9 Hz), 109.8, 107.9, 58.2, 52.1, 41.6, 40.7, 28.8, 28.3, 27.2, 27.1, 26.6, 25.5. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −105.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 31050, 3066, 2931, 2856, 1678, 1595, 1487, 1224, 1156, 1224, 1156, 753, 734. HRMS calcd for C<sub>26</sub>H<sub>33</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 438.2551, found 438.2547. <i>t</i><sub>R</sub> = 12.0 min; purity = 97.4%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 1-(4-(4-(2-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>83</b>)</h4><div class="NLM_p last">Yield 61% (121 mg), off-white solid, mp = 152–154 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.36 (bs, 1H), 7.75 (td, <i>J</i> = 7.6, 1.9 Hz, 1H), 7.57–7.47 (m, 1H), 7.25–6.96 (m, 6H), 3.91 (t, <i>J</i> = 6.5 Hz, 2H), 3.32–3.21 (m, 1H), 3.15–3.04 (m, 2H), 2.71 (t, <i>J</i> = 7.2 Hz, 2H), 2.52 (d, <i>J</i> = 11.7 Hz, 2H), 2.18–1.71 (m, 8H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 200.6 (d, <sup>3</sup><i>J</i><sub>C=O–F</sub> = 4.3 Hz), 161.2 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 253.1 Hz), 155.4, 134.7 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.1 Hz), 131.1 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 130.3, 127.9, 125.2 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 13.6 Hz), 124.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 3.3 Hz), 121.7, 121.6, 116.7 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 23.9 Hz), 109.7, 108.0, 57.5, 52.3, 46.2, 40.2, 26.5, 26.1, 22.7. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −112.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3066, 2935, 2773, 1697, 1682, 1607, 1486, 1448, 1205, 749. HRMS calcd for C<sub>23</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 396.2082, found 396.2079. <i>t</i><sub>R</sub> = 10.9 min; purity = 97.8%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 1-(4-(4-(3-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>84</b>)</h4><div class="NLM_p last">Yield 76% (150 mg), off-white solid, mp = 203–205 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (bs, 1H), 7.83–7.78 (m, 1H), 7.75–7.68 (m, 1H), 7.63–7.43 (m, 2H), 7.16–7.09 (m, 1H), 7.04–6.94 (m, 3H), 3.78 (t, <i>J</i> = 7.0 Hz, 2H), 3.43–3.28 (m, 1H), 2.83 (d, <i>J</i> = 11.3 Hz, 2H), 2.30 (t, <i>J</i> = 7.1 Hz, 2H), 2.02 (t, <i>J</i> = 11.4 Hz, 2H), 1.78–1.35 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.6 (d, <sup>4</sup><i>J</i><sub>C=O–F</sub> = 2.1 Hz), 162.3 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 245.3 Hz), 154.2, 138.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 6.0 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.8 Hz), 130.2, 128.2, 124.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.7 Hz), 120.6, 120.4, 119.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.3 Hz), 114.6 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 22.2 Hz), 108.6, 107.7, 57.3, 52.4, 42.9, 39.6, 28.3, 25.6, 23.4. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −114.7. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3136, 1946, 2924, 2771, 1697, 1672, 1488, 1442, 1398, 1265, 787, 680. HRMS calcd for C<sub>23</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 414.1988, found 414.1988. <i>t</i><sub>R</sub> = 11.0 min; purity = 99.3%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 1-(4-(4-(3,4-Difluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>85</b>)</h4><div class="NLM_p last">Yield 79% (163 mg), off-white solid, mp = 152–154 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.76 (bs, 1H), 7.82–7.64 (m, 2H), 7.31–7.18 (m, 1H), 7.16–6.96 (m, 4H), 3.92 (t, <i>J</i> = 6.9 Hz, 2H), 3.27–3.12 (m, 1H), 3.10–2.94 (m, 2H), 2.51 (t, <i>J</i> = 7.4 Hz, 2H), 2.33–2.15 (m, 2H), 2.07–1.75 (m, 6H), 1.74–1.58 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 199.9, 155.8, 155.7, 155.5, 152.7, 152.4, 151.6, 151.4, 148.6, 148.5, 133.2, 133.1, 133.0, 130.2, 128.2, 125.4, 125.3, 125.2, 125.2, 121.6, 121.3, 117.8, 117.5, 109.8, 108.0, 57.9, 52.8, 43.1, 40.5, 28.2, 26.2, 23.6. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −130.8, −136.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3131, 3066, 2941, 2801, 2758, 1709, 1681, 1513, 1487, 1404, 1275, 1141, 1109, 732. HRMS calcd for C<sub>23</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 414.1985, found 414.1988. <i>t</i><sub>R</sub> = 11.3 min; purity = 99.5%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 1-(4-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>86</b>)</h4><div class="NLM_p last">Yield 57% (118 mg), off-white solid, mp = 114–116 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.36 (s, 1H), 7.93–7.72 (m, 1H), 7.20–6.69 (m, 6H), 3.88 (t, <i>J</i> = 6.8 Hz, 2H), 3.27–2.93 (m, 3H), 2.86–2.21 (m, 5H), 2.09–1.61 (m, 7H). <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −102.8, −107.4. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2923, 1688, 1608, 1487, 1257, 973, 733. HRMS calcd for C<sub>23</sub>H<sub>26</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 414.1988, found 414.1988. <i>t</i><sub>R</sub> = 11.1 min; purity = 96.1%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 1-(4-(4-(4-Fluorobenzoyl)piperazin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>87</b>)</h4><div class="NLM_p last">Yield 88% (174 mg), off-white solid, mp = 129–131 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.30 (bs, 1H), 7.39 (dd, <i>J</i> = 8.7, 5.3 Hz, 2H), 7.13–6.96 (m, 6H), 3.91 (t, <i>J</i> = 7.1 Hz, 2H), 3.85–3.31 (m, 4H), 2.41 (t, <i>J</i> = 7.3 Hz, 6H), 1.82 (p, <i>J</i> = 7.2 Hz, 2H), 1.58 (d, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 169.5, 163.5 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 249.8 Hz), 155.6, 131.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.5 Hz), 130.4, 129.5 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 8.5 Hz), 128.1, 121.6, 121.4, 115.7 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.7, 108.0, 57.8, 53.2, 42.5, 40.7, 26.2, 24.0. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −111.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3136, 2934, 2804, 1705, 1685, 1625, 1605, 1486, 1454, 1400, 1294, 1141, 1011, 841, 747, 681. HRMS calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 397.2035, found 397.2035. <i>t</i><sub>R</sub> = 9.9 min; purity = 99.7%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 1-(4-(4-(4-Fluorobenzyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>88</b>)</h4><div class="NLM_p last">Yield 65% (124 mg), off-white solid, mp = 98–100 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.78 (bs, 1H), 7.23–6.84 (m, 8H), 3.88 (s, 2H), 3.28 (d, <i>J</i> = 11.8 Hz, 2H), 2.88–2.75 (m, 2H), 2.53 (d, <i>J</i> = 6.2 Hz, 2H), 2.43–2.27 (m, 2H), 1.91–1.56 (m, 9H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 161.6 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 244.1 Hz), 155.5, 135.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.3 Hz), 130.5 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 7.7 Hz), 130.1, 128.0, 121.8, 121.6, 115.3 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.1 Hz), 109.8, 108.0, 57.2, 53.2, 41.6, 39.9, 37.0, 29.9, 25.9, 22.0. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −118.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3144, 2939, 2922, 2861, 1688, 1509, 1487, 1404, 1223, 754. HRMS calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 382.2289, found 382.2289. <i>t</i><sub>R</sub> = 11.7 min; purity = 99.2%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 1-(4-(4-((4-Fluorophenyl)sulfonyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>89</b>)</h4><div class="NLM_p last">Yield 75% (162 mg), off-white solid, mp = 73–75 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.05 (bs, 1H), 7.86 (dd, <i>J</i> = 8.8, 5.1 Hz, 2H), 7.22 (t, <i>J</i> = 8.8 Hz, 2H), 7.13–6.95 (m, 4H), 3.89 (t, <i>J</i> = 7.0 Hz, 2H), 3.03–2.91 (m, 2H), 2.84 (dt, <i>J</i> = 12.2, 3.7 Hz, 1H), 2.39–2.29 (m, 2H), 2.01–1.46 (m, 10H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 166.0 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 256.5 Hz), 155.7, 132.9 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.2 Hz), 132.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5 Hz), 130.3, 128.1, 121.6, 121.4, 116.6 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 22.5 Hz), 109.7, 108.0, 62.2, 57.5, 52.4, 40.6, 26.2, 25.6, 24.1. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −104.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3102, 2950, 2814, 1689, 1589, 1489, 1311, 1288, 1138, 1085, 839, 673. HRMS calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 432.1752, found 432.1749. <i>t</i><sub>R</sub> = 10.3 min; purity = 99.9%; λ<sub>max</sub> = 280 nm.</div></div><div id="sec7_12_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 1-Butyl-3-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>90</b>)</h4><div class="NLM_p last">Yield 64% (145 mg), off-white solid, mp = 81–83 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.89 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.10–6.88 (m, 6H), 3.93–3.70 (m, 4H), 3.12 (p, <i>J</i> = 7.6 Hz, 1H), 2.91 (dt, <i>J</i> = 10.8, 2.6 Hz, 2H), 2.41–2.30 (m, 2H), 2.11–1.96 (m, 2H), 1.86–1.44 (m, 10H), 1.42–1.23 (m, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 200.9, 165.6 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.5 Hz), 154.2, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 130.8 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 129.5, 129.3, 121.0, 120.9, 115.7 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 107.6, 107.5, 58.0, 53.1, 43.6, 40.8, 40.8, 30.5, 28.6, 26.2, 24.0, 20.1, 13.7. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2931, 2874, 2802, 1697, 1678, 1598, 1493, 1229, 739. HRMS calcd for C<sub>27</sub>H<sub>35</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 452.2708, found 452.2712. <i>t</i><sub>R</sub> = 13.0 min; purity = 97.8%; λ<sub>max</sub> = 282 nm.</div></div><div id="sec7_12_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 5-Bromo-1-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>91</b>)</h4><div class="NLM_p last">Yield 81% (192 mg), off-white solid, mp = 153–155 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.40 (bs, 1H), 7.95 (dd, <i>J</i> = 8.9, 5.4 Hz, 2H), 7.29–7.08 (m, 4H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 3.89 (t, <i>J</i> = 7.0 Hz, 2H), 3.26–3.13 (m, 1H), 2.98 (d, <i>J</i> = 11.5 Hz, 2H), 2.43 (t, <i>J</i> = 7.3 Hz, 2H), 2.18–2.05 (m, 2H), 1.92–1.72 (m, 6H), 1.70–1.52 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.1, 165.7 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.5 Hz), 155.6, 132.5 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.1 Hz), 129.5, 129.3, 124.2, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 114.1, 112.9, 109.2, 58.1, 53.3, 43.7, 40.8, 28.7, 26.3, 24.1. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3170, 2919, 2809, 2760, 1690, 1675, 1593, 1483, 1403, 1333, 1204, 1156, 853, 785. HRMS calcd for C<sub>23</sub>H<sub>26</sub><sup>79</sup>BrFN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 474.1187, found 474.1183. <i>t</i><sub>R</sub> = 11.9 min; purity = 98.8%; λ<sub>max</sub> = 241 nm.</div></div><div id="sec7_12_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 5-Iodo-1-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>92</b>)</h4><div class="NLM_p last">Yield 89% (232 mg), off-white solid, mp = 195–197 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (bs, 1H), 8.00 (dd, <i>J</i> = 8.9, 5.5 Hz, 2H), 7.34–7.19 (m, 4H), 6.96 (d, <i>J</i> = 8.2 Hz, 1H), 3.72 (t, <i>J</i> = 6.9 Hz, 2H), 3.39–3.22 (m, 1H), 2.79 (d, <i>J</i> = 11.6 Hz, 2H), 2.25 (t, <i>J</i> = 7.1 Hz, 2H), 2.06–1.89 (m, 2H), 1.76–1.27 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.0, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.7 Hz), 153.7, 132.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.1, 130.0, 128.8, 116.7, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 110.0, 83.1, 57.1, 52.3, 42.5, 39.7, 28.2, 25.4, 23.1. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3162, 3107, 3014, 2937, 2916, 2862, 2805, 1682, 1596, 1487, 1145, 1108, 974, 749. HRMS calcd for C<sub>23</sub>H<sub>26</sub>FIN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 522.1048, found 522.1042. <i>t</i><sub>R</sub> = 12.1 min; purity = 99.4%; λ<sub>max</sub> = 241 nm.</div></div><div id="sec7_12_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 5,6-Dichloro-1-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>93</b>)</h4><div class="NLM_p last">Yield 65% (169 mg), colorless solid, mp = 164–166 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (bs, 1H, NH), 8.04 (dd, <i>J</i> = 9.0, 5.6 Hz, 2H), 7.48 (s, 1H), 7.34 (t, <i>J</i> = 8.9 Hz, 2H), 7.15 (s, 1H), 3.78 (t, <i>J</i> = 7.0 Hz, 2H), 3.42–3.23 (m, 1H), 2.84 (d, <i>J</i> = 11.7 Hz, 2H), 2.29 (t, <i>J</i> = 7.1 Hz, 2H), 2.01 (td, <i>J</i> = 11.4, 2.1 Hz, 2H), 1.81–1.34 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.6 Hz), 154.2, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.3, 128.3, 122.7, 122.6, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.9 Hz), 109.9, 109.3, 57.3, 52.5, 42.8, 39.9, 28.4, 25.4, 23.3. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2934, 2764, 1698, 1677, 1597, 1493, 1102, 851. HRMS calcd for C<sub>23</sub>H<sub>25</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 464.1302, found 464.1302. <i>t</i><sub>R</sub> = 12.3 min; purity = 100%; λ<sub>max1</sub>, 241 nm; λ<sub>max2</sub>, 298 nm.</div></div><div id="sec7_12_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 1-Butyl-5,6-dichloro-3-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>94</b>)</h4><div class="NLM_p last">Yield 68% (177 mg), light-brown oil. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.93 (dd, <i>J</i> = 9.0, 5.4 Hz, 2H), 7.11 (t, <i>J</i> = 8.7 Hz, 2H), 7.05 (s, 1H), 7.02 (s, 1H), 3.82 (q, <i>J</i> = 7.3 Hz, 4H), 3.24–3.10 (m, 1H), 2.95 (dt, <i>J</i> = 10.9, 2.7 Hz, 2H), 2.38 (t, <i>J</i> = 7.3 Hz, 2H), 2.13–2.00 (m, 2H), 1.87–1.62 (m, 8H), 1.61–1.47 (m, 2H), 1.44–1.26 (m, 2H), 0.93 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.0, 165.7 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.4 Hz), 154.2, 132.6 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 130.9 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 129.1, 129.0, 124.7, 124.6, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.3, 109.2, 58.0, 53.3, 43.8, 41.3, 41.2, 30.4, 28.8, 26.2, 24.0, 20.1, 13.8. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.6. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2932, 2872, 2808, 2769, 1704, 1678, 1595, 1500, 1404, 1227, 1104, 850, 650. HRMS calcd for C<sub>27</sub>H<sub>33</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 520.1928, found 520.1923. <i>t</i><sub>R</sub> = 14.2 min; purity = 97.1%; λ<sub>max</sub> = 244 nm.</div></div><div id="sec7_12_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 5,7-Dichloro-1-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>95</b>)</h4><div class="NLM_p last">Yield 71% (165 mg), off-white solid, mp = 212–214 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 8.04 (dd, <i>J</i> = 8.8, 5.6 Hz, 2H), 7.34 (t, <i>J</i> = 8.8 Hz, 2H), 7.13 (d, <i>J</i> = 1.9 Hz, 1H), 6.99 (d, <i>J</i> = 2.0 Hz, 1H), 4.01 (t, <i>J</i> = 7.2 Hz, 2H), 3.51–3.19 (m, 1H), 2.83 (d, <i>J</i> = 11.5 Hz, 2H), 2.29 (t, <i>J</i> = 7.1 Hz, 2H), 2.01 (t, <i>J</i> = 10.7 Hz, 2H), 1.83–1.34 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.6 Hz), 154.1, 132.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.3, 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 125.3, 125.2, 121.2, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.7 Hz), 113.3, 107.9, 57.4, 52.5, 42.8, 41.0, 28.4, 28.0, 23.3. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3100, 2921, 2859, 1467, 1401, 1114, 980, 829, 746. HRMS calcd for C<sub>23</sub>H<sub>25</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 464.1302, found 464.1300. <i>t</i><sub>R</sub> = 12.4 min; purity = 99.6%; λ<sub>max</sub> = 241 nm.</div></div><div id="sec7_12_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 3-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>96</b>)</h4><div class="NLM_p last">Yield 52% (103 mg), colorless solid, mp = 159–161 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 9.84 (bs, 1H, NH), 8.05 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H), 7.95 (dd, <i>J</i> = 8.7, 5.4 Hz, 2H), 7.29 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.13 (t, <i>J</i> = 8.7 Hz, 2H), 6.98 (dd, <i>J</i> = 7.7, 5.2 Hz, 1H), 4.04 (t, <i>J</i> = 7.1 Hz, 2H), 3.31–3.09 (m, 1H), 3.00 (d, <i>J</i> = 11.8 Hz, 2H), 2.45 (d, <i>J</i> = 7.5 Hz, 2H), 2.24–2.00 (m, 2H), 1.97–1.72 (m, 6H), 1.73–1.51 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.1, 165.8 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.5 Hz), 155.1, 144.5, 141.0, 132.6 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.1 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.2 Hz), 122.4, 117.3, 115.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 115.5, 58.4, 53.3, 43.7, 39.8, 28.7, 26.6, 24.2. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3072, 2942, 2805, 2765, 1717, 1693, 1676, 1597, 1467, 1394, 1226, 1203, 1103, 888, 794, 771, 679. HRMS calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 397.2034, found 397.2030. <i>t</i><sub>R</sub> = 10.3 min; purity = 100%; λ<sub>max</sub> = 247 nm.</div></div><div id="sec7_12_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>97</b>)</h4><div class="NLM_p last">Yield 55% (109 mg), colorless solid, mp = 147–149 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.49 (bs, 1H), 8.04 (dd, <i>J</i> = 8.8, 5.7 Hz, 2H), 7.90 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.47 (dd, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.34 (t, <i>J</i> = 8.8 Hz, 2H), 7.01 (dd, <i>J</i> = 7.7, 5.3 Hz, 1H), 3.80 (t, <i>J</i> = 6.9 Hz, 2H), 3.37–3.29 (m, 1H), 2.90–2.79 (m, 2H), 2.41–2.22 (m, 2H), 2.11–1.91 (m, 2H), 1.79–1.35 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.6 Hz), 153.6, 143.5, 139.7, 132.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 124.3, 116.5, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 113.7, 57.2, 52.4, 42.7, 39.6, 28.4, 25.5, 23.4. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3121, 3062, 2950, 2806, 2770, 1705, 1671, 1593, 1443, 1406, 1135, 975, 867, 688. HRMS calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 397.2034, found 397.2031. <i>t</i><sub>R</sub> = 10.1 min; purity = 99.7%; λ<sub>max</sub> = 248 nm.</div></div><div id="sec7_12_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 1-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one (<b>98</b>)</h4><div class="NLM_p last">Yield 42% (83 mg), off-white solid, mp = 145–147 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.37 (s, 1H), 8.32 (d, <i>J</i> = 5.3 Hz, 1H), 7.95 (dd, <i>J</i> = 8.8, 5.4 Hz, 2H), 7.13 (t, <i>J</i> = 8.6 Hz, 2H), 6.98 (d, <i>J</i> = 5.3 Hz, 1H), 3.91 (t, <i>J</i> = 6.9 Hz, 2H), 3.37–3.19 (m, 1H), 3.09–2.95 (m, 2H), 2.63–2.46 (m, 2H), 2.37–2.18 (m, 2H), 2.07–1.76 (m, 6H), 1.74–1.59 (m, 2H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 200.9, 165.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 254.9 Hz), 154.9, 143.1, 136.8, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 3.0 Hz), 131.0 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.3 Hz), 130.4, 125.6, 116.0 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.7 Hz), 103.5, 57.8, 52.8, 42.7, 40.9, 28.1, 26.2, 23.6. <sup>19</sup>F NMR (235 MHz, CDCl<sub>3</sub> + TFT) δ −106.3. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3179, 3044, 2949, 2925, 2804, 1726, 1676, 1598, 1504, 1114, 976, 835, 606. HRMS calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 397.2034, found 397.2033.</div></div><div id="sec7_12_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> 3-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>99</b>)</h4><div class="NLM_p last">Yield 66% (131 mg), off-white solid, mp = 93–95 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04 (dd, <i>J</i> = 8.8, 5.7 Hz, 2H), 7.39–7.28 (m, 4H), 7.27–7.08 (m, 2H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 3.45–3.35 (m, 1H), 2.84 (d, <i>J</i> = 11.4 Hz, 2H), 2.31 (t, <i>J</i> = 7.1 Hz, 2H), 2.12–1.92 (m, 2H), 1.79–1.63 (m, 4H), 1.61–1.38 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.7 Hz), 153.8, 141.9, 132.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.4 Hz), 131.0, 123.8, 122.1, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.6, 109.2, 57.1, 52.5, 42.7, 41.5, 28.4, 25.0, 23.2. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3273, 3072, 2972, 2938, 2819, 2779, 1778, 1676, 1597, 1486, 1360, 1223, 828, 735. HRMS calcd for C<sub>23</sub>H<sub>26</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 397.1922, found 397.1919. <i>t</i><sub>R</sub> = 11.7 min; purity = 99.9%; λ<sub>max</sub> = 254 nm.</div></div><div id="sec7_12_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 3-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>100</b>)</h4><div class="NLM_p last">Yield 58% 115 mg), off-white solid, mp = 96–98 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 8.04 (dd, <i>J</i> = 8.9, 5.5 Hz, 2H), 7.70 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.34 (t, <i>J</i> = 8.9 Hz, 2H), 7.16 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 3.84 (t, <i>J</i> = 7.0 Hz, 2H), 3.46–3.33 (m, 1H), 2.83 (d, <i>J</i> = 11.4 Hz, 2H), 2.31 (t, <i>J</i> = 7.2 Hz, 2H), 2.13–1.93 (m, 2H), 1.88–1.65 (m, 4H), 1.63–1.39 (m, 4H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.5 Hz), 152.9, 145.5, 142.7, 136.5, 132.3 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.8 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5 Hz), 118.2, 116.3, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 57.3, 52.5, 42.7, 40.7, 28.4, 25.0, 23.4. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2932, 2863, 2805, 1777, 1674, 1593, 1479, 1457, 1263, 1204, 1157, 972, 763. HRMS calcd for C<sub>22</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 398.1874, found 398.1872. <i>t</i><sub>R</sub> = 11.1 min; purity = 99.9%; λ<sub>max</sub> = 248 nm.</div></div><div id="sec7_12_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 3-(5-(4-(4-Fluorobenzoyl)piperidin-1-yl)pentyl)benzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (<b>101</b>)</h4><div class="NLM_p last">Yield 63% (129 mg), off-white solid, mp = 86–88 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03 (dd, <i>J</i> = 8.7, 5.7 Hz, 2H), 7.37–7.27 (m, 4H), 7.21 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 7.11 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 3.81 (t, <i>J</i> = 7.0 Hz, 2H), 3.34–3.25 (m, 1H), 2.83 (d, <i>J</i> = 11.5 Hz, 2H), 2.24 (t, <i>J</i> = 7.1 Hz, 2H), 1.99 (t, <i>J</i> = 10.6 Hz, 2H), 1.82–1.62 (m, 4H), 1.61–1.38 (m, 4H), 1.36–1.21 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.7 Hz), 153.8, 141.9, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5 Hz), 131.0, 123.9, 122.1, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 109.6, 109.2, 57.8, 52.6, 42.8, 41.6, 28.4, 27.0, 25.8, 23.9. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2941, 2864, 2806, 2751, 1761, 1667, 1593, 1487, 1364, 1250, 1222, 1161, 754. HRMS calcd for C<sub>24</sub>H<sub>28</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 411.2078, found 411.2076. <i>t</i><sub>R</sub> = 12.2 min; purity = 100%; λ<sub>max</sub> = 254 nm.</div></div><div id="sec7_12_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 3-(5-(4-(4-Fluorobenzoyl)piperidin-1-yl)pentyl)oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one (<b>102</b>)</h4><div class="NLM_p last">Yield 76% (156 mg), colorless solid, mp = 80–82 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 8.04 (dd, <i>J</i> = 8.9, 5.6 Hz, 2H), 7.71 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.34 (t, <i>J</i> = 8.9 Hz, 2H), 7.16 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 3.43–3.23 (m, 1H), 2.84 (d, <i>J</i> = 11.6 Hz, 2H), 2.24 (t, <i>J</i> = 7.1 Hz, 2H), 1.99 (td, <i>J</i> = 11.7, 2.5 Hz, 2H), 1.75 (td, <i>J</i> = 13.5, 12.7, 6.0 Hz, 4H), 1.61–1.39 (m, 4H), 1.38–1.25 (m, 2H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.2, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.7 Hz), 152.8, 145.5, 142.8, 136.4, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.5 Hz), 118.2, 116.3, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 57.8, 52.6, 42.8, 40.6, 28.4, 26.8, 25.8, 23.9. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2944, 2927, 2854, 2808, 1766, 1675, 1597, 1475, 1455, 1361, 1265, 1217, 979, 789. HRMS calcd for C<sub>23</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 412.2031, found 412.2028. <i>t</i><sub>R</sub> = 11.3 min; purity = 96.9%; λ<sub>max</sub> = 249 nm.</div></div><div id="sec7_12_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> 2-(4-(4-(4-Fluorobenzoyl)piperidin-1-yl)butyl)isoindoline-1,3-dione (<b>103</b>)</h4><div class="NLM_p last">Yield 65% (133 mg), colorless solid; mp = 105–107 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04 (dd, <i>J</i> = 8.9, 5.6 Hz, 2H), 7.90–7.79 (m, 4H), 7.33 (t, <i>J</i> = 8.8 Hz, 2H), 3.58 (t, <i>J</i> = 6.9 Hz, 2H), 3.43–3.35 (m, 1H), 2.84 (d, <i>J</i> = 11.7 Hz, 2H), 2.29 (t, <i>J</i> = 7.2 Hz, 2H), 2.02 (td, <i>J</i> = 11.4, 2.0 Hz, 2H), 1.77–1.36 (m, 8H). <sup>13</sup>C NMR (63 MHz, DMSO-<i>d</i><sub>6</sub>) δ 201.1, 168.0, 164.9 (d, <sup>1</sup><i>J</i><sub>C–F</sub> = 251.6 Hz), 134.3, 132.4 (d, <sup>4</sup><i>J</i><sub>C–F</sub> = 2.9 Hz), 131.6, 131.1 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 9.4 Hz), 123.0, 115.8 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 21.8 Hz), 57.4, 52.5, 42.8, 37.4, 28.4, 25.9, 23.7. <sup>19</sup>F NMR (235 MHz, DMSO-<i>d</i><sub>6</sub> + TFT) δ −108.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2943, 2927, 2871, 2807, 1766, 1712, 1682, 1592, 1395, 1370, 1224, 1047, 972, 860, 721. HRMS calcd for C<sub>24</sub>H<sub>26</sub>FN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 409.1922, found 409.1920. <i>t</i><sub>R</sub> = 11.6 min; purity = 96.4%; λ<sub>max</sub> = 290 nm.</div></div><div id="sec7_12_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> 1-(4-(4-(4-Nitrobenzoyl)piperidin-1-yl)butyl)-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>111</b>)</h4><div class="NLM_p last">Yield 80% (169 mg), light-yellow solid; mp = 128–130 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.20 (bs, 1H), 8.29 (d, <i>J</i> = 8.6 Hz, 2H), 8.04 (d, <i>J</i> = 8.6 Hz, 2H), 7.16–6.98 (m, 4H), 3.92 (t, <i>J</i> = 7.1 Hz, 2H), 3.27–3.15 (m, 1H), 2.97 (d, <i>J</i> = 11.6 Hz, 2H), 2.42 (t, <i>J</i> = 7.4 Hz, 2H), 2.10 (td, <i>J</i> = 11.1, 2.7 Hz, 2H), 1.90–1.73 (m, 6H), 1.66–1.54 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 201.2, 155.8, 150.3, 140.8, 130.4, 129.3, 128.2, 124.0, 121.5, 121.3, 109.8, 108.0, 58.1, 53.1, 44.4, 40.7, 28.5, 26.3, 24.1. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3138, 3066, 2930, 2856, 2807, 1708, 1683, 1522, 1485, 1400, 1358, 1201, 751. HRMS calcd for C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 423.2027, found 423.2022. <i>t</i><sub>R</sub> = 11.1 min; purity = 98.5%; λ<sub>max</sub> = 273 nm.</div></div><div id="sec7_12_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 1-(6-(4-(4-Nitrobenzoyl)piperidin-1-yl)butyl)-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>112</b>)</h4><div class="NLM_p last">Yield 99% (223 mg), off-white solid, mp = 193–195 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.72 (bs, 1H), 8.30 (d, <i>J</i> = 8.8 Hz, 2H), 8.05 (d, <i>J</i> = 8.8 Hz, 2H), 7.14–6.93 (m, 4H), 3.88 (t, <i>J</i> = 7.2 Hz, 2H), 3.30–3.13 (m, 1H), 2.98 (d, <i>J</i> = 11.8 Hz, 2H), 2.39–2.26 (m, 2H), 2.07 (dt, <i>J</i> = 11.2, 5.8 Hz, 2H), 1.92–1.72 (m, 6H), 1.56–1.31 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 201.3, 155.6, 150.3, 140.9, 130.5, 129.4, 128.1, 124.1, 121.5, 121.4, 109.7, 108.0, 58.9, 53.2, 44.5, 40.9, 28.6, 28.5, 27.4, 26.9, 26.8. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3132, 2942, 2923, 2871, 2758, 1712, 1685, 1520, 1487, 1405, 1200, 1142, 753. HRMS calcd for C<sub>25</sub>H<sub>31</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 451.2340, found 451.2337. <i>t</i><sub>R</sub> = 11.7 min; purity = 96.8%; λ<sub>max</sub> = 273 nm.</div></div></div><div id="sec7_12_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> Ethyl 1-Benzoylpiperidine-4-carboxylate (<b>105</b>)</h3><div class="NLM_p last">Benzoyl chloride (7.4 mL, 63.61 mmol, 1 equiv) was added dropwise to a stirred solution of ethyl isonipecotate <b>104</b> (10 g, 63.61 mmol, 1 equiv) and triethylamine (13.3 mL, 95.42 mmol, 1.5 equiv) in dry DCM (100 mL) at room temperature. The mixture was stirred at room temperature for 20 h. The solution was quenched with water, and the organic layer was extracted three times with DCM. The combined organic layers were washed with aqueous 0.5 M HCl and satd NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Product <b>105</b> was isolated and engaged in the next step without further purification. Yield 100% (16.623 g), off-white solid, mp = 69–71 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 7.38 (s, 5H), 4.49 (s, 1H), 4.23–4.07 (m, 2H), 3.73 (s, 1H), 3.03 (t, <i>J</i> = 12.0 Hz, 2H), 2.67–2.46 (m, 1H), 2.30–1.46 (m, 4H), 1.34–1.17 (m, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 174.2, 170.4, 136.1, 129.6, 128.5, 126.8, 60.7, 46.9, 41.6, 41.1, 28.3, 14.2. IR (cm<sup>–1</sup>) υ<sub>max</sub> 2959, 2930, 2859, 1717, 1631, 1427, 1316, 1182, 1046, 707. HRMS calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 262.1437, found 262.1441.</div></div><div id="sec7_12_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> 1-Benzoylpiperidine-4-carboxylic Acid (<b>106</b>)</h3><div class="NLM_p last">At room temperature, sodium hydroxide (6.12 g, 0.153 mol) was added portionwise to a stirred solution of benzamide <b>105</b> (7.4 mL, 63.61 mmol, 1 equiv) in EtOH 70% (60 mL), and the mixture was stirred for 18 h. The solution was slowly acidified to pH 3 with AcOH, and the resulting mixture was concentrated in vacuo. The oily residue was partitioned between DCM and water, and the aqueous layer was extracted three times with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, concentrated in vacuo, coevaporated with toluene to remove traces of AcOH, and yielded the desired carboxylic acid <b>106</b> in analytically pure form. Yield 89% (12.795 g), colorless solid, mp = 125–127 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 10.71 (bs, 1H), 7.38 (s, 5H), 4.48 (s, 1H), 3.71 (s, 1H), 3.06 (t, <i>J</i> = 11.8 Hz, 2H), 2.68–2.48 (m, 1H), 2.15–1.52 (m, 4H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 178.5, 170.9, 135.5, 129.8, 128.5, 126.9, 47.0, 41.7, 40.7, 27.9. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3055, 2976, 2858, 1729, 1611, 1575, 1446, 1401, 1293, 1169, 1014, 707. HRMS calcd for C<sub>13</sub>H<sub>16</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 234.1125, found 234.1126.</div></div><div id="sec7_12_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> (1-Benzoylpiperidin-4-yl)(4-bromophenyl)methanone (<b>107</b>)</h3><div class="NLM_p last">oxalyl chloride (1.9 mL, 22.40 mmol, 1.1 equiv) was added dropwise to a stirred solution of carboxylic acid <b>106</b> (4.75 g, 20.36 mmol, 1 equiv) dissolved in anhydrous DCM (190 mL) at room temperature. The solution was stirred for 15 h and concentrated in vacuo. The residue was dissolved in bromobenzene (24 mL), and aluminum chloride (4.07 g, 30.54 mmol, 1.5 equiv) was added portionwise to the stirred solution. The mixture was heated at 90 °C for 6.5 h, cooled to room temperature, and poured onto iced water. The aqueous layer was extracted three times with DCM, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel using a PE/AcOEt mixture (7:3 to 1:1) to afford the desired product <b>107</b>. Yield 40% (3.032 g), colorless solid, mp = 118–120 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 8.6 Hz, 2H), 7.62 (d, <i>J</i> = 8.6 Hz, 2H), 7.41 (s, 5H), 4.95–4.53 (m, 1H), 4.11–3.69 (m, 1H), 3.56–3.42 (m, 1H), 3.25–2.96 (m, 2H), 2.08–1.70 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 200.7, 170.6, 136.0, 134.5, 132.3, 129.9, 129.8, 128.6, 128.6, 127.0, 47.2, 43.4, 41.8, 28.7. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3060, 2940, 2857, 1678, 1616, 1585, 1444, 1317, 1215, 1070, 971, 707. HRMS calcd for C<sub>19</sub>H<sub>19</sub><sup>79</sup>BrNO<sub>2</sub> [M + H]<sup>+</sup> 372.0594, found 372.0596.</div></div><div id="sec7_12_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> (4-(4-Aminobenzoyl)piperidin-1-yl) (phenyl)methanone (<b>108</b>)</h3><div class="NLM_p last">An oven-dried tube was successively charged with brominated product <b>107</b> (3.9 g, 10.48 mmol, 1 equiv), copper iodide (201 mg, 1.048 mmol, 10 mol %), and potassium phosphate (4.44 g, 20.9 mmol, 2 equiv), sealed, and purged with vacuum–argon cycles. The solid mixture was dissolved in ammonium hydroxide 28% (21 mL) and DMF (30 mL) and purged again with vacuum–argon cycles. The resulting mixture was heated at 90 °C for 27 h, cooled down to room temperature, and partitioned between DCM and water. The aqueous layer was extracted three times with DCM, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel using a PE/AcOEt/MeOH mixture (1:1:0 then 0:1:0 then 0:95:5) to yield the desired benzoylamine <b>108</b>. Yield 85% (2.329 g), colorless solid, mp = 184–186 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (d, <i>J</i> = 8.8 Hz, 2H), 7.40 (s, 5H), 6.64 (d, <i>J</i> = 8.8 Hz, 2H), 4.70 (m, 1H), 4.24 (m, 2H), 3.85 (m, 1H), 3.53–3.40 (m, 1H), 3.09 (m, 2H), 2.07–1.66 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 199.8, 170.6, 151.6, 136.2, 130.9, 129.7, 128.6, 126.9, 125.9, 114.0, 47.4, 42.7, 42.0, 29.0. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3453, 3340, 3220, 2958, 2928, 1654, 1588, 1575, 1558, 1432, 1333, 1170, 972. HRMS calcd for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1598, found 309.1597.</div></div><div id="sec7_12_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> (1-Benzoylpiperidin-4-yl)(4-nitrophenyl)methanone (<b>109</b>)</h3><div class="NLM_p last">A solution of benzoylamine <b>108</b> (2.73 g, 8.85 mmol, 1 equiv) in CHCl<sub>3</sub> (150 mL) was added dropwise to a stirred solution of <i>m</i>-CPBA (8.73 g, 35.41 mmol, 4 equiv) in CHCl<sub>3</sub> (150 mL). the mixture was heated at 60 °C for 45 min then the cooled solution was washed with aqueous 1N NaOH and water, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel using a PE/AcOEt mixture (6:4 to 4:6) to yield the desired 4-nitrobenzoyl derivative <b>109</b>. Yield 65% (1.261 g), light-brown solid; mp = 149–151 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 8.8 Hz, 2H), 8.10 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (s, 5H), 4.79–4.60 (m, 1H), 4.03–3.77 (m, 1H), 3.62–3.50 (m, 1H), 3.14 (s, 2H), 2.09–1.74 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 200.3, 170.6, 150.5, 140.4, 135.9, 129.9, 129.4, 128.7, 127.0, 124.2, 47.0, 44.0, 41.7, 28.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3065, 2941, 2860, 1687, 1615, 1526, 1443, 1347, 1313, 1211, 1103, 968, 704. HRMS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 339.1339, found 339.1339.</div></div><div id="sec7_12_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> (4-Nitrophenyl)(piperidin-4-yl)methanone (<b>110</b>)</h3><div class="NLM_p last">A solution of nitrobenzoylpiperidine <b>109</b> (500 mg, 1.48 mmol, 1 equiv) was solubilized in EtOH 70% (6 mL) and 12 M HCl (aq) (20 mL). The solution was heated at 110 °C for 24 h. The cooled mixture was concentrated in vacuo until no EtOH remained. The residue was carefully alkalized with a saturated solution of KOH until pH = 13–14. The aqueous layer was extracted three times with AcOEt. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield product <b>110</b> in analytically pure form. Yield 81% (280 mg), light-yellow solid; mp = 65–67 °C. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 9.0 Hz, 2H), 8.07 (d, <i>J</i> = 9.0 Hz, 2H), 3.37 (tt, <i>J</i> = 11.1, 3.7 Hz, 1H), 3.20 (dt, <i>J</i> = 12.8, 3.3 Hz, 2H), 2.77 (td, <i>J</i> = 12.4, 2.8 Hz, 2H), 1.90–1.79 (m, 2H), 1.78–1.62 (m, 2H), 1.60 (bs, 1H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>) δ 201.1, 150.3, 140.8, 129.4, 124.0, 46.0, 44.8, 29.5. IR (cm<sup>–1</sup>) υ<sub>max</sub> 3235, 3112, 2934, 2804, 1520, 1349, 1275, 990, 707. HRMS calcd for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 235.1077, found 235.1079.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i147"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00874">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00874" class="ext-link">10.1021/acs.jmedchem.5b00874</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR of synthetic intermediates and final products, HPLC chromatograms of products tested in vitro and in vivo, reference and negative controls of 5-CT, SB-26970, and ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b> for cAMP accumulation (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_001.pdf">jm5b00874_si_001.pdf (26.82 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_002.csv">jm5b00874_si_002.csv (6.38 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00874" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franck Suzenet</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e88e9a89868b83c69b9d928d868d9ca89d86819ec5879a848d89869bc68e9a"><span class="__cf_email__" data-cfemail="a1c7d3c0cfc2ca8fd2d4dbc4cfc4d5e1d4cfc8d78cced3cdc4c0cfd28fc7d3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gérald Guillaumet</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#81e6e4f3e0ede5afe6f4e8edede0f4ece4f5c1f4efe8f7aceef3ede4e0eff2afe7f3"><span class="__cf_email__" data-cfemail="6e090b1c0f020a40091b0702020f1b030b1a2e1b00071843011c020b0f001d40081c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel Deau</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elodie Robin</span> - <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, Centre
National de la Recherche Scientifique (CNRS), UPR 4301, Université
d’Orléans et INSERM, rue Charles Sadron, 45071 Orléans Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raluca Voinea</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span>; 
    <span class="hlFld-Affiliation affiliation">Centrul
de Cercetare ‘Chimie Aplicată şi Inginerie de
Proces’, Universitatea din Bacău, Calea Mărăşesti,
nr. 157, 600115 Bacău, Romania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathalie Percina</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grzegorz Satała</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacology, Polish Academy
of Sciences, 12 Smętna
Street, Kraków 31-343, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adriana-Luminita Finaru</span> - <span class="hlFld-Affiliation affiliation">Centrul
de Cercetare ‘Chimie Aplicată şi Inginerie de
Proces’, Universitatea din Bacău, Calea Mărăşesti,
nr. 157, 600115 Bacău, Romania</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnès Chartier</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique (ICOA), Université d’Orléans, CNRS, UMR 7311, rue de Chartres, F-45067 Orleans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilles Tamagnan</span> - <span class="hlFld-Affiliation affiliation">Molecular
NeuroImaging, 60 Temple
Street, New Haven, Connecticut 06510, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Alagille</span> - <span class="hlFld-Affiliation affiliation">Molecular
NeuroImaging, 60 Temple
Street, New Haven, Connecticut 06510, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrzej J. Bojarski</span> - <span class="hlFld-Affiliation affiliation">Institute of Pharmacology, Polish Academy
of Sciences, 12 Smętna
Street, Kraków 31-343, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Séverine Morisset-Lopez</span> - <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, Centre
National de la Recherche Scientifique (CNRS), UPR 4301, Université
d’Orléans et INSERM, rue Charles Sadron, 45071 Orléans Cedex 2, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. E.D. and E.R. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1946e13246-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i149">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">E.D. and E.R. thank the Région Centre (Project serosero7) for financial support. Christelle Pillard (Greenpharma, Orléans, France) is gratefully acknowledged for performing the synthesis of the three nitro precursors. This work has been partially supported by University of Orleans, Region Centre, CNRS, Labex SynOrg (ANR-11-LABX-0029), the Ligue Contre le Cancer (Loiret and Cher Comities), and EFRD. Radioligand binding experiments were financially supported by the project POIG.01.01.02-12-004/09-00 (De-Me-Ter), which was cofinanced by the European Union from the European Fund of Regional Development (EFRD).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i150" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i150"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i151" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i151"> Abbreviations Used</h2><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine (serotonin)</p></td></tr><tr><td class="NLM_term">5-HT<sub>7</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>7</sub> receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">3′-5′-cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">LGIC</td><td class="NLM_def"><p class="first last">ligand-gated ion channel</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenyl phosphorylazide</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">AcOEt</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">methylene chloride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">TFT</td><td class="NLM_def"><p class="first last">α,α,α-trifluorotoluene</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standard uptake value</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i152">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zgombick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaysse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshank, R. L.</span><span> </span><span class="NLM_article-title">Cloning of a Novel Human Serotonin Receptor (5-HT<sub>7</sub>) Positively Linked to Adenylate Cyclase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">23422</span><span class="NLM_x">–</span> <span class="NLM_lpage">23426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=23422-23426&author=J.+A.+Bardauthor=J.+Zgombickauthor=N.+Adhamauthor=P.+Vaysseauthor=T.+A.+Branchekauthor=R.+L.+Weinshank&title=Cloning+of+a+Novel+Human+Serotonin+Receptor+%285-HT7%29+Positively+Linked+to+Adenylate+Cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBard%26aufirst%3DJ.%2BA.%26aulast%3DZgombick%26aufirst%3DJ.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DVaysse%26aufirst%3DP.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26atitle%3DCloning%2520of%2520a%2520Novel%2520Human%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Positively%2520Linked%2520to%2520Adenylate%2520Cyclase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D23422%26epage%3D23426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Molecular Cloning, Characterization, and Localization of a High-Affinity Serotonin Receptor (5-HT<sub>7</sub>) Activating cAMP Formation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">8547</span><span class="NLM_x">–</span> <span class="NLM_lpage">8551</span><span class="refDoi"> DOI: 10.1073/pnas.90.18.8547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1073%2Fpnas.90.18.8547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8397408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2cXmvF2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=8547-8551&author=M.+Ruatauthor=E.+Traiffortauthor=R.+Leursauthor=J.+Tardivel-Lacombeauthor=J.+Diazauthor=J.-M.+Arrangauthor=J.-C.+Schwartz&title=Molecular+Cloning%2C+Characterization%2C+and+Localization+of+a+High-Affinity+Serotonin+Receptor+%285-HT7%29+Activating+cAMP+Formation&doi=10.1073%2Fpnas.90.18.8547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation</span></div><div class="casAuthors">Ruat, Martial; Traiffort, Elisabeth; Leurs, Rob; Tardivel-Lacombe, Joel; Diaz, Jorge; Arrang, Jean Michel; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8547-51</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">By using a strategy based on nucleotide sequence homol., the authors have cloned a cDNA encoding a functional serotonin (5-HT) receptor.  The deduced amino acid sequence of the 5-HT7 receptor displays limited homol. with that of other 5-HT receptors.  In addn. to the seven stretches of hydrophobic amino acids that characterize the superfamily of receptors interacting with guanine nucleotide-binding proteins, the 448-aa sequence of the 5-HT7 receptor contains a hydrophobic domain located at its N-terminal end.  Genomic anal. indicated the presence of introns interrupting the coding sequence.  The 5-HT7 receptor, stably expressed in transfected CHO cells, bound [3H]5-HT with high affinity (Kd = 1 nM), like receptors of the 5-HT1 subfamily from which, however, it was clearly distinguished by its pharmacol.  5-HT in nanomolar concns. stimulated cAMP accumulation in these CHO cells by ≈10-fold, whereas lysergic acid diethylamide displayed low intrinsic agonist activity.  These various properties differentiate the 5-HT7 receptor from the four other subfamilies of mammalian 5-HT receptors (i.e., the 5-HT1-, 5-HT2-, 5-HT3-, and 5-HT4-like subfamilies) and, therefore, appear to define another receptor subfamily.  Northern blot and in situ hybridization analyses showed the 5-HT7 transcripts to be expressed in discrete areas of the limbic brain (e.g., pyramidal hippocampus cells, tenia tecta, amygdaloid, or mammillary nuclei), suggesting that the receptor mediates serotoninergic controls in functions like mood, learning, or neuroendocrine and vegetative behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCfAyKuaslFLVg90H21EOLACvtfcHk0lgttmTs3DPZ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvF2ktw%253D%253D&md5=62d1a8f53171f5498f1a949ea8caf5f5</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.18.8547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.18.8547%26sid%3Dliteratum%253Aachs%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DMolecular%2520Cloning%252C%2520Characterization%252C%2520and%2520Localization%2520of%2520a%2520High-Affinity%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Activating%2520cAMP%2520Formation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D8547%26epage%3D8551%26doi%3D10.1073%2Fpnas.90.18.8547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlander, M. G.</span><span> </span><span class="NLM_article-title">A Novel Adenylyl Cyclase-Activated Serotonin Receptor (5-HT<sub>7</sub>) Implicated in the Regulation of Mammalian Circadian Rhythms</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1016/0896-6273(93)90149-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0896-6273%2893%2990149-L" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=449-458&author=T.+W.+Lovenbergauthor=B.+M.+Baronauthor=L.+De+Leceaauthor=J.+D.+Millerauthor=R.+A.+Prosserauthor=M.+A.+Reaauthor=P.+E.+Foyeauthor=M.+Rackeauthor=A.+L.+Sloneauthor=B.+W.+Siegelauthor=P.+E.+Danielsonauthor=J.+G.+Sutcliffeauthor=M.+G.+Erlander&title=A+Novel+Adenylyl+Cyclase-Activated+Serotonin+Receptor+%285-HT7%29+Implicated+in+the+Regulation+of+Mammalian+Circadian+Rhythms&doi=10.1016%2F0896-6273%2893%2990149-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2893%2990149-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252893%252990149-L%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBaron%26aufirst%3DB.%2BM.%26aulast%3DDe%2BLecea%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DJ.%2BD.%26aulast%3DProsser%26aufirst%3DR.%2BA.%26aulast%3DRea%26aufirst%3DM.%2BA.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DRacke%26aufirst%3DM.%26aulast%3DSlone%26aufirst%3DA.%2BL.%26aulast%3DSiegel%26aufirst%3DB.%2BW.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26aulast%3DErlander%26aufirst%3DM.%2BG.%26atitle%3DA%2520Novel%2520Adenylyl%2520Cyclase-Activated%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Implicated%2520in%2520the%2520Regulation%2520of%2520Mammalian%2520Circadian%2520Rhythms%26jtitle%3DNeuron%26date%3D1993%26volume%3D11%26spage%3D449%26epage%3D458%26doi%3D10.1016%2F0896-6273%2893%2990149-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><div class="note"><p class="first last">For a comprehensive review on 5-HT<sub>7</sub>R biochemistry and molecular biology, please see:</p></div><span class="NLM_contrib-group">Gellynck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyninck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andressen, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegeman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoenacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Craenenbroeck, K.</span><span> </span><span class="NLM_article-title">The Serotonin 5-HT<sub>7</sub> Receptors: Two decades of Research</span> <span class="citation_source-journal">Exp. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1007/s00221-013-3694-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00221-013-3694-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24042216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOksL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2013&pages=555-568&author=E.+Gellynckauthor=K.+Heyninckauthor=K.+W.+Andressenauthor=G.+Haegemanauthor=F.+O.+Levyauthor=P.+Vanhoenackerauthor=K.+Van+Craenenbroeck&title=The+Serotonin+5-HT7+Receptors%3A+Two+decades+of+Research&doi=10.1007%2Fs00221-013-3694-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin 5-HT7 receptors: two decades of research</span></div><div class="casAuthors">Gellynck, Evelien; Heyninck, Karen; Andressen, Kjetil W.; Haegeman, Guy; Levy, Finn Olav; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Brain Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">555-568</span>CODEN:
                <span class="NLM_cas:coden">EXBRAP</span>;
        ISSN:<span class="NLM_cas:issn">0014-4819</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Like most neurotransmitters, serotonin possesses a simple structure.  However, the pharmacol. consequences are more complex and diverse.  Serotonin is involved in numerous functions in the human body including the control of appetite, sleep, memory and learning, temp. regulation, mood, behavior, cardiovascular function, muscle contraction, endocrine regulation, and depression.  Low levels of serotonin may be assocd. with several disorders, namely increase in aggressive and angry behaviors, clin. depression, Parkinson's disease, obsessive-compulsive disorder, eating disorders, migraine, irritable bowel syndrome, tinnitus, and bipolar disease.  These effects are mediated via different serotonin (5-HT) receptors.  In this review, we will focus on the last discovered member of this serotonin receptor family, the 5-HT7 receptor.  This receptor belongs to the G protein-coupled receptor superfamily and was cloned two decades ago.  Later, different splice variants were described but no major functional differences have been described so far.  All 5-HT7 receptor variants are coupled to Gαs proteins and stimulate cAMP formation.  Recently, several interacting proteins have been reported, which can influence receptor signaling and trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUX98eSf0SHbVg90H21EOLACvtfcHk0lh6kNAK93BBKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOksL7N&md5=c61a6999c8b69f7635a7a726878140c9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00221-013-3694-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00221-013-3694-y%26sid%3Dliteratum%253Aachs%26aulast%3DGellynck%26aufirst%3DE.%26aulast%3DHeyninck%26aufirst%3DK.%26aulast%3DAndressen%26aufirst%3DK.%2BW.%26aulast%3DHaegeman%26aufirst%3DG.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26aulast%3DVanhoenacker%26aufirst%3DP.%26aulast%3DVan%2BCraenenbroeck%26aufirst%3DK.%26atitle%3DThe%2520Serotonin%25205-HT7%2520Receptors%253A%2520Two%2520decades%2520of%2520Research%26jtitle%3DExp.%2520Brain%2520Res.%26date%3D2013%26volume%3D230%26spage%3D555%26epage%3D568%26doi%3D10.1007%2Fs00221-013-3694-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hassaine, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deluz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tol, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmyter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitevin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nury, H.</span><span> </span><span class="NLM_article-title">X-ray Structure of Mouse Serotonin 5-HT<sub>3</sub> Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/nature13552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnature13552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=276-281&author=G.+Hassaineauthor=C.+Deluzauthor=L.+Grassoauthor=R.+Wyssauthor=M.+B.+Tolauthor=R.+Hoviusauthor=A.+Graffauthor=H.+Stahlbergauthor=T.+Tomizakiauthor=A.+Desmyterauthor=C.+Moreauauthor=X.-D.+Liauthor=F.+Poitevinauthor=H.+Vogelauthor=H.+Nury&title=X-ray+Structure+of+Mouse+Serotonin+5-HT3+Receptor&doi=10.1038%2Fnature13552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature13552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13552%26sid%3Dliteratum%253Aachs%26aulast%3DHassaine%26aufirst%3DG.%26aulast%3DDeluz%26aufirst%3DC.%26aulast%3DGrasso%26aufirst%3DL.%26aulast%3DWyss%26aufirst%3DR.%26aulast%3DTol%26aufirst%3DM.%2BB.%26aulast%3DHovius%26aufirst%3DR.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DDesmyter%26aufirst%3DA.%26aulast%3DMoreau%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.-D.%26aulast%3DPoitevin%26aufirst%3DF.%26aulast%3DVogel%26aufirst%3DH.%26aulast%3DNury%26aufirst%3DH.%26atitle%3DX-ray%2520Structure%2520of%2520Mouse%2520Serotonin%25205-HT3%2520Receptor%26jtitle%3DNature%26date%3D2014%26volume%3D512%26spage%3D276%26epage%3D281%26doi%3D10.1038%2Fnature13552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Structure-Affinity Relationship Study on <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a New Class of 5-Hydroxytryptamine 7 Receptor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6616</span><span class="NLM_x">–</span> <span class="NLM_lpage">6624</span><span class="refDoi"> DOI: 10.1021/jm049702f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049702f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6616-6624&author=M.+Leopoldoauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Continoauthor=E.+Lacivitaauthor=M.+Nisoauthor=R.+Perroneauthor=V.+Tortorella&title=Structure-Affinity+Relationship+Study+on+N-%281%2C2%2C3%2C4-Tetrahydronaphthalen-1-yl%29-4-aryl-1-piperazinealkylamides%2C+a+New+Class+of+5-Hydroxytryptamine+7+Receptor+Agents&doi=10.1021%2Fjm049702f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm049702f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049702f%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DStructure-Affinity%2520Relationship%2520Study%2520on%2520N-%25281%252C2%252C3%252C4-Tetrahydronaphthalen-1-yl%2529-4-aryl-1-piperazinealkylamides%252C%2520a%2520New%2520Class%2520of%25205-Hydroxytryptamine%25207%2520Receptor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6616%26epage%3D6624%26doi%3D10.1021%2Fjm049702f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study on <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a Class of 5-HT<sub>7</sub> Receptor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4214</span><span class="NLM_x">–</span> <span class="NLM_lpage">4221</span><span class="refDoi"> DOI: 10.1021/jm070487n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070487n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4214-4221&author=M.+Leopoldoauthor=E.+Lacivitaauthor=M.+Continoauthor=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perrone&title=Structure-Activity+Relationship+Study+on+N-%281%2C2%2C3%2C4-Tetrahydronaphthalen-1-yl%29-4-aryl-1-piperazinehexanamides%2C+a+Class+of+5-HT7+Receptor+Agents&doi=10.1021%2Fjm070487n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm070487n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070487n%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520on%2520N-%25281%252C2%252C3%252C4-Tetrahydronaphthalen-1-yl%2529-4-aryl-1-piperazinehexanamides%252C%2520a%2520Class%2520of%25205-HT7%2520Receptor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4214%26epage%3D4221%26doi%3D10.1021%2Fjm070487n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton King, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purandare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortolani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G.</span><span> </span><span class="NLM_article-title">Aminotriazine 5-HT<sub>7</sub> Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4245</span><span class="NLM_x">–</span> <span class="NLM_lpage">4248</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmcl.2004.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4245-4248&author=R.+J.+Mattsonauthor=D.+J.+Denhartauthor=J.+D.+Cattauthor=M.+F.+Deeauthor=J.+A.+Deskusauthor=J.+L.+Dittaauthor=J.+Eppersonauthor=H.+Dalton+Kingauthor=A.+Gaoauthor=M.+A.+Possauthor=A.+Purandareauthor=D.+Tortolaniauthor=Y.+Zhaoauthor=H.+Yangauthor=S.+Yeolaauthor=J.+Palmerauthor=J.+Torrenteauthor=A.+Starkauthor=G.+Johnson&title=Aminotriazine+5-HT7+Antagonists&doi=10.1016%2Fj.bmcl.2004.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DCatt%26aufirst%3DJ.%2BD.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DEpperson%26aufirst%3DJ.%26aulast%3DDalton%2BKing%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DPurandare%26aufirst%3DA.%26aulast%3DTortolani%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DTorrente%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DG.%26atitle%3DAminotriazine%25205-HT7%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4245%26epage%3D4248%26doi%3D10.1016%2Fj.bmcl.2004.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Characterization of SB-269970-A, a Selective 5-HT<sub>7</sub> Receptor Antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0703357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10821781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=539-548&author=J.+J.+Haganauthor=G.+W.+Priceauthor=P.+Jeffreyauthor=N.+J.+Deeksauthor=T.+Steanauthor=D.+Piperauthor=M.+I.+Smithauthor=N.+Uptonauthor=A.+D.+Medhurstauthor=D.+N.+Middlemissauthor=G.+J.+Rileyauthor=P.+J.+Lovellauthor=S.+M.+Bromidgeauthor=D.+R.+Thomas&title=Characterization+of+SB-269970-A%2C+a+Selective+5-HT7+Receptor+Antagonist&doi=10.1038%2Fsj.bjp.0703357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist</span></div><div class="casAuthors">Hagan, Jim J.; Price, Gary W.; Jeffrey, Phillip; Deeks, Nigel J.; Stean, Tania; Piper, David; Smith, Martin I.; Upton, Neil; Medhurst, Andrew D.; Middlemiss, Derek N.; Riley, Graham J.; Lovell, Peter J.; Bromidge, Steven M.; Thomas, David R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-548</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The novel 5-HT7 receptor antagonist, SB-269970-A, potently displaced [3H]-5-CT from human 5-HT7(a) (pKi 8.9±0.1) and 5-HT7 receptors in guinea-pig cortex (pKi 8.3±0.2).  2 5-CT stimulated adenylyl cyclase activity in 5-HT7(a)/HEK293 membranes (pEC50 7.5±0.1) and SB-269970-A (0.03-1 μM) inhibited the 5-CT concn.-response with no significant alteration in the maximal response.  The pA2 (8.5±0.2) for SB-269970-A agreed well with the pKi detd. from [3H]-5-CT binding studies.  3 5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes (pEC50 of 8.4±0.2) was inhibited by SB-269970-A (0.3 μM) with a pKB (8.3±0.1) in good agreement with its antagonist potency at the human cloned 5-HT7(a) receptor and its binding affinity at guinea-pig cortical membranes.  4 5-HT7 receptor mRNA was highly expressed in human hypothalamus, amygdala, thalamus, hippocampus and testis.  5 SB-269970-A was CNS penetrant (steady-state brain: blood ratio of ∼0.83:1 in rats) but was rapidly cleared from the blood (CLb=∼140 mL min-1 kg-1).  Following a single dose (3 mg kg-1) SB-269970 was detectable in rat brain at 30 (87 nM) and 60 min (58 nM).  In guinea-pigs, brain levels averaged 31 and 51 nM resp. at 30 and 60 min after dosing, although the compd. was undetectable in one of the three animals tested.  6 5-CT (0.3 mg kg-1 i.p.) induced hypothermia in guinea-pigs was blocked by SB-269970-A (ED50 2.96 mg kg-1 i.p.) and the non-selective 5-HT7 receptor antagonist metergoline (0.3-3 mg kg-1 s.c.), suggesting a role for 5-HT7 receptor stimulation in 5-CT induced hypothermia in guinea-pigs.  7 SB-269970-A (30 mg kg-1) administered at the start of the sleep period, significantly reduced time spent in Paradoxical Sleep (PS) during the first 3 h of EEG recording in conscious rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHkJZD5reQRbVg90H21EOLACvtfcHk0lh6ZWmPd5-P8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjs7w%253D&md5=f36e588d4da0447d259a7974c4b781c5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703357%26sid%3Dliteratum%253Aachs%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DPiper%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DM.%2BI.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520SB-269970-A%252C%2520a%2520Selective%25205-HT7%2520Receptor%2520Antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D539%26epage%3D548%26doi%3D10.1038%2Fsj.bjp.0703357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">SB-656104-A: A Novel 5-HT<sub>7</sub> Receptor Antagonist with Improved In Vivo Properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3344</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00690-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2802%2900690-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3341-3344&author=I.+T.+Forbesauthor=S.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=A.+E.+Garnerauthor=G.+J.+Rileyauthor=P.+Jeffreyauthor=A.+J.+Stevensauthor=T.+O.+Steanauthor=D.+R.+Thomas&title=SB-656104-A%3A+A+Novel+5-HT7+Receptor+Antagonist+with+Improved+In+Vivo+Properties&doi=10.1016%2FS0960-894X%2802%2900690-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900690-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900690-X%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DDouglas%26aufirst%3DS.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DGarner%26aufirst%3DA.%2BE.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DSB-656104-A%253A%2520A%2520Novel%25205-HT7%2520Receptor%2520Antagonist%2520with%2520Improved%2520In%2520Vivo%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3341%26epage%3D3344%26doi%3D10.1016%2FS0960-894X%2802%2900690-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Identification of a Novel Series of Selective 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00077-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2803%2900077-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1055-1058&author=I.+T.+Forbesauthor=D.+G.+Cooperauthor=E.+K.+Doddsauthor=S.+E.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=M.+Meesonauthor=L.+P.+Campbellauthor=T.+Colemanauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=Identification+of+a+Novel+Series+of+Selective+5-HT7+Receptor+Antagonists&doi=10.1016%2FS0960-894X%2803%2900077-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900077-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900077-5%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DCooper%26aufirst%3DD.%2BG.%26aulast%3DDodds%26aufirst%3DE.%2BK.%26aulast%3DDouglas%26aufirst%3DS.%2BE.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DMeeson%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1055%26epage%3D1058%26doi%3D10.1016%2FS0960-894X%2803%2900077-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kikuchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, M.</span><span> </span><span class="NLM_article-title">New Tetrahydrobenzindoles as Potent and Selective 5-HT<sub>7</sub> Antagonists with Increased In Vitro Metabolic Stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00842-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2802%2900842-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=61-64&author=C.+Kikuchiauthor=H.+Suzukiauthor=T.+Hiranumaauthor=M.+Koyama&title=New+Tetrahydrobenzindoles+as+Potent+and+Selective+5-HT7+Antagonists+with+Increased+In+Vitro+Metabolic+Stability&doi=10.1016%2FS0960-894X%2802%2900842-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900842-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900842-9%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DHiranuma%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DM.%26atitle%3DNew%2520Tetrahydrobenzindoles%2520as%2520Potent%2520and%2520Selective%25205-HT7%2520Antagonists%2520with%2520Increased%2520In%2520Vitro%2520Metabolic%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D61%26epage%3D64%26doi%3D10.1016%2FS0960-894X%2802%2900842-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lόpez-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of New Serotonin 5-HT<sub>7</sub> Receptor Ligands. Determinants of 5-HT<sub>7</sub>/5-HT<sub>1A</sub> Receptor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2384</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1021/jm8014553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsleksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2384-2392&author=R.+A.+Medinaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=E.+Porrasauthor=M.+Campilloauthor=L.+Pardoauthor=M.+L.+L%CF%8Cpez-Rodr%C3%ADguez&title=Synthesis+of+New+Serotonin+5-HT7+Receptor+Ligands.+Determinants+of+5-HT7%2F5-HT1A+Receptor+Selectivity&doi=10.1021%2Fjm8014553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of New Serotonin 5-HT7 Receptor Ligands. Determinants of 5-HT7/5-HT1A Receptor Selectivity</span></div><div class="casAuthors">Medina, Rocio A.; Sallander, Jessica; Benhamu, Bellinda; Porras, Esther; Campillo, Mercedes; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2384-2392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a new set of compds. of general structure, e.g., I, with structural modifications in the pharmacophoric elements of the previously reported lead UCM-5600 is reported.  The new derivs. have been evaluated for binding affinity at 5-HT7 and 5-HT1A receptors.  The influence of the different structural features in terms of 5-HT7/5-HT1A receptor affinity and selectivity was analyzed by computational simulations of the complexes between the obtained compds. and β2-based 3-D models of these receptors.  The hydrochloride of compd. I (HYD1 = 1,3-dihydro-2H-indol-2-one; spacer = -(CH2)4-; HYD2 + HYD3 = 3,4-dihydroisoquinolin-2(1H)-yl) exhibits high 5-HT7R affinity (Ki = 7 nM) and selectivity over the 5-HT1AR (31-fold), and has been characterized as a partial agonist of the human 5-HT7R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmM3iJOOfrlrVg90H21EOLACvtfcHk0lgxTcqXIvX_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsleksrs%253D&md5=b6753d482acd1ed861511249a91c7352</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm8014553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014553%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25CF%258Cpez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520New%2520Serotonin%25205-HT7%2520Receptor%2520Ligands.%2520Determinants%2520of%25205-HT7%252F5-HT1A%2520Receptor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2384%26epage%3D2392%26doi%3D10.1021%2Fjm8014553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holmberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leideborg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldirola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatoidsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, R.</span><span> </span><span class="NLM_article-title">Novel 2-Aminotetralin and 3-Aminochroman Derivatives as Selective Serotonin 5-HT7 Receptor Agonists and Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3927</span><span class="NLM_x">–</span> <span class="NLM_lpage">3930</span><span class="refDoi"> DOI: 10.1021/jm0498102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0498102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3927-3930&author=P.+Holmbergauthor=D.+Sohnauthor=R.+Leideborgauthor=P.+Caldirolaauthor=P.+Zlatoidskyauthor=S.+Hansonauthor=N.+Mohellauthor=S.+Rosqvistauthor=G.+Nordvallauthor=A.+M.+Johanssonauthor=R.+Johansson&title=Novel+2-Aminotetralin+and+3-Aminochroman+Derivatives+as+Selective+Serotonin+5-HT7+Receptor+Agonists+and+Antagonists&doi=10.1021%2Fjm0498102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0498102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498102%26sid%3Dliteratum%253Aachs%26aulast%3DHolmberg%26aufirst%3DP.%26aulast%3DSohn%26aufirst%3DD.%26aulast%3DLeideborg%26aufirst%3DR.%26aulast%3DCaldirola%26aufirst%3DP.%26aulast%3DZlatoidsky%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DS.%26aulast%3DMohell%26aufirst%3DN.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DNordvall%26aufirst%3DG.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DJohansson%26aufirst%3DR.%26atitle%3DNovel%25202-Aminotetralin%2520and%25203-Aminochroman%2520Derivatives%2520as%2520Selective%2520Serotonin%25205-HT7%2520Receptor%2520Agonists%2520and%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3927%26epage%3D3930%26doi%3D10.1021%2Fjm0498102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Romero-Alonso, L.; Zamanillo-Castanedo, D.; Vela-Hernandez, J.-M.; Buschmann, H. H.</span><span> </span><span class="NLM_article-title">Combination of a 5-HT<sub>7</sub> Receptor Ligand and an Opioid Ligand</span>. WO2008/145335, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">19899</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Romero-Alonso&author=D.+Zamanillo-Castanedo&author=J.-M.+Vela-Hernandez&author=H.+H.+Buschmann&title=Combination+of+a+5-HT7+Receptor+Ligand+and+an+Opioid+Ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRomero-Alonso%26aufirst%3DL.%26atitle%3DCombination%2520of%2520a%25205-HT7%2520Receptor%2520Ligand%2520and%2520an%2520Opioid%2520Ligand%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D150%26spage%3D19899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garcia-Lopez, M.; Torrens-Jover, A.; Romero-Alonso, L.; Buschmann, H. H.</span><span> </span><span class="NLM_article-title">Heterocyclic-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments</span>. WO2008/077625, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">79600</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Garcia-Lopez&author=A.+Torrens-Jover&author=L.+Romero-Alonso&author=H.+H.+Buschmann&title=Heterocyclic-substituted-ethylamino-phenyl+derivatives%2C+their+preparation+and+use+as+medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Lopez%26aufirst%3DM.%26atitle%3DHeterocyclic-substituted-ethylamino-phenyl%2520derivatives%252C%2520their%2520preparation%2520and%2520use%2520as%2520medicaments%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D79600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Brenchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Activation Inhibits Mechanical Hypersensitivity Secondary to Capsaicin Sensitization in Mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1016/j.pain.2008.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.pain.2008.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19118950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2009&pages=239-247&author=A.+Brenchatauthor=L.+Romeroauthor=M.+Garc%C3%ADaauthor=M.+Pujolauthor=J.+Burgue%C3%B1oauthor=A.+Torrensauthor=M.+Hamonauthor=J.+M.+Baeyensauthor=H.+Buschmannauthor=D.+Zamanilloauthor=J.+M.+Vela&title=5-HT7+Receptor+Activation+Inhibits+Mechanical+Hypersensitivity+Secondary+to+Capsaicin+Sensitization+in+Mice&doi=10.1016%2Fj.pain.2008.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice</span></div><div class="casAuthors">Brenchat, Alex; Romero, Luz; Garcia, Monica; Pujol, Marta; Burgueno, Javier; Torrens, Antoni; Hamon, Michel; Baeyens, Jose Manuel; Buschmann, Helmut; Zamanillo, Daniel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This work aimed to evaluate the potential role of the 5-HT7 receptor in nociception secondary to a sensitizing stimulus in mice.  For this purpose, the effects of relevant ligands (5-HT7 receptor agonists: AS-19, MSD-5a, E-55888; 5-HT7 receptor antagonists: SB-258719, SB-269970; 5-HT1A receptor agonist: F-13640; 5-HT1A receptor antagonist: WAY-100635) were assessed on capsaicin-induced mech. hypersensitivity, a pain behavior involving hypersensitivity of dorsal horn neurons (central sensitization).  For the 5-HT7 receptor agonists used, binding profile and intrinsic efficacy to stimulate cAMP formation in HEK-293F cells expressing the human 5-HT7 receptor were also evaluated.  AS-19 and E-55888 were selective for 5-HT7 receptors.  E-55888 was a full agonist whereas AS-19 and MSD-5a behaved as partial agonists, with maximal effects corresponding to 77% and 61%, resp., of the cAMP response evoked by the full agonist 5-HT.  Our in vivo results revealed that systemic administration of 5-HT7 receptor agonists exerted a clear-cut dose-dependent antinociceptive effect that was prevented by 5-HT7 receptor antagonists, but not by the 5-HT1A receptor antagonist.  The order of efficacy (E-55888 > AS-19 > MSD-5a) matched their in vitro efficacy as 5-HT7 receptor agonists.  Contrary to agonists, a dose-dependent promotion of mech. hypersensitivity was obsd. after administration of 5-HT7 receptor antagonists, substantiating the involvement of the 5-HT7 receptor in the control of capsaicin-induced mech. hypersensitivity.  These findings suggest that serotonin exerts an inhibitory role in the control of nociception through activation of 5-HT7 receptors, and point to a new potential therapeutic use of 5-HT7 receptor agonists in the field of analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ2M6RjsdjhLVg90H21EOLACvtfcHk0lgxTcqXIvX_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSlt74%253D&md5=97c1ceb07221903c90a5f87835c07d69</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DBrenchat%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DPujol%26aufirst%3DM.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3D5-HT7%2520Receptor%2520Activation%2520Inhibits%2520Mechanical%2520Hypersensitivity%2520Secondary%2520to%2520Capsaicin%2520Sensitization%2520in%2520Mice%26jtitle%3DPain%26date%3D2009%26volume%3D141%26spage%3D239%26epage%3D247%26doi%3D10.1016%2Fj.pain.2008.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitron-Resendiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.biopsych.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16018977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ght7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=831-837&author=P.+B.+Hedlundauthor=S.+Huitron-Resendizauthor=S.+J.+Henriksenauthor=J.+G.+Sutcliffe&title=5-HT7+Receptor+Inhibition+and+Inactivation+Induce+Antidepressantlike+Behavior+and+Sleep+Pattern&doi=10.1016%2Fj.biopsych.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern</span></div><div class="casAuthors">Hedlund, Peter B.; Huitron-Resendiz, Salvador; Henriksen, Steven J.; Sutcliffe, J. Gregor</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">831-837</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: The 5-hydroxytryptamine7 receptor (5-HT7) is implicated in circadian rhythm phase resetting, and 5-HT7 receptor-selective antagonists alter rapid eye movement (REM) sleep parameters in a pattern opposite from those in patients with clin. depression.  Methods: As sleep, circadian rhythm, and mood regulation are related, we examd. 5-HT7 receptor knockout mice in two behavioral models of depression.  The forced swim and tail suspension tests are highly predictive for antidepressant drug activity.  Results: Unmedicated 5-HT7-/- mice showed decreased immobility in both tests, consistent with an antidepressantlike behavior.  The selective 5-HT7 receptor antagonist SB-269970 also decreased immobility.  The selective serotonin reuptake inhibitor citalopram, a widely used antidepressant, decreased immobility in both 5-HT7+/+ and 5-HT7-/- mice in the tail suspension test, suggesting that it utilizes an independent mechanism.  The 5-HT7-/- mice spent less time in and had less frequent episodes of REM sleep, also consistent with an antidepressantlike state.  Conclusions: The 5-HT7 receptor might have a role in mood disorders and antagonists might have therapeutic value as antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJOvlUGGoK7Vg90H21EOLACvtfcHk0lhrP4YYwOON7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ght7jJ&md5=f8299459bf442f96e9ce2d9ecc12edaa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DHuitron-Resendiz%26aufirst%3DS.%26aulast%3DHenriksen%26aufirst%3DS.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3D5-HT7%2520Receptor%2520Inhibition%2520and%2520Inactivation%2520Induce%2520Antidepressantlike%2520Behavior%2520and%2520Sleep%2520Pattern%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D58%26spage%3D831%26epage%3D837%26doi%3D10.1016%2Fj.biopsych.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span> </span><span class="NLM_article-title">Stable Expression of Constitutively Activated Mutant h5HT<sub>6</sub> and h5HT<sub>7</sub> Serotonin Receptors: Inverse Agonist Activity of Antipsychotic Drugs</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1007/s00213-004-2057-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-004-2057-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=461-469&author=A.+Purohitauthor=C.+Smithauthor=K.+Herrick-Davisauthor=M.+Teitler&title=Stable+Expression+of+Constitutively+Activated+Mutant+h5HT6+and+h5HT7+Serotonin+Receptors%3A+Inverse+Agonist+Activity+of+Antipsychotic+Drugs&doi=10.1007%2Fs00213-004-2057-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2057-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2057-6%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DTeitler%26aufirst%3DM.%26atitle%3DStable%2520Expression%2520of%2520Constitutively%2520Activated%2520Mutant%2520h5HT6%2520and%2520h5HT7%2520Serotonin%2520Receptors%253A%2520Inverse%2520Agonist%2520Activity%2520of%2520Antipsychotic%2520Drugs%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D461%26epage%3D469%26doi%3D10.1007%2Fs00213-004-2057-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, N.</span><span> </span><span class="NLM_article-title">Positive Association of the Serotonin 5-HT<sub>7</sub> Receptor Gene with Schizophrenia in a Japanese Population</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.npp.1300901" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=866-871&author=M.+Ikedaauthor=N.+Iwataauthor=T.+Kitajimaauthor=T.+Suzukiauthor=Y.+Yamanouchiauthor=Y.+Kinoshitaauthor=N.+Ozaki&title=Positive+Association+of+the+Serotonin+5-HT7+Receptor+Gene+with+Schizophrenia+in+a+Japanese+Population&doi=10.1038%2Fsj.npp.1300901"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300901%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DKitajima%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamanouchi%26aufirst%3DY.%26aulast%3DKinoshita%26aufirst%3DY.%26aulast%3DOzaki%26aufirst%3DN.%26atitle%3DPositive%2520Association%2520of%2520the%2520Serotonin%25205-HT7%2520Receptor%2520Gene%2520with%2520Schizophrenia%2520in%2520a%2520Japanese%2520Population%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D866%26epage%3D871%26doi%3D10.1038%2Fsj.npp.1300901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cates, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitron-Resendiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Effects of Lurasidone in Behavioral Models of Depression. Role of the 5-HT<sub>7</sub> receptor subtype</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2013.01.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=211-217&author=L.+N.+Catesauthor=A.+J.+Robertsauthor=S.+Huitron-Resendizauthor=P.+B.+Hedlund&title=Effects+of+Lurasidone+in+Behavioral+Models+of+Depression.+Role+of+the+5-HT7+receptor+subtype&doi=10.1016%2Fj.neuropharm.2013.01.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DCates%26aufirst%3DL.%2BN.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DHuitron-Resendiz%26aufirst%3DS.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DEffects%2520of%2520Lurasidone%2520in%2520Behavioral%2520Models%2520of%2520Depression.%2520Role%2520of%2520the%25205-HT7%2520receptor%2520subtype%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D211%26epage%3D217%26doi%3D10.1016%2Fj.neuropharm.2013.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">For a comprehensive review on 5-HT<sub>7</sub>R and its association to psychiatric disorders, please see:</p></div><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>7</sub> Receptor and Disorders of the Nervous System: an Overview</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1007/s00213-009-1626-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-009-1626-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19649616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlakt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=345-354&author=P.+B.+Hedlund&title=The+5-HT7+Receptor+and+Disorders+of+the+Nervous+System%3A+an+Overview&doi=10.1007%2Fs00213-009-1626-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT7 receptor and disorders of the nervous system: an overview</span></div><div class="casAuthors">Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Rationale: The 5-HT7 receptor is a more recently discovered G-protein-coupled receptor for serotonin.  The functions and possible clin. relevance of this receptor are not yet fully understood.  Objective: The present paper reviews to what extent the use of animal models of human psychiatric and neurol. disorders have implicated the 5-HT7 receptor in such disorders.  The studies have used a combination of pharmacol. and genetic tools targeting the receptor to evaluate effects on behavior.  Results: Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT7 receptor described in these disorders.  Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions.  There is a considerable amt. of evidence supporting a role for the 5-HT7 receptor in depression.  Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression.  Supporting evidence has also been obtained in sleep studies.  Esp. interesting are the augmented effects achieved by combining antidepressants and 5-HT7 receptor antagonists.  The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT7 receptor.  Conclusions: The use of pharmacol. and genetic tools in preclin. animal models strongly supports a role for the 5-HT7 receptor in depression.  Indirect evidence exists showing that 5-HT7 receptor antagonism is clin. useful in the treatment of depression.  Available data also indicate a possible involvement of the 5-HT7 receptor in anxiety, epilepsy, pain, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAr_t6Buj0bLVg90H21EOLACvtfcHk0lhrP4YYwOON7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlakt78%253D&md5=5cef1e8c6f7348fd15afac30c6e6c6db</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1626-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1626-0%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DThe%25205-HT7%2520Receptor%2520and%2520Disorders%2520of%2520the%2520Nervous%2520System%253A%2520an%2520Overview%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D206%26spage%3D345%26epage%3D354%26doi%3D10.1007%2Fs00213-009-1626-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nativio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricceri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.1038/npp.2014.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnpp.2014.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24809912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2506-2518&author=B.+De+Filippisauthor=P.+Nativioauthor=A.+Fabbriauthor=L.+Ricceriauthor=W.+Adrianiauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Passarelliauthor=A.+Fusoauthor=G.+Laviola&title=Pharmacological+Stimulation+of+the+Brain+Serotonin+Receptor+7+as+a+Novel+Therapeutic+Approach+for+Rett+Syndrome&doi=10.1038%2Fnpp.2014.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Nativio, Paola; Fabbri, Alessia; Ricceri, Laura; Adriani, Walter; Lacivita, Enza; Leopoldo, Marcello; Passarelli, Francesca; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2518</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG-binding protein 2 gene (MECP2) cause >95% of classic cases, and currently there is no cure for this devastating disorder.  The serotonin receptor 7 (5-HT7R) is linked to neuro-physiol. regulation of circadian rhythm, mood, cognition, and synaptic plasticity.  We presently report that 5-HT7R d. is consistently reduced in cortical and hippocampal brain areas of symptomatic MeCP2-308 male mice, a RTT model.  Systemic repeated treatment with LP-211 (0.25 mg/kg once/day for 7 days), a brain-penetrant selective 5-HT7R agonist, was able to rescue RTT-related defective performance: anxiety-related profiles in a Light/Dark test, motor abilities in a Dowel test, the exploratory behavior in the Marble Burying test, as well as memory in the Novelty Preference task.  In the brain of RTT mice, LP-211 also reversed the abnormal activation of PAK and cofilin (key regulators of actin cytoskeleton dynamics) and of the ribosomal protein (rp) S6, whose reduced activation in MECP2 mutant neurons by mTOR is responsible for the altered protein translational control.  Present findings indicate that pharmacol. targeting of 5-HT7R improves specific behavioral and mol. manifestations of RTT, thus representing a first step toward the validation of an innovative systemic treatment.  Beyond RTT, the latter might be extended to other disorders assocd. with intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrsCidW_X5rVg90H21EOLACvtfcHk0lga5lmDmzwxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D&md5=3ca5c55ceaee5c6091033f92eb30a60d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.105%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DNativio%26aufirst%3DP.%26aulast%3DFabbri%26aufirst%3DA.%26aulast%3DRicceri%26aufirst%3DL.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DPassarelli%26aufirst%3DF.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DPharmacological%2520Stimulation%2520of%2520the%2520Brain%2520Serotonin%2520Receptor%25207%2520as%2520a%2520Novel%2520Therapeutic%2520Approach%2520for%2520Rett%2520Syndrome%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2506%26epage%3D2518%26doi%3D10.1038%2Fnpp.2014.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massagrande, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span> </span><span class="NLM_article-title">SB-656104-A, a Novel Selective 5-HT<sub>7</sub> Receptor Antagonist Modulates REM Sleep in rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0705290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12812993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2003&pages=705-714&author=D.+R.+Thomasauthor=S.+Melottoauthor=M.+Massagrandeauthor=A.+D.+Gribbleauthor=P.+Jeffreyauthor=A.+J.+Stevensauthor=N.+J.+Deeksauthor=P.+J.+Eddershawauthor=S.+H.+Fenwickauthor=G.+Rileyauthor=T.+Steanauthor=C.+M.+Scottauthor=M.+J.+Hillauthor=D.+N.+Middlemissauthor=J.+J.+Haganauthor=G.+W.+Priceauthor=I.+T.+Forbes&title=SB-656104-A%2C+a+Novel+Selective+5-HT7+Receptor+Antagonist+Modulates+REM+Sleep+in+rats&doi=10.1038%2Fsj.bjp.0705290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats</span></div><div class="casAuthors">Thomas, David R.; Melotto, Sergio; Massagrande, Mario; Gribble, Andrew D.; Jeffrey, Phillip; Stevens, Alexander J.; Deeks, Nigel J.; Eddershaw, Peter J.; Fenwick, Susan H.; Riley, Graham; Stean, Tania; Scott, Claire M.; Hill, Matthew J.; Middlemiss, Derek N.; Hagan, Jim J.; Price, Gary W.; Forbes, Ian T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">(6-((R)-2-{2-[4-(4-Chloro-phenoxy)-piperidin-1-yl]-ethyl}-pyrrolidine- 1-sulfonyl)-1H-indole hydrochloride) (SB-656104-A), a novel 5-hydroxytryptamine (5-HT7) receptor antagonist, potently inhibited [3H]-SB-269970 binding to the human cloned 5-HT7(a) (pKi 8.7±0.1) and 5-HT7(b) (pKi 8.5±0.2) receptor variants and the rat native receptor (pKi 8.8±0.2).  The compd. displayed at least 30-fold selectivity for the human 5-HT7(a) receptor vs. other human cloned 5-HT receptors apart from the 5-HT1D receptor (∼ 10-fold selective).  SB-656104-A antagonized competitively the 5-carboxamidotryptamine (5-CT)-induced accumulation of cAMP in h5-HT7(a)/HEK293 cells with a pA2 of 8.5.  Following a const. rate iv infusion to steady state in rats, SB-656104 had a blood clearance (CLb) of 58±6 mL min-1 kg-1 and was CNS penetrant with a steady-state brain: blood ratio of 0.9: 1.  Following i.p. administration to rats (10 mg kg-1), the compd. displayed a t1/2 of 1.4 h with mean brain and blood concns. (at 1 h after dosing) of 0.80 and 1.0 μM, resp.  SB-656104-A produced a significant reversal of the 5-CT-induced hypothermic effect in guinea pigs, a pharmacodynamic model of 5-HT7 receptor interaction in vivo (ED50 2 mg kg-1).  SB-656104-A, administered to rats at the beginning of the sleep period (CT 0), significantly increased the latency to onset of rapid eye movement (REM) sleep at 30 mg kg-1 i.p. (+93%) and reduced the total amt. of REM sleep at 10 and 30 mg kg-1 i.p. with no significant effect on the latency to, or amt. of, non-REM sleep.  SB-269970-A produced qual. similar effects in the same study.  In summary, SB-656104-A is a novel 5-HT7 receptor antagonist which has been utilized in the present study to provide further evidence for a role for 5-HT7 receptors in the modulation of REM sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGLUG9QaVLxrVg90H21EOLACvtfcHk0lga5lmDmzwxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVOiuro%253D&md5=7f0a81d506a85abb4650facb830de413</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705290%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DMelotto%26aufirst%3DS.%26aulast%3DMassagrande%26aufirst%3DM.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DFenwick%26aufirst%3DS.%2BH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DHill%26aufirst%3DM.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26atitle%3DSB-656104-A%252C%2520a%2520Novel%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520Modulates%2520REM%2520Sleep%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D139%26spage%3D705%26epage%3D714%26doi%3D10.1038%2Fsj.bjp.0705290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Systemic Administration and Local Microinjection into the Central Nervous System of the 5-HT<sub>7</sub> Receptor Agonist LP-211 Modify the Sleep-Wake Cycle in the Rat</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1016/j.bbr.2013.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2013.11.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=2014&pages=321-329&author=J.+M.+Montiauthor=M.+Leopoldoauthor=H.+Jantos&title=Systemic+Administration+and+Local+Microinjection+into+the+Central+Nervous+System+of+the+5-HT7+Receptor+Agonist+LP-211+Modify+the+Sleep-Wake+Cycle+in+the+Rat&doi=10.1016%2Fj.bbr.2013.11.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DSystemic%2520Administration%2520and%2520Local%2520Microinjection%2520into%2520the%2520Central%2520Nervous%2520System%2520of%2520the%25205-HT7%2520Receptor%2520Agonist%2520LP-211%2520Modify%2520the%2520Sleep-Wake%2520Cycle%2520in%2520the%2520Rat%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2014%26volume%3D259%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.bbr.2013.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guscott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span> </span><span class="NLM_article-title">The Hypothermic Effect of 5-CT in Mice is Mediated Through the 5-HT<sub>7</sub> Receptor</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1016/S0028-3908(03)00117-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0028-3908%2803%2900117-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12763096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1031-1037&author=M.+R.+Guscottauthor=E.+Eganauthor=G.+P.+Cookauthor=J.+A.+Stantonauthor=M.+S.+Beerauthor=T.+W.+Rosahlauthor=S.+Hartmannauthor=J.+Kulagowskiauthor=G.+McAllisterauthor=K.+C.+Foneauthor=P.+H.+Hutson&title=The+Hypothermic+Effect+of+5-CT+in+Mice+is+Mediated+Through+the+5-HT7+Receptor&doi=10.1016%2FS0028-3908%2803%2900117-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor</span></div><div class="casAuthors">Guscott, M. R.; Egan, E.; Cook, G. P.; Stanton, J. A.; Beer, M. S.; Rosahl, T. W.; Hartmann, S.; Kulagowski, J.; McAllister, G.; Fone, K. C. F.; Hutson, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The 5-HT7 receptor is a recent addn. to the 5-HT receptor family and to date there is no clear idea as to its potential role in the CNS.  The receptor has been mapped by in situ hybridization and 5-HT7-like immunoreactivity and has been detected in discrete areas of the brain including the hypothalamus (Oliver et al., 1999).  This suggests the receptor may be involved in temp. regulation and have shown that a selective 5-HT7 receptor antagonist reverses the hypothermic effect of 5-CT in guinea-pigs.  The current study confirmed that the 5-HT7 receptor antagonists, SB-269970 (1-30 mg/kg, i.p.) and SB-258719 (5-20 mg/kg, i.p.), but not the 5-HT1A receptor antagonist, WAY 100635(0.1-1 mg/kg, s.c.), or the 5-HT1B/D antagonist, GR127935 (1.25-5 mg/kg, i.p.), reversed the hypothermic effect of 5-CT in mice.  In addn. the effect of 5-CT on body temp. was examd. on 5-HT7 receptor null mutant mice. 5-CT (0.1-1 mg/kg, i.p.) significantly reduced rectal temp. in wild-type but not 5-HT7 receptor knockout mice.  This suggests that the hypothermic effects of 5-CT are mediated through the 5-HT7 receptor.  All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act (1986).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNczXKqpDK6rVg90H21EOLACvtfcHk0lga5lmDmzwxJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFeksLk%253D&md5=6ac84e94f9da78d01d657d059eea472d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2803%2900117-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252803%252900117-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuscott%26aufirst%3DM.%2BR.%26aulast%3DEgan%26aufirst%3DE.%26aulast%3DCook%26aufirst%3DG.%2BP.%26aulast%3DStanton%26aufirst%3DJ.%2BA.%26aulast%3DBeer%26aufirst%3DM.%2BS.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DKulagowski%26aufirst%3DJ.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DFone%26aufirst%3DK.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Hypothermic%2520Effect%2520of%25205-CT%2520in%2520Mice%2520is%2520Mediated%2520Through%2520the%25205-HT7%2520Receptor%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D1031%26epage%3D1037%26doi%3D10.1016%2FS0028-3908%2803%2900117-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">No Hypothermic Response to Serotonin in 5-HT<sub>7</sub> Receptor Knockout Mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span><span class="refDoi"> DOI: 10.1073/pnas.0337340100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1073%2Fpnas.0337340100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12529502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtF2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1375-1380&author=P.+B.+Hedlundauthor=P.+E.+Danielsonauthor=E.+A.+Thomasauthor=K.+Slaninaauthor=M.+J.+Carsonauthor=J.+G.+Sutcliffe&title=No+Hypothermic+Response+to+Serotonin+in+5-HT7+Receptor+Knockout+Mice&doi=10.1073%2Fpnas.0337340100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">No hypothermic response to serotonin in 5-HT7 receptor knockout mice</span></div><div class="casAuthors">Hedlund, P. B.; Danielson, P. E.; Thomas, E. A.; Slanina, K.; Carson, M. J.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1375-1380</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">With data from recently available selective antagonists for the 5-HT7 receptor, it was hypothesized that 5-hydroxytryptamine (5-HT)-induced hypothermia is mediated by the 5-HT7 receptor, an effect previously attributed to other receptor subtypes.  It was established that the biol active lipid oleamide allosterically interacts with the 5-HT7 receptor to regulate its transmission.  The most well characterized effects of oleamide administration are induction of sleep and hypothermia.  Here, the authors demonstrate, by mice lacking the 5-HT7 receptor, that 5-HT-induced hypothermia is mediated by the 5-HT7 receptor.  Both 5-HT and 5-carboxamidotryptamine, a 5-HT1 and 5-HT7 receptor agonist, in physiol. doses fail to induce hypothermia in 5-HT7 knockout mice.  In contrast, oleamide was equally effective in inducing hypothermia in mice lacking the 5-HT7 receptors as in wild-type mice.  When administered together, 5-HT and oleamide showed additive or greater than additive effects in reducing body temp.  Taken together, the results show that 5-HT-induced hypothermia is mediated by the 5-HT7 receptor, and that oleamide may act through an independent mechanism as well as at an allosteric 5-HT7 receptor site to regulate body temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL2VIYgHY8yrVg90H21EOLACvtfcHk0ljGYcCVnHtdOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtF2gu7g%253D&md5=176e68f72d602e14e960de6307fa9ce3</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0337340100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0337340100%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DSlanina%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DM.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DNo%2520Hypothermic%2520Response%2520to%2520Serotonin%2520in%25205-HT7%2520Receptor%2520Knockout%2520Mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1375%26epage%3D1380%26doi%3D10.1073%2Fpnas.0337340100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobirnac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptors Coupled to Induction of Interleukin-6 in Human Microglial MC-3 Cells</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2005.01.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=40-47&author=C.+Mah%C3%A9author=E.+Loetscherauthor=K.+K.+Devauthor=I.+Bobirnacauthor=U.+Ottenauthor=P.+Schoeffter&title=Serotonin+5-HT7+Receptors+Coupled+to+Induction+of+Interleukin-6+in+Human+Microglial+MC-3+Cells&doi=10.1016%2Fj.neuropharm.2005.01.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMah%25C3%25A9%26aufirst%3DC.%26aulast%3DLoetscher%26aufirst%3DE.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBobirnac%26aufirst%3DI.%26aulast%3DOtten%26aufirst%3DU.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DSerotonin%25205-HT7%2520Receptors%2520Coupled%2520to%2520Induction%2520of%2520Interleukin-6%2520in%2520Human%2520Microglial%2520MC-3%2520Cells%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D40%26epage%3D47%26doi%3D10.1016%2Fj.neuropharm.2005.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lieb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waschbisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlikowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akundi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelario-Jalil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebich, B. L.</span><span> </span><span class="NLM_article-title">Serotonin via 5-HT7 Receptors Activates p38 Mitogen-Activated Protein Kinase and Protein Kinase C ε Resulting in Interleukin-6 Synthesis in Human U373 MG Astrocytoma Cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03079.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1471-4159.2005.03079.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15836614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2005&pages=549-559&author=K.+Liebauthor=L.+Biersackauthor=A.+Waschbischauthor=S.+Orlikowskiauthor=R.+S.+Akundiauthor=E.+Candelario-Jalilauthor=M.+Hullauthor=B.+L.+Fiebich&title=Serotonin+via+5-HT7+Receptors+Activates+p38+Mitogen-Activated+Protein+Kinase+and+Protein+Kinase+C+%CE%B5+Resulting+in+Interleukin-6+Synthesis+in+Human+U373+MG+Astrocytoma+Cells&doi=10.1111%2Fj.1471-4159.2005.03079.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C ε resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells</span></div><div class="casAuthors">Lieb, Klaus; Biersack, Lisa; Waschbisch, Anne; Orlikowski, Sonja; Akundi, Ravi Shankar; Candelario-Jalil, Eduardo; Huell, Michael; Fiebich, Bernd L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-559</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Serotonin [5-hydroxytryptamine (5-HT)] is a widely distributed neurotransmitter which is involved in neuroimmunomodulatory processes.  Previously, it has been demonstrated that 5-HT may induce interleukin (IL)-6 expression in primary rat hippocampal astrocytes.  The present study was undertaken to investigate the mol. pathways underlying this induction of IL-6 synthesis.  As a model system, the authors used the human astrocytoma cell line U373 MG, which synthesizes IL-6 upon stimulation with various inducers.  5-HT dose- and time-dependently induced IL-6 protein synthesis.  The authors identified several 5-HT receptors to be expressed on U373 MG cells, including the 5-HT1D, 5-HT2A, 5-HT3 and 5-HT7 receptors.  The authors show that the 5-HT-induced IL-6 release is mediated by the 5-HT7 receptor based on several agonist/antagonists that were used.  5-HT-induced IL-6 synthesis is inhibited by the partially selective 5-HT7 receptor antagonist, pimozide, and the selective antagonist SB269970.  Furthermore, IL-6 synthesis was induced by the 5-HT7 receptor agonist carboxamidotryptamine.  In addn., the authors found p38 MAPKs and protein kinase C (PKC) ε to be involved in 5-HT-induced IL-6 synthesis as specific inhibitors of these enzymes (SB202190 and RO-31-8425, resp.) blocked 5-HT-induced IL-6 synthesis.  Furthermore, 5-HT mediated the phosphorylation of both p38 MAPK as well as the PKC ε isoform.  The p42/44 MAPKs, however, were not involved in 5-HT-induced IL-6 synthesis.  This study shows, for the first time, a central role of 5-HT7 receptor linked to p38 MAPK and PKC ε for the induction of cytokine synthesis in astrocytic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQIg48BXifgbVg90H21EOLACvtfcHk0ljGYcCVnHtdOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtbw%253D&md5=8d8c0712161e57e5199c78092ceacff4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03079.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03079.x%26sid%3Dliteratum%253Aachs%26aulast%3DLieb%26aufirst%3DK.%26aulast%3DBiersack%26aufirst%3DL.%26aulast%3DWaschbisch%26aufirst%3DA.%26aulast%3DOrlikowski%26aufirst%3DS.%26aulast%3DAkundi%26aufirst%3DR.%2BS.%26aulast%3DCandelario-Jalil%26aufirst%3DE.%26aulast%3DHull%26aufirst%3DM.%26aulast%3DFiebich%26aufirst%3DB.%2BL.%26atitle%3DSerotonin%2520via%25205-HT7%2520Receptors%2520Activates%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520and%2520Protein%2520Kinase%2520C%2520%25CE%25B5%2520Resulting%2520in%2520Interleukin-6%2520Synthesis%2520in%2520Human%2520U373%2520MG%2520Astrocytoma%2520Cells%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D93%26spage%3D549%26epage%3D559%26doi%3D10.1111%2Fj.1471-4159.2005.03079.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krucker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slanina, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Mice Lacking 5-HT<sub>7</sub> Receptors Show Specific Impairements in Contextual Learning</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1922</span><span class="refDoi"> DOI: 10.1111/j.1460-9568.2004.03288.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1460-9568.2004.03288.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15078565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD2c7otlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=1913-1922&author=A.+J.+Robertsauthor=T.+Kruckerauthor=C.+L.+Levyauthor=K.+A.+Slaninaauthor=J.+G.+Sutcliffeauthor=P.+B.+Hedlund&title=Mice+Lacking+5-HT7+Receptors+Show+Specific+Impairements+in+Contextual+Learning&doi=10.1111%2Fj.1460-9568.2004.03288.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice lacking 5-HT receptors show specific impairments in contextual learning</span></div><div class="casAuthors">Roberts Amanda J; Krucker Thomas; Levy Coree L; Slanina Kristen A; Sutcliffe J Gregor; Hedlund Peter B</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1913-22</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Using 5-HT(7) receptor knockout mice it has been shown that the 5-HT(7) receptor is the main mediator of serotonin-induced hypothermia but very little is known about the relevance of 5-HT(7) receptors in behaviour.  We here report that lack of 5-HT(7) receptors leads to a specific learning deficit that is not due to general sensory or behavioural deficits.  The knockout mice show impaired contextual fear conditioning but no significant deficits in motor and spatial learning or cued and operant conditioning.  In addition, we demonstrate that 5-HT(7) receptor knockout mice display decreased long-term synaptic plasticity within the CA1 region of the hippocampus.  The results indicate an important role for the 5-HT(7) receptor in contextual hippocampal-dependent learning and suggest a possible neuronal correlate for such a role is present within the CA1 region of the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQp0dItz82IMsK3uFsUIZtkfW6udTcc2eYfngDzzL2UZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7otlWntQ%253D%253D&md5=0981fd9f1b9f79c6cce36bf5a4231864</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2004.03288.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2004.03288.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DKrucker%26aufirst%3DT.%26aulast%3DLevy%26aufirst%3DC.%2BL.%26aulast%3DSlanina%26aufirst%3DK.%2BA.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DMice%2520Lacking%25205-HT7%2520Receptors%2520Show%2520Specific%2520Impairements%2520in%2520Contextual%2520Learning%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2004%26volume%3D19%26spage%3D1913%26epage%3D1922%26doi%3D10.1111%2Fj.1460-9568.2004.03288.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">Effects of the Potential 5-HT<sub>7</sub> Receptor Agonist AS 19 in an Autoshaping Learning Task</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.bbr.2005.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2005.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2005&pages=136-140&author=G.+Perez-Garc%C3%ADaauthor=A.+Meneses&title=Effects+of+the+Potential+5-HT7+Receptor+Agonist+AS+19+in+an+Autoshaping+Learning+Task&doi=10.1016%2Fj.bbr.2005.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2005.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2005.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520Potential%25205-HT7%2520Receptor%2520Agonist%2520AS%252019%2520in%2520an%2520Autoshaping%2520Learning%2520Task%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2005%26volume%3D163%26spage%3D136%26epage%3D140%26doi%3D10.1016%2Fj.bbr.2005.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pérez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Espinosa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">An mRNA Expression Analysis of Stimulation and blockade of 5-HT<sub>7</sub> Receptors During Memory Consolidation</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.bbr.2005.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2005.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2006&pages=83-92&author=G.+P%C3%A9rez-Garc%C3%ADaauthor=C.+Gonzalez-Espinosaauthor=A.+Meneses&title=An+mRNA+Expression+Analysis+of+Stimulation+and+blockade+of+5-HT7+Receptors+During+Memory+Consolidation&doi=10.1016%2Fj.bbr.2005.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2005.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2005.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DGonzalez-Espinosa%26aufirst%3DC.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DAn%2520mRNA%2520Expression%2520Analysis%2520of%2520Stimulation%2520and%2520blockade%2520of%25205-HT7%2520Receptors%2520During%2520Memory%2520Consolidation%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2006%26volume%3D169%26spage%3D83%26epage%3D92%26doi%3D10.1016%2Fj.bbr.2005.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Perez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title"><i>Ex vivo</i> Study of 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> Receptor Agonists and Antagonists on cAMP Accumulation During Memory Formation and Amnesia</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/j.bbr.2008.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2008.07.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=139-146&author=G.+Perez-Garc%C3%ADaauthor=A.+Meneses&title=Ex+vivo+Study+of+5-HT1A+and+5-HT7+Receptor+Agonists+and+Antagonists+on+cAMP+Accumulation+During+Memory+Formation+and+Amnesia&doi=10.1016%2Fj.bbr.2008.07.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2008.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2008.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DEx%2520vivo%2520Study%2520of%25205-HT1A%2520and%25205-HT7%2520Receptor%2520Agonists%2520and%2520Antagonists%2520on%2520cAMP%2520Accumulation%2520During%2520Memory%2520Formation%2520and%2520Amnesia%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D139%26epage%3D146%26doi%3D10.1016%2Fj.bbr.2008.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Horiguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span> </span><span class="NLM_article-title">The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1124/jpet.111.180638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1124%2Fjpet.111.180638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=21558435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=605-614&author=M.+Horiguchiauthor=M.+Huangauthor=H.+Y.+Meltzer&title=The+Role+of+5-Hydroxytryptamine+7+Receptors+in+the+Phencyclidine-Induced+Novel+Object+Recognition+Deficit+in+Rats&doi=10.1124%2Fjpet.111.180638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats</span></div><div class="casAuthors">Horiguchi, M.; Huang, M.; Meltzer, H. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">605-614</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The role of 5-hydroxytryptamine (serotonin) (5-HT)7 receptor antagonism in the actions of atypical antipsychotic drugs (APDs), e.g., amisulpride, clozapine, and lurasidone, if any, is uncertain.  We examd. the ability of 5-HT7 receptor antagonism alone and as a component of amisulpride and lurasidone to reverse deficits in rat novel object recognition (NOR) produced by subchronic treatment with the N-methyl-D-aspartate receptor antagonist phencyclidine (PCP), and we examd. the ability of supplemental 5-HT7 antagonism to augment the inability of sulpiride, haloperidol, and (1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY379268), a metabotropic glutamate receptor (mGluR) 2/3 agonist, which lack 5-HT7 antagonism, to reverse the NOR deficit.  The 5-HT7 receptor antagonist, (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine (SB269970) (0.1-1 mg/kg) dose-dependently reversed PCP-induced NOR deficits.  In addn., the ability of lurasidone (0.1 mg/kg) and amisulpride (3 mg/kg) to reverse this deficit was blocked by cotreatment with the 5-HT7 receptor agonist (2S)-(+)-5-(1,3,5-trimethylpyrazol-4-yl)-2-(dimethylamino)tetralin (AS19) (5-10 mg/kg), which did not affect NOR in naive rats.  Sulpiride, a less potent 5-HT7 antagonist than amisulpride, did not itself improve the PCP-induced NOR deficit.  However, a subeffective dose of SB269970 (0.1 mg/kg) in combination with subeffective doses of lurasidone (0.03 mg/kg), amisulpride (1 mg/kg), or sulpiride (20 mg/kg), also reversed the PCP-induced NOR deficit.  Pimavanserin, a 5-HT2A inverse agonist, LY379268, and haloperidol did not potentiate the ability of subeffective SB269970 to improve the NOR deficit.  Furthermore, the mGluR2/3 antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl)propanoic acid (LY341495), which blocks the effect of clozapine to reverse the NOR deficit, did not block the SB269970-induced amelioration of the NOR deficit.  These results suggest 5-HT7 antagonism may contribute to the efficacy of some atypical APDs in the treatment of cognitive impairment in schizophrenia and may itself have some benefit in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruAyKj3PlyU7Vg90H21EOLACvtfcHk0likR3YXs4-X5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFelsrw%253D&md5=ceb18a798a18e8e4f46cd9616b7039cd</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180638%26sid%3Dliteratum%253Aachs%26aulast%3DHoriguchi%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26atitle%3DThe%2520Role%2520of%25205-Hydroxytryptamine%25207%2520Receptors%2520in%2520the%2520Phencyclidine-Induced%2520Novel%2520Object%2520Recognition%2520Deficit%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D605%26epage%3D614%26doi%3D10.1124%2Fjpet.111.180638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paizanis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gusmao-Montaigne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span> </span><span class="NLM_article-title">Modulation of 5-HT<sub>7</sub> Receptor: Effect on Object Recognition Performances in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1007/s00213-013-3247-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-013-3247-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=393-400&author=T.+Freretauthor=E.+Paizanisauthor=G.+Beaudetauthor=A.+Gusmao-Montaigneauthor=G.+Neeauthor=F.+Dauphinauthor=V.+Bouetauthor=M.+Boulouard&title=Modulation+of+5-HT7+Receptor%3A+Effect+on+Object+Recognition+Performances+in+mice&doi=10.1007%2Fs00213-013-3247-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3247-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3247-x%26sid%3Dliteratum%253Aachs%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DPaizanis%26aufirst%3DE.%26aulast%3DBeaudet%26aufirst%3DG.%26aulast%3DGusmao-Montaigne%26aufirst%3DA.%26aulast%3DNee%26aufirst%3DG.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DBoulouard%26aufirst%3DM.%26atitle%3DModulation%2520of%25205-HT7%2520Receptor%253A%2520Effect%2520on%2520Object%2520Recognition%2520Performances%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D393%26epage%3D400%26doi%3D10.1007%2Fs00213-013-3247-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15ff"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Stimulation and Blockade: a Therapeutic Paradox about Memory Formation and Amnesia</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.3389%2Ffnbeh.2014.00207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24971055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=207&author=A.+Meneses&title=5-HT7+Receptor+Stimulation+and+Blockade%3A+a+Therapeutic+Paradox+about+Memory+Formation+and+Amnesia&doi=10.3389%2Ffnbeh.2014.00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15ffR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia</span></div><div class="casAuthors">Meneses, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">207/1-207/4, 4</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2VhYgUedJLVg90H21EOLACvtfcHk0lgr0hQDNuAozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrzJ&md5=734f6e4f4e06286bedf9968401c7f280</span></div><a href="/servlet/linkout?suffix=cit15ff&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00207%26sid%3Dliteratum%253Aachs%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3D5-HT7%2520Receptor%2520Stimulation%2520and%2520Blockade%253A%2520a%2520Therapeutic%2520Paradox%2520about%2520Memory%2520Formation%2520and%2520Amnesia%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D207%26doi%3D10.3389%2Ffnbeh.2014.00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kvachnina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityatev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityateva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voyno-Yasenetskaya, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Is Coupled to Gα Subunits of Heterotrimeric G12-Protein to Regulate Gene Transcription and Neuronal Morphology</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7821</span><span class="NLM_x">–</span> <span class="NLM_lpage">7830</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1790-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1523%2FJNEUROSCI.1790-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16120784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7821-7830&author=E.+Kvachninaauthor=G.+Liuauthor=A.+Dityatevauthor=U.+Rennerauthor=A.+Dumuisauthor=D.+W.+Richterauthor=G.+Dityatevaauthor=M.+Schachnerauthor=T.+A.+Voyno-Yasenetskayaauthor=E.+G.+Ponimaskin&title=5-HT7+Receptor+Is+Coupled+to+G%CE%B1+Subunits+of+Heterotrimeric+G12-Protein+to+Regulate+Gene+Transcription+and+Neuronal+Morphology&doi=10.1523%2FJNEUROSCI.1790-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span></div><div class="casAuthors">Kvachnina, Elena; Liu, Guoquan; Dityatev, Alexander; Renner, Ute; Dumuis, Aline; Richter, Diethelm W.; Dityateva, Galina; Schachner, Melitta; Voyno-Yasenetskaya, Tatyana A.; Ponimaskin, Evgeni G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7821-7830</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neurotransmitter serotonin (5-HT) plays an important role in the regulation of multiple events in the CNS.  The authors demonstrated recently a coupling between the 5-HT4 receptor and the heterotrimeric G13-protein resulting in RhoA-dependent neurite retraction and cell rounding.  In the present study, the authors identified G12 as an addnl. G-protein that can be activated by another member of serotonin receptors, the 5-HT7 receptor.  Expression of 5-HT7 receptor induced constitutive and agonist-dependent activation of a serum response element-mediated gene transcription through G12-mediated activation of small GTPases.  In NIH3T3 cells, activation of the 5-HT7 receptor induced filopodia formation via a Cdc42-mediated pathway correlating with RhoA-dependent cell rounding.  In mouse hippocampal neurons, activation of the endogenous 5-HT7 receptors significantly increased neurite length, whereas stimulation of 5-HT4 receptors led to a decrease in the length and no. of neurites.  These data demonstrate distinct roles for 5-HT7R/G12 and 5-HT4R/G13 signaling pathways in neurite outgrowth and retraction, suggesting that serotonin plays a prominent role in regulating the neuronal cytoarchitecture in addn. to its classical role as neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYY4-5ryShm7Vg90H21EOLACvtfcHk0lgr0hQDNuAozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D&md5=46861cf8fcd57de268bfa8f7450cac69</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1790-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1790-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKvachnina%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DDityatev%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DDityateva%26aufirst%3DG.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DVoyno-Yasenetskaya%26aufirst%3DT.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7%2520Receptor%2520Is%2520Coupled%2520to%2520G%25CE%25B1%2520Subunits%2520of%2520Heterotrimeric%2520G12-Protein%2520to%2520Regulate%2520Gene%2520Transcription%2520and%2520Neuronal%2520Morphology%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7821%26epage%3D7830%26doi%3D10.1523%2FJNEUROSCI.1790-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tajiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayata-Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiriki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1007/s12031-012-9861-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs12031-012-9861-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=22843252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=473-481&author=M.+Tajiriauthor=A.+Hayata-Takanoauthor=K.+Seirikiauthor=K.+Ogataauthor=K.+Hazamaauthor=N.+Shintaniauthor=A.+Babaauthor=H.+Hashimoto&title=Serotonin+5-HT7+Receptor+Blockade+Reverses+Behavioral+Abnormalities+in+PACAP-Deficient+Mice+and+Receptor+Activation+Promotes+Neurite+Extension+in+Primary+Embryonic+Hippocampal+Neurons&doi=10.1007%2Fs12031-012-9861-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons</span></div><div class="casAuthors">Tajiri, Minako; Hayata-Takano, Atsuko; Seiriki, Kaoru; Ogata, Katsuya; Hazama, Keisuke; Shintani, Norihito; Baba, Akemichi; Hashimoto, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The serotonin 5-HT7 receptor has been linked to various psychiatric disorders, including schizophrenia, anxiety and depression, and is antagonized by antipsychotics such as risperidone, clozapine and lurasidone.  In this study, we examd. whether inhibiting the 5-HT7 receptor could reverse behavioral abnormalities in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP), an exptl. mouse model for psychiatric disorders such as schizophrenia.  The selective 5-HT7 antagonist SB-269970 effectively suppressed abnormal jumping behavior in PACAP-deficient mice.  SB-269970 tended to alleviate the higher immobility in the forced swim test in PACAP-deficient mice, although SB-269970 reduced the immobility also in wild-type mice.  In addn., we found that mutant mice had impaired performance in the Y-maze test, which was reversed by SB-269970.  In the mutant mouse brain, 5-HT7 protein expression did not differ from wild-type mice.  In primary embryonic hippocampal neurons, the 5-HT7 agonist AS19 increased neurite length and no.  Furthermore, SB-269970 significantly inhibited the increase in neurite extension mediated by the 5-HT1A/7 agonist 8-OH-DPAT.  These results indicate that 5-HT7 receptor blockade ameliorates psychomotor and cognitive deficits in PACAP-deficient mice, providing addnl. evidence that the 5-HT7 receptor is a rational target for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWr0x9JOU047Vg90H21EOLACvtfcHk0lgr0hQDNuAozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKkurfF&md5=66af19c09cdfe3385a0d721fc45b6739</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs12031-012-9861-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-012-9861-y%26sid%3Dliteratum%253Aachs%26aulast%3DTajiri%26aufirst%3DM.%26aulast%3DHayata-Takano%26aufirst%3DA.%26aulast%3DSeiriki%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DK.%26aulast%3DHazama%26aufirst%3DK.%26aulast%3DShintani%26aufirst%3DN.%26aulast%3DBaba%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DSerotonin%25205-HT7%2520Receptor%2520Blockade%2520Reverses%2520Behavioral%2520Abnormalities%2520in%2520PACAP-Deficient%2520Mice%2520and%2520Receptor%2520Activation%2520Promotes%2520Neurite%2520Extension%2520in%2520Primary%2520Embryonic%2520Hippocampal%2520Neurons%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2012%26volume%3D48%26spage%3D473%26epage%3D481%26doi%3D10.1007%2Fs12031-012-9861-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rojas, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, J. L.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT) Regulates Neurite Outgrowth Through 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> Receptors in Cultured Hippocampal Neurons</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1002/jnr.23390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjnr.23390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24752854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVWhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=1000-1009&author=P.+S.+Rojasauthor=D.+Neiraauthor=M.+Mu%C3%B1ozauthor=S.+Lavanderoauthor=J.+L.+Fiedler&title=Serotonin+%285-HT%29+Regulates+Neurite+Outgrowth+Through+5-HT1A+and+5-HT7+Receptors+in+Cultured+Hippocampal+Neurons&doi=10.1002%2Fjnr.23390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons</span></div><div class="casAuthors">Rojas, Paulina S.; Neira, David; Munoz, Mauricio; Lavandero, Sergio; Fiedler, Jenny L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1000-1009</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Serotonin (5-HT) prodn. and expression of 5-HT receptors (5-HTRs) occur early during prenatal development.  Recent evidence suggests that, in addn. to its classical role as a neurotransmitter, 5-HT regulates neuronal connectivity during mammalian development by modulating cell migration and neuronal cytoarchitecture.  Given the variety of 5-HTRs, researchers have had difficulty clarifying the specific role of each receptor subtype in brain development.  Signaling mediated by the G-protein-coupled 5-HT1AR and 5-HT7R, however, has been assocd. with neuronal plasticity.  Thus, we hypothesized that 5-HT promotes neurite outgrowth through 5-HT1AR and 5-HT7R.  The involvement of 5-HT1AR and 5-HT7R in the morphol. of rat hippocampal neurons was evaluated by treating primary cultures at 2 days in vitro with 5-HT and specific antagonists for 5-HT1AR and 5-HT7R (WAY-100635 and SB 269970, resp.).  The stimulation of hippocampal neurons with 100 nM 5-HT for 24 h produced no effect on either the no. or the length of primary neurites.  Nonetheless, after 5-HT7R was blocked, the addn. of 5-HT increased the no. of primary neurites, suggesting that 5-HT7R could inhibit neuritogenesis.  In contrast, 5-HT induced secondary neurite outgrowth, an effect inhibited by 1 μM WAY-100635 or SB 269970.  These results suggest that both serotonergic receptors participate in secondary neurite outgrowth.  We conclude that 5-HT1AR and 5-HT7R regulate neuronal morphol. in primary hippocampal cultures by promoting secondary neurite outgrowth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLao8X2DXuH7Vg90H21EOLACvtfcHk0lgr0hQDNuAozQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVWhtb8%253D&md5=0a28484dcab0e6a6516e6268e8d80805</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23390%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DP.%2BS.%26aulast%3DNeira%26aufirst%3DD.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DLavandero%26aufirst%3DS.%26aulast%3DFiedler%26aufirst%3DJ.%2BL.%26atitle%3DSerotonin%2520%25285-HT%2529%2520Regulates%2520Neurite%2520Outgrowth%2520Through%25205-HT1A%2520and%25205-HT7%2520Receptors%2520in%2520Cultured%2520Hippocampal%2520Neurons%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2014%26volume%3D92%26spage%3D1000%26epage%3D1009%26doi%3D10.1002%2Fjnr.23390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Canese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoratto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altabella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pasquale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span> </span><span class="NLM_article-title">Persistent Modification of Forebrain Networks and Metabolism in Rats Following Adolescent Exposure to a 5-HT7 Receptor Agonist</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="refDoi"> DOI: 10.1007/s00213-014-3639-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-014-3639-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24923983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVeisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=75&author=R.+Caneseauthor=F.+Zorattoauthor=L.+Altabellaauthor=P.+Porcariauthor=L.+Mercurioauthor=F.+de+Pasqualeauthor=E.+Buttiauthor=G.+Martinoauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+Laviolaauthor=W.+Adriani&title=Persistent+Modification+of+Forebrain+Networks+and+Metabolism+in+Rats+Following+Adolescent+Exposure+to+a+5-HT7+Receptor+Agonist&doi=10.1007%2Fs00213-014-3639-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist</span></div><div class="casAuthors">Canese, Rossella; Zoratto, Francesca; Altabella, Luisa; Porcari, Paola; Mercurio, Laura; de Pasquale, Francesco; Butti, Erica; Martino, Gianvito; Lacivita, Enza; Leopoldo, Marcello; Laviola, Giovanni; Adriani, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The serotonin 7 receptor (5-HT7-R) is part of a neuro-transmission system with a proposed role in neural plasticity and in mood, cognitive or sleep regulation.  Objectives: We investigated long-term consequences of sub-chronic treatment, during adolescence (43-45 to 47-49 days old) in rats, with a novel 5-HT7-R agonist (LP-211, 0 or 0.250 mg/kg/day).  Methods: We evaluated behavioral changes as well as forebrain structural/functional modifications by in vivo magnetic resonance (MR) in a 4.7 T system, followed by ex vivo histol.  Results: Adult rats pre-treated during adolescence showed reduced anxiety-related behavior, in terms of reduced avoidance in the light/dark test and a less fragmented pattern of exploration in the novel object recognition test.  Diffusion tensor imaging (DTI) revealed decreased mean diffusivity (MD) in the amygdala, increased fractional anisotropy (FA) in the hippocampus (Hip) and reduced axial (D||) together with increased radial (D.perp.) diffusivity in the nucleus accumbens (NAcc).  An increased neural dendritic arborization was confirmed in the NAcc by ex vivo histol.  Seed-based functional MR imaging (fMRI) identified increased strength of connectivity within and between "limbic" and "cortical" loops, with affected cross-correlations between amygdala, NAcc and Hip.  The latter displayed enhanced connections through the dorsal striatum (dStr) to dorso-lateral prefrontal cortex (dl-PFC) and cerebellum.  Functional connection also increased between amygdala and limbic elements such as NAcc, orbito-frontal cortex (OFC) and hypothalamus.  MR spectroscopy (1H-MRS) indicated that adolescent LP-211 exposure increased glutamate and total creatine in the adult Hip.  Conclusions: Persistent MR-detectable modifications indicate a rearrangement within forebrain networks, accounting for long-lasting behavioral changes as a function of developmental 5-HT7-R stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Ai9hO1QTEbVg90H21EOLACvtfcHk0liN2833ZFepCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVeisLg%253D&md5=2b2215c5f311434f529753beef4631cf</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3639-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3639-6%26sid%3Dliteratum%253Aachs%26aulast%3DCanese%26aufirst%3DR.%26aulast%3DZoratto%26aufirst%3DF.%26aulast%3DAltabella%26aufirst%3DL.%26aulast%3DPorcari%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DL.%26aulast%3Dde%2BPasquale%26aufirst%3DF.%26aulast%3DButti%26aufirst%3DE.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLaviola%26aufirst%3DG.%26aulast%3DAdriani%26aufirst%3DW.%26atitle%3DPersistent%2520Modification%2520of%2520Forebrain%2520Networks%2520and%2520Metabolism%2520in%2520Rats%2520Following%2520Adolescent%2520Exposure%2520to%2520a%25205-HT7%2520Receptor%2520Agonist%26jtitle%3DPsychopharmacology%26date%3D2015%26volume%3D232%26spage%3D75%26doi%3D10.1007%2Fs00213-014-3639-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhin, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinsworth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettys, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewal, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnovskaya, M. N.</span><span> </span><span class="NLM_article-title">Multiplicity of Mechanisms of Serotonin Receptor Signal Transduction</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1016/S0163-7258(01)00169-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0163-7258%2801%2900169-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11916537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2001&pages=179-212&author=J.+R.+Raymondauthor=Y.+V.+Mukhinauthor=A.+Gelascoauthor=J.+Turnerauthor=G.+Collinsworthauthor=T.+W.+Gettysauthor=J.+S.+Grewalauthor=M.+N.+Garnovskaya&title=Multiplicity+of+Mechanisms+of+Serotonin+Receptor+Signal+Transduction&doi=10.1016%2FS0163-7258%2801%2900169-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplicity of mechanisms of serotonin receptor signal transduction</span></div><div class="casAuthors">Raymond, John R.; Mukhin, Yurii V.; Gelasco, Andrew; Turner, Justin; Collinsworth, Georgiann; Gettys, Thomas W.; Grewal, Jasjit S.; Garnovskaya, Maria N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">179-212</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The serotonin (5-hydroxytryptamine, 5-HT) receptors have been divided into 7 subfamilies by convention, 6 of which include 13 different genes for G-protein-coupled receptors.  Those subfamilies have been characterized by overlapping pharmacol. properties, amino acid sequences, gene organization, and second messenger coupling pathways.  Post-genomic modifications, such as alternative mRNA splicing or mRNA editing, creates at least 20 more G-protein-coupled 5-HT receptors, such that there are at least 30 distinct 5-HT receptors that signal through G-proteins.  This review will focus on what is known about the signaling linkages of the G-protein-linked 5-HT receptors, and will highlight some fascinating new insights into 5-HT receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBVczzTDd0LVg90H21EOLACvtfcHk0liN2833ZFepCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlejs7s%253D&md5=e0782176f1e92603ada72bd50be86d7c</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2801%2900169-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252801%252900169-3%26sid%3Dliteratum%253Aachs%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DMukhin%26aufirst%3DY.%2BV.%26aulast%3DGelasco%26aufirst%3DA.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DCollinsworth%26aufirst%3DG.%26aulast%3DGettys%26aufirst%3DT.%2BW.%26aulast%3DGrewal%26aufirst%3DJ.%2BS.%26aulast%3DGarnovskaya%26aufirst%3DM.%2BN.%26atitle%3DMultiplicity%2520of%2520Mechanisms%2520of%2520Serotonin%2520Receptor%2520Signal%2520Transduction%26jtitle%3DPharmacol.%2520Ther.%26date%3D2001%26volume%3D92%26spage%3D179%26epage%3D212%26doi%3D10.1016%2FS0163-7258%2801%2900169-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span> </span><span class="NLM_article-title">Functional Characterization of Agonists at Human Recombinant 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> in CHO-K1 Cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0702751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0702751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10498829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=13-20&author=R.+H.+P.+Porterauthor=K.+R.+Benwellauthor=H.+Lambauthor=C.+S.+Malcolmauthor=N.+H.+Allenauthor=D.+F.+Revellauthor=D.+R.+Adamsauthor=M.+J.+Sheardown&title=Functional+Characterization+of+Agonists+at+Human+Recombinant+5-HT2A%2C+5-HT2B+and+5-HT2C+in+CHO-K1+Cells&doi=10.1038%2Fsj.bjp.0702751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span></div><div class="casAuthors">Porter, R. H. P.; Benwell, K. R.; Lamb, H.; Malcolm, C. S.; Allen, N. H.; Revell, D. F.; Adams, D. R.; Sheardown, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The goal of this study was to characterize the agonist pharmacol. of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells.  We used a fluorometric imaging plate reader (FLIPR) which allows rapid detection of rises in intracellular calcium levels upon the addn. of agonists.  Stimulation of all three receptors by 5-HT caused a robust concn. dependent increase in intracellular calcium levels.  No such effect was obsd. from non-transfected control CHO-K1 cells.  The rank order of potency of agonists at the different receptor subtypes varied.  Tryptamines, BW-723C86, d-norfenfluramine, Ro 60-0175 and LSD exhibited the following rank order of potency; 5-HT2B>5-HT2C>5-HT2A.  Piperazines such as m-chlorophenylpiperazine (mCPP), ORG-12962, MK-212 and also ORG-37684 exhibited a rank order of potency of 5-HT2C>5-HT2B>5-HT2A.  The phenylisopropylamines DOI and DOB had a rank order of 5-HT2A>5-HT2B>5-HT2C.  Many agonists tested had partial agonist actions when compared to 5-HT, and a wide range of relative efficacies were exhibited, which was cell line dependent.  For example, mCPP had a relative efficacy of 65% at 5-HT2C receptors but <25% at either 5-HT2A or 5-HT2B receptors.  Interpretation of literature values of functional assays using different cell lines, different receptor expression levels and different receptor isoforms, is complex.  Species differences and the previous use of antagonist radioligands to characterize agonist potency in binding assays emphasizes the importance of studying agonists in the same expt. using the same assay conditions and parental cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNDFqRrlEtbVg90H21EOLACvtfcHk0liN2833ZFepCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D&md5=ff33f4122999f10960865e75161179ca</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702751%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DBenwell%26aufirst%3DK.%2BR.%26aulast%3DLamb%26aufirst%3DH.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DAllen%26aufirst%3DN.%2BH.%26aulast%3DRevell%26aufirst%3DD.%2BF.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26atitle%3DFunctional%2520Characterization%2520of%2520Agonists%2520at%2520Human%2520Recombinant%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520in%2520CHO-K1%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D13%26epage%3D20%26doi%3D10.1038%2Fsj.bjp.0702751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nakaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, E.</span><span> </span><span class="NLM_article-title">Phasic and Tonic Components in 5-HT2 Receptor-Mediated Rat Aorta Contraction: Participation of Ca++ Channels and Phospholipase C</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=2410594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaL2MXltlGkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1985&pages=442-446&author=T.+Nakakiauthor=B.+L.+Rothauthor=D.+M.+Chuangauthor=E.+Costa&title=Phasic+and+Tonic+Components+in+5-HT2+Receptor-Mediated+Rat+Aorta+Contraction%3A+Participation+of+Ca%2B%2B+Channels+and+Phospholipase+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction:  participation of calcium channels and phospholipase C</span></div><div class="casAuthors">Nakaki, Toshio; Roth, Bryan L.; Chuang, De Maw; Costa, Erminio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">442-6</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The mechanisms of 5-HT  [50-67-9]-induced contraction of rat aorta were investigated in vitro.  The 5-HT-induced contraction could be analyzed into 2 distinct components (phasic and tonic) by the use of appropriate inhibitors; nifedipine, an inhibitor of voltage-dependent Ca2+ channels, inhibited only the phasic component of 5-HT-induced contraction while totally blocking the KCl-induced contraction.  2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate, an inhibitor of phospholipase C  [9001-86-9], inhibited the tonic components of 5-HT-induced contraction as well as the 5-HT-induced stimulation of phosphoinositide hydrolysis in rat aorta.  This component of contraction was mimicked by a protein kinase C activator 12-O-tetradecanoyl phorbol 13-acetate.  Apparently, 5-HT2 receptors differentially regulate a voltage-dependent Ca2+ channel and phospholipase C activity; the voltage-dependent Ca2+ channel is involved in the phasic component of contraction, whereas the phosphoinositide hydrolysis that results in the activation of protein kinase C and Ca mobilization by inositol triphosphate plays a physiol. important role in the tonic component of the aortic contraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99TAhU0CxBLVg90H21EOLACvtfcHk0liN77mFGPm3vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlGkuro%253D&md5=86f3e65c19dbdf81124090344e6b0aab</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakaki%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BM.%26aulast%3DCosta%26aufirst%3DE.%26atitle%3DPhasic%2520and%2520Tonic%2520Components%2520in%25205-HT2%2520Receptor-Mediated%2520Rat%2520Aorta%2520Contraction%253A%2520Participation%2520of%2520Ca%252B%252B%2520Channels%2520and%2520Phospholipase%2520C%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D234%26spage%3D442%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malleron, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comte, M. – T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueremy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyronel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zundel, J. – L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viroulaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, J.</span><span> </span><span class="NLM_article-title">Naphthosultam Derivatives: A New class of Potent and Selective 5-HT<sub>2</sub> Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span><span class="refDoi"> DOI: 10.1021/jm00112a025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2477-2483&author=J.-L.+Malleronauthor=M.+%E2%80%93+T.+Comteauthor=C.+Gueremyauthor=J.+F.+Peyronelauthor=A.+Truchonauthor=J.+C.+Blanchardauthor=A.+Dobleauthor=O.+Piotauthor=J.+%E2%80%93+L.+Zundelauthor=C.+Huonauthor=B.+Martinauthor=P.+Moutonauthor=A.+Viroulaudauthor=D.+Allamauthor=J.+Betschart&title=Naphthosultam+Derivatives%3A+A+New+class+of+Potent+and+Selective+5-HT2+Antagonists&doi=10.1021%2Fjm00112a025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a025%26sid%3Dliteratum%253Aachs%26aulast%3DMalleron%26aufirst%3DJ.-L.%26aulast%3DComte%26aufirst%3DM.%2B%25E2%2580%2593%2BT.%26aulast%3DGueremy%26aufirst%3DC.%26aulast%3DPeyronel%26aufirst%3DJ.%2BF.%26aulast%3DTruchon%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DPiot%26aufirst%3DO.%26aulast%3DZundel%26aufirst%3DJ.%2B%25E2%2580%2593%2BL.%26aulast%3DHuon%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DMouton%26aufirst%3DP.%26aulast%3DViroulaud%26aufirst%3DA.%26aulast%3DAllam%26aufirst%3DD.%26aulast%3DBetschart%26aufirst%3DJ.%26atitle%3DNaphthosultam%2520Derivatives%253A%2520A%2520New%2520class%2520of%2520Potent%2520and%2520Selective%25205-HT2%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2477%26epage%3D2483%26doi%3D10.1021%2Fjm00112a025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girdlestone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boireau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guérémy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zundel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of RP 62203, a Novel 5-Hydroxytryptamine 5-HT<sub>2</sub> Receptor Antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1992.tb14206.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1476-5381.1992.tb14206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1596688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK38Xit1yjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1992&pages=27-36&author=A.+Dobleauthor=D.+Girdlestoneauthor=O.+Piotauthor=D.+Allamauthor=J.+Betschartauthor=A.+Boireauauthor=A.+Dupuyauthor=C.+Gu%C3%A9r%C3%A9myauthor=J.+M%C3%A9nagerauthor=J.+L.+Zundelauthor=J.+C.+Blanchard&title=Pharmacological+Characterization+of+RP+62203%2C+a+Novel+5-Hydroxytryptamine+5-HT2+Receptor+Antagonist&doi=10.1111%2Fj.1476-5381.1992.tb14206.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist</span></div><div class="casAuthors">Doble, A.; Girdlestone, D.; Piot, O.; Allam, D.; Betschart, J.; Boireau, A.; Dupuy, A.; Gueremy, C.; Menager, J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-36</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">RP 62203 (I) is a novel naphthosultam deriv. which shows very high affinity for 5-HT2 receptors in the rat cerebral cortex (Ki = 50.0 pM).  RP 62203 is relatively selective for this sub-type of 5-hydroxytryptamine (5-HT) receptor, having lower affinity for the 5-HT1A receptor and very low affinity for the 5-HT3 receptor.  RP 62203 displayed low to moderate affinity for α1-adrenoceptors, dopamine D2 receptors and histamine H1 receptors.  In vivo binding expts. demonstrated that oral administration of low doses of RP 62203 led to a long-lasting (>6 h) occupation of cortical 5-HT2 receptors (ID50 = 0.39 mg kg-1).  In cortical slices from the neonatal rat, RP 62203 potently inhibited inositol phosphate formation evoked by 5-HT, with an IC50 of 7.76 nM.  The activity of neurons in the raphe and their responses to microiontophoretically applied 5-HT were studied with extracellular recording electrodes in the anesthetized rat.  RP 62203 potently and dose-dependently blocked excitations evoked by 5-HT when administered at doses of 0.5-4.0 mg kg-1, i.p.  In contrast, neither 5-HT-evoked depressions nor glutamate-evoked excitations of raphe neuronal firing were blocked by RP 62203 at doses as high as 8.0 mg kg-1, i.p.  Head twitches induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) could be abolished by low doses of RP 62203 in mice (ED50 = 0.44 mg kg-1, p.o.) and in rats (ED50 = 1.54 p.o.).  Similar results were obtained with mescaline and 5-hydroxytryptophan (5-HTP).  The potency of RP 62203 was compared with that of three other 5-HT receptor antagonists, ritanserin, ICI 169,369 and ICI 170,809.  In all models, RP 62203 showed similar activity to ritanserin, whereas either ICI 169,369 or ICI 170,809 was several fold less active.  It is concluded that RP 62203 is a potent and selective antagonist at 5-HT2 receptors in the rodent central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVkPUhdZOMM7Vg90H21EOLACvtfcHk0liN77mFGPm3vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1yjt70%253D&md5=b244fb288a4c321ee148b68bab7b2c53</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb14206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb14206.x%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DGirdlestone%26aufirst%3DD.%26aulast%3DPiot%26aufirst%3DO.%26aulast%3DAllam%26aufirst%3DD.%26aulast%3DBetschart%26aufirst%3DJ.%26aulast%3DBoireau%26aufirst%3DA.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DGu%25C3%25A9r%25C3%25A9my%26aufirst%3DC.%26aulast%3DM%25C3%25A9nager%26aufirst%3DJ.%26aulast%3DZundel%26aufirst%3DJ.%2BL.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26atitle%3DPharmacological%2520Characterization%2520of%2520RP%252062203%252C%2520a%2520Novel%25205-Hydroxytryptamine%25205-HT2%2520Receptor%2520Antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D105%26spage%3D27%26epage%3D36%26doi%3D10.1111%2Fj.1476-5381.1992.tb14206.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Heuillet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malleron, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavayre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Néliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. – C.</span><span> </span><span class="NLM_article-title">The Naphthosultam Derivative RP 62203 (Fananserin) has High Affinity for the Dopamine D<sub>4</sub> Receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1016/S0014-2999(96)00554-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0014-2999%2896%2900554-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8957240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK28XnsFKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1996&pages=229-233&author=E.+Heuilletauthor=F.+Petitetauthor=S.+Mignaniauthor=J.-L.+Malleronauthor=J.+Lavayreauthor=G.+N%C3%A9liatauthor=A.+Dobleauthor=J.+%E2%80%93+C.+Blanchard&title=The+Naphthosultam+Derivative+RP+62203+%28Fananserin%29+has+High+Affinity+for+the+Dopamine+D4+Receptor&doi=10.1016%2FS0014-2999%2896%2900554-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">The naphthosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor</span></div><div class="casAuthors">Heuillet, Edith; Petitet, Francois; Mignani, Serge; Malleron, Jean-Luc; Lavayre, Jacques; Neliat, Gervais; Doble, Adam; Blanchard, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The dopamine D4 receptor is a potential target for novel antipsychotic drugs.  Most available compds. with affinity for the dopamine D4 receptor also bind to dopamine D4 receptors.  This report describes the affinity of the 5-HT2A receptor antagonist RP 62203 (fananserin) for the human dopamine D4 receptor.  Fananserin displaces [3H]spiperone binding to recombinant human dopamine D4 receptors with a Ki of 2.93 nM.  This compares with an affinity (Ki) of 0.37 nM for the rat 5-HT2A receptor and of 726 nM for the rat dopamine D2 receptor.  [3H]Fananserin can be used to label the recombinant dopamine D4 receptor expressed in Chinese hamster ovary cells with a KD of 0.725 nM.  Fananserin is, thus, the first compd. to be reported that distinguishes between dopamine D4 and D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFk_yEIjx_prVg90H21EOLACvtfcHk0li9qExOz4mm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFKms7Y%253D&md5=7d0f04c6f915e1c315ea52de33b4a482</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900554-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900554-7%26sid%3Dliteratum%253Aachs%26aulast%3DHeuillet%26aufirst%3DE.%26aulast%3DPetitet%26aufirst%3DF.%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DMalleron%26aufirst%3DJ.-L.%26aulast%3DLavayre%26aufirst%3DJ.%26aulast%3DN%25C3%25A9liat%26aufirst%3DG.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2B%25E2%2580%2593%2BC.%26atitle%3DThe%2520Naphthosultam%2520Derivative%2520RP%252062203%2520%2528Fananserin%2529%2520has%2520High%2520Affinity%2520for%2520the%2520Dopamine%2520D4%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D314%26spage%3D229%26epage%3D233%26doi%3D10.1016%2FS0014-2999%2896%2900554-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Herth, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Synthesis and In Vitro Affinities of Various MDL 100907 Derivatives as Potential <sup>18</sup>F-Radioligands for 5-HT<sub>2A</sub> Receptor Imaging with PET</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3002</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2009.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19329329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2989-3002&author=M.+M.+Herthauthor=V.+Kramerauthor=M.+Pielauthor=M.+Palnerauthor=P.+J.+Rissauthor=G.+M.+Knudsenauthor=F.+R%C3%B6sch&title=Synthesis+and+In+Vitro+Affinities+of+Various+MDL+100907+Derivatives+as+Potential+18F-Radioligands+for+5-HT2A+Receptor+Imaging+with+PET&doi=10.1016%2Fj.bmc.2009.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET</span></div><div class="casAuthors">Herth, Matthias M.; Kramer, Vasko; Piel, Markus; Palner, Mikael; Riss, Patrick J.; Knudsen, Gitte M.; Roesch, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2989-3002</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Radiolabeled piperidine derivs. such as [11C]MDL 100907 and [18F]altanserin have played an important role in diagnosing malfunction in the serotonergic neurotransmission.  A variety of novel piperidine MDL 100907 derivs., possible to label with 18F-fluorine, were synthesized to improve mol. imaging properties of [11C]MDL 100907.  Their in vitro affinities to a broad spectrum of neuroreceptors and their lipophilicities were detd. and compared to the clin. used ref. compds. MDL 100907 and altanserin.  The novel compds. MA-1 (53) and (R)-MH.MZ (56) show K i-values in the nanomolar range towards the 5-HT2A receptor and insignificant binding to other 5-HT receptor subtypes or receptors.  Interestingly, compds. MA-1 (53), MH.MZ (55) and (R)-MH.MZ (56) provide a receptor selectivity profile similar to MDL 100907.  These compds. could possibly be preferable antagonistic 18F-tracers for visualization of the 5-HT2A receptor status.  Medium affine compds. (VK-1 (32), (51), (52), (54)) were synthesized and have K i values between 30 and 120 nM.  All promising compds. show log P values between 2 and 3, i.e., within the range of those for the established radiotracers altanserin and MDL 100907.  The novel compds. MA-1 (53) and (R)-MH.MZ (56) thus appear to be promising high affine and selective tracers of 18F-labeled analogs for 5-HT2A imaging with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGuDhmyQor1bVg90H21EOLACvtfcHk0li9qExOz4mm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWlu7w%253D&md5=6af998051cfd6829df09eae91354ee8c</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DHerth%26aufirst%3DM.%2BM.%26aulast%3DKramer%26aufirst%3DV.%26aulast%3DPiel%26aufirst%3DM.%26aulast%3DPalner%26aufirst%3DM.%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520In%2520Vitro%2520Affinities%2520of%2520Various%2520MDL%2520100907%2520Derivatives%2520as%2520Potential%252018F-Radioligands%2520for%25205-HT2A%2520Receptor%2520Imaging%2520with%2520PET%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2989%26epage%3D3002%26doi%3D10.1016%2Fj.bmc.2009.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Eison, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J.R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span> </span><span class="NLM_article-title">Nefazodone: Preclinical Pharmacology of a New Anti-depressant</span> <span class="citation_source-journal">Psychopharmacol. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=2274630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK3MXisVSgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=311-315&author=A.+S.+Eisonauthor=M.+S.+Eisonauthor=J.R.+Torrenteauthor=R.+N.+Wrightauthor=F.+D.+Yocca&title=Nefazodone%3A+Preclinical+Pharmacology+of+a+New+Anti-depressant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Nefazodone:  preclinical pharmacology of a new antidepressant</span></div><div class="casAuthors">Eison, Arlene S.; Eison, Michael S.; Torrente, John R.; Wright, Robert N.; Yocca, Frank D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-15</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">Recent pharmacol. studies suggest that nefazodone (I) may possess antidepressant activity.  I is active in behavioral models predictive of antidepressant potential.  It is active in reversing learned helplessness, prevents reserpine-induced ptosis, and enhances response efficiency in the differential reinforcement for low rates of response paradigm.  In in vitro studies, I inhibits the binding of [3H]ketanserin to cortical serotonin2 (5-HT2) binding sites, whereas in vivo, it antagonizes the 5-HT2-mediated quipazine-induced head shake in rats.  In ex vivo studies, acute oral administration of I inhibits cortical seotonin uptake and occupies frontal cortical 5-HT2 receptor binding sites.  Chronic administration of I produces a redn. in 5-HT2-mediated behavior and decreases cortical 5-HT2 receptor binding site d.  Further, a chronic high-dose I regimen significantly potentiates 5-HT1A-mediated behavioral responses in rats.  I exhibits decreased anticholinergic, α-adrenolytic, and sedative actiivty relative to other antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp22B3vChlPeLVg90H21EOLACvtfcHk0li9qExOz4mm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVSgurs%253D&md5=08b2fb5fda095e4dc251b9ab37641c05</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEison%26aufirst%3DA.%2BS.%26aulast%3DEison%26aufirst%3DM.%2BS.%26aulast%3DTorrente%26aufirst%3DJ.R.%26aulast%3DWright%26aufirst%3DR.%2BN.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26atitle%3DNefazodone%253A%2520Preclinical%2520Pharmacology%2520of%2520a%2520New%2520Anti-depressant%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1990%26volume%3D26%26spage%3D311%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Armitage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roffwarg, H. P.</span><span> </span><span class="NLM_article-title">The effects of Nefazodone on Sleep Architecture in Depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1038/npp.1994.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnpp.1994.14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1994&pages=123-127&author=R.+Armitageauthor=A.+J.+Rushauthor=M.+Trivediauthor=J.+Cainauthor=H.+P.+Roffwarg&title=The+effects+of+Nefazodone+on+Sleep+Architecture+in+Depression&doi=10.1038%2Fnpp.1994.14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.1994.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.1994.14%26sid%3Dliteratum%253Aachs%26aulast%3DArmitage%26aufirst%3DR.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DJ.%26aulast%3DRoffwarg%26aufirst%3DH.%2BP.%26atitle%3DThe%2520effects%2520of%2520Nefazodone%2520on%2520Sleep%2520Architecture%2520in%2520Depression%26jtitle%3DNeuropsychopharmacology%26date%3D1994%26volume%3D10%26spage%3D123%26epage%3D127%26doi%3D10.1038%2Fnpp.1994.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pullar, I.A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedley, S.</span><span> </span><span class="NLM_article-title">LY367265, an Inhibitor of the 5-Hydroxytryptamine Transporter and 5-Hydroxytryptamine 2A Receptor Antagonist: a Comparison with the Antidepressant, Nefazodone</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/S0014-2999(00)00728-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0014-2999%2800%2900728-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11050288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=39-46&author=I.A.+Pullarauthor=S.+L.+Carneyauthor=E.+M.+Colvinauthor=V.+L.+Lucaitesauthor=D.+L.+Nelsonauthor=S.+Wedley&title=LY367265%2C+an+Inhibitor+of+the+5-Hydroxytryptamine+Transporter+and+5-Hydroxytryptamine+2A+Receptor+Antagonist%3A+a+Comparison+with+the+Antidepressant%2C+Nefazodone&doi=10.1016%2FS0014-2999%2800%2900728-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone</span></div><div class="casAuthors">Pullar, I. A.; Carney, S. L.; Colvin, E. M.; Lucaites, V. L.; Nelson, D. L.; Wedley, S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The potential antidepressant, LY367265 (1-[2-[4-(6-fluoro-1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl]ethyl]-5,6-dihydro-1H,4H-[1,2,5]thiadiazolo[4.3.2-ij]quinoline-2,2,-dioxide) has been shown to have a higher affinity for the 5-hydroxytryptamine (5-HT) transporter (Ki=2.3 nM) and 5-HT2A (Ki=0.81 nM) receptor than the clin. effective antidepressant, nefazodone.  It is a potent inhibitor of [3H]5-HT uptake into rat cortical synaptosomes (IC50=3.1 nM) and shows selectivity over that for [3H]noradrenaline (IC50°1000 nM).  It potentiates potassium-induced [3H]5-HT outflow from prelabeled guinea pig cortical slices both in the presence (EC50=950 nM) and absence (EC50=250 nM) of a satg. concn. of the 5-HT transport inhibitor, paroxetine, indicating a low level of activity at the 5-HT1B/1D autoreceptor.  These studies indicate that LY367265 is a putative antidepressant which, because of its 5-HT2A receptor antagonist activity, has the potential to produce less sleep disturbance and sexual dysfunction than selective serotonin uptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCax7sIb7CuLVg90H21EOLACvtfcHk0lhjKEfj2Eo4QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFWqt7o%253D&md5=f20cbf13b5c9d04cba0a86aeeed0eca2</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900728-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900728-7%26sid%3Dliteratum%253Aachs%26aulast%3DPullar%26aufirst%3DI.A.%26aulast%3DCarney%26aufirst%3DS.%2BL.%26aulast%3DColvin%26aufirst%3DE.%2BM.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWedley%26aufirst%3DS.%26atitle%3DLY367265%252C%2520an%2520Inhibitor%2520of%2520the%25205-Hydroxytryptamine%2520Transporter%2520and%25205-Hydroxytryptamine%25202A%2520Receptor%2520Antagonist%253A%2520a%2520Comparison%2520with%2520the%2520Antidepressant%252C%2520Nefazodone%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D407%26spage%3D39%26epage%3D46%26doi%3D10.1016%2FS0014-2999%2800%2900728-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">For a comprehensive review on Nefazodone:</p></div><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, H. M.</span><span> </span><span class="NLM_article-title">Nefazodone. A Review of its Pharmacology and Clinical Efficacy in the Management of Major Depression</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.2165/00003495-199753040-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2165%2F00003495-199753040-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=608-636&author=R.+Davisauthor=R.+Whittingtonauthor=H.+M.+Bryson&title=Nefazodone.+A+Review+of+its+Pharmacology+and+Clinical+Efficacy+in+the+Management+of+Major+Depression&doi=10.2165%2F00003495-199753040-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.2165%2F00003495-199753040-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199753040-00006%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DWhittington%26aufirst%3DR.%26aulast%3DBryson%26aufirst%3DH.%2BM.%26atitle%3DNefazodone.%2520A%2520Review%2520of%2520its%2520Pharmacology%2520and%2520Clinical%2520Efficacy%2520in%2520the%2520Management%2520of%2520Major%2520Depression%26jtitle%3DDrugs%26date%3D1997%26volume%3D53%26spage%3D608%26epage%3D636%26doi%3D10.2165%2F00003495-199753040-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M.</span><span> </span><span class="NLM_article-title">Atypical Neuroleptics Have Low Affinity for Dopamine D<sub>2</sub> Receptors or Are Selective for D<sub>4</sub> Receptors</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/S0893-133X(96)00187-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0893-133X%2896%2900187-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=93-110&author=P.+Seemanauthor=R.+Corbettauthor=H.+H.+M.+Van+Tol&title=Atypical+Neuroleptics+Have+Low+Affinity+for+Dopamine+D2+Receptors+or+Are+Selective+for+D4+Receptors&doi=10.1016%2FS0893-133X%2896%2900187-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2896%2900187-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252896%252900187-X%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DAtypical%2520Neuroleptics%2520Have%2520Low%2520Affinity%2520for%2520Dopamine%2520D2%2520Receptors%2520or%2520Are%2520Selective%2520for%2520D4%2520Receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D93%26epage%3D110%26doi%3D10.1016%2FS0893-133X%2896%2900187-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ichikawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span> </span><span class="NLM_article-title">Atypical Antipsychotic Drugs, Quetiapine, Iloperidone, and Melperone Preferentially Increase Dopamine and Acetylcholine Release in Rat Medial Prefrontal Cortex: Role of 5-HT<sub>1A</sub> Receptor Agonism</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">956</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1016/S0006-8993(02)03570-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0006-8993%2802%2903570-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12445705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xoslamtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=956&publication_year=2002&pages=349-357&author=J.+Ichikawaauthor=Z.+Liauthor=J.+Daiauthor=H.+Y.+Meltzer&title=Atypical+Antipsychotic+Drugs%2C+Quetiapine%2C+Iloperidone%2C+and+Melperone+Preferentially+Increase+Dopamine+and+Acetylcholine+Release+in+Rat+Medial+Prefrontal+Cortex%3A+Role+of+5-HT1A+Receptor+Agonism&doi=10.1016%2FS0006-8993%2802%2903570-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism</span></div><div class="casAuthors">Ichikawa, Junji; Li, Zhu; Dai, Jin; Meltzer, Herbert Y.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">956</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Preferential increases in both cortical dopamine (DA) and acetylcholine (ACh) release have been proposed to distinguish the atypical antipsychotic drugs (APDs) clozapine, olanzapine, risperidone and ziprasidone from typical APDs such as haloperidol.  Although only clozapine and ziprasidone are directly acting 5-HT1A agonists, WAY100635, a selective 5-HT1A antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT2A and D2 blockade.  However, WAY100635 does not attenuate clozapine-induced cortical ACh release.  The present study detd. whether quetiapine, iloperidone and melperone, 5-HT2A/D2 antagonist atypical APDs, also increase cortical DA and ACh release, and whether these effects are related to 5-HT1A agonism.  Quetiapine (30 mg/kg), iloperidone (1-10 mg/kg), and melperone (3-10 mg/kg) increased DA and ACh release in the medial prefrontal cortex (mPFC).  Iloperidone (10 mg/kg) and melperone (10 mg/kg), but not quetiapine (30 mg/kg), produced an equiv. or a smaller increase in DA release in the nucleus accumbens (NAC), resp., compared to the mPFC, whereas none of them increased ACh release in the NAC.  WAY100635 (0.2 mg/kg), which alone did not affect DA or ACh release, partially attenuated quetiapine (30 mg/kg)-, iloperidone (10 mg/kg)- and melperone (10 mg/kg)-induced DA release in the mPFC.  WAY100635 also partially attenuated quetiapine (30 mg/kg)-induced ACh release in the mPFC, but not that induced by iloperidone (10 mg/kg) or melperone (10 mg/kg).  These results indicate that quetiapine, iloperidone and melperone preferentially increase DA release in the mPFC, compared to the NAC via a 5-HT1A-related mechanism.  However, 5-HT1A agonism may be important only for quetiapine-induced ACh release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6oSrcameDX7Vg90H21EOLACvtfcHk0lhjKEfj2Eo4QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xoslamtrw%253D&md5=77244027fc93095506663826c32ee129</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903570-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903570-9%26sid%3Dliteratum%253Aachs%26aulast%3DIchikawa%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26atitle%3DAtypical%2520Antipsychotic%2520Drugs%252C%2520Quetiapine%252C%2520Iloperidone%252C%2520and%2520Melperone%2520Preferentially%2520Increase%2520Dopamine%2520and%2520Acetylcholine%2520Release%2520in%2520Rat%2520Medial%2520Prefrontal%2520Cortex%253A%2520Role%2520of%25205-HT1A%2520Receptor%2520Agonism%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D956%26spage%3D349%26epage%3D357%26doi%3D10.1016%2FS0006-8993%2802%2903570-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Uhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namendorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenhagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebinger, M.</span><span> </span><span class="NLM_article-title">P-Glycoprotein is a Factor in the Uptake of Dextromethorphan, but not of Melperone, into the Mouse Brain: Evidence for an Overlap in Substrate Specificity Between P-gp and CYP2D6</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1177/0269881104047278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1177%2F0269881104047278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15582917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=509-515&author=M.+Uhrauthor=C.+Namendorfauthor=M.+T.+Grauerauthor=M.+Rosenhagenauthor=M.+Ebinger&title=P-Glycoprotein+is+a+Factor+in+the+Uptake+of+Dextromethorphan%2C+but+not+of+Melperone%2C+into+the+Mouse+Brain%3A+Evidence+for+an+Overlap+in+Substrate+Specificity+Between+P-gp+and+CYP2D6&doi=10.1177%2F0269881104047278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6</span></div><div class="casAuthors">Uhr, Manfred; Namendorf, Christian; Grauer, Markus T.; Rosenhagen, Markus; Ebinger, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">509-515</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">In this study, the role of P-glycoprotein (P-gp) for the pharmacokinetics of dextromethorphan, a CYP2D6 substrate, and of melperone, a CYP2D6 inhibitor, was investigated.  The substances were administered s.c. near the nape of the neck of wild-type mice and of abcb1ab (-/-) mice.  One hour after injection, concns. of the two drugs in cerebrum, plasma and in different organs were measured by high-performance liq. chromatog.  No significant differences between wild-type mice and abcb1ab (-/-) mice were obsd. for melperone, suggesting that P-gp is not involved in the uptake of melperone into the brain or other organs of mice.  The concn. of dextromethorphan in the brain was more than twice as high in abcb1ab (-/-) mice compared to wild-type mice.  Therefore, P-gp appears to be a factor in the uptake of dextromethorphan into the mouse brain, and abcb1-polymorphisms need to be considered for CYP2D6 phenotyping expts. with this drug.  There is an overlap in substrate specificity between P-gp and CYP2D6.  P-gp is a factor in the uptake of dextromethorphan, but not of melperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfB1y9TUnGC7Vg90H21EOLACvtfcHk0lhjKEfj2Eo4QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVWlsw%253D%253D&md5=28a2223aa6c1dda5933fdf30c751d691</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1177%2F0269881104047278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881104047278%26sid%3Dliteratum%253Aachs%26aulast%3DUhr%26aufirst%3DM.%26aulast%3DNamendorf%26aufirst%3DC.%26aulast%3DGrauer%26aufirst%3DM.%2BT.%26aulast%3DRosenhagen%26aufirst%3DM.%26aulast%3DEbinger%26aufirst%3DM.%26atitle%3DP-Glycoprotein%2520is%2520a%2520Factor%2520in%2520the%2520Uptake%2520of%2520Dextromethorphan%252C%2520but%2520not%2520of%2520Melperone%252C%2520into%2520the%2520Mouse%2520Brain%253A%2520Evidence%2520for%2520an%2520Overlap%2520in%2520Substrate%2520Specificity%2520Between%2520P-gp%2520and%2520CYP2D6%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2004%26volume%3D18%26spage%3D509%26epage%3D515%26doi%3D10.1177%2F0269881104047278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sorensen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehne, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadayel, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketteler, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Characterization of 5-HT2 Receptor Antagonist MDL 100907 as a Putative Atypical Antipsychotic: Behavioral, Electrophysiological and Neurochemical Studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8102646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2cXitlelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1993&pages=684-691&author=S.+M.+Sorensenauthor=J.+H.+Kehneauthor=G.+M.+Fadayelauthor=T.+M.+Humphreysauthor=H.+J.+Kettelerauthor=C.+K.+Sullivanauthor=V.+L.+Taylorauthor=C.+J.+Schmidt&title=Characterization+of+5-HT2+Receptor+Antagonist+MDL+100907+as+a+Putative+Atypical+Antipsychotic%3A+Behavioral%2C+Electrophysiological+and+Neurochemical+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies</span></div><div class="casAuthors">Sorensen, Stephen M.; Kehne, John H.; Fadayel, Gina M.; Humphreys, Teresa M.; Ketteler, Herbert J.; Sullivan, Christine K.; Taylor, Vicki L.; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">684-91</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Progress toward understanding the role of the 5-hydroxytryptamine (5-HT)2 receptor in the therapy for schizophrenia has been hampered by the lack of high selective antagonists.  The authors now report on the effects of MDL 100,907 [R(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol], a highly selective and potent 5-HT2 receptor antagonist, in behavioral, electrophysiol. and neurochem. models of antipsychotic activity and extrapyramidal side-effect liability.  In mice, MDL 100,907 blocked amphetamine-stimulated locomotion at doses that did not significantly affect apomorphine-stimulated climbing behavior.  Neither MDL 100,907 nor clozapine reduced apomorphine-induced stereotypies or produced catalepsy in rats.  MDL 100,907 blocked the slowing of ventral tegmental area (A10) dopaminergic neurons by amphetamine but, like clozapine, produced only small increases in the no. of active substantia nigra zona compacta (A9) and A10 dopamine neurons after acute administration.  When administered chronically, MDL 100,907 and clozapine selectively reduced the no. of spontaneously active A10 neurons, whereas haloperidol reduced activity in both the A9 and A10 regions.  Consistent with their acute effect on A9 and A10 activity, neither MDL 100,907 nor clozapine increased dopamine metab. in the striatum or nucleus accumbens, whereas acute haloperidol accelerated dopamine turnover in both regions.  The administration of the dopamine uptake blocker amfonelic acid with haloperidol produced a massive increase in DA metab. characteristic of typical antipsychotics.  In contrast, MDL 100,907 and clozapine were without effect on dopamine turnover when given in the presence of amfonelic acid.  These data indicate that MDL 100,907 has a clozapine-like profile of potential antipsychotic activity with low extrapyramidal side-effect liability.  The receptor selectivity of MDL 100,907 and the proposed regulation of dopaminergic function by 5-HT2 receptors support the conclusion that further clin. evaluation of selective 5-HT2 antagonists as antipsychotic agents is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBFqMWvGTiLVg90H21EOLACvtfcHk0lj9fziH-Y4OKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlelug%253D%253D&md5=5519667c5d7e79ee2132247738de91a7</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DS.%2BM.%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DFadayel%26aufirst%3DG.%2BM.%26aulast%3DHumphreys%26aufirst%3DT.%2BM.%26aulast%3DKetteler%26aufirst%3DH.%2BJ.%26aulast%3DSullivan%26aufirst%3DC.%2BK.%26aulast%3DTaylor%26aufirst%3DV.%2BL.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DCharacterization%2520of%25205-HT2%2520Receptor%2520Antagonist%2520MDL%2520100907%2520as%2520a%2520Putative%2520Atypical%2520Antipsychotic%253A%2520Behavioral%252C%2520Electrophysiological%2520and%2520Neurochemical%2520Studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D266%26spage%3D684%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kehne, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Giersbergen, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloskey, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senyah, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildmaier, C.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of the Potential of the Putative Atypical Antipsychotic MDL 100,907 as a Potent 5-HT2A Antagonist with a Favorable CNS Safety Profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8627580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK28XivFeht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=968-981&author=J.+H.+Kehneauthor=M.+M.+Baronauthor=A.+A.+Carrauthor=S.+F.+Chaneyauthor=J.+Elandsauthor=D.+J.+Feldmanauthor=R.+A.+Franckauthor=P.+L.+Van+Giersbergenauthor=T.+C.+McCloskeyauthor=M.+P.+Johnsonauthor=D.+R.+McCartyauthor=M.+Poirotauthor=Y.+Senyahauthor=B.+W.+Siegelauthor=C.+Wildmaier&title=Preclinical+Characterization+of+the+Potential+of+the+Putative+Atypical+Antipsychotic+MDL+100%2C907+as+a+Potent+5-HT2A+Antagonist+with+a+Favorable+CNS+Safety+Profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile</span></div><div class="casAuthors">Kehne, John H.; Baron, Bruce M.; Carr, Albert A.; Chaney, Stephen F.; Elands, Jack; Feldman, Daniel J.; Frank, Robert A.; Van Giersbergen, Paul L. M.; McCloskey, Timothy C.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">968-981</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In preclin. studies, [R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol] (MDL 100,907), a putative atypical antipsychotic, was characterized in vitro as a potent and selective ligand for the serotonin2A (5-HT2A) receptor and was evaluated in vitro and in vivo as a potent 5-HT2A receptor antagonist.  Furthermore, MDL 100,907's potential CNS safety profile and selectivity as a potential antipsychotic agent were evaluated and compared with benchmark compds.  MDL 100,907 demonstrated low nanomolar or subnanomolar binding in vitro at the 5-HT2A receptor and showed a > 100-fold sepn. from all other receptors measured.  MDL 100,907 has subnanomolar potency as a 5-HT2A antagonist in vitro in reversing 5-HT-stimulated inositol phosphate accumulation in NIH 3T3 cells transfected with the rat 5-HT2A receptor.  In vivo, MDL 100,907 potently inhibited 5-methoxy-N,N-dimethyltryptamine-induced head twitches in mice or 5-hydroxytrypophan-induced head twitched in rats.  In vivo functional tests in mice revealed a > 500-fold sepn. between doses that produced 5-HT2A antagonism and doses that produced α1-adrenergic or striatal D2 antagonism.  Using inhibition of D-amphetamine-stimulated locomotion in mice as a measure of potential antipsychotic efficacy, MDL 100,907 showed a superior CNS safety index relative to the ref. compds., haloperidol, clozapine, risperidone,ritanserin, and amperozide, in each of five tests for side effect potential, including measures of ataxia, general depressant effects, α1-adrenergic antagonism, striatal D2 receptor antagonism, and muscle relaxation.  MDL 100,907 did not antagonize apomorphine-induced stereotypies in rats, suggesting that it potentially lacks extrapyramidal side effect liability.  MDL 100,907 showed selectivity as a potential antipsychotic in that it lacked consistent activity in selected rodent models of anticonvulsant, anti-depressant, analgesic, or anxiolytic activity.  In summary, these preclin. data indicate that MDL 100,907 is a potent and selective ligand at the 5-HT2A receptor.  MDL 100,907's potent 5-HT2A antagonist activity might account for its activity in preclin. models of antipsychotic potential.  Ongoing clin. evaluation with MDL 100,907 will test the hypothesis that 5-HT2A receptor antagonism is sufficient for antipsychotic activity in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqravKtRD4ZLbVg90H21EOLACvtfcHk0lj9fziH-Y4OKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFeht7s%253D&md5=01a7031bf3ef86ac47fe60ac14493a64</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DBaron%26aufirst%3DM.%2BM.%26aulast%3DCarr%26aufirst%3DA.%2BA.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BJ.%26aulast%3DFranck%26aufirst%3DR.%2BA.%26aulast%3DVan%2BGiersbergen%26aufirst%3DP.%2BL.%26aulast%3DMcCloskey%26aufirst%3DT.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DPoirot%26aufirst%3DM.%26aulast%3DSenyah%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DB.%2BW.%26aulast%3DWildmaier%26aufirst%3DC.%26atitle%3DPreclinical%2520Characterization%2520of%2520the%2520Potential%2520of%2520the%2520Putative%2520Atypical%2520Antipsychotic%2520MDL%2520100%252C907%2520as%2520a%2520Potent%25205-HT2A%2520Antagonist%2520with%2520a%2520Favorable%2520CNS%2520Safety%2520Profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26spage%3D968%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ardayfio, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">The Hydroxytryptamine<sub>2A</sub> Receptor Antagonist <i>R</i>-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) Attenuates Impulsivity after Both Drug-Induced Disruption (Dizocilpine) and Enhancement (Antidepressant Drugs) of Differential-Reinforcement-of-Low-Rate 72-s Behavior in the Rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1124/jpet.108.143370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1124%2Fjpet.108.143370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=18772320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=891-897&author=P.+A.+Ardayfioauthor=M.+J.+Benvengaauthor=S.+F.+Chaneyauthor=P.+L.+Loveauthor=J.+Catlowauthor=S.+P.+Swansonauthor=G.+J.+Marek&title=The+Hydroxytryptamine2A+Receptor+Antagonist+R-%28%2B%29-%CE%B1-%282%2C3-Dimethoxyphenyl%29-1-%5B2-%284-fluorophenyl%29ethyl-4-piperidinemethanol+%28M100907%29+Attenuates+Impulsivity+after+Both+Drug-Induced+Disruption+%28Dizocilpine%29+and+Enhancement+%28Antidepressant+Drugs%29+of+Differential-Reinforcement-of-Low-Rate+72-s+Behavior+in+the+Rat&doi=10.1124%2Fjpet.108.143370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-hydroxytryptamine2A receptor antagonist R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat</span></div><div class="casAuthors">Ardayfio, Paul A.; Benvenga, Mark J.; Chaney, Stephen F.; Love, Patrick L.; Catlow, John; Swanson, Steven P.; Marek, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">891-897</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work has suggested that N-methyl-D-aspartate (NMDA) receptor antagonism and 5-hydroxytryptamine (5-HT)2A receptor blockade may enhance and attenuate, resp., certain types of impulsivity mediated by corticothalamostriatal circuits.  More specifically, past demonstrations of synergistic "antidepressant-like" effects of a 5-HT2A receptor antagonist and fluoxetine on differential-reinforcement-of-low-rate (DRL) 72-s schedule of operant reinforcement may speak to the role of 5-HT2A receptor blockade with respect to response inhibition as an important prefrontal cortical executive function relating to motor impulsivity.  To examine the dynamic range over which 5-HT2A receptor blockade may exert effects on impulsivity, M100907 was examd. both alone and in combination with the psychotomimetic NMDA receptor antagonist dizocilpine [e.g., (-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate; MK-801] and two different antidepressants, the tricyclic antidepressant desmethylimipramine (DMI) and the monoamine oxidase inhibitor tranylcypromine in rats performing under a DRL 72-s schedule.  MK-801 increased the response rate, decreased the no. of reinforcers obtained, and exerted a leftward shift in the inter-response time (IRT) distribution as expected.  A dose of M100907 that exerted minimal effect on DRL behavior by itself attenuated the psychotomimetic effects of MK-801.  Extending previous M100907-fluoxetine observations, addn. of a minimally active dose of M100907 to low doses of DMI and tranylcypromine enhanced the antidepressant-like effect of the antidepressants.  Therefore, it may be that a tonic excitation of 5-HT2A receptors modulates impulsivity and function of corticothalamostriatal circuits over an extensive dynamic range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgN9ZC1HG7tLVg90H21EOLACvtfcHk0ljjWS4HD0XpwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjE&md5=af0ff38682682675835cccb955ce7314</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143370%26sid%3Dliteratum%253Aachs%26aulast%3DArdayfio%26aufirst%3DP.%2BA.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DLove%26aufirst%3DP.%2BL.%26aulast%3DCatlow%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520Hydroxytryptamine2A%2520Receptor%2520Antagonist%2520R-%2528%252B%2529-%25CE%25B1-%25282%252C3-Dimethoxyphenyl%2529-1-%255B2-%25284-fluorophenyl%2529ethyl-4-piperidinemethanol%2520%2528M100907%2529%2520Attenuates%2520Impulsivity%2520after%2520Both%2520Drug-Induced%2520Disruption%2520%2528Dizocilpine%2529%2520and%2520Enhancement%2520%2528Antidepressant%2520Drugs%2529%2520of%2520Differential-Reinforcement-of-Low-Rate%252072-s%2520Behavior%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D891%26epage%3D897%26doi%3D10.1124%2Fjpet.108.143370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leysen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awouters, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span> </span><span class="NLM_article-title">Receptor Binding Profile of R 41 468, a Novel Antagonist at 5-HT<sub>2</sub> Receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90747-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0024-3205%2881%2990747-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1981&pages=1015-1022&author=J.+E.+Leysenauthor=F.+Awoutersauthor=L.+Kennisauthor=P.+M.+Laduronauthor=J.+Vandenberkauthor=P.+A.+J.+Janssen&title=Receptor+Binding+Profile+of+R+41+468%2C+a+Novel+Antagonist+at+5-HT2+Receptors&doi=10.1016%2F0024-3205%2881%2990747-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990747-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990747-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26aulast%3DAwouters%26aufirst%3DF.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DVandenberk%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26atitle%3DReceptor%2520Binding%2520Profile%2520of%2520R%252041%2520468%252C%2520a%2520Novel%2520Antagonist%2520at%25205-HT2%2520Receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D28%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2F0024-3205%2881%2990747-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Nueten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Beek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xhonneux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeuren, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, P. M.</span><span> </span><span class="NLM_article-title">Vascular Effects of Ketanserin (R 41468), a Novel Antagonist of 5-HT2 Serotonergic Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=6113280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaL3MXksFCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=1981&pages=217-230&author=J.+M.+Van+Nuetenauthor=P.+A.+Janssenauthor=J.+Van+Beekauthor=R.+Xhonneuxauthor=T.+J.+Verbeurenauthor=P.+M.+Vanhoutte&title=Vascular+Effects+of+Ketanserin+%28R+41468%29%2C+a+Novel+Antagonist+of+5-HT2+Serotonergic+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects of R 41468, a novel antagonist of 5-HT2 serotonergic receptors</span></div><div class="casAuthors">Van Nueten, J. M.; Janssen, P. A. J.; Van Beek, J.; Xhonneux, R.; Verbeuren, T. J.; Vanhoutte, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-30</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The serotonergic receptor antagonist R 41468 (I)  [74050-98-9] dose-dependently inhibited the contractile responses to 5-hydroxytryptamine sulfate  [2906-14-1] of isolated rat caudal artery, canine basilar, carotid, coronary and gastrosplenic arteries, canine gastrosplenic veins (threshold 10-10-10-9 M) and canine saphenous veins (threshold 10-8 M).  In concns. up to 2.5 × 10-5 M, it did not have agonistic properties.  From 10-8 M on R 41468 inhibited the conjuctional α-adrenergic activation.  In the rat caudal artery, R 41468, in concns. which did not affect the contractile response to norepinephrine, abolished the amplifying effect of low concns. of 5-hydroxytryptamine during sympathetic nerve stimulation.  In the perfused guinea pig stomach, R 41468 depressed and in certain expts. reversed the vasoconstrictor response to 5-hydroxytryptamine.  In isolated perfused kidneys from both normotensive and spontaneously hypertensive rats, R 41468, in concns. which did not depress vasoconstrictor responses to exogenous norepinephrine, inhibited those to 5-hydroxytryptamine.  The compd. caused a dose-related redn. in aortic blood pressure in unanesthetized spontaneously hypertensive rats, which was larger and occurred at lower concns., than in control animals.  Thus, R 41468 is a potent antagonist of the vasoconstrictor effects of 5-hydroxytryptamine, in particular of its amplifying effect on threshold amts. of norepinephrine, which may help explain its antihypertensive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJVDLWABeurVg90H21EOLACvtfcHk0ljjWS4HD0XpwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFCrt7g%253D&md5=54ad01a31dff318c7dcfefcf72090138</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNueten%26aufirst%3DJ.%2BM.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26aulast%3DVan%2BBeek%26aufirst%3DJ.%26aulast%3DXhonneux%26aufirst%3DR.%26aulast%3DVerbeuren%26aufirst%3DT.%2BJ.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26atitle%3DVascular%2520Effects%2520of%2520Ketanserin%2520%2528R%252041468%2529%252C%2520a%2520Novel%2520Antagonist%2520of%25205-HT2%2520Serotonergic%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1981%26volume%3D218%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Razzaque, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span> </span><span class="NLM_article-title">Differences in the Effects of Ketanserin and GR127935 on the 5-HT-Receptor Mediated Responses in Rabbit Saphenous Vein and Guinea-Pig jugular Vein</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/0014-2999(95)00349-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0014-2999%2895%2900349-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=7498311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1995&pages=199-206&author=Z.+Razzaqueauthor=J.+Longmoreauthor=R.+G.+Hill&title=Differences+in+the+Effects+of+Ketanserin+and+GR127935+on+the+5-HT-Receptor+Mediated+Responses+in+Rabbit+Saphenous+Vein+and+Guinea-Pig+jugular+Vein&doi=10.1016%2F0014-2999%2895%2900349-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein</span></div><div class="casAuthors">Razzaque, Zerin; Longmore, Jeanette; Hill, Raymond G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ketanserin has higher affinity for 5-HT1Dα receptors compared to 5-HT1Dβ receptors, whereas, GR127935 (N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2(methyl-4(-(5-methyl-1,2 ,4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide), a novel and selective 5-HT1D receptor antagonist, has higher affinity for 5-HT1Dβ receptors compared to 5-HT1Dα receptors.  In the present study, we compared the effects of ketanserin and GR127935 on sumatriptan-induced responses of rabbit saphenous vein and guinea-pig jugular vein.  In rabbit saphenous vein, contractile responses elicited by sumatriptan were antagonized by ketanserin (pA2 = 6.76) and GR127935 (apparent pA2 = 9.4).  In guinea-pig jugular vein, concn.-dependent relaxations evoked by sumatriptan were antagonized by ketanserin and GR127935 (apparent pA2 = 5.9 and 10, resp.).  Ketanserin but not GR127935, inhibited Ca2+-induced contraction of depolarized strips of guinea-pig ileum longitudinal muscle/myenteric plexus, however, in rabbit saphenous vein and guinea-pig jugular vein, 5-HT receptor mediated responses were insensitive to nifedipine (Ca2+ channel blocker), eliminating the possibility that the inhibitory effects of ketanserin and GR127935 were due to the blockade of voltage-operated Ca2+ channels.  Thus, antagonism by ketanserin and GR127935 confirms the presence of 5-HT1D receptors in rabbit saphenous vein and guinea-pig jugular vein.  The differential effects of ketanserin and GR127935 on responses elicited by sumatriptan in rabbit saphenous vein and guinea-pig jugular vein may reflect either species differences in 5-HT1D receptors or the involvement of 5-HT1Dα and 5-HT1Dβ receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoot0O7-tDemLVg90H21EOLACvtfcHk0ljjWS4HD0XpwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFWhs7k%253D&md5=fad25e62b91c9f4e9a2839177f96a3ec</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900349-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900349-P%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaque%26aufirst%3DZ.%26aulast%3DLongmore%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DR.%2BG.%26atitle%3DDifferences%2520in%2520the%2520Effects%2520of%2520Ketanserin%2520and%2520GR127935%2520on%2520the%25205-HT-Receptor%2520Mediated%2520Responses%2520in%2520Rabbit%2520Saphenous%2520Vein%2520and%2520Guinea-Pig%2520jugular%2520Vein%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D283%26spage%3D199%26epage%3D206%26doi%3D10.1016%2F0014-2999%2895%2900349-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zgombick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharewicz, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshank, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span> </span><span class="NLM_article-title">Ketanserin and Ritanserin Discriminate Between Recombinant Human 5-HT<sub>1Dα</sub> and 5-HT<sub>1Dβ</sub> Receptor Subtypes</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/0922-4106(95)90183-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0922-4106%2895%2990183-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8549648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXotFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1995&pages=9-15&author=J.+M.+Zgombickauthor=L.+E.+Schechterauthor=S.+A.+Kucharewiczauthor=R.+L.+Weinshankauthor=T.+A.+Branchek&title=Ketanserin+and+Ritanserin+Discriminate+Between+Recombinant+Human+5-HT1D%CE%B1+and+5-HT1D%CE%B2+Receptor+Subtypes&doi=10.1016%2F0922-4106%2895%2990183-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes</span></div><div class="casAuthors">Zgombick, John M.; Schechter, Lee E.; Kucharewicz, Stefan A.; Weinshank, Richard L.; Branchek, Theresa A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Compds. able to discriminate functionally between the closely related cloned human 5-HT1Dα and 5-HT1Dβ receptor subtypes have not been reported previously.  In [3H]5-HT competition assays, the classical 5-HT2A receptor antagonists, ritanserin and ketanserin, displayed moderate affinity (pKi = 7.30 and 7.17, resp.) and marked selectivity (22-and 71-fold, resp.) for the recombinant human 5-HT1Dα subtype relative to the 5-HT1Dβ receptor.  In contrast, the nonselective 5-HT1/2 receptor antagonist, methiothepin, exhibited similar binding affinities (pKi = 7.64-8.01) for both recombinant 5-HT1D subtypes.  The antagonistic properties of these compds. were evaluated for their ability to block 5-HT-induced inhibition of forskolin-stimulated cAMP accumulation in intact cells stably expressing either 5-HT1Dα or 5-HT1Dβ receptors.  All 3 compds. behaved as antagonists devoid of intrinsic activity in the functional assays.  The apparent pKb values detd. in functional assays closely matched their pKi values obtained in binding assays.  Since ketanserin exhibits significant selectivity for the human 5-HT1Dα receptor, this antagonist can be used as a pharmacol. tool to discriminate between 5-HT1Dα and 5-HT1Dβ receptor-mediated responses in human tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSPHZ48iN1c7Vg90H21EOLACvtfcHk0ljUb6fKCE11_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFCls7g%253D&md5=3d848b04687b7b1df31c6e3314bfc429</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2895%2990183-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252895%252990183-3%26sid%3Dliteratum%253Aachs%26aulast%3DZgombick%26aufirst%3DJ.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DKucharewicz%26aufirst%3DS.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26atitle%3DKetanserin%2520and%2520Ritanserin%2520Discriminate%2520Between%2520Recombinant%2520Human%25205-HT1D%25CE%25B1%2520and%25205-HT1D%25CE%25B2%2520Receptor%2520Subtypes%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1995%26volume%3D291%26spage%3D9%26epage%3D15%26doi%3D10.1016%2F0922-4106%2895%2990183-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Comparisons of Hallucinogenic Phenylisopropylamine Binding Affinities at Cloned Human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> Receptors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/PL00005315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FPL00005315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=9933142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=1-6&author=D.+L.+Nelsonauthor=V.+L.+Lucaitesauthor=D.+B.+Wainscottauthor=R.+A.+Glennon&title=Comparisons+of+Hallucinogenic+Phenylisopropylamine+Binding+Affinities+at+Cloned+Human+5-HT2A%2C+5-HT2B%2C+and+5-HT2C+Receptors&doi=10.1007%2FPL00005315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors</span></div><div class="casAuthors">Nelson, D. L.; Lucaites, V. L.; Wainscott, D. B.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Since the classical hallucinogens were initially reported to produce their behavioral effects via a 5-HT2 agonist mechanism (i.e., the 5-HT2 hypothesis of hallucinogen action), 5-HT2 receptors have been demonstrated to represent a family of receptors that consists of three distinct subpopulations: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Today, there is greater support for 5-HT2A than for 5-HT2C receptor involvement in the behavioral effects evoked by these agents.  However, with the recent discovery of 5-HT2B receptors, a new question arises: do classical hallucinogens bind at 5-HT2B receptors.  In the present study, the authors examd. and compared the binding of 17 phenylisopropylamines at human 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Although there was a notable pos. correlation (r>0.9) between the affinities of the agents at all three populations of 5-HT2 receptors, structural modification resulted only in small differences in 5-HT2B receptor affinity such that the range of affinities was only about 50-fold.  As with 5-HT2A and 5-HT2C receptor affinity, there is a significant correlation (r>0.9) between 5-HT2B receptor affinity and human hallucinogenic potency.  Nevertheless, given that 5-HT2A and 5-HT2A/2C antagonists - antagonists with low affinity for 5-HT2B receptors - have been previously shown to block the stimulus effects of phenylisopropylamine hallucinogens, it is likely that 5-HT2A receptors play a more prominent role than 5-HT2B and 5-HT2C receptors in mediating such effects despite the affinity of these agents for all three 5-HT2 receptor subpopulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcUJ72-JQ2LVg90H21EOLACvtfcHk0ljUb6fKCE11_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D&md5=0aa21959353f624601097271883a49de</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1007%2FPL00005315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005315%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DComparisons%2520of%2520Hallucinogenic%2520Phenylisopropylamine%2520Binding%2520Affinities%2520at%2520Cloned%2520Human%25205-HT2A%252C%25205-HT2B%252C%2520and%25205-HT2C%2520Receptors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D1%26epage%3D6%26doi%3D10.1007%2FPL00005315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Effect of the Serotonin 5-HT<sub>2A/2C</sub> Receptor Agonist DOI and of the Selective 5-HT<sub>2A</sub> or 5-HT<sub>2C</sub> Receptor Antagonists EMD 281014 and SB-243213, Respectively, on Sleep and Waking in the Rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2006.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.ejphar.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=17059817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=163-170&author=J.+M.+Montiauthor=H.+Jantos&title=Effect+of+the+Serotonin+5-HT2A%2F2C+Receptor+Agonist+DOI+and+of+the+Selective+5-HT2A+or+5-HT2C+Receptor+Antagonists+EMD+281014+and+SB-243213%2C+Respectively%2C+on+Sleep+and+Waking+in+the+Rat&doi=10.1016%2Fj.ejphar.2006.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat</span></div><div class="casAuthors">Monti, Jaime M.; Jantos, Hector</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of the serotonin 5-HT2A/2C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and of the selective 5-HT2A or 5-HT2C receptor antagonists 7-{4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl}-1H-indole-3-carbonitrile HCl (EMD 281014) and 5-methyl-1-[[-2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline HCl (SB-243213), resp., on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings.  S.c. administration of DOI (0.35-0.7 mmol/kg) significantly increased waking and light sleep and reduced slow wave sleep, rapid-eye-movement (REM) sleep, and the no. of REM periods.  With s.c. EMD 281014 (1.2-4.8 mmol/kg) or SB-243213 (1.2-4.8 mmol/kg) a significant redn. in time spent in REM sleep was also seen.  Pretreatment with EMD 281014 prevented the DOI-induced increase of waking and light sleep and the redn. of slow wave sleep.  However, REM sleep remained suppressed.  SB-243213 failed to reverse the changes of sleep and waking induced by DOI.  Thus, on the basis of these results it appears that serotonin 5-HT2A receptor mechanisms might be responsible for the DOI-induced effects on waking and slow wave sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYNE3-PqoT7Vg90H21EOLACvtfcHk0ljUb6fKCE11_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM&md5=562384708b4da429f87b73286570f5de</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DEffect%2520of%2520the%2520Serotonin%25205-HT2A%252F2C%2520Receptor%2520Agonist%2520DOI%2520and%2520of%2520the%2520Selective%25205-HT2A%2520or%25205-HT2C%2520Receptor%2520Antagonists%2520EMD%2520281014%2520and%2520SB-243213%252C%2520Respectively%252C%2520on%2520Sleep%2520and%2520Waking%2520in%2520the%2520Rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D163%26epage%3D170%26doi%3D10.1016%2Fj.ejphar.2006.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. L.</span><span> </span><span class="NLM_article-title">Hallucinogen-Like Effects of 2-([2-(4-Cyano-2,5-dimethoxyphenyl)ethylamino] methyl)phenol (25CN-NBOH), a Novel <i>N</i>-Benzylphenethylamine with 100-Fold Selectivity for 5-HT<sub>2A</sub> Receptors, in Mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1007/s00213-014-3739-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-014-3739-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=1039-1047&author=W.+E.+Fantegrossiauthor=B.+W.+Grayauthor=J.+M.+Baileyauthor=D.+A.+Smithauthor=M.+Hansenauthor=J.+L.+Kristensen&title=Hallucinogen-Like+Effects+of+2-%28%5B2-%284-Cyano-2%2C5-dimethoxyphenyl%29ethylamino%5D+methyl%29phenol+%2825CN-NBOH%29%2C+a+Novel+N-Benzylphenethylamine+with+100-Fold+Selectivity+for+5-HT2A+Receptors%2C+in+Mice&doi=10.1007%2Fs00213-014-3739-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3739-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3739-3%26sid%3Dliteratum%253Aachs%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DGray%26aufirst%3DB.%2BW.%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DKristensen%26aufirst%3DJ.%2BL.%26atitle%3DHallucinogen-Like%2520Effects%2520of%25202-%2528%255B2-%25284-Cyano-2%252C5-dimethoxyphenyl%2529ethylamino%255D%2520methyl%2529phenol%2520%252825CN-NBOH%2529%252C%2520a%2520Novel%2520N-Benzylphenethylamine%2520with%2520100-Fold%2520Selectivity%2520for%25205-HT2A%2520Receptors%252C%2520in%2520Mice%26jtitle%3DPsychopharmacology%26date%3D2015%26volume%3D232%26spage%3D1039%26epage%3D1047%26doi%3D10.1007%2Fs00213-014-3739-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phonekeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leth-Petersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begtrup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. L.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of <i>N</i>-Benzyl phenethylamines as 5-HT<sub>2A/2C</sub> Agonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1021/cn400216u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400216u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=243-249&author=M.+Hansenauthor=K.+Phonekeoauthor=J.+S.+Paineauthor=S.+Leth-Petersenauthor=M.+Begtrupauthor=H.+Br%C3%A4uner-Osborneauthor=J.+L.+Kristensen&title=Synthesis+and+Structure-Activity+Relationships+of+N-Benzyl+phenethylamines+as+5-HT2A%2F2C+Agonists&doi=10.1021%2Fcn400216u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists</span></div><div class="casAuthors">Hansen, Martin; Phonekeo, Karina; Paine, James S.; Leth-Petersen, Sebastian; Begtrup, Mikael; Brauner-Osborne, Hans; Kristensen, Jesper L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor.  We have prepd. a series of 48 compds. with structural variations in both the phenethylamine and N-benzyl part of the mol. to det. the effects on receptor binding affinity and functional activity at 5-HT2A and 5-HT2C receptors.  The compds. generally had high affinity for the 5-HT2A receptor with 2-((4-Ethyl-2,5-dimethoxyphenethylamino)methyl)phenol HCl having the highest affinity at 0.29 nM but with several other compds. also exhibiting subnanomolar binding affinities.  The functional activity of the compds. was distributed over a wider range with (I) being the most potent at 0.074 nM.  Most of the compds. exhibited low to moderate selectivity (1- to 40-fold) for the 5-HT2A receptor in the binding assays, although one, 4-(2-(2-Hydroxybenzylamino)ethyl)-2,5-dimethoxybenzonitrile HCl, showed an impressive 100-fold selectivity for the 5-HT2A receptor.  In the functional assay, selectivity was generally higher with I being more than 400-fold selective for the 5-HT2A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ZkfztjBttLVg90H21EOLACvtfcHk0lhROKFMxoAcXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVertQ%253D%253D&md5=665522d747c8a2fbc98ce960111bf3cb</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fcn400216u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400216u%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DPhonekeo%26aufirst%3DK.%26aulast%3DPaine%26aufirst%3DJ.%2BS.%26aulast%3DLeth-Petersen%26aufirst%3DS.%26aulast%3DBegtrup%26aufirst%3DM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DKristensen%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520N-Benzyl%2520phenethylamines%2520as%25205-HT2A%252F2C%2520Agonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D243%26epage%3D249%26doi%3D10.1021%2Fcn400216u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloriam, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frølund, B.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Pharmacological Characterization of <i>N</i>- and <i>O</i>-Substituted 5,6,7,8-Tetrahydro-4<i>H</i>-isoxazolo[4,5-<i>d</i>]azepin-3-ol Analogues: Novel 5-HT<sub>2A</sub>/5-HT<sub>2C</sub> Receptor Agonists with Pro-Cognitive Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1021/jm301656h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301656h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1yhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1211-1227&author=A.+A.+Jensenauthor=N.+Plathauthor=M.+H.+F.+Pedersenauthor=V.+Isbergauthor=J.+Krallauthor=P.+Wellendorphauthor=T.+B.+Stensb%C3%B8lauthor=D.+E.+Gloriamauthor=P.+Krogsgaard-Larsenauthor=B.+Fr%C3%B8lund&title=Design%2C+Synthesis%2C+and+Pharmacological+Characterization+of+N-+and+O-Substituted+5%2C6%2C7%2C8-Tetrahydro-4H-isoxazolo%5B4%2C5-d%5Dazepin-3-ol+Analogues%3A+Novel+5-HT2A%2F5-HT2C+Receptor+Agonists+with+Pro-Cognitive+Properties&doi=10.1021%2Fjm301656h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties</span></div><div class="casAuthors">Jensen, Anders A.; Plath, Niels; Pedersen, Martin H. F.; Isberg, Vignir; Krall, Jacob; Wellendorph, Petrine; Stensboel, Tine B.; Gloriam, David E.; Krogsgaard-Larsen, Povl; Froelund, Bente</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1211-1227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The isoxazol-3-one tautomer of the bicyclic isoxazole, 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol (THAZ), has previously been shown to be a weak GABAA and glycine receptor antagonist.  In the present study, the potential in this scaffold has been explored through the synthesis and pharmacol. characterization of a series of N- and O-substituted THAZ analogs.  The analogs N-Bn-THAZ (3d, I) and O-Bn-THAZ (4d, II) were found to be potent agonists of the human 5-HT2A and 5-HT2C receptors.  Judging from an elaborate pharmacol. profiling at numerous other CNS targets, the 3d analog appears to be selective for the two receptors.  Administration of 3d substantially improved the cognitive performance of mice in a place recognition Y-maze model, an effect fully reversible by coadministration of the selective 5-HT2C antagonist SB242084.  In conclusion, as novel bioavailable cognitive enhancers that most likely mediate their effects through 5-HT2A and/or 5-HT2C receptors, the isoxazoles 3d and 4d constitute interesting leads for further medicinal chem. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGnquX4JkP7rVg90H21EOLACvtfcHk0lhROKFMxoAcXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1yhsg%253D%253D&md5=cdf977de75375930a0d10a060de840a4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301656h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301656h%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPlath%26aufirst%3DN.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3DKrall%26aufirst%3DJ.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26aulast%3DFr%25C3%25B8lund%26aufirst%3DB.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Pharmacological%2520Characterization%2520of%2520N-%2520and%2520O-Substituted%25205%252C6%252C7%252C8-Tetrahydro-4H-isoxazolo%255B4%252C5-d%255Dazepin-3-ol%2520Analogues%253A%2520Novel%25205-HT2A%252F5-HT2C%2520Receptor%2520Agonists%2520with%2520Pro-Cognitive%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1211%26epage%3D1227%26doi%3D10.1021%2Fjm301656h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McLean, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marona-Lewicka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT<sub>2A</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5794</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span><span class="refDoi"> DOI: 10.1021/jm060656o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060656o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVCitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5794-5803&author=T.+H.+McLeanauthor=J.+C.+Parrishauthor=M.+R.+Bradenauthor=D.+Marona-Lewickaauthor=A.+Gallardo-Godoyauthor=D.+E.+Nichols&title=1-Aminomethylbenzocycloalkanes%3A+Conformationally+Restricted+Hallucinogenic+Phenethylamine+Analogues+as+Functionally+Selective+5-HT2A+Receptor+Agonists&doi=10.1021%2Fjm060656o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists</span></div><div class="casAuthors">McLean, Thomas H.; Parrish, Jason C.; Braden, Michael R.; Marona-Lewicka, Danuta; Gallardo-Godoy, Alejandra; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5794-5803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of conformationally restricted analogs of the hallucinogenic phenethylamine 1 (2,5-dimethoxy-4-bromophenethylamine, 2C-B) was synthesized to test several hypotheses concerning the bioactive conformation of phenethylamine ligands upon binding to the 5-HT2A receptor.  These benzocycloalkane analogs were assayed for their receptor binding affinity and ability to activate downstream signaling pathways, and one exceptional compd. was selected for testing in an in vivo drug discrimination model of hallucinogenesis.  All compds. were examd. in silico by virtual docking into a homol. model of the 5-HT2A receptor.  On the basis of these docking expts., it was predicted that the R enantiomer of benzocyclobutene analog 2 would be the most potent.  Subsequent chem. resoln. and X-ray crystallog. confirmed this prediction, as (R)-2(I) proved to be equipotent to LSD in rats trained to discriminate LSD from saline.  Thus, we propose that the conformation of 2 mimics the active binding conformation of the more flexible phenethylamine type hallucinogens.  In addn., (R)-2 is one of the most potent and selective compds. yet discovered in the in vivo drug discrimination assay.  Further, 2 was found to be a functionally selective agonist at the 5-HT2A receptor, having 65-fold greater potency in stimulating phosphoinositide turnover than in producing arachidonic acid release.  If hallucinogenic effects are correlated with arachidonic acid prodn., such functionally selective 5-HT2A receptor agonists may lack the intoxicating properties of hallucinogens such as LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNv796JhOoSrVg90H21EOLACvtfcHk0lhNBEDPZBwIvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVCitbo%253D&md5=e6021aa27549a8c096d7b401d5859ee5</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm060656o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060656o%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DT.%2BH.%26aulast%3DParrish%26aufirst%3DJ.%2BC.%26aulast%3DBraden%26aufirst%3DM.%2BR.%26aulast%3DMarona-Lewicka%26aufirst%3DD.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3D1-Aminomethylbenzocycloalkanes%253A%2520Conformationally%2520Restricted%2520Hallucinogenic%2520Phenethylamine%2520Analogues%2520as%2520Functionally%2520Selective%25205-HT2A%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5794%26epage%3D5803%26doi%3D10.1021%2Fjm060656o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fox, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPorte, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackler, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. L.</span><span> </span><span class="NLM_article-title">The Serotonin 5-HT<sub>2A</sub> Receptor Agonist TCB-2: a Behavioral and Neurophysiological Analysis</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1007/s00213-009-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-009-1694-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=13-23&author=M.+A.+Foxauthor=H.+T.+Frenchauthor=J.+L.+LaPorteauthor=A.+R.+Blacklerauthor=D.+L.+Murphy&title=The+Serotonin+5-HT2A+Receptor+Agonist+TCB-2%3A+a+Behavioral+and+Neurophysiological+Analysis&doi=10.1007%2Fs00213-009-1694-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DM.%2BA.%26aulast%3DFrench%26aufirst%3DH.%2BT.%26aulast%3DLaPorte%26aufirst%3DJ.%2BL.%26aulast%3DBlackler%26aufirst%3DA.%2BR.%26aulast%3DMurphy%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Serotonin%25205-HT2A%2520Receptor%2520Agonist%2520TCB-2%253A%2520a%2520Behavioral%2520and%2520Neurophysiological%2520Analysis%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D212%26spage%3D13%26epage%3D23%26doi%3D10.1007%2Fs00213-009-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgeirsdottir, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchow, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackman, R. W.,  Jr.</span><span> </span><span class="NLM_article-title">Stimulation of Serotonin 2A Receptors facilitates Consolidation and Extinction of Fear Memory in C57BL/6J Mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2012.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=403-413&author=G.+Zhangauthor=H.+N.+Asgeirsdottirauthor=S.+J.+Cohenauthor=A.+H.+Munchowauthor=M.+P.+Barreraauthor=R.+W.+Stackman&title=Stimulation+of+Serotonin+2A+Receptors+facilitates+Consolidation+and+Extinction+of+Fear+Memory+in+C57BL%2F6J+Mice&doi=10.1016%2Fj.neuropharm.2012.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAsgeirsdottir%26aufirst%3DH.%2BN.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DMunchow%26aufirst%3DA.%2BH.%26aulast%3DBarrera%26aufirst%3DM.%2BP.%26aulast%3DStackman%26aufirst%3DR.%2BW.%26atitle%3DStimulation%2520of%2520Serotonin%25202A%2520Receptors%2520facilitates%2520Consolidation%2520and%2520Extinction%2520of%2520Fear%2520Memory%2520in%2520C57BL%252F6J%2520Mice%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D403%26epage%3D413%26doi%3D10.1016%2Fj.neuropharm.2012.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blasi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Virgilio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papazacharias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taurisano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ursini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinibaldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masellis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giorgio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Bianco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caforio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piva, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popolizio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellantuono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todarello, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolino, A.</span><span> </span><span class="NLM_article-title">Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene with Prefrontal function and Olanzapine Treatment</span> <span class="citation_source-journal">JAMA Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span><span class="refDoi"> DOI: 10.1001/jamapsychiatry.2013.1378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1001%2Fjamapsychiatry.2013.1378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=921-930&author=G.+Blasiauthor=C.+De+Virgilioauthor=A.+Papazachariasauthor=P.+Taurisanoauthor=B.+Gelaoauthor=L.+Fazioauthor=G.+Ursiniauthor=L.+Sinibaldiauthor=I.+Andriolaauthor=R.+Masellisauthor=R.+Romanoauthor=A.+Rampinoauthor=A.+Di+Giorgioauthor=L.+Lo+Biancoauthor=G.+Caforioauthor=F.+Pivaauthor=T.+Popolizioauthor=C.+Bellantuonoauthor=O.+Todarelloauthor=J.+E.+Kleinmanauthor=G.+Gadaletaauthor=D.+R.+Weinbergerauthor=A.+Bertolino&title=Converging+Evidence+for+the+Association+of+Functional+Genetic+Variation+in+the+Serotonin+Receptor+2a+Gene+with+Prefrontal+function+and+Olanzapine+Treatment&doi=10.1001%2Fjamapsychiatry.2013.1378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2013.1378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2013.1378%26sid%3Dliteratum%253Aachs%26aulast%3DBlasi%26aufirst%3DG.%26aulast%3DDe%2BVirgilio%26aufirst%3DC.%26aulast%3DPapazacharias%26aufirst%3DA.%26aulast%3DTaurisano%26aufirst%3DP.%26aulast%3DGelao%26aufirst%3DB.%26aulast%3DFazio%26aufirst%3DL.%26aulast%3DUrsini%26aufirst%3DG.%26aulast%3DSinibaldi%26aufirst%3DL.%26aulast%3DAndriola%26aufirst%3DI.%26aulast%3DMasellis%26aufirst%3DR.%26aulast%3DRomano%26aufirst%3DR.%26aulast%3DRampino%26aufirst%3DA.%26aulast%3DDi%2BGiorgio%26aufirst%3DA.%26aulast%3DLo%2BBianco%26aufirst%3DL.%26aulast%3DCaforio%26aufirst%3DG.%26aulast%3DPiva%26aufirst%3DF.%26aulast%3DPopolizio%26aufirst%3DT.%26aulast%3DBellantuono%26aufirst%3DC.%26aulast%3DTodarello%26aufirst%3DO.%26aulast%3DKleinman%26aufirst%3DJ.%2BE.%26aulast%3DGadaleta%26aufirst%3DG.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26aulast%3DBertolino%26aufirst%3DA.%26atitle%3DConverging%2520Evidence%2520for%2520the%2520Association%2520of%2520Functional%2520Genetic%2520Variation%2520in%2520the%2520Serotonin%2520Receptor%25202a%2520Gene%2520with%2520Prefrontal%2520function%2520and%2520Olanzapine%2520Treatment%26jtitle%3DJAMA%2520Psychiatry%26date%3D2013%26volume%3D70%26spage%3D921%26epage%3D930%26doi%3D10.1001%2Fjamapsychiatry.2013.1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mestre, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2A Receptors Antagonists as Potential Treatment for Psychiatric Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1517/13543784.2013.769957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1517%2F13543784.2013.769957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=411-421&author=T.+A.+Mestreauthor=M.+Zurowskiauthor=S.+H.+Fox&title=5-Hydroxytryptamine+2A+Receptors+Antagonists+as+Potential+Treatment+for+Psychiatric+Disorders&doi=10.1517%2F13543784.2013.769957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.769957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.769957%26sid%3Dliteratum%253Aachs%26aulast%3DMestre%26aufirst%3DT.%2BA.%26aulast%3DZurowski%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DS.%2BH.%26atitle%3D5-Hydroxytryptamine%25202A%2520Receptors%2520Antagonists%2520as%2520Potential%2520Treatment%2520for%2520Psychiatric%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D411%26epage%3D421%26doi%3D10.1517%2F13543784.2013.769957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, K.</span><span> </span><span class="NLM_article-title">Pimavanserin, a 5-HT2A Receptor Inverse Agonist, Reverses Psychosis-Like Behaviors in a Rodent Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1097/FBP.0b013e3283566082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1097%2FFBP.0b013e3283566082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=426-433&author=D.+L.+Priceauthor=D.+W.+Bonhausauthor=K.+McFarland&title=Pimavanserin%2C+a+5-HT2A+Receptor+Inverse+Agonist%2C+Reverses+Psychosis-Like+Behaviors+in+a+Rodent+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1097%2FFBP.0b013e3283566082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3283566082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3283566082%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DMcFarland%26aufirst%3DK.%26atitle%3DPimavanserin%252C%2520a%25205-HT2A%2520Receptor%2520Inverse%2520Agonist%252C%2520Reverses%2520Psychosis-Like%2520Behaviors%2520in%2520a%2520Rodent%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2012%26volume%3D23%26spage%3D426%26epage%3D433%26doi%3D10.1097%2FFBP.0b013e3283566082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Gong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Variations in 5-HT2A Influence Spatial Cognitive Abilities and Working Memory</span> <span class="citation_source-journal">Can. J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1017/S0317167100011513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1017%2FS0317167100011513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=21320838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BC3M7pt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=303-308&author=P.+Gongauthor=J.+Liauthor=J.+Wangauthor=X.+Leiauthor=D.+Chenauthor=K.+Zhangauthor=W.+Zhangauthor=A.+Zhenauthor=X.+Gaoauthor=F.+Zhang&title=Variations+in+5-HT2A+Influence+Spatial+Cognitive+Abilities+and+Working+Memory&doi=10.1017%2FS0317167100011513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28eR"><div class="casContent"><span class="casTitleNuber">28e</span><div class="casTitle"><span class="NLM_cas:atitle">Variations in 5-HT2A influence spatial cognitive abilities and working memory</span></div><div class="casAuthors">Gong Pingyuan; Li Jing; Wang Jian; Lei Xu; Chen Dongmei; Zhang Kejin; Zhang Wenjiang; Zhen Anyuan; Gao Xiaocai; Zhang Fuchang</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-8</span>
        ISSN:<span class="NLM_cas:issn">0317-1671</span>.
    </div><div class="casAbstract">BACKGROUND:  5-hydroxytryptamine receptor 2A (5-HT2A) participates in diverse psychiatric disorders by regulating the activity of serotonin.  Some previous studies have also suggested that the receptor is involved in cognitive abilities of disease groups.  We hypothesize that some functional genetic variants in 5-HT2A have certain specific influences on cognitive abilities in a normal population.  METHOD:  To confirm this hypothesis, two polymorphisms (rs6313 and rs4941573) in 5-HT2A were selected, and a population-based study was performed in a young healthy Chinese Han cohort.  RESULTS:  The results indicated that the rs6313 and rs4941573 were associated with touching blocks and mental rotation-3D error ratio in males, and the rs4941573 was associated with visuo-spatial working memory in the whole cohort.  CONCLUSION:  All the findings suggest that 5-HT2A participates in human spatial cognitive abilities and spatial working memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVc-Qq91xFSjToTC3aBaesfW6udTcc2eZtw78N4odL2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7pt1Krtg%253D%253D&md5=ebd50eb87e2625edb06e1e3c78025d50</span></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=10.1017%2FS0317167100011513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0317167100011513%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhen%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DVariations%2520in%25205-HT2A%2520Influence%2520Spatial%2520Cognitive%2520Abilities%2520and%2520Working%2520Memory%26jtitle%3DCan.%2520J.%2520Neurol.%2520Sci.%26date%3D2011%26volume%3D38%26spage%3D303%26epage%3D308%26doi%3D10.1017%2FS0317167100011513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Hasselbalch, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svarer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinborg, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldemar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span> </span><span class="NLM_article-title">Reduced 5-HT2A Receptor Binding in Patients with Mild Cognitive Impairment</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1830</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2007.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neurobiolaging.2007.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=17544547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KnsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1830-1838&author=S.+G.+Hasselbalchauthor=K.+Madsenauthor=C.+Svarerauthor=L.+H.+Pinborgauthor=S.+Holmauthor=O.+B.+Paulsonauthor=G.+Waldemarauthor=G.+M.+Knudsen&title=Reduced+5-HT2A+Receptor+Binding+in+Patients+with+Mild+Cognitive+Impairment&doi=10.1016%2Fj.neurobiolaging.2007.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28fR"><div class="casContent"><span class="casTitleNuber">28f</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced 5-HT2A receptor binding in patients with mild cognitive impairment</span></div><div class="casAuthors">Hasselbalch, S. G.; Madsen, K.; Svarer, C.; Pinborg, L. H.; Holm, S.; Paulson, O. B.; Waldemar, G.; Knudsen, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1830-1838</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previous studies of patients with Alzheimer's disease (AD) have described reduced brain serotonin 2A (5-HT2A) receptor d.  It is unclear whether this abnormality sets in early in the course of the disease and whether it is related to early cognitive and neuropsychiatric symptoms.  We assessed cerebral 5-HT2A receptor binding in patients with mild cognitive impairment (MCI) and related 5-HT2A receptor binding to clin. symptoms.  Sixteen patients with MCI of the amnestic type (mean age 73, mean MMSE 26.1) and 17 age and sex matched control subjects were studied with MRI and [18F]altanserin PET in a bolus-infusion approach.  A significant global redn. of 20-30% in 5-HT2A binding (atrophy cor.) was found in most neocortical areas.  Reduced 5-HT2A binding in the striatum correlated significantly with Neuropsychiatric Inventory depression and anxiety scores.  We conclude that widespread redns. in 5-HT2A receptor binding were found in amnestic MCI, pointing at the presence of serotonergic dysfunction in prodromal AD.  This may provide some of the pathophysiol. background for the neuropsychiatric symptoms found in early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6JpJzo8viu7Vg90H21EOLACvtfcHk0liBRz7hSuf8Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KnsL7K&md5=f12d9f4c71b00f8da123777f76194530</span></div><a href="/servlet/linkout?suffix=cit28f&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHasselbalch%26aufirst%3DS.%2BG.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DSvarer%26aufirst%3DC.%26aulast%3DPinborg%26aufirst%3DL.%2BH.%26aulast%3DHolm%26aufirst%3DS.%26aulast%3DPaulson%26aufirst%3DO.%2BB.%26aulast%3DWaldemar%26aufirst%3DG.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26atitle%3DReduced%25205-HT2A%2520Receptor%2520Binding%2520in%2520Patients%2520with%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DNeurobiol.%2520Aging%26date%3D2008%26volume%3D29%26spage%3D1830%26epage%3D1838%26doi%3D10.1016%2Fj.neurobiolaging.2007.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amargόs-Bosch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">The Therapeutic Role of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> Receptors in Depression</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15309042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD2cvgsV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=252-265&author=P.+Celadaauthor=M.+V.+Puigauthor=M.+Amarg%CF%8Cs-Boschauthor=A.+Adellauthor=F.+Artigas&title=The+Therapeutic+Role+of+5-HT1A+and+5-HT2A+Receptors+in+Depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28gR"><div class="casContent"><span class="casTitleNuber">28g</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic role of 5-HT1A and 5-HT2A receptors in depression</span></div><div class="casAuthors">Celada Pau; Puig M; Amargos-Bosch Merce; Adell Albert; Artigas Francesc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-65</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects.  They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic action requires weeks of treatment.  This delay is the result of presynaptic and postsynaptic adaptive mechanisms secondary to reuptake inhibition.  The prevention of a negative feedback mechanism operating at the 5-HT autoreceptor level enhances the neurochemical and clinical effects of SSRIs.  The blockade of 5-HT2A receptors also seems to improve the clinical effects of SSRIs.  These receptors are located postsynaptically to 5-HT axons, mainly in the neocortex.  Pyramidal neurons in the prefrontal cortex are particularly enriched in 5-HT2A receptors.  Their blockade may affect the function of prefrontal-subcortical circuits, an effect that probably underlies the beneficial effects of the addition of atypical antipsychotic drugs, which are 5-HT2A receptor antagonists, to SSRIs in treatment-resistant patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZfG1UEEH_MrqxQ2mb9Pu8fW6udTcc2ebd6lZWS70yh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvgsV2jsQ%253D%253D&md5=bbfa333672f3b963422fbf8e8893cec8</span></div><a href="/servlet/linkout?suffix=cit28g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DM.%2BV.%26aulast%3DAmarg%25CF%258Cs-Bosch%26aufirst%3DM.%26aulast%3DAdell%26aufirst%3DA.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DThe%2520Therapeutic%2520Role%2520of%25205-HT1A%2520and%25205-HT2A%2520Receptors%2520in%2520Depression%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2004%26volume%3D29%26spage%3D252%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ohuoha, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, J. E.</span><span> </span><span class="NLM_article-title">The role of Serotonin in Schizophrenia: an Overview of the Nomenclature, Distribution and Alterations of Serotonin Receptors in the Central Nervous System</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/BF02245003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FBF02245003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1993&pages=S5-15&author=D.+C.+Ohuohaauthor=T.+M.+Hydeauthor=J.+E.+Kleinman&title=The+role+of+Serotonin+in+Schizophrenia%3A+an+Overview+of+the+Nomenclature%2C+Distribution+and+Alterations+of+Serotonin+Receptors+in+the+Central+Nervous+System&doi=10.1007%2FBF02245003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28h&amp;dbid=16384&amp;doi=10.1007%2FBF02245003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245003%26sid%3Dliteratum%253Aachs%26aulast%3DOhuoha%26aufirst%3DD.%2BC.%26aulast%3DHyde%26aufirst%3DT.%2BM.%26aulast%3DKleinman%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520role%2520of%2520Serotonin%2520in%2520Schizophrenia%253A%2520an%2520Overview%2520of%2520the%2520Nomenclature%252C%2520Distribution%2520and%2520Alterations%2520of%2520Serotonin%2520Receptors%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D112%26spage%3DS5%26epage%3D15%26doi%3D10.1007%2FBF02245003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moritomo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akuzawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of New Carbonyl Guanidine Derivatives as Novel Dual 5-HT<sub>2B</sub> and 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7841</span><span class="NLM_x">–</span> <span class="NLM_lpage">7852</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2013.10.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7841-7852&author=A.+Moritomoauthor=H.+Yamadaauthor=T.+Watanabeauthor=H.+Itahanaauthor=S.+Akuzawaauthor=M.+Okadaauthor=M.+Ohta&title=Synthesis+and+Structure-Activity+Relationships+of+New+Carbonyl+Guanidine+Derivatives+as+Novel+Dual+5-HT2B+and+5-HT7+Receptor+Antagonists&doi=10.1016%2Fj.bmc.2013.10.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DItahana%26aufirst%3DH.%26aulast%3DAkuzawa%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520New%2520Carbonyl%2520Guanidine%2520Derivatives%2520as%2520Novel%2520Dual%25205-HT2B%2520and%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7841%26epage%3D7852%26doi%3D10.1016%2Fj.bmc.2013.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein</p></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a thorough review on 5-HT receptors, please see:</p></div><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span> </span><span class="NLM_article-title">A Review of Central 5-HT Receptors and their Function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/S0028-3908(99)00010-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0028-3908%2899%2900010-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10462127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1083-1152&author=N.+M.+Barnesauthor=T.+Sharp&title=A+Review+of+Central+5-HT+Receptors+and+their+Function&doi=10.1016%2FS0028-3908%2899%2900010-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">A review of central 5-HT receptors and their function</span></div><div class="casAuthors">Barnes, Nicholas M.; Sharp, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1152</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with ∼700 refs.  It is now nearly 5 yr since the last of the currently recognized 5-HT receptors was identified in terms of its cDNA sequence.  Over this period, much effort has been directed towards understanding the function attributable to individual 5-HT receptors in the brain.  This has been helped, in part, by the synthesis of a no. of compds. that selectively interact with individual 5-HT receptor subtypes-although some 5-HT receptors still lack any selective ligands (e.g., 5-ht1E, 5-ht5A and 5-ht5B receptors).  The present review provides background information for each 5-HT receptor subtype and subsequently reviews in more detail the functional responses attributed to each receptor in the brain.  Clearly this latter area has moved forward in recent years and this progression is likely to continue given the level of interest assocd. with the actions of 5-HT.  This interest is stimulated by the belief that pharmacol. manipulation of the central 5-HT system will have therapeutic potential.  In support of which, a no. of 5-HT receptor ligands are currently utilized, or are in clin. development, to reduce the symptoms of CNS dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2De_9ij4c_LVg90H21EOLACvtfcHk0lhikDh5q2yoag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCgsrg%253D&md5=7e92e3b6586ce16c00a1afab5ae06e01</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900010-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DA%2520Review%2520of%2520Central%25205-HT%2520Receptors%2520and%2520their%2520Function%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1083%26epage%3D1152%26doi%3D10.1016%2FS0028-3908%2899%2900010-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Badarau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzenet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fînaru, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Benzimidazolone-Based Serotonin 5-HT<sub>1A</sub> or 5-HT<sub>7</sub>R Ligands: Synthesis and Biological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1600</span><span class="NLM_x">–</span> <span class="NLM_lpage">1603</span><div class="note"><p class="first last">5-HT<sub>2A</sub>R. Binding result on (<b>I</b>) is unpublished</p></div><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmcl.2009.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19237285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1600-1603&author=E.+Badarauauthor=F.+Suzenetauthor=A.+J.+Bojarskiauthor=A.-L.+F%C3%AEnaruauthor=G.+Guillaumet&title=Benzimidazolone-Based+Serotonin+5-HT1A+or+5-HT7R+Ligands%3A+Synthesis+and+Biological+Evaluation&doi=10.1016%2Fj.bmcl.2009.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: Synthesis and biological evaluation</span></div><div class="casAuthors">Badarau, Eduard; Suzenet, Franck; Bojarski, Andrzej J.; Finaru, Adriana-Luminita; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1600-1603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new group of serotoninergic 5-HT1A or 5-HT7 receptor ligands was identified.  These compds. were designed and synthesized on a benzimidazolone scaffold and they enrich the well-known arylpiperazine class of 5-HT ligands.  Diverse pharmacomodulations induced a shift in the affinity and selectivity profile with final identification of new potent hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwILwj8xQcfLVg90H21EOLACvtfcHk0lhikDh5q2yoag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsLs%253D&md5=399986c7c98b7cd4f499f074cf94659c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBadarau%26aufirst%3DE.%26aulast%3DSuzenet%26aufirst%3DF.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DF%25C3%25AEnaru%26aufirst%3DA.-L.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DBenzimidazolone-Based%2520Serotonin%25205-HT1A%2520or%25205-HT7R%2520Ligands%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1600%26epage%3D1603%26doi%3D10.1016%2Fj.bmcl.2009.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sit, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, N.</span><span> </span><span class="NLM_article-title">Regiospecific Functionalization of 1,3-Dihydro-2<i>H</i>-benzimidazol-2-one and Structurally Related Cyclic Urea Derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1021/jo00111a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00111a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXktlemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=1565-1582&author=N.+A.+Meanwellauthor=S.+Y.+Sitauthor=J.+Gaoauthor=H.+S.+Wongauthor=Q.+Gaoauthor=D.+R.+St.+Laurentauthor=N.+Balasubramanian&title=Regiospecific+Functionalization+of+1%2C3-Dihydro-2H-benzimidazol-2-one+and+Structurally+Related+Cyclic+Urea+Derivatives&doi=10.1021%2Fjo00111a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Regiospecific Functionalization of 1,3-Dihydro-2H-benzimidazol-2-one and Structurally Related Cyclic Urea Derivatives</span></div><div class="casAuthors">Meanwell, Nicholas A.; Sit, Sing Yuen; Gao, Jinnian; Wong, Henry S.; Gao, Qi; St. Laurent, Denis R.; Balasubramanian, Neelakantan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1565-82</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for selectively protecting one of the degenerate nitrogen atoms of the cyclic urea derivs. 1,3-dihydro-2H-benzimidazol-2-one (6a), 1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones, 1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one, and 1,3-dihydro-4-phenyl-2H-imidazol-2-one were developed.  Heating these cyclic ureas with Et 2-pyridyl carbonate in the presence of a base in CH3CN at reflux or DMF at 100 °C cleanly provided the mono(ethoxycarbonyl) derivs.  Alternatively, treatment of 6a with an excess of di-Et pyrocarbonate or di-tert-Bu dicarbonate afforded the bis(alkoxycarbonyl) derivs., which underwent disproportionation to mono(alkoxycarbonyl) deriv. upon heating with 1 mol equiv of 6a and K2CO3 in CH3CN at reflux.  The regiochem. of the introduction of alkoxycarbonyl groups to benzimidazol-2-one derivs. was not significantly influenced by an electron-withdrawing (CF3) or an electron-donating (OCH3) substituent at C-5 of the heterocyclic ring.  However, the reaction was found to be sensitive to steric factors since a chlorine substituent ortho to one of the urea N atoms completely directed the alkoxycarbonyl moiety to the less sterically encumbered N atom.  Alkylation or halogenation of the monoprotected derivs. occurred regiospecifically.  A protecting group interchange strategy that took advantage of the distinctive chem. reactivities of the EtO2C and t-BuO2C protecting groups toward isopropylamine was developed that provided access to the isomerically substituted series of monohalo, mono-N-alkylated benzimidazol-2-ones.  The efficient derivatization of the unprotected N atom of these monoprotected cyclic urea derivs. was accomplished by treating with activated and unactivated halides in the presence of K2CO3 or exposure to alcs. under Mitsunobu conditions.  In several cases, mixts. of O- and N-alkylated products were produced which were readily sepd. by chromatog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXJfNueaz6m7Vg90H21EOLACvtfcHk0lhikDh5q2yoag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktlemurY%253D&md5=5678fe70c56296b153b32a46274907c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00111a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00111a014%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSit%26aufirst%3DS.%2BY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DBalasubramanian%26aufirst%3DN.%26atitle%3DRegiospecific%2520Functionalization%2520of%25201%252C3-Dihydro-2H-benzimidazol-2-one%2520and%2520Structurally%2520Related%2520Cyclic%2520Urea%2520Derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D1565%26epage%3D1582%26doi%3D10.1021%2Fjo00111a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+Applications+of+Halogen+Bonding+in+Medicinal+Chemistry+and+Chemical+Biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0li_Kicf0K3Khg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520Applications%2520of%2520Halogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%2520and%2520Chemical%2520Biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Topliss, J. G.</span><span> </span><span class="NLM_article-title">Utilization of Operational Schemes for Analog Synthesis in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span><span class="refDoi"> DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+Operational+Schemes+for+Analog+Synthesis+in+Drug+Design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0li_Kicf0K3Khg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520Operational%2520Schemes%2520for%2520Analog%2520Synthesis%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5HT<sub>7</sub> Receptor Modulators: a Medicinal Chemistry Survey of Recent Patent Literature (2004–2009)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1517/13543776.2010.484802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1517%2F13543776.2010.484802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=20476847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=739-754&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perrone&title=5HT7+Receptor+Modulators%3A+a+Medicinal+Chemistry+Survey+of+Recent+Patent+Literature+%282004%E2%80%932009%29&doi=10.1517%2F13543776.2010.484802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009)</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-754</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT7 receptors are discretely localized within the CNS (thalamus, hypothalamus, limbic and cortical regions).  The 5-HT7 receptors are also present in smooth muscle cells from blood vessels and have been reported in gastrointestinal tract as well as in rat lumbar dorsal root and sympathetic ganglia.  The 5-HT7 receptors have been implicated in depression, disorders related to circadian rhythms, pain and migraine.  Thus, there is a great interest in developing potent and selective 5-HT7 receptor modulators.Areas covered in this review: This review article highlights the research advances published in the patent literature between Jan. 2004 and Dec. 2009, giving emphasis to the medicinal chemist's standpoint.What the reader will gain: Readers will rapidly gain an overview of the various 5-HT7 receptor modulators reported in the patent literature in the past 6 years.  Furthermore, the readers will learn which structure type can interact with 5-HT7 receptor and also the different companies that are the main players in the field.Take home message: Although no 5-HT7 modulator has entered clin. trials, the development and future use of different agonists and antagonists suitable for use in vivo seem very promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_eZylyhMWbVg90H21EOLACvtfcHk0li_Kicf0K3Khg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtro%253D&md5=9ee8b9f849c844b9d9cb65d1a48dd54d</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.484802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.484802%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5HT7%2520Receptor%2520Modulators%253A%2520a%2520Medicinal%2520Chemistry%2520Survey%2520of%2520Recent%2520Patent%2520Literature%2520%25282004%25E2%2580%25932009%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D739%26epage%3D754%26doi%3D10.1517%2F13543776.2010.484802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptor Agents: Structure-Activity Relationships and Potential Therapeutic Applications in Central Nervous system Disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.pharmthera.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=20923682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=120-148&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perroneauthor=P.+B.+Hedlund&title=Serotonin+5-HT7+Receptor+Agents%3A+Structure-Activity+Relationships+and+Potential+Therapeutic+Applications+in+Central+Nervous+system+Disorders&doi=10.1016%2Fj.pharmthera.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto; Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-148</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Since its discovery in the 1940s in serum, the mammalian intestinal mucosa, and in the central nervous system, serotonin (5-HT) has been shown to be involved in virtually all cognitive and behavioral human functions, and alterations in its neurochem. have been implicated in the etiol. of a plethora of neuropsychiatric disorders.  The cloning of 5-HT receptor subtypes has been of importance in enabling them to be classified as specific protein mols. encoded by specific genes.  The 5-HT7 receptor is the most recently classified member of the serotonin receptor family.  Since its identification, it has been the subject of intense research efforts driven by its presence in functionally relevant regions of the brain.  The availability of some selective antagonists and agonists, in combination with genetically modified mice lacking the 5-HT7 receptor, has allowed for a better understanding of the pathophysiol. role of this receptor.  This paper reviews data on localization and pharmacol. properties of the 5-HT7 receptor, and summarizes the results of structure-activity relationship studies aimed at the discovery of selective 5-HT7 receptor ligands.  Addnl., an overview of the potential therapeutic applications of 5-HT7 receptor agonists and antagonists in central nervous system disorders is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpaPQfXAkrVg90H21EOLACvtfcHk0liVaELMhaLxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D&md5=060ef6a028b4f9a2b6f842a2accdae2c</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DSerotonin%25205-HT7%2520Receptor%2520Agents%253A%2520Structure-Activity%2520Relationships%2520and%2520Potential%2520Therapeutic%2520Applications%2520in%2520Central%2520Nervous%2520system%2520Disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D129%26spage%3D120%26epage%3D148%26doi%3D10.1016%2Fj.pharmthera.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span> </span><span class="NLM_article-title">Arylpiperazine Derivatives Acting at 5-HT(1A) Receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.2174/0929867023371030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2174%2F0929867023371030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11945120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=443-469&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Ayalaauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=A.+Viso&title=Arylpiperazine+Derivatives+Acting+at+5-HT%281A%29+Receptors&doi=10.2174%2F0929867023371030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Arylpiperazine derivatives acting at 5-HT1A receptors</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Ayala, D.; Benhamu, B.; Morcillo, M. J.; Viso, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists.  Among 5-HTRs, the 5-HT1A subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1AR sites.  Among these, arylpiperazine derivs. represent one of the most important classes of 5-HT1AR ligands.  This article will review the development of arylpiperazine derivs. acting at 5-HT1ARs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08_YI2jco87Vg90H21EOLACvtfcHk0liVaELMhaLxfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D&md5=88125d9e44708938260bdadeb73c6efb</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.2174%2F0929867023371030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371030%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DAyala%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DViso%26aufirst%3DA.%26atitle%3DArylpiperazine%2520Derivatives%2520Acting%2520at%25205-HT%25281A%2529%2520Receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D443%26epage%3D469%26doi%3D10.2174%2F0929867023371030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Śniecikowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jastrzębska-Więsek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, P.</span><span> </span><span class="NLM_article-title">Novel 5-HT6 Receptor Antagonists/D2 Receptor Partial Agonists Targeting Behavioral and Psychological Symptoms of Dementia</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.ejmech.2014.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=221-235&author=M.+Ko%C5%82aczkowskiauthor=M.+Marcinkowskaauthor=A.+Buckiauthor=J.+%C5%9Aniecikowskaauthor=M.+Paw%C5%82owskiauthor=G.+Kazekauthor=A.+Siwekauthor=M.+Jastrz%C4%99bska-Wi%C4%99sekauthor=A.+Partykaauthor=A.+Wasikauthor=A.+Weso%C5%82owskaauthor=P.+Mierzejewskiauthor=P.+Bienkowski&title=Novel+5-HT6+Receptor+Antagonists%2FD2+Receptor+Partial+Agonists+Targeting+Behavioral+and+Psychological+Symptoms+of+Dementia&doi=10.1016%2Fj.ejmech.2014.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMarcinkowska%26aufirst%3DM.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3D%25C5%259Aniecikowska%26aufirst%3DJ.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26aulast%3DKazek%26aufirst%3DG.%26aulast%3DSiwek%26aufirst%3DA.%26aulast%3DJastrz%25C4%2599bska-Wi%25C4%2599sek%26aufirst%3DM.%26aulast%3DPartyka%26aufirst%3DA.%26aulast%3DWasik%26aufirst%3DA.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBienkowski%26aufirst%3DP.%26atitle%3DNovel%25205-HT6%2520Receptor%2520Antagonists%252FD2%2520Receptor%2520Partial%2520Agonists%2520Targeting%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D221%26epage%3D235%26doi%3D10.1016%2Fj.ejmech.2014.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">The full binding profiles of the most active compounds were not evaluated.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+full+binding+profiles+of+the+most+active+compounds+were+not+evaluated."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkóczy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udvari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacsályi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kompagne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egyed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hársing, L. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">(Phenylpiperazinyl-butyl)oxindoles as Selective 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2532</span><span class="refDoi"> DOI: 10.1021/jm070279v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070279v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2522-2532&author=B.+Volkauthor=J.+Bark%C3%B3czyauthor=E.+Hegedusauthor=S.+Udvariauthor=I.+Gacs%C3%A1lyiauthor=T.+Mezeiauthor=K.+Pallagiauthor=H.+Kompagneauthor=G.+L%C3%A9vayauthor=A.+Egyedauthor=L.+G.+H%C3%A1rsingauthor=M.+Speddingauthor=G.+Simig&title=%28Phenylpiperazinyl-butyl%29oxindoles+as+Selective+5-HT7+Receptor+Antagonists&doi=10.1021%2Fjm070279v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">(Phenylpiperazinyl-butyl)oxindoles as Selective 5-HT7 Receptor Antagonists</span></div><div class="casAuthors">Volk, Balazs; Barkoczy, Jozsef; Hegedus, Endre; Udvari, Szabolcs; Gacsalyi, Istvan; Mezei, Tibor; Pallagi, Katalin; Kompagne, Hajnalka; Levay, Gyoergy; Egyed, Andras; Harsing, Laszlo G., Jr.; Spedding, Michael; Simig, Gyula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2522-2532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent 5-hydroxytryptamine7 (5-HT7) ligands has been synthesized that contain a 1,3-dihydro-2H-indol-2-one (oxindole) skeleton.  The binding of these compds. to the 5-HT7 and 5-HT1A receptors was measured.  Despite the structural similarity of these two serotonin receptor subtypes, several derivs. exhibited a high selectivity to the 5-HT7 receptor.  According to the structure-activity relationship observations, compds. unsubstituted at the oxindole nitrogen atom and contg. a tetramethylene spacer between the oxindole skeleton and the basic nitrogen atom are the most potent ligands.  Concerning the basic group, besides the moieties of the 4-phenylpiperazine type, halophenyl-1,2,3,6-tetrahydropyridines also proved to be 5-HT7 receptor ligands.  Because of halogen substitution on the arom. rings, good metabolic stability could be achieved.  A representative of the family, 3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-6-fluoro-1,3-dihydro-2H-indol-2-one exhibited selective 5-HT7 antagonist activity (Ki = 0.79 nM).  The in vivo pharmacol. potencies of these 5-HT7 receptor-ligands were estd. by the conflict drinking (Vogel) and the light-dark anxiolytic tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogYXSXhs8zUbVg90H21EOLACvtfcHk0li7wZMvHIwsPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslahurc%253D&md5=c1f806b8a01a4842aee4c6986cf8c7db</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fjm070279v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070279v%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DBark%25C3%25B3czy%26aufirst%3DJ.%26aulast%3DHegedus%26aufirst%3DE.%26aulast%3DUdvari%26aufirst%3DS.%26aulast%3DGacs%25C3%25A1lyi%26aufirst%3DI.%26aulast%3DMezei%26aufirst%3DT.%26aulast%3DPallagi%26aufirst%3DK.%26aulast%3DKompagne%26aufirst%3DH.%26aulast%3DL%25C3%25A9vay%26aufirst%3DG.%26aulast%3DEgyed%26aufirst%3DA.%26aulast%3DH%25C3%25A1rsing%26aufirst%3DL.%2BG.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D%2528Phenylpiperazinyl-butyl%2529oxindoles%2520as%2520Selective%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2522%26epage%3D2532%26doi%3D10.1021%2Fjm070279v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacsalyi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poszavacz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyonos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bako, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szenasi, G.</span><span> </span><span class="NLM_article-title">Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT7 Receptor Antagonist Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6657</span><span class="NLM_x">–</span> <span class="NLM_lpage">6669</span><span class="refDoi"> DOI: 10.1021/jm200547z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200547z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6657-6669&author=B.+Volkauthor=I.+Gacsalyiauthor=K.+Pallagiauthor=L.+Poszavaczauthor=I.+Gyonosauthor=E.+Szaboauthor=T.+Bakoauthor=M.+Speddingauthor=G.+Simigauthor=G.+Szenasi&title=Optimization+of+%28Arylpiperazinylbutyl%29oxindoles+Exhibiting+Selective+5-HT7+Receptor+Antagonist+Activity&doi=10.1021%2Fjm200547z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT7 Receptor Antagonist Activity</span></div><div class="casAuthors">Volk, Balazs; Gacsalyi, Istvan; Pallagi, Katalin; Poszavacz, Laszlo; Gyonos, Ildiko; Szabo, Eva; Bako, Tibor; Spedding, Michael; Simig, Gyula; Szenasi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6657-6669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of (arylpiperazinylbutyl)oxindoles I (R1 = H, Et; R2 = H, Cl, F; R3 = H, F; R4 = H, Cl; R5 = Ph, 2-MeOC6H4, 4-ClC6H4, 2,4-Cl2C6H3, etc.) and their (aryltetrahydropyridinyl)butyl analogs has been synthesized and studied as highly potent 5-HT7 receptor antagonists for their selectivity toward the 5-HT1A receptor and α1-adrenoceptor.  Several derivs. exhibited high 5-HT7/5-HT1A selectivity, and the key structural factors for reducing undesired α1-adrenergic receptor binding have also been identified.  Rapid metab., a common problem within this family of compds., could be circumvented with appropriate substitution patterns on the oxindole carbocycle.  Contrary to expectations, none of the compds. produced an antidepressant-like action in the forced swimming test in mice despite sufficiently high brain concns.  On the other hand, certain analogs showed significant anxiolytic activity in two different animal models: the Vogel conflict drinking test in rats and the light-dark test in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonMPKyKUteS7Vg90H21EOLACvtfcHk0li7wZMvHIwsPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7rK&md5=d1f46d3725b029ec92a88bd1944c8a95</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm200547z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200547z%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DGacsalyi%26aufirst%3DI.%26aulast%3DPallagi%26aufirst%3DK.%26aulast%3DPoszavacz%26aufirst%3DL.%26aulast%3DGyonos%26aufirst%3DI.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DBako%26aufirst%3DT.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26aulast%3DSzenasi%26aufirst%3DG.%26atitle%3DOptimization%2520of%2520%2528Arylpiperazinylbutyl%2529oxindoles%2520Exhibiting%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6657%26epage%3D6669%26doi%3D10.1021%2Fjm200547z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships Between Radiotracer Properties and Image Quality in Molecular Imaging of the Brain with Positron Emission Tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+Between+Radiotracer+Properties+and+Image+Quality+in+Molecular+Imaging+of+the+Brain+with+Positron+Emission+Tomography&doi=10.1016%2Fj.mibio.2003.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eZV5Zg2WYCTS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520Between%2520Radiotracer%2520Properties%2520and%2520Image%2520Quality%2520in%2520Molecular%2520Imaging%2520of%2520the%2520Brain%2520with%2520Positron%2520Emission%2520Tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375%26doi%3D10.1016%2Fj.mibio.2003.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of Lipophilicity and its Use as a Predictor of Blood-Brain Barrier Penetration of Molecular Imaging Agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+Lipophilicity+and+its+Use+as+a+Predictor+of+Blood-Brain+Barrier+Penetration+of+Molecular+Imaging+Agents&doi=10.1016%2Fj.mibio.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2ebk7Dlqriw2zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520Lipophilicity%2520and%2520its%2520Use%2520as%2520a%2520Predictor%2520of%2520Blood-Brain%2520Barrier%2520Penetration%2520of%2520Molecular%2520Imaging%2520Agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389%26doi%3D10.1016%2Fj.mibio.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For a comprehensive review on drugs’ physicochemical properties and CNS penetration see:</p></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36cR"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebk7Dlqriw2zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span><span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+Calculation+of+Molecular+Polar+Surface+Area+as+a+Sum+of+Fragment-Based+Contributions+and+Its+Application+to+the+Prediction+of+Drug+Transport+Properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lixPX4u7ad_wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520Calculation%2520of%2520Molecular%2520Polar%2520Surface%2520Area%2520as%2520a%2520Sum%2520of%2520Fragment-Based%2520Contributions%2520and%2520Its%2520Application%2520to%2520the%2520Prediction%2520of%2520Drug%2520Transport%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayada, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbressine, L. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploemen, J. – P.</span><span> </span><span class="NLM_article-title">Polar Molecular Surface as a dominating Determinant for Oral Absorption and Brain Penetration of Drugs</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span><span class="refDoi"> DOI: 10.1023/A:1015040217741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=P+D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.+%E2%80%93+P.+Ploemen&title=Polar+Molecular+Surface+as+a+dominating+Determinant+for+Oral+Absorption+and+Brain+Penetration+of+Drugs&doi=10.1023%2FA%3A1015040217741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0lgFn6BtLuq1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DP%2BD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.%2B%25E2%2580%2593%2BP.%26atitle%3DPolar%2520Molecular%2520Surface%2520as%2520a%2520dominating%2520Determinant%2520for%2520Oral%2520Absorption%2520and%2520Brain%2520Penetration%2520of%2520Drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519%26doi%3D10.1023%2FA%3A1015040217741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">A Novel, Potent, and Selective 5-HT<sub>7</sub> Antagonist: (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.1021/jm991151j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991151j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=342-345&author=P.+J.+Lovellauthor=S.+M.+Bromidgeauthor=S.+Dabbsauthor=D.+M.+Duckworthauthor=I.+T.+Forbesauthor=A.+J.+Jenningsauthor=F.+D.+Kingauthor=D.+N.+Middlemissauthor=S.+K.+Rahmanauthor=D.+V.+Saundersauthor=L.+L.+Collinauthor=J.+J.+Haganauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=A+Novel%2C+Potent%2C+and+Selective+5-HT7+Antagonist%3A+%28R%29-3-%282-%282-%284-Methylpiperidin-1-yl%29-ethyl%29pyrrolidine-1-sulfonyl%29phenol+%28SB-269970%29&doi=10.1021%2Fjm991151j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm991151j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991151j%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DDuckworth%26aufirst%3DD.%2BM.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRahman%26aufirst%3DS.%2BK.%26aulast%3DSaunders%26aufirst%3DD.%2BV.%26aulast%3DCollin%26aufirst%3DL.%2BL.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DA%2520Novel%252C%2520Potent%252C%2520and%2520Selective%25205-HT7%2520Antagonist%253A%2520%2528R%2529-3-%25282-%25282-%25284-Methylpiperidin-1-yl%2529-ethyl%2529pyrrolidine-1-sulfonyl%2529phenol%2520%2528SB-269970%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D342%26epage%3D345%26doi%3D10.1021%2Fjm991151j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lazareno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J.</span><span> </span><span class="NLM_article-title">Estimation of Competitive Antagonist Affinity from Functional Inhibition Curves Using the Gaddum, Schild and Cheng-Prusoff Equations</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1993.tb13737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1476-5381.1993.tb13737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8401922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1993&pages=1110-1119&author=S.+Lazarenoauthor=N.+J.+Birdsall&title=Estimation+of+Competitive+Antagonist+Affinity+from+Functional+Inhibition+Curves+Using+the+Gaddum%2C+Schild+and+Cheng-Prusoff+Equations&doi=10.1111%2Fj.1476-5381.1993.tb13737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations</span></div><div class="casAuthors">Lazareno, S.; Birdsall, N. J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1110-19</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The estn. of antagonist affinity from functional expts. in which the effect of a fixed agonist concn. is reduced by a range of antagonist concns. ('functional inhibition curves') has been considered from both a theor. and exptl. viewpoint.  Theor. predictions are compared with results obtained from the stimulation of [35S]-GTPγS binding by acetylcholine to membranes of Chinese hamster ovary (CHO) cells stably transfected with human m1-m4 muscarinic receptors, and inhibition of the stimulated binding by pirenzepine and AQ-RA 741.  The usual procedure of applying the Cheng-Prusoff correction is shown to be theor. invalid, and predictions are made of the size and distribution of errors assocd. with this procedure.  A different procedure for estg. antagonist affinity, using the principles of dose-ratio anal. and analogous to use of the Gaddum equation, is found to be accurate and theor. valid.  A novel method of anal. allows accurate estn. of both antagonist affinity and Schild slope, by fitting the combined data from an antagonist inhibition curve and an agonist activation curve directly to a form of the Schild equation (derived by Waud) using non-linear regression anal.  It is shown that the conventional Schild anal. can be enhanced by treating part of the data as a family of inhibition curves and including in the Schild plot dose-ratios estd. from the inhibition curves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwkiSVn8LIPLVg90H21EOLACvtfcHk0lgFn6BtLuq1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGjtrs%253D&md5=1eb880b7a282a8de7c3f17ba95a11501</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13737.x%26sid%3Dliteratum%253Aachs%26aulast%3DLazareno%26aufirst%3DS.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%26atitle%3DEstimation%2520of%2520Competitive%2520Antagonist%2520Affinity%2520from%2520Functional%2520Inhibition%2520Curves%2520Using%2520the%2520Gaddum%252C%2520Schild%2520and%2520Cheng-Prusoff%2520Equations%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D109%26spage%3D1110%26epage%3D1119%26doi%3D10.1111%2Fj.1476-5381.1993.tb13737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET Radiotracers: Crossing the Blood-Brain Barrier and Surviving Metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1016/j.tips.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+Radiotracers%3A+Crossing+the+Blood-Brain+Barrier+and+Surviving+Metabolism&doi=10.1016%2Fj.tips.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0lgFn6BtLuq1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520Radiotracers%253A%2520Crossing%2520the%2520Blood-Brain%2520Barrier%2520and%2520Surviving%2520Metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440%26doi%3D10.1016%2Fj.tips.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efange, S. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and in Vitro and in Vivo Evaluation of <sup>18</sup>F-Labeled Positron Emission Tomography (PET) Ligands for Imaging the Vesicular Acetylcholine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span><span class="refDoi"> DOI: 10.1021/jm8012344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8012344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1358-1369&author=Z.+Tuauthor=S.+M.+N.+Efangeauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=S.+M.+Parsonsauthor=R.+H.+Mach&title=Synthesis+and+in+Vitro+and+in+Vivo+Evaluation+of+18F-Labeled+Positron+Emission+Tomography+%28PET%29+Ligands+for+Imaging+the+Vesicular+Acetylcholine+Transporter&doi=10.1021%2Fjm8012344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm8012344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8012344%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DEfange%26aufirst%3DS.%2BM.%2BN.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DParsons%26aufirst%3DS.%2BM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%252018F-Labeled%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Ligands%2520for%2520Imaging%2520the%2520Vesicular%2520Acetylcholine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1358%26epage%3D1369%26doi%3D10.1021%2Fjm8012344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mengod, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raurich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Gimenez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span> </span><span class="NLM_article-title">5-HT Receptors in Mammalian Brain: Receptor Autoradiography and In Situ Hybridization Studies of New Ligands and Newly Identified Receptors</span> <span class="citation_source-journal">Histochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1007/BF02272148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FBF02272148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8968727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=747-758&author=G.+Mengodauthor=M.+T.+Vilaroauthor=A.+Raurichauthor=J.+F.+Lopez-Gimenezauthor=R.+Cortesauthor=J.+M.+Palacios&title=5-HT+Receptors+in+Mammalian+Brain%3A+Receptor+Autoradiography+and+In+Situ+Hybridization+Studies+of+New+Ligands+and+Newly+Identified+Receptors&doi=10.1007%2FBF02272148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT receptors in mammalian brain: Receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors</span></div><div class="casAuthors">Mengod, G.; Vilaro, M. T.; Raurich, A.; Lopez-gimenez, J. F.; Cortes, R.; Palacios, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Histochemical Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">747-758</span>CODEN:
                <span class="NLM_cas:coden">HISJAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-2214</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">In recent years the family of mammalian serotonin receptors has grown to 14 different subtypes, characterized by pharmacol. or mol. biol. techniques.  In parallel, new ligand mols. have been developed for their study.  However, selective ligands are not yet available to study every one of them.  In addn. the degree of selectivity of ligands, hitherto regarded as specific for a particular receptor subtype has been called in question by their affinities for newly discovered receptors.  Consequently, a re-evaluation of past ligand receptor autoradiog. work is necessary in view of the redefined receptor profiles of these ligands, and the introduction of newly developed ligands.  A further difficulty for the characterization of these receptors is the absence of selective antagonist ligands which, for some of the subtypes, have become available only recently.  To overcome these difficulties we have combined in situ hybridization histochem. and receptor ligand autoradiog. to study the regional and cellular localization of several serotonin receptors in the rodent brain.  In addn., for some receptors, we have expanded these studies to primates, including humans.  We have found that the distribution of 5-HT1A receptors in monkey brain, labeled with the agonist 3H-8-OH-DPAT and the antagonist 3H-WAY 100635 was very similar at the levels examd., and corresponded well with that obsd. for the cells contg. mRNA coding for this receptor, confirming the somatodendritic localization of 5-HT1A receptors in monkey brain.  The labeling conditions to visualize 5-HT1F receptors in guinea pig brain, namely 3H-sumatriptan in the presence of 10-8 M 5-CT to block 5-HT1D receptors, are suitable for visualizing this receptor, since the results agreed with those obsd. by in situ hybridization.  By using 3H-ketanserin and 3H-mesulergine in parallel with in situ hybridization using the corresponding oligonucleotides, we were able to show that these ligands label resp. 5-HT2A and 5-HT2C binding sites in monkey brain.  5-HT4 receptors were localized in the brain of several species including humans by using 125I-SB 207710.  In situ hybridization expts. performed in guinea pig confirmed that 5-HT4 receptors are localized on the terminals of the striatopallidal and striatonigral projections.  5-HT7 binding sites were labeled in rat and guinea pig brains by incubating with 3H-5-CT in the presence of 100 μM WAY 100135 and 250 μM GR 127935; the distribution obtained in both species agreed, in general, with that of the corresponding mRNA coding for them.  These results are an illustration of the understanding of our current knowledge of the chem. neuroanatomy of the mammalian 5-HT system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog9URQGz8DGLVg90H21EOLACvtfcHk0liXpZNemux7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVeitQ%253D%253D&md5=ca1be9db68453b5bca425ad9afc817ae</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1007%2FBF02272148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02272148%26sid%3Dliteratum%253Aachs%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DVilaro%26aufirst%3DM.%2BT.%26aulast%3DRaurich%26aufirst%3DA.%26aulast%3DLopez-Gimenez%26aufirst%3DJ.%2BF.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26atitle%3D5-HT%2520Receptors%2520in%2520Mammalian%2520Brain%253A%2520Receptor%2520Autoradiography%2520and%2520In%2520Situ%2520Hybridization%2520Studies%2520of%2520New%2520Ligands%2520and%2520Newly%2520Identified%2520Receptors%26jtitle%3DHistochem.%2520J.%26date%3D1996%26volume%3D28%26spage%3D747%26epage%3D758%26doi%3D10.1007%2FBF02272148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Martin-Cora, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, A.</span><span> </span><span class="NLM_article-title">Autoradiographic Distribution of 5-HT7 Receptors in the Human Brain Using [3H]Mesulergine: Comparison to Other Mammalian Species</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0705576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14656806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFalurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=92-104&author=F.+J.+Martin-Coraauthor=A.+Pazos&title=Autoradiographic+Distribution+of+5-HT7+Receptors+in+the+Human+Brain+Using+%5B3H%5DMesulergine%3A+Comparison+to+Other+Mammalian+Species&doi=10.1038%2Fsj.bjp.0705576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: Comparison to other mammalian species</span></div><div class="casAuthors">Martin-Cora, Francisco J.; Pazos, Angel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-104</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The main aim of this investigation was to delineate the distribution of the 5-HT7 receptor in human brain.  Autoradiog. studies in guinea-pig and rat brain were also carried out to revisit and compare the anatomical distribution of 5-HT7 receptors in different mammalian species.  Binding studies were performed in rat frontal cortex membranes using 10 nM [3H]mesulergine in the presence of raclopride (10 μM) and DOI (0.8 μM).  Under these conditions, a binding site with pharmacol. characteristics consistent with those of the 5-HT7 receptors was identified (rank order of binding affinity values: 5-CT>5-HT>5-MeOT> mesulergine ≈ methiothepin>8-OH-DPAT = spiperone ≈ (+)-butaclamol» imipramine ≈ (±)-pindolol» ondansetron ≈ clonidine ≈ prazosin).  The autoradiog. studies revealed that the anatomical distribution of 5-HT7 receptors throughout the human brain was heterogeneous.  High densities were found over the caudate and putamen nuclei, the pyramidal layer of the CA2 field of the hippocampus, the centromedial thalamic nucleus, and the dorsal raphe nucleus.  The inner layer of the frontal cortex, the dentate gyrus of the hippocampus, the subthalamic nucleus and superior colliculus, among others, presented intermediate concns. of 5-HT7 receptors.  A similar brain anatomical distribution of 5-HT7 receptors was obsd. in all three mammalian species studied.  By using [3H]mesulergine, the authors have mapped for the first time the anatomical distribution of 5-HT7 receptors in the human brain, overcoming the limitations previously found in radiometric studies with other radioligands, and also revisiting the distribution in guinea-pig and rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4iWtlqH5OPLVg90H21EOLACvtfcHk0liXpZNemux7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFalurY%253D&md5=889fa47ca634f6f6c787f2cbbfdc71c4</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705576%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Cora%26aufirst%3DF.%2BJ.%26aulast%3DPazos%26aufirst%3DA.%26atitle%3DAutoradiographic%2520Distribution%2520of%25205-HT7%2520Receptors%2520in%2520the%2520Human%2520Brain%2520Using%2520%255B3H%255DMesulergine%253A%2520Comparison%2520to%2520Other%2520Mammalian%2520Species%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D92%26epage%3D104%26doi%3D10.1038%2Fsj.bjp.0705576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pilato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herth, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettrup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Radiolabeling and In Vivo Evaluation of Potential Positron Emission Tomography (PET) Radioligands for Brain Imaging of the 5-HT<sub>7</sub> Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1736</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2014.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24508140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1736-1750&author=E.+Lacivitaauthor=M.+Nisoauthor=H.+D.+Hansenauthor=P.+Di+Pilatoauthor=M.+M.+Herthauthor=S.+Lehelauthor=A.+Ettrupauthor=L.+Montenegroauthor=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=G.+M.+Knudsen&title=Design%2C+Synthesis%2C+Radiolabeling+and+In+Vivo+Evaluation+of+Potential+Positron+Emission+Tomography+%28PET%29+Radioligands+for+Brain+Imaging+of+the+5-HT7+Receptor&doi=10.1016%2Fj.bmc.2014.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor</span></div><div class="casAuthors">Lacivita, Enza; Niso, Mauro; Hansen, Hanne D.; Di Pilato, Pantaleo; Herth, Matthias M.; Lehel, Szabolcs; Ettrup, Anders; Montenegro, Lisa; Perrone, Roberto; Berardi, Francesco; Colabufo, Nicola A.; Leopoldo, Marcello; Knudsen, Gitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1736-1750</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the design, synthesis, and pharmacol. evaluation of a set of compds. structurally related to the high affinity serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (6, LP-211).  Specific structural modifications were performed in order to maintain affinity for the target receptor and to improve the selectivity over 5-HT1A and adrenergic α1 receptors.  The synthesized compds. have chem. features that could enable labeling with a positron emitter radioisotope (carbon-11 or fluorine-18) and lipophilicity within the range considered optimal for brain penetration and low non-specific binding. 4-[2-(4-Methoxyphenyl)phenyl]-N-(pyridin-4-ylmethyl)piperazinehexanamide (23a) and N-pyridin-4-ylmethyl-[3-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]propanamide (26a) were radiolabeled on the methoxy group with carbon-11.  Positron emission tomog. (PET) anal. revealed that [11C]-23a and [11C]-26a were P-glycoprotein (P-gp) substrates and rapidly metabolized, resulting in poor brain uptake.  These features were not predicted by in vitro tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYULxFqd_ijbVg90H21EOLACvtfcHk0liXpZNemux7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGrtrw%253D&md5=0a2a8df8298e279a5676c8b8c6d1eca6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%2BD.%26aulast%3DDi%2BPilato%26aufirst%3DP.%26aulast%3DHerth%26aufirst%3DM.%2BM.%26aulast%3DLehel%26aufirst%3DS.%26aulast%3DEttrup%26aufirst%3DA.%26aulast%3DMontenegro%26aufirst%3DL.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Radiolabeling%2520and%2520In%2520Vivo%2520Evaluation%2520of%2520Potential%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Radioligands%2520for%2520Brain%2520Imaging%2520of%2520the%25205-HT7%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1736%26epage%3D1750%26doi%3D10.1016%2Fj.bmc.2014.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrikse, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waarde, A.</span><span> </span><span class="NLM_article-title">PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span><span class="refDoi"> DOI: 10.2174/1381612043384736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2174%2F1381612043384736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15134571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVykurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1493-1503&author=P.+H.+Elsingaauthor=N.+H.+Hendrikseauthor=J.+Bartauthor=W.+Vaalburgauthor=A.+Van+Waarde&title=PET+Studies+on+P-Glycoprotein+Function+in+the+Blood-Brain+Barrier%3A+How+it+Affects+Uptake+and+Binding+of+Drugs+within+the+CNS&doi=10.2174%2F1381612043384736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS</span></div><div class="casAuthors">Elsinga, Philip H.; Hendrikse, N. Harry; Bart, Joost; Vaalburg, Willem; Van Waarde, Aren</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1493-1503</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Permeability of the blood-brain barrier (BBB) is one of the factors detg. the bioavailability of therapeutic drugs.  The BBB only allows entry of lipophilic compds. with low mol. wts. by passive diffusion.  However, many lipophilic drugs show negligible brain uptake.  They are substrates for transporters such as P-glycoprotein (P-gp), multidrug-resistance assocd. protein (MRP) and org. anion transporting polypeptides (OATPs).  The action of these carrier systems results in rapid efflux of xenobiotics from the central nervous system (CNS).  Classification of candidate drugs as substrates or inhibitors of such carrier proteins is of crucial importance in drug development.  Positron emission tomog. (PET) can play an important role in the screening process by providing in vivo information, after the putative drug has passed in vitro tests.  Although radiolabeled probes for MRP and OATP function are not yet available, many radiotracers have been prepd. to study P-glycoprotein function in vivo with PET.  These include alkaloids (11C-colchicine), antineoplastic agents (11C-daunorubicin, 18F-paclitaxel), modulators of L-type calcium channels (11C-(±)verapamil, 11C-R(+)-verapamil), β-adrenoceptor antagonists (11C-(S)-carazolol, 18F-(S)-1'-fluorocarazolol, 11C-carvedilol), serotonin 5-HT1A receptor antagonists (18F-MPPF), opioid receptor antagonists (11C-loperamide, 11C-carfentanyl), and various 64Cu-labeled copper complexes.  Studies in exptl. animals have indicated that it is possible to assess P-glycoprotein function in the BBB and its effect on the uptake and binding of drugs within the intact CNS, using suitable P-gp modulators labeled with positron emitters.  Provided that radiopharmaceuticals (and P-gp modulators) can be developed for human use, several exciting fields of study may be explored, viz. (i) direct evaluation of the effect of modulators on the cerebral uptake of therapeutic drugs; (ii) assessment of mechanisms underlying drug resistance in epilepsy; (iii) examn. of the role of the BBB in the pathophysiol. of neurodegenerative and affective disorders; and (iv) exploration of the relationship between polymorphisms of transporter genes and the pharmacokinetics of test compds. within the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAxP1udd9dx7Vg90H21EOLACvtfcHk0liHyRBghrZBKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVykurc%253D&md5=ceb0e638fcae7d5180a7c4a2f353f200</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.2174%2F1381612043384736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384736%26sid%3Dliteratum%253Aachs%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26aulast%3DBart%26aufirst%3DJ.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3DVan%2BWaarde%26aufirst%3DA.%26atitle%3DPET%2520Studies%2520on%2520P-Glycoprotein%2520Function%2520in%2520the%2520Blood-Brain%2520Barrier%253A%2520How%2520it%2520Affects%2520Uptake%2520and%2520Binding%2520of%2520Drugs%2520within%2520the%2520CNS%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1493%26epage%3D1503%26doi%3D10.2174%2F1381612043384736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrikse, N. H.</span><span> </span><span class="NLM_article-title">In Vivo Evaluation of P-Glycoproteins Modulation of 8 PET Radioligands Used Clinically</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=81-87&author=K.+Ishiwataauthor=K.+Kawamuraauthor=K.+Yanaiauthor=N.+H.+Hendrikse&title=In+Vivo+Evaluation+of+P-Glycoproteins+Modulation+of+8+PET+Radioligands+Used+Clinically"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26atitle%3DIn%2520Vivo%2520Evaluation%2520of%2520P-Glycoproteins%2520Modulation%2520of%25208%2520PET%2520Radioligands%2520Used%2520Clinically%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D81%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Armarego, W. L. F.; Chai, C. L. L.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">6th</span> ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FB978-1-85617-567-8.50011-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=W.+L.+F.+Armarego&author=C.+L.+L.+Chai&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FB978-1-85617-567-8.50011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-85617-567-8.50011-1%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DElsevier%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Ding, Y. – S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. – S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span> </span><span class="NLM_article-title">Comparative Evaluation of Positron Emission Tomography Radiotracers for Imaging the Norepinephrine Transporter: (<i>S</i>,<i>S</i>) and (<i>R</i>,<i>R</i>) Enantiomers of Reboxetine Analogs ([<sup>11</sup>C]Methylreboxetine, 3-Cl-[<sup>11</sup>C]Methylreboxetine and [<sup>18</sup>F]Fluororeboxetine), (<i>R</i>)-[<sup>11</sup>C]Nisoxetine, [<sup>11</sup>C]Oxaprotiline and [<sup>11</sup>C]Lortalamine</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03202.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1471-4159.2005.03202.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15998285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVarsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=337-351&author=Y.+%E2%80%93+S.+Dingauthor=K.+%E2%80%93+S.+Linauthor=J.+Loganauthor=H.+Benvenisteauthor=P.+Carter&title=Comparative+Evaluation+of+Positron+Emission+Tomography+Radiotracers+for+Imaging+the+Norepinephrine+Transporter%3A+%28S%2CS%29+and+%28R%2CR%29+Enantiomers+of+Reboxetine+Analogs+%28%5B11C%5DMethylreboxetine%2C+3-Cl-%5B11C%5DMethylreboxetine+and+%5B18F%5DFluororeboxetine%29%2C+%28R%29-%5B11C%5DNisoxetine%2C+%5B11C%5DOxaprotiline+and+%5B11C%5DLortalamine&doi=10.1111%2Fj.1471-4159.2005.03202.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine</span></div><div class="casAuthors">Ding, Yu-Shin; Lin, Kuo-Shyan; Logan, Jean; Benveniste, Helene; Carter, Pauline</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-351</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">We have synthesized and evaluated several new ligands for imaging the norepinephrine transporter (NET) system in baboons with positron emission tomog. (PET).  Ligands possessing high brain penetration, high affinity and selectivity, appropriate lipophilicity (log P = 1.0-3.5), high plasma free fraction and reasonable stability in plasma were selected for further studies.  Based on our characterization studies in baboons, including 11C-labeled (R)-nisoxetine (Nis), oxaprotiline (Oxap), lortalamine (Lort) and new analogs of methylreboxetine (MRB), in conjunction with our earlier evaluation of 11C and 18F derivs. of reboxetine, MRB and their individual (R,R) and (S,S) enantiomers, we have identified the superiority of (S,S)-[11C]MRB and the suitability of MRB analogs [(S,S)-[11C]MRB > (S,S)-[11C]3-Cl-MRB > (S,S)-[18F]fluororeboxetine] as potential NET ligands for PET.  In contrast, Nis, Oxap and Lort displayed high uptake in striatum (higher than in thalamus).  The use of these ligands is further limited by high non-specific binding and relatively low specific signal, as is characteristic of many earlier NET ligands.  Thus, to our knowledge (S,S)-[11C]MRB remains by far the most promising NET ligand for PET studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPC3UwcybIbVg90H21EOLACvtfcHk0liHyRBghrZBKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVarsLg%253D&md5=b9762414ff6e1ff795d20b10df23c851</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03202.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03202.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%2B%25E2%2580%2593%2BS.%26aulast%3DLin%26aufirst%3DK.%2B%25E2%2580%2593%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DBenveniste%26aufirst%3DH.%26aulast%3DCarter%26aufirst%3DP.%26atitle%3DComparative%2520Evaluation%2520of%2520Positron%2520Emission%2520Tomography%2520Radiotracers%2520for%2520Imaging%2520the%2520Norepinephrine%2520Transporter%253A%2520%2528S%252CS%2529%2520and%2520%2528R%252CR%2529%2520Enantiomers%2520of%2520Reboxetine%2520Analogs%2520%2528%255B11C%255DMethylreboxetine%252C%25203-Cl-%255B11C%255DMethylreboxetine%2520and%2520%255B18F%255DFluororeboxetine%2529%252C%2520%2528R%2529-%255B11C%255DNisoxetine%252C%2520%255B11C%255DOxaprotiline%2520and%2520%255B11C%255DLortalamine%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D94%26spage%3D337%26epage%3D351%26doi%3D10.1111%2Fj.1471-4159.2005.03202.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonoda, N.</span><span> </span><span class="NLM_article-title">A New Synthesis of Cyclic Ureas, Cyclic Urethanes, and a Quinozolinedione. Selenium-Assisted Carbonylation of Aromatic Amines with Carbon Monoxide</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span><span class="refDoi"> DOI: 10.1246/bcsj.60.1793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1246%2Fbcsj.60.1793" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=1793-1799&author=T.+Yoshidaauthor=N.+Kambeauthor=S.+Muraiauthor=N.+Sonoda&title=A+New+Synthesis+of+Cyclic+Ureas%2C+Cyclic+Urethanes%2C+and+a+Quinozolinedione.+Selenium-Assisted+Carbonylation+of+Aromatic+Amines+with+Carbon+Monoxide&doi=10.1246%2Fbcsj.60.1793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.60.1793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.60.1793%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKambe%26aufirst%3DN.%26aulast%3DMurai%26aufirst%3DS.%26aulast%3DSonoda%26aufirst%3DN.%26atitle%3DA%2520New%2520Synthesis%2520of%2520Cyclic%2520Ureas%252C%2520Cyclic%2520Urethanes%252C%2520and%2520a%2520Quinozolinedione.%2520Selenium-Assisted%2520Carbonylation%2520of%2520Aromatic%2520Amines%2520with%2520Carbon%2520Monoxide%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1987%26volume%3D60%26spage%3D1793%26epage%3D1799%26doi%3D10.1246%2Fbcsj.60.1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Pagani Zecchini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradisi, P.</span><span> </span><span class="NLM_article-title">The Reactivity of 2,3-Diaminopyridine toward Alkyl Chloroformates and Dicarbonates</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span><span class="refDoi"> DOI: 10.1002/jhet.5570220427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjhet.5570220427" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1985&pages=1061-1064&author=G.+Pagani+Zecchiniauthor=I.+Torriniauthor=P.+Paradisi&title=The+Reactivity+of+2%2C3-Diaminopyridine+toward+Alkyl+Chloroformates+and+Dicarbonates&doi=10.1002%2Fjhet.5570220427"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570220427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570220427%26sid%3Dliteratum%253Aachs%26aulast%3DPagani%2BZecchini%26aufirst%3DG.%26aulast%3DTorrini%26aufirst%3DI.%26aulast%3DParadisi%26aufirst%3DP.%26atitle%3DThe%2520Reactivity%2520of%25202%252C3-Diaminopyridine%2520toward%2520Alkyl%2520Chloroformates%2520and%2520Dicarbonates%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1985%26volume%3D22%26spage%3D1061%26epage%3D1064%26doi%3D10.1002%2Fjhet.5570220427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49c"><span><span class="NLM_contrib-group">Borgens, R. B.; Shi, R.; Stephen, R.; Daniel, T.</span><span> </span><span class="NLM_article-title">Pyridines for Treating Injured Mammalian Nerve Tissue</span>. WO2004/052291, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">47362</span>. <div class="note"><p class="first last">For alternative syntheses of 1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one, please see:</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+B.+Borgens&author=R.+Shi&author=R.+Stephen&author=T.+Daniel&title=Pyridines+for+Treating+Injured+Mammalian+Nerve+Tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorgens%26aufirst%3DR.%2BB.%26atitle%3DPyridines%2520for%2520Treating%2520Injured%2520Mammalian%2520Nerve%2520Tissue%26jtitle%3DChem.%2520Abstr.%26date%3D2004%26volume%3D141%26spage%3D47362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Debeljak-Šuštar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrimšek, Z.</span><span> </span><span class="NLM_article-title">Neighboring Group Interaction in Ortho-Substituted Aminopyridines. Pyridopyrimidines and Related Systems</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1021/jo00397a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00397a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=393-397&author=M.+Debeljak-%C5%A0u%C5%A1tarauthor=B.+Stanovnikauthor=M.+Ti%C5%A1lerauthor=Z.+Zrim%C5%A1ek&title=Neighboring+Group+Interaction+in+Ortho-Substituted+Aminopyridines.+Pyridopyrimidines+and+Related+Systems&doi=10.1021%2Fjo00397a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Fjo00397a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00397a003%26sid%3Dliteratum%253Aachs%26aulast%3DDebeljak-%25C5%25A0u%25C5%25A1tar%26aufirst%3DM.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26aulast%3DZrim%25C5%25A1ek%26aufirst%3DZ.%26atitle%3DNeighboring%2520Group%2520Interaction%2520in%2520Ortho-Substituted%2520Aminopyridines.%2520Pyridopyrimidines%2520and%2520Related%2520Systems%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D393%26epage%3D397%26doi%3D10.1021%2Fjo00397a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tomažič, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span> </span><span class="NLM_article-title">Syntheses of Some Azinylhydroxylamines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span><span class="refDoi"> DOI: 10.1002/jhet.5570160507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjhet.5570160507" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=861-864&author=A.+Toma%C5%BEi%C4%8Dauthor=M.+Ti%C5%A1lerauthor=B.+Stanovnik&title=Syntheses+of+Some+Azinylhydroxylamines&doi=10.1002%2Fjhet.5570160507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570160507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570160507%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25BEi%25C4%258D%26aufirst%3DA.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26aulast%3DStanovnik%26aufirst%3DB.%26atitle%3DSyntheses%2520of%2520Some%2520Azinylhydroxylamines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D861%26epage%3D864%26doi%3D10.1002%2Fjhet.5570160507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b','cit15c','cit15d','cit15e','cit15f','cit15ff'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a'],'ref20':['cit20a','cit20b','cit20c','cit20d'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23a','cit23b','cit23c','cit23d'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28a','cit28b','cit28c','cit28d','cit28e','cit28f','cit28g','cit28h'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33a','cit33b'],'ref34':['cit34a','cit34b','cit34c'],'ref35':['cit35a','cit35b'],'ref36':['cit36a','cit36b','cit36c'],'ref37':['cit37a','cit37b'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44a','cit44b'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49c','cit49a','cit49b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kevin
M. Blattner, Daniel J. Canney, Douglas A. Pippin, <span class="NLM_string-name hlFld-ContribAuthor">Benjamin E. Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology and Therapeutic Potential of the 5-HT7 Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 89-119. <a href="https://doi.org/10.1021/acschemneuro.8b00283" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00283%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPharmacology%252Band%252BTherapeutic%252BPotential%252Bof%252Bthe%252B5-HT7%252BReceptor%26aulast%3DBlattner%26aufirst%3DKevin%2BM.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06062018%26date%3D18072018%26date%3D04092018%26date%3D18072018%26volume%3D10%26issue%3D1%26spage%3D89%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Spies</span>, <span class="hlFld-ContribAuthor ">Patricia Anna  Handschuh</span>, <span class="hlFld-ContribAuthor ">Rupert  Lanzenberger</span>, <span class="hlFld-ContribAuthor ">Georg S.  Kranz</span>. </span><span class="cited-content_cbyCitation_article-title">Sex and the serotonergic underpinnings of depression and migraine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 117-140. <a href="https://doi.org/10.1016/B978-0-444-64123-6.00009-6" title="DOI URL">https://doi.org/10.1016/B978-0-444-64123-6.00009-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64123-6.00009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64123-6.00009-6%26sid%3Dliteratum%253Aachs%26atitle%3DSex%252Band%252Bthe%252Bserotonergic%252Bunderpinnings%252Bof%252Bdepression%252Band%252Bmigraine%26aulast%3DSpies%26aufirst%3DMarie%26date%3D2020%26spage%3D117%26epage%3D140%26pub%3DElsevier%26atitle%3DSex%252BDifferences%252Bin%252BNeurology%252Band%252BPsychiatry%26date%3D2020%26volume%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Billard</span>, <span class="hlFld-ContribAuthor ">François  Liger</span>, <span class="hlFld-ContribAuthor ">Mathieu  Verdurand</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonin receptor imaging by 18F-PET. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 459-518. <a href="https://doi.org/10.1016/B978-0-12-812733-9.00013-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-812733-9.00013-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812733-9.00013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812733-9.00013-1%26sid%3Dliteratum%253Aachs%26atitle%3DSerotonin%252Breceptor%252Bimaging%252Bby%252B18F-PET%26aulast%3DBillard%26aufirst%3DThierry%26date%3D2019%26spage%3D459%26epage%3D518%26pub%3DElsevier%26atitle%3DFluorine%252Bin%252BLife%252BSciences%25253A%252BPharmaceuticals%25252C%252BMedicinal%252BDiagnostics%25252C%252Band%252BAgrochemicals%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ádám Andor  Kelemen</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro[pyrrolidine-3,3′-oxindoles] as 5-HT 7 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (14)
                                     , 2418-2421. <a href="https://doi.org/10.1016/j.bmcl.2018.06.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiro%25255Bpyrrolidine-3%25252C3%2525E2%252580%2525B2-oxindoles%25255D%252Bas%252B5-HT%252B7%252Breceptor%252Bligands%26aulast%3DKelemen%26aufirst%3D%25C3%2581d%25C3%25A1m%2BAndor%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2418%26epage%3D2421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Fabien  Caillé</span>, <span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Olivier  Loreau</span>, <span class="hlFld-ContribAuthor ">Kaisa  Horkka</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Magnus  Schou</span>, <span class="hlFld-ContribAuthor ">Nathalie  Camus</span>, <span class="hlFld-ContribAuthor ">Pascal  Kessler</span>, <span class="hlFld-ContribAuthor ">Bertrand  Kuhnast</span>, <span class="hlFld-ContribAuthor ">Frédéric  Taran</span>, <span class="hlFld-ContribAuthor ">Davide  Audisio</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO
              2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (31)
                                     , 9892-9896. <a href="https://doi.org/10.1002/ange.201804838" title="DOI URL">https://doi.org/10.1002/ange.201804838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201804838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201804838%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DLate-Stage%252BIsotopic%252BCarbon%252BLabeling%252Bof%252BPharmaceutically%252BRelevant%252BCyclic%252BUreas%252BDirectly%252Bfrom%252BCO%252B2%26aulast%3DDel%25E2%2580%2585Vecchio%26aufirst%3DAntonio%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D31%26spage%3D9892%26epage%3D9896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Fabien  Caillé</span>, <span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Olivier  Loreau</span>, <span class="hlFld-ContribAuthor ">Kaisa  Horkka</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Magnus  Schou</span>, <span class="hlFld-ContribAuthor ">Nathalie  Camus</span>, <span class="hlFld-ContribAuthor ">Pascal  Kessler</span>, <span class="hlFld-ContribAuthor ">Bertrand  Kuhnast</span>, <span class="hlFld-ContribAuthor ">Frédéric  Taran</span>, <span class="hlFld-ContribAuthor ">Davide  Audisio</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO
              2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (31)
                                     , 9744-9748. <a href="https://doi.org/10.1002/anie.201804838" title="DOI URL">https://doi.org/10.1002/anie.201804838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201804838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201804838%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DLate-Stage%252BIsotopic%252BCarbon%252BLabeling%252Bof%252BPharmaceutically%252BRelevant%252BCyclic%252BUreas%252BDirectly%252Bfrom%252BCO%252B2%26aulast%3DDel%25E2%2580%2585Vecchio%26aufirst%3DAntonio%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D31%26spage%3D9744%26epage%3D9748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam S.  Hogendorf</span>, <span class="hlFld-ContribAuthor ">Agata  Hogendorf</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Tomasz  Lenda</span>, <span class="hlFld-ContribAuthor ">Maria  Walczak</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">Joanna M.  Wierońska</span>, <span class="hlFld-ContribAuthor ">Monika  Woźniak</span>, <span class="hlFld-ContribAuthor ">Paulina  Cieślik</span>, <span class="hlFld-ContribAuthor ">Ryszard  Bugno</span>, <span class="hlFld-ContribAuthor ">Jakub  Staroń</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>. </span><span class="cited-content_cbyCitation_article-title">Low-basicity 5-HT7 Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-00822-4" title="DOI URL">https://doi.org/10.1038/s41598-017-00822-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-00822-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-00822-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLow-basicity%252B5-HT7%252BReceptor%252BAgonists%252BSynthesized%252BUsing%252Bthe%252Bvan%252BLeusen%252BMulticomponent%252BProtocol%26aulast%3DHogendorf%26aufirst%3DAdam%2BS.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramón  Armenta</span>, <span class="hlFld-ContribAuthor ">Juan I.  Sarmiento-Sánchez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,3-dihydro-2H-benzimidazol-2-ones (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (12)
                                     , 1002-1004. <a href="https://doi.org/10.1007/s10593-017-1999-7" title="DOI URL">https://doi.org/10.1007/s10593-017-1999-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-1999-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-1999-7%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252B1%25252C3-dihydro-2H-benzimidazol-2-ones%252B%252528microreview%252529%26aulast%3DArmenta%26aufirst%3DRam%25C3%25B3n%26date%3D2016%26date%3D2017%26volume%3D52%26issue%3D12%26spage%3D1002%26epage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected examples of selective 5-HT<sub>7</sub>R antagonists (left) and agonists (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected examples of selective 5-HT<sub>2A</sub>R antagonists (left) and agonists (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Previous work and current work on the synthesis of dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R ligands and brain penetration study by PET imaging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Pathway and Access to Novel <i>N</i>-Alkylated or <i>N</i>,<i>N</i>′-Dialkylated 1<i>H</i>-Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, 1<i>H</i>-Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, 1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones and Radiosynthesis of a Dual 5-HT<sub>7</sub>R/5-HT<sub>2A</sub>R Radioligand for the Evaluation of the Blood–Brain Barrier Permeability</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>N</i>-Alkylated, <i>N</i>,<i>N</i>′-Dialkylated, Monohalo-, and Dihalobenzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH (1.1 equiv), Boc<sub>2</sub>O (1 equiv), DMF, rt, 24 h. (b) TBAB (0.05 equiv), K<sub>2</sub>CO<sub>3</sub> (5 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br or <i>n</i>BuBr (5 equiv), H<sub>2</sub>O, 80 °C (μw), 1 h. (c) TFA (3 equiv), DCM, rt, 3 h. (d) ethylpyridin-2-yl carbonate (<b>20</b>) (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), ACN, reflux, 2 h. Note: <b>20</b> was prepared using a modified protocol. For details, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Sections">Experimental Sections</a>. (e) Br<sub>2</sub> (1.2 equiv) or ICl (2 equiv), AcOH, 65 °C, 3 h. (f) TBAB (0.05 equiv), K<sub>2</sub>CO<sub>3</sub> (5 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (5 equiv) or <i>n</i>BuBr (5 equiv), H<sub>2</sub>O, 60 °C (μw), 1 h. (g) <i>i</i>PrNH<sub>2</sub> (1.2 equiv), THF, rt, 12 h. (h) NCS (2 equiv), DMF, rt, 6 h. (i) DPPA (1.1 equiv), TEA (1 equiv), dioxane, reflux, 12 h. (j) DMAP (0.1 equiv), Boc<sub>2</sub>O (1.025 equiv), THF, reflux, 2 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Alkylated Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, and Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CDI, THF, 66 °C (μw), 2 h. (b) DPPA (1.1 equiv), TEA (1 equiv), dioxane, reflux, 12 h. (c) NaH (1.1 equiv), Boc<sub>2</sub>O (1 equiv), DMF, rt, 24 h. (d) K<sub>2</sub>CO<sub>3</sub> (1 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (2 equiv), DMF, rt, 2 h, then TFA (5 equiv), DCM, rt, 3 h. (e) ethylpyridin-2-yl carbonate (<b>20</b>) (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.1 equiv), ACN, reflux, 2 h. Note: <b>20</b> was prepared using a modified protocol. For details, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>. (f) DMAP (0.1 equiv), Boc<sub>2</sub>O (1.2 equiv), THF, rt, 2 h, then <i>i</i>PrNH<sub>2</sub> (1.2 equiv). (g) K<sub>2</sub>CO<sub>3</sub> (3 equiv), Br(CH<sub>2</sub>)<sub><i>n</i></sub>Br (5 equiv), DMF, 60 °C (μw), 3 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Series <b>A</b>–<b>E</b>: Tertiary Amine-Bearing <i>N</i>-Alkylated Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones, Imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-ones, Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones, Oxazolo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-ones, and <i>N</i>,<i>N</i>′-Dialkylated Benzo[<i>d</i>]imidazol-2(3<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: RNHR (or ·HCl or ·HBr) (1.2 equiv), DIPEA (2.5 equiv), ACN, 90 °C, sealed tube, 12 h. For detailed experimental protocols, spectroscopic data, HPLC chromatograms of final products, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of the main SAR results.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Functional assays of 5-HT<sub>7</sub>R agonist 5-CT, antagonist SB-269970, and ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b>. Inhibition of 5-CT induced cAMP accumulation was determined using HEK-293 cells stably expressing 5-HT<sub>7</sub>R. Cells were incubated with 10 nM 5-CT and increasing concentrations of products. cAMP accumulation was measured with a LANCE cAMP detection kit (PerkinElmer). Data are means ± SEM from three to six independent experiments. The IC<sub>50</sub> for each drug was determined using GraphPad prism software and indicated in the <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. For detailed experimental protocols of functional characterization, negative controls of 5-CT, SB-26970, and ligands, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Functional assays of 5-HT<sub>2A</sub>R antagonists <b>62</b>, <b>79</b>, and <b>81</b>. Inositol monophosphate (IP1) accumulation was measured with HTRF assay by CEREP. HEK 293 cells were stimulated with serotonin (100 nM) and then with the different drugs (compounds <b>62</b>, <b>79</b>, and <b>81</b>, concentration range from 1.10<sup>–11</sup> M to 1.10<sup>–6</sup> M). Data are means ± SEM from one representative experiment performed in duplicate. Concentration/response curves were analyzed using Prism 4 software. The <i>K</i><sub>B</sub> value of the different drugs as antagonist and the IC<sub>50</sub> (the inhibitory concentration50) of antagonist were determined by CEREP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Retrosynthetic Pathway and Access to (4-Nitrophenyl)(piperidin-4-yl)methanone <b>110</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0017.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of (4-Nitrophenyl)(piperidin-4-yl)methanone <b>110</b> from Ethyl Isonipecotate <b>104</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N (1.5 equiv), BzCl (1 equiv), DCM, rt, 20 h; (b) NaOH (2.5 equiv), aqueous EtOH (70%), rt, 18 h; (c) (COCl)<sub>2</sub> (1.1 equiv), DCM, rt, 15 h; (d) PhBr, AlCl<sub>3</sub> (1.5 equiv), 90 °C, 6.5 h; (e) CuI (10 mol %), K<sub>3</sub>PO<sub>4</sub> (2 equiv), NH<sub>4</sub>OH (28%), DMF, sealed tube, 90 °C, 27 h; (f) <i>m</i>-CPBA (4 equiv), CHCl<sub>3</sub>, reflux, 45 min; (g) EtOH 70%, 12 M HCl, reflux, 24 h. For detailed experimental protocols and spectroscopic data of intermediates, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></p></figure><figure data-id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0018.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Nitro Precursors <b>111</b> and <b>112</b> and Radiosynthesis of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> by Nucleophilic Aromatic Substitution</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Average image of <b>[</b><sup><b>18</b></sup><b>F]79</b> over 120 min. A = brain stem; B = thalamus; C = hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Average image of <b>[</b><sup><b>18</b></sup><b>F]81</b> over 120 min. A = anterior cingulate; B = thalamus; C = hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0009.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Time–activity curves over 240 min in a Rhesus macaque post intravenous administration of <b>[</b><sup><b>18</b></sup><b>F]79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0010.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Time–activity curves over 240 min at baseline condition in a Rhesus macaque post intravenous administration of <b>[</b><sup><b>18</b></sup><b>F]81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/medium/jm-2015-008744_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0011.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Parent fraction profile in plasma of <b>[</b><sup><b>18</b></sup><b>F]79</b> and <b>[</b><sup><b>18</b></sup><b>F]81</b> post administration in Rhesus macaques.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00874/20151016/images/large/jm-2015-008744_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00874&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i152">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zgombick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaysse, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshank, R. L.</span><span> </span><span class="NLM_article-title">Cloning of a Novel Human Serotonin Receptor (5-HT<sub>7</sub>) Positively Linked to Adenylate Cyclase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">23422</span><span class="NLM_x">–</span> <span class="NLM_lpage">23426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=23422-23426&author=J.+A.+Bardauthor=J.+Zgombickauthor=N.+Adhamauthor=P.+Vaysseauthor=T.+A.+Branchekauthor=R.+L.+Weinshank&title=Cloning+of+a+Novel+Human+Serotonin+Receptor+%285-HT7%29+Positively+Linked+to+Adenylate+Cyclase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBard%26aufirst%3DJ.%2BA.%26aulast%3DZgombick%26aufirst%3DJ.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DVaysse%26aufirst%3DP.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26atitle%3DCloning%2520of%2520a%2520Novel%2520Human%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Positively%2520Linked%2520to%2520Adenylate%2520Cyclase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D23422%26epage%3D23426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tardivel-Lacombe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Molecular Cloning, Characterization, and Localization of a High-Affinity Serotonin Receptor (5-HT<sub>7</sub>) Activating cAMP Formation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">8547</span><span class="NLM_x">–</span> <span class="NLM_lpage">8551</span><span class="refDoi"> DOI: 10.1073/pnas.90.18.8547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1073%2Fpnas.90.18.8547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8397408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2cXmvF2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=8547-8551&author=M.+Ruatauthor=E.+Traiffortauthor=R.+Leursauthor=J.+Tardivel-Lacombeauthor=J.+Diazauthor=J.-M.+Arrangauthor=J.-C.+Schwartz&title=Molecular+Cloning%2C+Characterization%2C+and+Localization+of+a+High-Affinity+Serotonin+Receptor+%285-HT7%29+Activating+cAMP+Formation&doi=10.1073%2Fpnas.90.18.8547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation</span></div><div class="casAuthors">Ruat, Martial; Traiffort, Elisabeth; Leurs, Rob; Tardivel-Lacombe, Joel; Diaz, Jorge; Arrang, Jean Michel; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8547-51</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">By using a strategy based on nucleotide sequence homol., the authors have cloned a cDNA encoding a functional serotonin (5-HT) receptor.  The deduced amino acid sequence of the 5-HT7 receptor displays limited homol. with that of other 5-HT receptors.  In addn. to the seven stretches of hydrophobic amino acids that characterize the superfamily of receptors interacting with guanine nucleotide-binding proteins, the 448-aa sequence of the 5-HT7 receptor contains a hydrophobic domain located at its N-terminal end.  Genomic anal. indicated the presence of introns interrupting the coding sequence.  The 5-HT7 receptor, stably expressed in transfected CHO cells, bound [3H]5-HT with high affinity (Kd = 1 nM), like receptors of the 5-HT1 subfamily from which, however, it was clearly distinguished by its pharmacol.  5-HT in nanomolar concns. stimulated cAMP accumulation in these CHO cells by ≈10-fold, whereas lysergic acid diethylamide displayed low intrinsic agonist activity.  These various properties differentiate the 5-HT7 receptor from the four other subfamilies of mammalian 5-HT receptors (i.e., the 5-HT1-, 5-HT2-, 5-HT3-, and 5-HT4-like subfamilies) and, therefore, appear to define another receptor subfamily.  Northern blot and in situ hybridization analyses showed the 5-HT7 transcripts to be expressed in discrete areas of the limbic brain (e.g., pyramidal hippocampus cells, tenia tecta, amygdaloid, or mammillary nuclei), suggesting that the receptor mediates serotoninergic controls in functions like mood, learning, or neuroendocrine and vegetative behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCfAyKuaslFLVg90H21EOLACvtfcHk0ljuBq2c8cUwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvF2ktw%253D%253D&md5=62d1a8f53171f5498f1a949ea8caf5f5</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.18.8547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.18.8547%26sid%3Dliteratum%253Aachs%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTardivel-Lacombe%26aufirst%3DJ.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DMolecular%2520Cloning%252C%2520Characterization%252C%2520and%2520Localization%2520of%2520a%2520High-Affinity%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Activating%2520cAMP%2520Formation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D8547%26epage%3D8551%26doi%3D10.1073%2Fpnas.90.18.8547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foye, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slone, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlander, M. G.</span><span> </span><span class="NLM_article-title">A Novel Adenylyl Cyclase-Activated Serotonin Receptor (5-HT<sub>7</sub>) Implicated in the Regulation of Mammalian Circadian Rhythms</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1016/0896-6273(93)90149-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0896-6273%2893%2990149-L" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=449-458&author=T.+W.+Lovenbergauthor=B.+M.+Baronauthor=L.+De+Leceaauthor=J.+D.+Millerauthor=R.+A.+Prosserauthor=M.+A.+Reaauthor=P.+E.+Foyeauthor=M.+Rackeauthor=A.+L.+Sloneauthor=B.+W.+Siegelauthor=P.+E.+Danielsonauthor=J.+G.+Sutcliffeauthor=M.+G.+Erlander&title=A+Novel+Adenylyl+Cyclase-Activated+Serotonin+Receptor+%285-HT7%29+Implicated+in+the+Regulation+of+Mammalian+Circadian+Rhythms&doi=10.1016%2F0896-6273%2893%2990149-L"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2893%2990149-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252893%252990149-L%26sid%3Dliteratum%253Aachs%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBaron%26aufirst%3DB.%2BM.%26aulast%3DDe%2BLecea%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DJ.%2BD.%26aulast%3DProsser%26aufirst%3DR.%2BA.%26aulast%3DRea%26aufirst%3DM.%2BA.%26aulast%3DFoye%26aufirst%3DP.%2BE.%26aulast%3DRacke%26aufirst%3DM.%26aulast%3DSlone%26aufirst%3DA.%2BL.%26aulast%3DSiegel%26aufirst%3DB.%2BW.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26aulast%3DErlander%26aufirst%3DM.%2BG.%26atitle%3DA%2520Novel%2520Adenylyl%2520Cyclase-Activated%2520Serotonin%2520Receptor%2520%25285-HT7%2529%2520Implicated%2520in%2520the%2520Regulation%2520of%2520Mammalian%2520Circadian%2520Rhythms%26jtitle%3DNeuron%26date%3D1993%26volume%3D11%26spage%3D449%26epage%3D458%26doi%3D10.1016%2F0896-6273%2893%2990149-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><div class="note"><p class="first last">For a comprehensive review on 5-HT<sub>7</sub>R biochemistry and molecular biology, please see:</p></div><span class="NLM_contrib-group">Gellynck, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyninck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andressen, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haegeman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoenacker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Craenenbroeck, K.</span><span> </span><span class="NLM_article-title">The Serotonin 5-HT<sub>7</sub> Receptors: Two decades of Research</span> <span class="citation_source-journal">Exp. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1007/s00221-013-3694-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00221-013-3694-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24042216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOksL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2013&pages=555-568&author=E.+Gellynckauthor=K.+Heyninckauthor=K.+W.+Andressenauthor=G.+Haegemanauthor=F.+O.+Levyauthor=P.+Vanhoenackerauthor=K.+Van+Craenenbroeck&title=The+Serotonin+5-HT7+Receptors%3A+Two+decades+of+Research&doi=10.1007%2Fs00221-013-3694-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin 5-HT7 receptors: two decades of research</span></div><div class="casAuthors">Gellynck, Evelien; Heyninck, Karen; Andressen, Kjetil W.; Haegeman, Guy; Levy, Finn Olav; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Brain Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">555-568</span>CODEN:
                <span class="NLM_cas:coden">EXBRAP</span>;
        ISSN:<span class="NLM_cas:issn">0014-4819</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Like most neurotransmitters, serotonin possesses a simple structure.  However, the pharmacol. consequences are more complex and diverse.  Serotonin is involved in numerous functions in the human body including the control of appetite, sleep, memory and learning, temp. regulation, mood, behavior, cardiovascular function, muscle contraction, endocrine regulation, and depression.  Low levels of serotonin may be assocd. with several disorders, namely increase in aggressive and angry behaviors, clin. depression, Parkinson's disease, obsessive-compulsive disorder, eating disorders, migraine, irritable bowel syndrome, tinnitus, and bipolar disease.  These effects are mediated via different serotonin (5-HT) receptors.  In this review, we will focus on the last discovered member of this serotonin receptor family, the 5-HT7 receptor.  This receptor belongs to the G protein-coupled receptor superfamily and was cloned two decades ago.  Later, different splice variants were described but no major functional differences have been described so far.  All 5-HT7 receptor variants are coupled to Gαs proteins and stimulate cAMP formation.  Recently, several interacting proteins have been reported, which can influence receptor signaling and trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUX98eSf0SHbVg90H21EOLACvtfcHk0ljuBq2c8cUwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOksL7N&md5=c61a6999c8b69f7635a7a726878140c9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00221-013-3694-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00221-013-3694-y%26sid%3Dliteratum%253Aachs%26aulast%3DGellynck%26aufirst%3DE.%26aulast%3DHeyninck%26aufirst%3DK.%26aulast%3DAndressen%26aufirst%3DK.%2BW.%26aulast%3DHaegeman%26aufirst%3DG.%26aulast%3DLevy%26aufirst%3DF.%2BO.%26aulast%3DVanhoenacker%26aufirst%3DP.%26aulast%3DVan%2BCraenenbroeck%26aufirst%3DK.%26atitle%3DThe%2520Serotonin%25205-HT7%2520Receptors%253A%2520Two%2520decades%2520of%2520Research%26jtitle%3DExp.%2520Brain%2520Res.%26date%3D2013%26volume%3D230%26spage%3D555%26epage%3D568%26doi%3D10.1007%2Fs00221-013-3694-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hassaine, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deluz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tol, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmyter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitevin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nury, H.</span><span> </span><span class="NLM_article-title">X-ray Structure of Mouse Serotonin 5-HT<sub>3</sub> Receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">512</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1038/nature13552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnature13552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=512&publication_year=2014&pages=276-281&author=G.+Hassaineauthor=C.+Deluzauthor=L.+Grassoauthor=R.+Wyssauthor=M.+B.+Tolauthor=R.+Hoviusauthor=A.+Graffauthor=H.+Stahlbergauthor=T.+Tomizakiauthor=A.+Desmyterauthor=C.+Moreauauthor=X.-D.+Liauthor=F.+Poitevinauthor=H.+Vogelauthor=H.+Nury&title=X-ray+Structure+of+Mouse+Serotonin+5-HT3+Receptor&doi=10.1038%2Fnature13552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature13552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13552%26sid%3Dliteratum%253Aachs%26aulast%3DHassaine%26aufirst%3DG.%26aulast%3DDeluz%26aufirst%3DC.%26aulast%3DGrasso%26aufirst%3DL.%26aulast%3DWyss%26aufirst%3DR.%26aulast%3DTol%26aufirst%3DM.%2BB.%26aulast%3DHovius%26aufirst%3DR.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DStahlberg%26aufirst%3DH.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DDesmyter%26aufirst%3DA.%26aulast%3DMoreau%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.-D.%26aulast%3DPoitevin%26aufirst%3DF.%26aulast%3DVogel%26aufirst%3DH.%26aulast%3DNury%26aufirst%3DH.%26atitle%3DX-ray%2520Structure%2520of%2520Mouse%2520Serotonin%25205-HT3%2520Receptor%26jtitle%3DNature%26date%3D2014%26volume%3D512%26spage%3D276%26epage%3D281%26doi%3D10.1038%2Fnature13552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span> </span><span class="NLM_article-title">Structure-Affinity Relationship Study on <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a New Class of 5-Hydroxytryptamine 7 Receptor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6616</span><span class="NLM_x">–</span> <span class="NLM_lpage">6624</span><span class="refDoi"> DOI: 10.1021/jm049702f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049702f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6616-6624&author=M.+Leopoldoauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Continoauthor=E.+Lacivitaauthor=M.+Nisoauthor=R.+Perroneauthor=V.+Tortorella&title=Structure-Affinity+Relationship+Study+on+N-%281%2C2%2C3%2C4-Tetrahydronaphthalen-1-yl%29-4-aryl-1-piperazinealkylamides%2C+a+New+Class+of+5-Hydroxytryptamine+7+Receptor+Agents&doi=10.1021%2Fjm049702f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm049702f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049702f%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DTortorella%26aufirst%3DV.%26atitle%3DStructure-Affinity%2520Relationship%2520Study%2520on%2520N-%25281%252C2%252C3%252C4-Tetrahydronaphthalen-1-yl%2529-4-aryl-1-piperazinealkylamides%252C%2520a%2520New%2520Class%2520of%25205-Hydroxytryptamine%25207%2520Receptor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6616%26epage%3D6624%26doi%3D10.1021%2Fjm049702f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study on <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a Class of 5-HT<sub>7</sub> Receptor Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4214</span><span class="NLM_x">–</span> <span class="NLM_lpage">4221</span><span class="refDoi"> DOI: 10.1021/jm070487n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070487n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4214-4221&author=M.+Leopoldoauthor=E.+Lacivitaauthor=M.+Continoauthor=N.+A.+Colabufoauthor=F.+Berardiauthor=R.+Perrone&title=Structure-Activity+Relationship+Study+on+N-%281%2C2%2C3%2C4-Tetrahydronaphthalen-1-yl%29-4-aryl-1-piperazinehexanamides%2C+a+Class+of+5-HT7+Receptor+Agents&doi=10.1021%2Fjm070487n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm070487n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070487n%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520on%2520N-%25281%252C2%252C3%252C4-Tetrahydronaphthalen-1-yl%2529-4-aryl-1-piperazinehexanamides%252C%2520a%2520Class%2520of%25205-HT7%2520Receptor%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4214%26epage%3D4221%26doi%3D10.1021%2Fjm070487n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epperson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton King, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purandare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortolani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G.</span><span> </span><span class="NLM_article-title">Aminotriazine 5-HT<sub>7</sub> Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4245</span><span class="NLM_x">–</span> <span class="NLM_lpage">4248</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmcl.2004.06.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4245-4248&author=R.+J.+Mattsonauthor=D.+J.+Denhartauthor=J.+D.+Cattauthor=M.+F.+Deeauthor=J.+A.+Deskusauthor=J.+L.+Dittaauthor=J.+Eppersonauthor=H.+Dalton+Kingauthor=A.+Gaoauthor=M.+A.+Possauthor=A.+Purandareauthor=D.+Tortolaniauthor=Y.+Zhaoauthor=H.+Yangauthor=S.+Yeolaauthor=J.+Palmerauthor=J.+Torrenteauthor=A.+Starkauthor=G.+Johnson&title=Aminotriazine+5-HT7+Antagonists&doi=10.1016%2Fj.bmcl.2004.06.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DCatt%26aufirst%3DJ.%2BD.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DEpperson%26aufirst%3DJ.%26aulast%3DDalton%2BKing%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DPurandare%26aufirst%3DA.%26aulast%3DTortolani%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DJ.%26aulast%3DTorrente%26aufirst%3DJ.%26aulast%3DStark%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DG.%26atitle%3DAminotriazine%25205-HT7%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4245%26epage%3D4248%26doi%3D10.1016%2Fj.bmcl.2004.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Characterization of SB-269970-A, a Selective 5-HT<sub>7</sub> Receptor Antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0703357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10821781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=539-548&author=J.+J.+Haganauthor=G.+W.+Priceauthor=P.+Jeffreyauthor=N.+J.+Deeksauthor=T.+Steanauthor=D.+Piperauthor=M.+I.+Smithauthor=N.+Uptonauthor=A.+D.+Medhurstauthor=D.+N.+Middlemissauthor=G.+J.+Rileyauthor=P.+J.+Lovellauthor=S.+M.+Bromidgeauthor=D.+R.+Thomas&title=Characterization+of+SB-269970-A%2C+a+Selective+5-HT7+Receptor+Antagonist&doi=10.1038%2Fsj.bjp.0703357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist</span></div><div class="casAuthors">Hagan, Jim J.; Price, Gary W.; Jeffrey, Phillip; Deeks, Nigel J.; Stean, Tania; Piper, David; Smith, Martin I.; Upton, Neil; Medhurst, Andrew D.; Middlemiss, Derek N.; Riley, Graham J.; Lovell, Peter J.; Bromidge, Steven M.; Thomas, David R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-548</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The novel 5-HT7 receptor antagonist, SB-269970-A, potently displaced [3H]-5-CT from human 5-HT7(a) (pKi 8.9±0.1) and 5-HT7 receptors in guinea-pig cortex (pKi 8.3±0.2).  2 5-CT stimulated adenylyl cyclase activity in 5-HT7(a)/HEK293 membranes (pEC50 7.5±0.1) and SB-269970-A (0.03-1 μM) inhibited the 5-CT concn.-response with no significant alteration in the maximal response.  The pA2 (8.5±0.2) for SB-269970-A agreed well with the pKi detd. from [3H]-5-CT binding studies.  3 5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes (pEC50 of 8.4±0.2) was inhibited by SB-269970-A (0.3 μM) with a pKB (8.3±0.1) in good agreement with its antagonist potency at the human cloned 5-HT7(a) receptor and its binding affinity at guinea-pig cortical membranes.  4 5-HT7 receptor mRNA was highly expressed in human hypothalamus, amygdala, thalamus, hippocampus and testis.  5 SB-269970-A was CNS penetrant (steady-state brain: blood ratio of ∼0.83:1 in rats) but was rapidly cleared from the blood (CLb=∼140 mL min-1 kg-1).  Following a single dose (3 mg kg-1) SB-269970 was detectable in rat brain at 30 (87 nM) and 60 min (58 nM).  In guinea-pigs, brain levels averaged 31 and 51 nM resp. at 30 and 60 min after dosing, although the compd. was undetectable in one of the three animals tested.  6 5-CT (0.3 mg kg-1 i.p.) induced hypothermia in guinea-pigs was blocked by SB-269970-A (ED50 2.96 mg kg-1 i.p.) and the non-selective 5-HT7 receptor antagonist metergoline (0.3-3 mg kg-1 s.c.), suggesting a role for 5-HT7 receptor stimulation in 5-CT induced hypothermia in guinea-pigs.  7 SB-269970-A (30 mg kg-1) administered at the start of the sleep period, significantly reduced time spent in Paradoxical Sleep (PS) during the first 3 h of EEG recording in conscious rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHkJZD5reQRbVg90H21EOLACvtfcHk0ljn4bVgAomKhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjs7w%253D&md5=f36e588d4da0447d259a7974c4b781c5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703357%26sid%3Dliteratum%253Aachs%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DPiper%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DM.%2BI.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520SB-269970-A%252C%2520a%2520Selective%25205-HT7%2520Receptor%2520Antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D539%26epage%3D548%26doi%3D10.1038%2Fsj.bjp.0703357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">SB-656104-A: A Novel 5-HT<sub>7</sub> Receptor Antagonist with Improved In Vivo Properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3344</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00690-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2802%2900690-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3341-3344&author=I.+T.+Forbesauthor=S.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=A.+E.+Garnerauthor=G.+J.+Rileyauthor=P.+Jeffreyauthor=A.+J.+Stevensauthor=T.+O.+Steanauthor=D.+R.+Thomas&title=SB-656104-A%3A+A+Novel+5-HT7+Receptor+Antagonist+with+Improved+In+Vivo+Properties&doi=10.1016%2FS0960-894X%2802%2900690-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900690-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900690-X%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DDouglas%26aufirst%3DS.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DGarner%26aufirst%3DA.%2BE.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DSB-656104-A%253A%2520A%2520Novel%25205-HT7%2520Receptor%2520Antagonist%2520with%2520Improved%2520In%2520Vivo%2520Properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3341%26epage%3D3344%26doi%3D10.1016%2FS0960-894X%2802%2900690-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">Identification of a Novel Series of Selective 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00077-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2803%2900077-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1055-1058&author=I.+T.+Forbesauthor=D.+G.+Cooperauthor=E.+K.+Doddsauthor=S.+E.+Douglasauthor=A.+D.+Gribbleauthor=R.+J.+Ifeauthor=A.+P.+Lightfootauthor=M.+Meesonauthor=L.+P.+Campbellauthor=T.+Colemanauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=Identification+of+a+Novel+Series+of+Selective+5-HT7+Receptor+Antagonists&doi=10.1016%2FS0960-894X%2803%2900077-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900077-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900077-5%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DCooper%26aufirst%3DD.%2BG.%26aulast%3DDodds%26aufirst%3DE.%2BK.%26aulast%3DDouglas%26aufirst%3DS.%2BE.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DMeeson%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Series%2520of%2520Selective%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1055%26epage%3D1058%26doi%3D10.1016%2FS0960-894X%2803%2900077-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kikuchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, M.</span><span> </span><span class="NLM_article-title">New Tetrahydrobenzindoles as Potent and Selective 5-HT<sub>7</sub> Antagonists with Increased In Vitro Metabolic Stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00842-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0960-894X%2802%2900842-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=61-64&author=C.+Kikuchiauthor=H.+Suzukiauthor=T.+Hiranumaauthor=M.+Koyama&title=New+Tetrahydrobenzindoles+as+Potent+and+Selective+5-HT7+Antagonists+with+Increased+In+Vitro+Metabolic+Stability&doi=10.1016%2FS0960-894X%2802%2900842-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900842-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900842-9%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DC.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DHiranuma%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DM.%26atitle%3DNew%2520Tetrahydrobenzindoles%2520as%2520Potent%2520and%2520Selective%25205-HT7%2520Antagonists%2520with%2520Increased%2520In%2520Vitro%2520Metabolic%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D61%26epage%3D64%26doi%3D10.1016%2FS0960-894X%2802%2900842-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Medina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallander, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lόpez-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Synthesis of New Serotonin 5-HT<sub>7</sub> Receptor Ligands. Determinants of 5-HT<sub>7</sub>/5-HT<sub>1A</sub> Receptor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2384</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span><span class="refDoi"> DOI: 10.1021/jm8014553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsleksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2384-2392&author=R.+A.+Medinaauthor=J.+Sallanderauthor=B.+Benham%C3%BAauthor=E.+Porrasauthor=M.+Campilloauthor=L.+Pardoauthor=M.+L.+L%CF%8Cpez-Rodr%C3%ADguez&title=Synthesis+of+New+Serotonin+5-HT7+Receptor+Ligands.+Determinants+of+5-HT7%2F5-HT1A+Receptor+Selectivity&doi=10.1021%2Fjm8014553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of New Serotonin 5-HT7 Receptor Ligands. Determinants of 5-HT7/5-HT1A Receptor Selectivity</span></div><div class="casAuthors">Medina, Rocio A.; Sallander, Jessica; Benhamu, Bellinda; Porras, Esther; Campillo, Mercedes; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2384-2392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a new set of compds. of general structure, e.g., I, with structural modifications in the pharmacophoric elements of the previously reported lead UCM-5600 is reported.  The new derivs. have been evaluated for binding affinity at 5-HT7 and 5-HT1A receptors.  The influence of the different structural features in terms of 5-HT7/5-HT1A receptor affinity and selectivity was analyzed by computational simulations of the complexes between the obtained compds. and β2-based 3-D models of these receptors.  The hydrochloride of compd. I (HYD1 = 1,3-dihydro-2H-indol-2-one; spacer = -(CH2)4-; HYD2 + HYD3 = 3,4-dihydroisoquinolin-2(1H)-yl) exhibits high 5-HT7R affinity (Ki = 7 nM) and selectivity over the 5-HT1AR (31-fold), and has been characterized as a partial agonist of the human 5-HT7R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmM3iJOOfrlrVg90H21EOLACvtfcHk0lhCmtXBPkVtTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsleksrs%253D&md5=b6753d482acd1ed861511249a91c7352</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm8014553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014553%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DR.%2BA.%26aulast%3DSallander%26aufirst%3DJ.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DCampillo%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25CF%258Cpez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520of%2520New%2520Serotonin%25205-HT7%2520Receptor%2520Ligands.%2520Determinants%2520of%25205-HT7%252F5-HT1A%2520Receptor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2384%26epage%3D2392%26doi%3D10.1021%2Fjm8014553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holmberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leideborg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldirola, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlatoidsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohell, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, R.</span><span> </span><span class="NLM_article-title">Novel 2-Aminotetralin and 3-Aminochroman Derivatives as Selective Serotonin 5-HT7 Receptor Agonists and Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3927</span><span class="NLM_x">–</span> <span class="NLM_lpage">3930</span><span class="refDoi"> DOI: 10.1021/jm0498102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0498102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3927-3930&author=P.+Holmbergauthor=D.+Sohnauthor=R.+Leideborgauthor=P.+Caldirolaauthor=P.+Zlatoidskyauthor=S.+Hansonauthor=N.+Mohellauthor=S.+Rosqvistauthor=G.+Nordvallauthor=A.+M.+Johanssonauthor=R.+Johansson&title=Novel+2-Aminotetralin+and+3-Aminochroman+Derivatives+as+Selective+Serotonin+5-HT7+Receptor+Agonists+and+Antagonists&doi=10.1021%2Fjm0498102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0498102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498102%26sid%3Dliteratum%253Aachs%26aulast%3DHolmberg%26aufirst%3DP.%26aulast%3DSohn%26aufirst%3DD.%26aulast%3DLeideborg%26aufirst%3DR.%26aulast%3DCaldirola%26aufirst%3DP.%26aulast%3DZlatoidsky%26aufirst%3DP.%26aulast%3DHanson%26aufirst%3DS.%26aulast%3DMohell%26aufirst%3DN.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DNordvall%26aufirst%3DG.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DJohansson%26aufirst%3DR.%26atitle%3DNovel%25202-Aminotetralin%2520and%25203-Aminochroman%2520Derivatives%2520as%2520Selective%2520Serotonin%25205-HT7%2520Receptor%2520Agonists%2520and%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3927%26epage%3D3930%26doi%3D10.1021%2Fjm0498102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Romero-Alonso, L.; Zamanillo-Castanedo, D.; Vela-Hernandez, J.-M.; Buschmann, H. H.</span><span> </span><span class="NLM_article-title">Combination of a 5-HT<sub>7</sub> Receptor Ligand and an Opioid Ligand</span>. WO2008/145335, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">19899</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Romero-Alonso&author=D.+Zamanillo-Castanedo&author=J.-M.+Vela-Hernandez&author=H.+H.+Buschmann&title=Combination+of+a+5-HT7+Receptor+Ligand+and+an+Opioid+Ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRomero-Alonso%26aufirst%3DL.%26atitle%3DCombination%2520of%2520a%25205-HT7%2520Receptor%2520Ligand%2520and%2520an%2520Opioid%2520Ligand%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D150%26spage%3D19899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garcia-Lopez, M.; Torrens-Jover, A.; Romero-Alonso, L.; Buschmann, H. H.</span><span> </span><span class="NLM_article-title">Heterocyclic-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments</span>. WO2008/077625, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">79600</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Garcia-Lopez&author=A.+Torrens-Jover&author=L.+Romero-Alonso&author=H.+H.+Buschmann&title=Heterocyclic-substituted-ethylamino-phenyl+derivatives%2C+their+preparation+and+use+as+medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Lopez%26aufirst%3DM.%26atitle%3DHeterocyclic-substituted-ethylamino-phenyl%2520derivatives%252C%2520their%2520preparation%2520and%2520use%2520as%2520medicaments%26jtitle%3DChem.%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D79600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Brenchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueño, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeyens, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamanillo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Activation Inhibits Mechanical Hypersensitivity Secondary to Capsaicin Sensitization in Mice</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span><span class="refDoi"> DOI: 10.1016/j.pain.2008.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.pain.2008.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19118950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2009&pages=239-247&author=A.+Brenchatauthor=L.+Romeroauthor=M.+Garc%C3%ADaauthor=M.+Pujolauthor=J.+Burgue%C3%B1oauthor=A.+Torrensauthor=M.+Hamonauthor=J.+M.+Baeyensauthor=H.+Buschmannauthor=D.+Zamanilloauthor=J.+M.+Vela&title=5-HT7+Receptor+Activation+Inhibits+Mechanical+Hypersensitivity+Secondary+to+Capsaicin+Sensitization+in+Mice&doi=10.1016%2Fj.pain.2008.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice</span></div><div class="casAuthors">Brenchat, Alex; Romero, Luz; Garcia, Monica; Pujol, Marta; Burgueno, Javier; Torrens, Antoni; Hamon, Michel; Baeyens, Jose Manuel; Buschmann, Helmut; Zamanillo, Daniel; Vela, Jose Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This work aimed to evaluate the potential role of the 5-HT7 receptor in nociception secondary to a sensitizing stimulus in mice.  For this purpose, the effects of relevant ligands (5-HT7 receptor agonists: AS-19, MSD-5a, E-55888; 5-HT7 receptor antagonists: SB-258719, SB-269970; 5-HT1A receptor agonist: F-13640; 5-HT1A receptor antagonist: WAY-100635) were assessed on capsaicin-induced mech. hypersensitivity, a pain behavior involving hypersensitivity of dorsal horn neurons (central sensitization).  For the 5-HT7 receptor agonists used, binding profile and intrinsic efficacy to stimulate cAMP formation in HEK-293F cells expressing the human 5-HT7 receptor were also evaluated.  AS-19 and E-55888 were selective for 5-HT7 receptors.  E-55888 was a full agonist whereas AS-19 and MSD-5a behaved as partial agonists, with maximal effects corresponding to 77% and 61%, resp., of the cAMP response evoked by the full agonist 5-HT.  Our in vivo results revealed that systemic administration of 5-HT7 receptor agonists exerted a clear-cut dose-dependent antinociceptive effect that was prevented by 5-HT7 receptor antagonists, but not by the 5-HT1A receptor antagonist.  The order of efficacy (E-55888 > AS-19 > MSD-5a) matched their in vitro efficacy as 5-HT7 receptor agonists.  Contrary to agonists, a dose-dependent promotion of mech. hypersensitivity was obsd. after administration of 5-HT7 receptor antagonists, substantiating the involvement of the 5-HT7 receptor in the control of capsaicin-induced mech. hypersensitivity.  These findings suggest that serotonin exerts an inhibitory role in the control of nociception through activation of 5-HT7 receptors, and point to a new potential therapeutic use of 5-HT7 receptor agonists in the field of analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ2M6RjsdjhLVg90H21EOLACvtfcHk0lhlrpY72cXifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSlt74%253D&md5=97c1ceb07221903c90a5f87835c07d69</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DBrenchat%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DPujol%26aufirst%3DM.%26aulast%3DBurgue%25C3%25B1o%26aufirst%3DJ.%26aulast%3DTorrens%26aufirst%3DA.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DBaeyens%26aufirst%3DJ.%2BM.%26aulast%3DBuschmann%26aufirst%3DH.%26aulast%3DZamanillo%26aufirst%3DD.%26aulast%3DVela%26aufirst%3DJ.%2BM.%26atitle%3D5-HT7%2520Receptor%2520Activation%2520Inhibits%2520Mechanical%2520Hypersensitivity%2520Secondary%2520to%2520Capsaicin%2520Sensitization%2520in%2520Mice%26jtitle%3DPain%26date%3D2009%26volume%3D141%26spage%3D239%26epage%3D247%26doi%3D10.1016%2Fj.pain.2008.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitron-Resendiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.biopsych.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16018977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ght7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=831-837&author=P.+B.+Hedlundauthor=S.+Huitron-Resendizauthor=S.+J.+Henriksenauthor=J.+G.+Sutcliffe&title=5-HT7+Receptor+Inhibition+and+Inactivation+Induce+Antidepressantlike+Behavior+and+Sleep+Pattern&doi=10.1016%2Fj.biopsych.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern</span></div><div class="casAuthors">Hedlund, Peter B.; Huitron-Resendiz, Salvador; Henriksen, Steven J.; Sutcliffe, J. Gregor</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">831-837</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: The 5-hydroxytryptamine7 receptor (5-HT7) is implicated in circadian rhythm phase resetting, and 5-HT7 receptor-selective antagonists alter rapid eye movement (REM) sleep parameters in a pattern opposite from those in patients with clin. depression.  Methods: As sleep, circadian rhythm, and mood regulation are related, we examd. 5-HT7 receptor knockout mice in two behavioral models of depression.  The forced swim and tail suspension tests are highly predictive for antidepressant drug activity.  Results: Unmedicated 5-HT7-/- mice showed decreased immobility in both tests, consistent with an antidepressantlike behavior.  The selective 5-HT7 receptor antagonist SB-269970 also decreased immobility.  The selective serotonin reuptake inhibitor citalopram, a widely used antidepressant, decreased immobility in both 5-HT7+/+ and 5-HT7-/- mice in the tail suspension test, suggesting that it utilizes an independent mechanism.  The 5-HT7-/- mice spent less time in and had less frequent episodes of REM sleep, also consistent with an antidepressantlike state.  Conclusions: The 5-HT7 receptor might have a role in mood disorders and antagonists might have therapeutic value as antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJOvlUGGoK7Vg90H21EOLACvtfcHk0lhlrpY72cXifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ght7jJ&md5=f8299459bf442f96e9ce2d9ecc12edaa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DHuitron-Resendiz%26aufirst%3DS.%26aulast%3DHenriksen%26aufirst%3DS.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3D5-HT7%2520Receptor%2520Inhibition%2520and%2520Inactivation%2520Induce%2520Antidepressantlike%2520Behavior%2520and%2520Sleep%2520Pattern%26jtitle%3DBiol.%2520Psychiatry%26date%3D2005%26volume%3D58%26spage%3D831%26epage%3D837%26doi%3D10.1016%2Fj.biopsych.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span> </span><span class="NLM_article-title">Stable Expression of Constitutively Activated Mutant h5HT<sub>6</sub> and h5HT<sub>7</sub> Serotonin Receptors: Inverse Agonist Activity of Antipsychotic Drugs</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.1007/s00213-004-2057-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-004-2057-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=461-469&author=A.+Purohitauthor=C.+Smithauthor=K.+Herrick-Davisauthor=M.+Teitler&title=Stable+Expression+of+Constitutively+Activated+Mutant+h5HT6+and+h5HT7+Serotonin+Receptors%3A+Inverse+Agonist+Activity+of+Antipsychotic+Drugs&doi=10.1007%2Fs00213-004-2057-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-2057-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-2057-6%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DTeitler%26aufirst%3DM.%26atitle%3DStable%2520Expression%2520of%2520Constitutively%2520Activated%2520Mutant%2520h5HT6%2520and%2520h5HT7%2520Serotonin%2520Receptors%253A%2520Inverse%2520Agonist%2520Activity%2520of%2520Antipsychotic%2520Drugs%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D461%26epage%3D469%26doi%3D10.1007%2Fs00213-004-2057-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, N.</span><span> </span><span class="NLM_article-title">Positive Association of the Serotonin 5-HT<sub>7</sub> Receptor Gene with Schizophrenia in a Japanese Population</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.npp.1300901" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=866-871&author=M.+Ikedaauthor=N.+Iwataauthor=T.+Kitajimaauthor=T.+Suzukiauthor=Y.+Yamanouchiauthor=Y.+Kinoshitaauthor=N.+Ozaki&title=Positive+Association+of+the+Serotonin+5-HT7+Receptor+Gene+with+Schizophrenia+in+a+Japanese+Population&doi=10.1038%2Fsj.npp.1300901"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300901%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DKitajima%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DYamanouchi%26aufirst%3DY.%26aulast%3DKinoshita%26aufirst%3DY.%26aulast%3DOzaki%26aufirst%3DN.%26atitle%3DPositive%2520Association%2520of%2520the%2520Serotonin%25205-HT7%2520Receptor%2520Gene%2520with%2520Schizophrenia%2520in%2520a%2520Japanese%2520Population%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D866%26epage%3D871%26doi%3D10.1038%2Fsj.npp.1300901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cates, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitron-Resendiz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Effects of Lurasidone in Behavioral Models of Depression. Role of the 5-HT<sub>7</sub> receptor subtype</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2013.01.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=211-217&author=L.+N.+Catesauthor=A.+J.+Robertsauthor=S.+Huitron-Resendizauthor=P.+B.+Hedlund&title=Effects+of+Lurasidone+in+Behavioral+Models+of+Depression.+Role+of+the+5-HT7+receptor+subtype&doi=10.1016%2Fj.neuropharm.2013.01.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DCates%26aufirst%3DL.%2BN.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DHuitron-Resendiz%26aufirst%3DS.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DEffects%2520of%2520Lurasidone%2520in%2520Behavioral%2520Models%2520of%2520Depression.%2520Role%2520of%2520the%25205-HT7%2520receptor%2520subtype%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D211%26epage%3D217%26doi%3D10.1016%2Fj.neuropharm.2013.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><div class="note"><p class="first last">For a comprehensive review on 5-HT<sub>7</sub>R and its association to psychiatric disorders, please see:</p></div><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>7</sub> Receptor and Disorders of the Nervous System: an Overview</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1007/s00213-009-1626-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-009-1626-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19649616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlakt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=345-354&author=P.+B.+Hedlund&title=The+5-HT7+Receptor+and+Disorders+of+the+Nervous+System%3A+an+Overview&doi=10.1007%2Fs00213-009-1626-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-HT7 receptor and disorders of the nervous system: an overview</span></div><div class="casAuthors">Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Rationale: The 5-HT7 receptor is a more recently discovered G-protein-coupled receptor for serotonin.  The functions and possible clin. relevance of this receptor are not yet fully understood.  Objective: The present paper reviews to what extent the use of animal models of human psychiatric and neurol. disorders have implicated the 5-HT7 receptor in such disorders.  The studies have used a combination of pharmacol. and genetic tools targeting the receptor to evaluate effects on behavior.  Results: Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT7 receptor described in these disorders.  Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions.  There is a considerable amt. of evidence supporting a role for the 5-HT7 receptor in depression.  Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression.  Supporting evidence has also been obtained in sleep studies.  Esp. interesting are the augmented effects achieved by combining antidepressants and 5-HT7 receptor antagonists.  The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT7 receptor.  Conclusions: The use of pharmacol. and genetic tools in preclin. animal models strongly supports a role for the 5-HT7 receptor in depression.  Indirect evidence exists showing that 5-HT7 receptor antagonism is clin. useful in the treatment of depression.  Available data also indicate a possible involvement of the 5-HT7 receptor in anxiety, epilepsy, pain, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAr_t6Buj0bLVg90H21EOLACvtfcHk0lgbi9VektR0hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlakt78%253D&md5=5cef1e8c6f7348fd15afac30c6e6c6db</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1626-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1626-0%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DThe%25205-HT7%2520Receptor%2520and%2520Disorders%2520of%2520the%2520Nervous%2520System%253A%2520an%2520Overview%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D206%26spage%3D345%26epage%3D354%26doi%3D10.1007%2Fs00213-009-1626-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nativio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricceri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.1038/npp.2014.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnpp.2014.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24809912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2506-2518&author=B.+De+Filippisauthor=P.+Nativioauthor=A.+Fabbriauthor=L.+Ricceriauthor=W.+Adrianiauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Passarelliauthor=A.+Fusoauthor=G.+Laviola&title=Pharmacological+Stimulation+of+the+Brain+Serotonin+Receptor+7+as+a+Novel+Therapeutic+Approach+for+Rett+Syndrome&doi=10.1038%2Fnpp.2014.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Nativio, Paola; Fabbri, Alessia; Ricceri, Laura; Adriani, Walter; Lacivita, Enza; Leopoldo, Marcello; Passarelli, Francesca; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2518</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG-binding protein 2 gene (MECP2) cause >95% of classic cases, and currently there is no cure for this devastating disorder.  The serotonin receptor 7 (5-HT7R) is linked to neuro-physiol. regulation of circadian rhythm, mood, cognition, and synaptic plasticity.  We presently report that 5-HT7R d. is consistently reduced in cortical and hippocampal brain areas of symptomatic MeCP2-308 male mice, a RTT model.  Systemic repeated treatment with LP-211 (0.25 mg/kg once/day for 7 days), a brain-penetrant selective 5-HT7R agonist, was able to rescue RTT-related defective performance: anxiety-related profiles in a Light/Dark test, motor abilities in a Dowel test, the exploratory behavior in the Marble Burying test, as well as memory in the Novelty Preference task.  In the brain of RTT mice, LP-211 also reversed the abnormal activation of PAK and cofilin (key regulators of actin cytoskeleton dynamics) and of the ribosomal protein (rp) S6, whose reduced activation in MECP2 mutant neurons by mTOR is responsible for the altered protein translational control.  Present findings indicate that pharmacol. targeting of 5-HT7R improves specific behavioral and mol. manifestations of RTT, thus representing a first step toward the validation of an innovative systemic treatment.  Beyond RTT, the latter might be extended to other disorders assocd. with intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrsCidW_X5rVg90H21EOLACvtfcHk0lgbi9VektR0hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D&md5=3ca5c55ceaee5c6091033f92eb30a60d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.105%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DNativio%26aufirst%3DP.%26aulast%3DFabbri%26aufirst%3DA.%26aulast%3DRicceri%26aufirst%3DL.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DPassarelli%26aufirst%3DF.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DPharmacological%2520Stimulation%2520of%2520the%2520Brain%2520Serotonin%2520Receptor%25207%2520as%2520a%2520Novel%2520Therapeutic%2520Approach%2520for%2520Rett%2520Syndrome%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2506%26epage%3D2518%26doi%3D10.1038%2Fnpp.2014.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massagrande, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span> </span><span class="NLM_article-title">SB-656104-A, a Novel Selective 5-HT<sub>7</sub> Receptor Antagonist Modulates REM Sleep in rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0705290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12812993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2003&pages=705-714&author=D.+R.+Thomasauthor=S.+Melottoauthor=M.+Massagrandeauthor=A.+D.+Gribbleauthor=P.+Jeffreyauthor=A.+J.+Stevensauthor=N.+J.+Deeksauthor=P.+J.+Eddershawauthor=S.+H.+Fenwickauthor=G.+Rileyauthor=T.+Steanauthor=C.+M.+Scottauthor=M.+J.+Hillauthor=D.+N.+Middlemissauthor=J.+J.+Haganauthor=G.+W.+Priceauthor=I.+T.+Forbes&title=SB-656104-A%2C+a+Novel+Selective+5-HT7+Receptor+Antagonist+Modulates+REM+Sleep+in+rats&doi=10.1038%2Fsj.bjp.0705290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats</span></div><div class="casAuthors">Thomas, David R.; Melotto, Sergio; Massagrande, Mario; Gribble, Andrew D.; Jeffrey, Phillip; Stevens, Alexander J.; Deeks, Nigel J.; Eddershaw, Peter J.; Fenwick, Susan H.; Riley, Graham; Stean, Tania; Scott, Claire M.; Hill, Matthew J.; Middlemiss, Derek N.; Hagan, Jim J.; Price, Gary W.; Forbes, Ian T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">(6-((R)-2-{2-[4-(4-Chloro-phenoxy)-piperidin-1-yl]-ethyl}-pyrrolidine- 1-sulfonyl)-1H-indole hydrochloride) (SB-656104-A), a novel 5-hydroxytryptamine (5-HT7) receptor antagonist, potently inhibited [3H]-SB-269970 binding to the human cloned 5-HT7(a) (pKi 8.7±0.1) and 5-HT7(b) (pKi 8.5±0.2) receptor variants and the rat native receptor (pKi 8.8±0.2).  The compd. displayed at least 30-fold selectivity for the human 5-HT7(a) receptor vs. other human cloned 5-HT receptors apart from the 5-HT1D receptor (∼ 10-fold selective).  SB-656104-A antagonized competitively the 5-carboxamidotryptamine (5-CT)-induced accumulation of cAMP in h5-HT7(a)/HEK293 cells with a pA2 of 8.5.  Following a const. rate iv infusion to steady state in rats, SB-656104 had a blood clearance (CLb) of 58±6 mL min-1 kg-1 and was CNS penetrant with a steady-state brain: blood ratio of 0.9: 1.  Following i.p. administration to rats (10 mg kg-1), the compd. displayed a t1/2 of 1.4 h with mean brain and blood concns. (at 1 h after dosing) of 0.80 and 1.0 μM, resp.  SB-656104-A produced a significant reversal of the 5-CT-induced hypothermic effect in guinea pigs, a pharmacodynamic model of 5-HT7 receptor interaction in vivo (ED50 2 mg kg-1).  SB-656104-A, administered to rats at the beginning of the sleep period (CT 0), significantly increased the latency to onset of rapid eye movement (REM) sleep at 30 mg kg-1 i.p. (+93%) and reduced the total amt. of REM sleep at 10 and 30 mg kg-1 i.p. with no significant effect on the latency to, or amt. of, non-REM sleep.  SB-269970-A produced qual. similar effects in the same study.  In summary, SB-656104-A is a novel 5-HT7 receptor antagonist which has been utilized in the present study to provide further evidence for a role for 5-HT7 receptors in the modulation of REM sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGLUG9QaVLxrVg90H21EOLACvtfcHk0lgbi9VektR0hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVOiuro%253D&md5=7f0a81d506a85abb4650facb830de413</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705290%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DMelotto%26aufirst%3DS.%26aulast%3DMassagrande%26aufirst%3DM.%26aulast%3DGribble%26aufirst%3DA.%2BD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DEddershaw%26aufirst%3DP.%2BJ.%26aulast%3DFenwick%26aufirst%3DS.%2BH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DStean%26aufirst%3DT.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DHill%26aufirst%3DM.%2BJ.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26atitle%3DSB-656104-A%252C%2520a%2520Novel%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520Modulates%2520REM%2520Sleep%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D139%26spage%3D705%26epage%3D714%26doi%3D10.1038%2Fsj.bjp.0705290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Systemic Administration and Local Microinjection into the Central Nervous System of the 5-HT<sub>7</sub> Receptor Agonist LP-211 Modify the Sleep-Wake Cycle in the Rat</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1016/j.bbr.2013.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2013.11.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=2014&pages=321-329&author=J.+M.+Montiauthor=M.+Leopoldoauthor=H.+Jantos&title=Systemic+Administration+and+Local+Microinjection+into+the+Central+Nervous+System+of+the+5-HT7+Receptor+Agonist+LP-211+Modify+the+Sleep-Wake+Cycle+in+the+Rat&doi=10.1016%2Fj.bbr.2013.11.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2013.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2013.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DSystemic%2520Administration%2520and%2520Local%2520Microinjection%2520into%2520the%2520Central%2520Nervous%2520System%2520of%2520the%25205-HT7%2520Receptor%2520Agonist%2520LP-211%2520Modify%2520the%2520Sleep-Wake%2520Cycle%2520in%2520the%2520Rat%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2014%26volume%3D259%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.bbr.2013.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guscott, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span> </span><span class="NLM_article-title">The Hypothermic Effect of 5-CT in Mice is Mediated Through the 5-HT<sub>7</sub> Receptor</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1016/S0028-3908(03)00117-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0028-3908%2803%2900117-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12763096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=1031-1037&author=M.+R.+Guscottauthor=E.+Eganauthor=G.+P.+Cookauthor=J.+A.+Stantonauthor=M.+S.+Beerauthor=T.+W.+Rosahlauthor=S.+Hartmannauthor=J.+Kulagowskiauthor=G.+McAllisterauthor=K.+C.+Foneauthor=P.+H.+Hutson&title=The+Hypothermic+Effect+of+5-CT+in+Mice+is+Mediated+Through+the+5-HT7+Receptor&doi=10.1016%2FS0028-3908%2803%2900117-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor</span></div><div class="casAuthors">Guscott, M. R.; Egan, E.; Cook, G. P.; Stanton, J. A.; Beer, M. S.; Rosahl, T. W.; Hartmann, S.; Kulagowski, J.; McAllister, G.; Fone, K. C. F.; Hutson, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1031-1037</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The 5-HT7 receptor is a recent addn. to the 5-HT receptor family and to date there is no clear idea as to its potential role in the CNS.  The receptor has been mapped by in situ hybridization and 5-HT7-like immunoreactivity and has been detected in discrete areas of the brain including the hypothalamus (Oliver et al., 1999).  This suggests the receptor may be involved in temp. regulation and have shown that a selective 5-HT7 receptor antagonist reverses the hypothermic effect of 5-CT in guinea-pigs.  The current study confirmed that the 5-HT7 receptor antagonists, SB-269970 (1-30 mg/kg, i.p.) and SB-258719 (5-20 mg/kg, i.p.), but not the 5-HT1A receptor antagonist, WAY 100635(0.1-1 mg/kg, s.c.), or the 5-HT1B/D antagonist, GR127935 (1.25-5 mg/kg, i.p.), reversed the hypothermic effect of 5-CT in mice.  In addn. the effect of 5-CT on body temp. was examd. on 5-HT7 receptor null mutant mice. 5-CT (0.1-1 mg/kg, i.p.) significantly reduced rectal temp. in wild-type but not 5-HT7 receptor knockout mice.  This suggests that the hypothermic effects of 5-CT are mediated through the 5-HT7 receptor.  All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act (1986).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNczXKqpDK6rVg90H21EOLACvtfcHk0liIZGZkLQTGbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFeksLk%253D&md5=6ac84e94f9da78d01d657d059eea472d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2803%2900117-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252803%252900117-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuscott%26aufirst%3DM.%2BR.%26aulast%3DEgan%26aufirst%3DE.%26aulast%3DCook%26aufirst%3DG.%2BP.%26aulast%3DStanton%26aufirst%3DJ.%2BA.%26aulast%3DBeer%26aufirst%3DM.%2BS.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DKulagowski%26aufirst%3DJ.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DFone%26aufirst%3DK.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Hypothermic%2520Effect%2520of%25205-CT%2520in%2520Mice%2520is%2520Mediated%2520Through%2520the%25205-HT7%2520Receptor%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D1031%26epage%3D1037%26doi%3D10.1016%2FS0028-3908%2803%2900117-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span> </span><span class="NLM_article-title">No Hypothermic Response to Serotonin in 5-HT<sub>7</sub> Receptor Knockout Mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span><span class="refDoi"> DOI: 10.1073/pnas.0337340100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1073%2Fpnas.0337340100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12529502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtF2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=1375-1380&author=P.+B.+Hedlundauthor=P.+E.+Danielsonauthor=E.+A.+Thomasauthor=K.+Slaninaauthor=M.+J.+Carsonauthor=J.+G.+Sutcliffe&title=No+Hypothermic+Response+to+Serotonin+in+5-HT7+Receptor+Knockout+Mice&doi=10.1073%2Fpnas.0337340100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">No hypothermic response to serotonin in 5-HT7 receptor knockout mice</span></div><div class="casAuthors">Hedlund, P. B.; Danielson, P. E.; Thomas, E. A.; Slanina, K.; Carson, M. J.; Sutcliffe, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1375-1380</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">With data from recently available selective antagonists for the 5-HT7 receptor, it was hypothesized that 5-hydroxytryptamine (5-HT)-induced hypothermia is mediated by the 5-HT7 receptor, an effect previously attributed to other receptor subtypes.  It was established that the biol active lipid oleamide allosterically interacts with the 5-HT7 receptor to regulate its transmission.  The most well characterized effects of oleamide administration are induction of sleep and hypothermia.  Here, the authors demonstrate, by mice lacking the 5-HT7 receptor, that 5-HT-induced hypothermia is mediated by the 5-HT7 receptor.  Both 5-HT and 5-carboxamidotryptamine, a 5-HT1 and 5-HT7 receptor agonist, in physiol. doses fail to induce hypothermia in 5-HT7 knockout mice.  In contrast, oleamide was equally effective in inducing hypothermia in mice lacking the 5-HT7 receptors as in wild-type mice.  When administered together, 5-HT and oleamide showed additive or greater than additive effects in reducing body temp.  Taken together, the results show that 5-HT-induced hypothermia is mediated by the 5-HT7 receptor, and that oleamide may act through an independent mechanism as well as at an allosteric 5-HT7 receptor site to regulate body temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL2VIYgHY8yrVg90H21EOLACvtfcHk0liIZGZkLQTGbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtF2gu7g%253D&md5=176e68f72d602e14e960de6307fa9ce3</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0337340100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0337340100%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DDanielson%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DSlanina%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DM.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26atitle%3DNo%2520Hypothermic%2520Response%2520to%2520Serotonin%2520in%25205-HT7%2520Receptor%2520Knockout%2520Mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D1375%26epage%3D1380%26doi%3D10.1073%2Fpnas.0337340100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobirnac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeffter, P.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptors Coupled to Induction of Interleukin-6 in Human Microglial MC-3 Cells</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2005.01.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=40-47&author=C.+Mah%C3%A9author=E.+Loetscherauthor=K.+K.+Devauthor=I.+Bobirnacauthor=U.+Ottenauthor=P.+Schoeffter&title=Serotonin+5-HT7+Receptors+Coupled+to+Induction+of+Interleukin-6+in+Human+Microglial+MC-3+Cells&doi=10.1016%2Fj.neuropharm.2005.01.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMah%25C3%25A9%26aufirst%3DC.%26aulast%3DLoetscher%26aufirst%3DE.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBobirnac%26aufirst%3DI.%26aulast%3DOtten%26aufirst%3DU.%26aulast%3DSchoeffter%26aufirst%3DP.%26atitle%3DSerotonin%25205-HT7%2520Receptors%2520Coupled%2520to%2520Induction%2520of%2520Interleukin-6%2520in%2520Human%2520Microglial%2520MC-3%2520Cells%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D40%26epage%3D47%26doi%3D10.1016%2Fj.neuropharm.2005.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lieb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biersack, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waschbisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlikowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akundi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelario-Jalil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiebich, B. L.</span><span> </span><span class="NLM_article-title">Serotonin via 5-HT7 Receptors Activates p38 Mitogen-Activated Protein Kinase and Protein Kinase C ε Resulting in Interleukin-6 Synthesis in Human U373 MG Astrocytoma Cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03079.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1471-4159.2005.03079.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15836614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2005&pages=549-559&author=K.+Liebauthor=L.+Biersackauthor=A.+Waschbischauthor=S.+Orlikowskiauthor=R.+S.+Akundiauthor=E.+Candelario-Jalilauthor=M.+Hullauthor=B.+L.+Fiebich&title=Serotonin+via+5-HT7+Receptors+Activates+p38+Mitogen-Activated+Protein+Kinase+and+Protein+Kinase+C+%CE%B5+Resulting+in+Interleukin-6+Synthesis+in+Human+U373+MG+Astrocytoma+Cells&doi=10.1111%2Fj.1471-4159.2005.03079.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C ε resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells</span></div><div class="casAuthors">Lieb, Klaus; Biersack, Lisa; Waschbisch, Anne; Orlikowski, Sonja; Akundi, Ravi Shankar; Candelario-Jalil, Eduardo; Huell, Michael; Fiebich, Bernd L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">549-559</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Serotonin [5-hydroxytryptamine (5-HT)] is a widely distributed neurotransmitter which is involved in neuroimmunomodulatory processes.  Previously, it has been demonstrated that 5-HT may induce interleukin (IL)-6 expression in primary rat hippocampal astrocytes.  The present study was undertaken to investigate the mol. pathways underlying this induction of IL-6 synthesis.  As a model system, the authors used the human astrocytoma cell line U373 MG, which synthesizes IL-6 upon stimulation with various inducers.  5-HT dose- and time-dependently induced IL-6 protein synthesis.  The authors identified several 5-HT receptors to be expressed on U373 MG cells, including the 5-HT1D, 5-HT2A, 5-HT3 and 5-HT7 receptors.  The authors show that the 5-HT-induced IL-6 release is mediated by the 5-HT7 receptor based on several agonist/antagonists that were used.  5-HT-induced IL-6 synthesis is inhibited by the partially selective 5-HT7 receptor antagonist, pimozide, and the selective antagonist SB269970.  Furthermore, IL-6 synthesis was induced by the 5-HT7 receptor agonist carboxamidotryptamine.  In addn., the authors found p38 MAPKs and protein kinase C (PKC) ε to be involved in 5-HT-induced IL-6 synthesis as specific inhibitors of these enzymes (SB202190 and RO-31-8425, resp.) blocked 5-HT-induced IL-6 synthesis.  Furthermore, 5-HT mediated the phosphorylation of both p38 MAPK as well as the PKC ε isoform.  The p42/44 MAPKs, however, were not involved in 5-HT-induced IL-6 synthesis.  This study shows, for the first time, a central role of 5-HT7 receptor linked to p38 MAPK and PKC ε for the induction of cytokine synthesis in astrocytic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQIg48BXifgbVg90H21EOLACvtfcHk0lhn4g4Mbw-VqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtbw%253D&md5=8d8c0712161e57e5199c78092ceacff4</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03079.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03079.x%26sid%3Dliteratum%253Aachs%26aulast%3DLieb%26aufirst%3DK.%26aulast%3DBiersack%26aufirst%3DL.%26aulast%3DWaschbisch%26aufirst%3DA.%26aulast%3DOrlikowski%26aufirst%3DS.%26aulast%3DAkundi%26aufirst%3DR.%2BS.%26aulast%3DCandelario-Jalil%26aufirst%3DE.%26aulast%3DHull%26aufirst%3DM.%26aulast%3DFiebich%26aufirst%3DB.%2BL.%26atitle%3DSerotonin%2520via%25205-HT7%2520Receptors%2520Activates%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520and%2520Protein%2520Kinase%2520C%2520%25CE%25B5%2520Resulting%2520in%2520Interleukin-6%2520Synthesis%2520in%2520Human%2520U373%2520MG%2520Astrocytoma%2520Cells%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D93%26spage%3D549%26epage%3D559%26doi%3D10.1111%2Fj.1471-4159.2005.03079.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krucker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slanina, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Mice Lacking 5-HT<sub>7</sub> Receptors Show Specific Impairements in Contextual Learning</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1913</span><span class="NLM_x">–</span> <span class="NLM_lpage">1922</span><span class="refDoi"> DOI: 10.1111/j.1460-9568.2004.03288.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1460-9568.2004.03288.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15078565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD2c7otlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=1913-1922&author=A.+J.+Robertsauthor=T.+Kruckerauthor=C.+L.+Levyauthor=K.+A.+Slaninaauthor=J.+G.+Sutcliffeauthor=P.+B.+Hedlund&title=Mice+Lacking+5-HT7+Receptors+Show+Specific+Impairements+in+Contextual+Learning&doi=10.1111%2Fj.1460-9568.2004.03288.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice lacking 5-HT receptors show specific impairments in contextual learning</span></div><div class="casAuthors">Roberts Amanda J; Krucker Thomas; Levy Coree L; Slanina Kristen A; Sutcliffe J Gregor; Hedlund Peter B</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1913-22</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Using 5-HT(7) receptor knockout mice it has been shown that the 5-HT(7) receptor is the main mediator of serotonin-induced hypothermia but very little is known about the relevance of 5-HT(7) receptors in behaviour.  We here report that lack of 5-HT(7) receptors leads to a specific learning deficit that is not due to general sensory or behavioural deficits.  The knockout mice show impaired contextual fear conditioning but no significant deficits in motor and spatial learning or cued and operant conditioning.  In addition, we demonstrate that 5-HT(7) receptor knockout mice display decreased long-term synaptic plasticity within the CA1 region of the hippocampus.  The results indicate an important role for the 5-HT(7) receptor in contextual hippocampal-dependent learning and suggest a possible neuronal correlate for such a role is present within the CA1 region of the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQp0dItz82IMsK3uFsUIZtkfW6udTcc2eZqDrBtCnu-Yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7otlWntQ%253D%253D&md5=0981fd9f1b9f79c6cce36bf5a4231864</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2004.03288.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2004.03288.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DKrucker%26aufirst%3DT.%26aulast%3DLevy%26aufirst%3DC.%2BL.%26aulast%3DSlanina%26aufirst%3DK.%2BA.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BG.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DMice%2520Lacking%25205-HT7%2520Receptors%2520Show%2520Specific%2520Impairements%2520in%2520Contextual%2520Learning%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2004%26volume%3D19%26spage%3D1913%26epage%3D1922%26doi%3D10.1111%2Fj.1460-9568.2004.03288.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">Effects of the Potential 5-HT<sub>7</sub> Receptor Agonist AS 19 in an Autoshaping Learning Task</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.bbr.2005.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2005.04.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2005&pages=136-140&author=G.+Perez-Garc%C3%ADaauthor=A.+Meneses&title=Effects+of+the+Potential+5-HT7+Receptor+Agonist+AS+19+in+an+Autoshaping+Learning+Task&doi=10.1016%2Fj.bbr.2005.04.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2005.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2005.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520Potential%25205-HT7%2520Receptor%2520Agonist%2520AS%252019%2520in%2520an%2520Autoshaping%2520Learning%2520Task%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2005%26volume%3D163%26spage%3D136%26epage%3D140%26doi%3D10.1016%2Fj.bbr.2005.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pérez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Espinosa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">An mRNA Expression Analysis of Stimulation and blockade of 5-HT<sub>7</sub> Receptors During Memory Consolidation</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.bbr.2005.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2005.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2006&pages=83-92&author=G.+P%C3%A9rez-Garc%C3%ADaauthor=C.+Gonzalez-Espinosaauthor=A.+Meneses&title=An+mRNA+Expression+Analysis+of+Stimulation+and+blockade+of+5-HT7+Receptors+During+Memory+Consolidation&doi=10.1016%2Fj.bbr.2005.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2005.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2005.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DGonzalez-Espinosa%26aufirst%3DC.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DAn%2520mRNA%2520Expression%2520Analysis%2520of%2520Stimulation%2520and%2520blockade%2520of%25205-HT7%2520Receptors%2520During%2520Memory%2520Consolidation%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2006%26volume%3D169%26spage%3D83%26epage%3D92%26doi%3D10.1016%2Fj.bbr.2005.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Perez-García, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title"><i>Ex vivo</i> Study of 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> Receptor Agonists and Antagonists on cAMP Accumulation During Memory Formation and Amnesia</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1016/j.bbr.2008.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bbr.2008.07.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=139-146&author=G.+Perez-Garc%C3%ADaauthor=A.+Meneses&title=Ex+vivo+Study+of+5-HT1A+and+5-HT7+Receptor+Agonists+and+Antagonists+on+cAMP+Accumulation+During+Memory+Formation+and+Amnesia&doi=10.1016%2Fj.bbr.2008.07.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2008.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2008.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DPerez-Garc%25C3%25ADa%26aufirst%3DG.%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3DEx%2520vivo%2520Study%2520of%25205-HT1A%2520and%25205-HT7%2520Receptor%2520Agonists%2520and%2520Antagonists%2520on%2520cAMP%2520Accumulation%2520During%2520Memory%2520Formation%2520and%2520Amnesia%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D139%26epage%3D146%26doi%3D10.1016%2Fj.bbr.2008.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Horiguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span> </span><span class="NLM_article-title">The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1124/jpet.111.180638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1124%2Fjpet.111.180638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=21558435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=605-614&author=M.+Horiguchiauthor=M.+Huangauthor=H.+Y.+Meltzer&title=The+Role+of+5-Hydroxytryptamine+7+Receptors+in+the+Phencyclidine-Induced+Novel+Object+Recognition+Deficit+in+Rats&doi=10.1124%2Fjpet.111.180638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats</span></div><div class="casAuthors">Horiguchi, M.; Huang, M.; Meltzer, H. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">605-614</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The role of 5-hydroxytryptamine (serotonin) (5-HT)7 receptor antagonism in the actions of atypical antipsychotic drugs (APDs), e.g., amisulpride, clozapine, and lurasidone, if any, is uncertain.  We examd. the ability of 5-HT7 receptor antagonism alone and as a component of amisulpride and lurasidone to reverse deficits in rat novel object recognition (NOR) produced by subchronic treatment with the N-methyl-D-aspartate receptor antagonist phencyclidine (PCP), and we examd. the ability of supplemental 5-HT7 antagonism to augment the inability of sulpiride, haloperidol, and (1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY379268), a metabotropic glutamate receptor (mGluR) 2/3 agonist, which lack 5-HT7 antagonism, to reverse the NOR deficit.  The 5-HT7 receptor antagonist, (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine (SB269970) (0.1-1 mg/kg) dose-dependently reversed PCP-induced NOR deficits.  In addn., the ability of lurasidone (0.1 mg/kg) and amisulpride (3 mg/kg) to reverse this deficit was blocked by cotreatment with the 5-HT7 receptor agonist (2S)-(+)-5-(1,3,5-trimethylpyrazol-4-yl)-2-(dimethylamino)tetralin (AS19) (5-10 mg/kg), which did not affect NOR in naive rats.  Sulpiride, a less potent 5-HT7 antagonist than amisulpride, did not itself improve the PCP-induced NOR deficit.  However, a subeffective dose of SB269970 (0.1 mg/kg) in combination with subeffective doses of lurasidone (0.03 mg/kg), amisulpride (1 mg/kg), or sulpiride (20 mg/kg), also reversed the PCP-induced NOR deficit.  Pimavanserin, a 5-HT2A inverse agonist, LY379268, and haloperidol did not potentiate the ability of subeffective SB269970 to improve the NOR deficit.  Furthermore, the mGluR2/3 antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl)propanoic acid (LY341495), which blocks the effect of clozapine to reverse the NOR deficit, did not block the SB269970-induced amelioration of the NOR deficit.  These results suggest 5-HT7 antagonism may contribute to the efficacy of some atypical APDs in the treatment of cognitive impairment in schizophrenia and may itself have some benefit in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruAyKj3PlyU7Vg90H21EOLACvtfcHk0lh2AsTbY3wVyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFelsrw%253D&md5=ceb18a798a18e8e4f46cd9616b7039cd</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.180638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.180638%26sid%3Dliteratum%253Aachs%26aulast%3DHoriguchi%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26atitle%3DThe%2520Role%2520of%25205-Hydroxytryptamine%25207%2520Receptors%2520in%2520the%2520Phencyclidine-Induced%2520Novel%2520Object%2520Recognition%2520Deficit%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D338%26spage%3D605%26epage%3D614%26doi%3D10.1124%2Fjpet.111.180638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paizanis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gusmao-Montaigne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span> </span><span class="NLM_article-title">Modulation of 5-HT<sub>7</sub> Receptor: Effect on Object Recognition Performances in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1007/s00213-013-3247-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-013-3247-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=393-400&author=T.+Freretauthor=E.+Paizanisauthor=G.+Beaudetauthor=A.+Gusmao-Montaigneauthor=G.+Neeauthor=F.+Dauphinauthor=V.+Bouetauthor=M.+Boulouard&title=Modulation+of+5-HT7+Receptor%3A+Effect+on+Object+Recognition+Performances+in+mice&doi=10.1007%2Fs00213-013-3247-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3247-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3247-x%26sid%3Dliteratum%253Aachs%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DPaizanis%26aufirst%3DE.%26aulast%3DBeaudet%26aufirst%3DG.%26aulast%3DGusmao-Montaigne%26aufirst%3DA.%26aulast%3DNee%26aufirst%3DG.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DBoulouard%26aufirst%3DM.%26atitle%3DModulation%2520of%25205-HT7%2520Receptor%253A%2520Effect%2520on%2520Object%2520Recognition%2520Performances%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D393%26epage%3D400%26doi%3D10.1007%2Fs00213-013-3247-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15ff"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Meneses, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Stimulation and Blockade: a Therapeutic Paradox about Memory Formation and Amnesia</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.3389%2Ffnbeh.2014.00207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24971055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15ff&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=207&author=A.+Meneses&title=5-HT7+Receptor+Stimulation+and+Blockade%3A+a+Therapeutic+Paradox+about+Memory+Formation+and+Amnesia&doi=10.3389%2Ffnbeh.2014.00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15ffR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia</span></div><div class="casAuthors">Meneses, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">207/1-207/4, 4</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2VhYgUedJLVg90H21EOLACvtfcHk0lh2AsTbY3wVyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrzJ&md5=734f6e4f4e06286bedf9968401c7f280</span></div><a href="/servlet/linkout?suffix=cit15ff&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00207%26sid%3Dliteratum%253Aachs%26aulast%3DMeneses%26aufirst%3DA.%26atitle%3D5-HT7%2520Receptor%2520Stimulation%2520and%2520Blockade%253A%2520a%2520Therapeutic%2520Paradox%2520about%2520Memory%2520Formation%2520and%2520Amnesia%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D207%26doi%3D10.3389%2Ffnbeh.2014.00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kvachnina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityatev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityateva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voyno-Yasenetskaya, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> Receptor Is Coupled to Gα Subunits of Heterotrimeric G12-Protein to Regulate Gene Transcription and Neuronal Morphology</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7821</span><span class="NLM_x">–</span> <span class="NLM_lpage">7830</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1790-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1523%2FJNEUROSCI.1790-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16120784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7821-7830&author=E.+Kvachninaauthor=G.+Liuauthor=A.+Dityatevauthor=U.+Rennerauthor=A.+Dumuisauthor=D.+W.+Richterauthor=G.+Dityatevaauthor=M.+Schachnerauthor=T.+A.+Voyno-Yasenetskayaauthor=E.+G.+Ponimaskin&title=5-HT7+Receptor+Is+Coupled+to+G%CE%B1+Subunits+of+Heterotrimeric+G12-Protein+to+Regulate+Gene+Transcription+and+Neuronal+Morphology&doi=10.1523%2FJNEUROSCI.1790-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span></div><div class="casAuthors">Kvachnina, Elena; Liu, Guoquan; Dityatev, Alexander; Renner, Ute; Dumuis, Aline; Richter, Diethelm W.; Dityateva, Galina; Schachner, Melitta; Voyno-Yasenetskaya, Tatyana A.; Ponimaskin, Evgeni G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7821-7830</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neurotransmitter serotonin (5-HT) plays an important role in the regulation of multiple events in the CNS.  The authors demonstrated recently a coupling between the 5-HT4 receptor and the heterotrimeric G13-protein resulting in RhoA-dependent neurite retraction and cell rounding.  In the present study, the authors identified G12 as an addnl. G-protein that can be activated by another member of serotonin receptors, the 5-HT7 receptor.  Expression of 5-HT7 receptor induced constitutive and agonist-dependent activation of a serum response element-mediated gene transcription through G12-mediated activation of small GTPases.  In NIH3T3 cells, activation of the 5-HT7 receptor induced filopodia formation via a Cdc42-mediated pathway correlating with RhoA-dependent cell rounding.  In mouse hippocampal neurons, activation of the endogenous 5-HT7 receptors significantly increased neurite length, whereas stimulation of 5-HT4 receptors led to a decrease in the length and no. of neurites.  These data demonstrate distinct roles for 5-HT7R/G12 and 5-HT4R/G13 signaling pathways in neurite outgrowth and retraction, suggesting that serotonin plays a prominent role in regulating the neuronal cytoarchitecture in addn. to its classical role as neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYY4-5ryShm7Vg90H21EOLACvtfcHk0lh2AsTbY3wVyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D&md5=46861cf8fcd57de268bfa8f7450cac69</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1790-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1790-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKvachnina%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DDityatev%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DDityateva%26aufirst%3DG.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DVoyno-Yasenetskaya%26aufirst%3DT.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7%2520Receptor%2520Is%2520Coupled%2520to%2520G%25CE%25B1%2520Subunits%2520of%2520Heterotrimeric%2520G12-Protein%2520to%2520Regulate%2520Gene%2520Transcription%2520and%2520Neuronal%2520Morphology%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7821%26epage%3D7830%26doi%3D10.1523%2FJNEUROSCI.1790-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tajiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayata-Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiriki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1007/s12031-012-9861-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs12031-012-9861-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=22843252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=473-481&author=M.+Tajiriauthor=A.+Hayata-Takanoauthor=K.+Seirikiauthor=K.+Ogataauthor=K.+Hazamaauthor=N.+Shintaniauthor=A.+Babaauthor=H.+Hashimoto&title=Serotonin+5-HT7+Receptor+Blockade+Reverses+Behavioral+Abnormalities+in+PACAP-Deficient+Mice+and+Receptor+Activation+Promotes+Neurite+Extension+in+Primary+Embryonic+Hippocampal+Neurons&doi=10.1007%2Fs12031-012-9861-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons</span></div><div class="casAuthors">Tajiri, Minako; Hayata-Takano, Atsuko; Seiriki, Kaoru; Ogata, Katsuya; Hazama, Keisuke; Shintani, Norihito; Baba, Akemichi; Hashimoto, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">The serotonin 5-HT7 receptor has been linked to various psychiatric disorders, including schizophrenia, anxiety and depression, and is antagonized by antipsychotics such as risperidone, clozapine and lurasidone.  In this study, we examd. whether inhibiting the 5-HT7 receptor could reverse behavioral abnormalities in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP), an exptl. mouse model for psychiatric disorders such as schizophrenia.  The selective 5-HT7 antagonist SB-269970 effectively suppressed abnormal jumping behavior in PACAP-deficient mice.  SB-269970 tended to alleviate the higher immobility in the forced swim test in PACAP-deficient mice, although SB-269970 reduced the immobility also in wild-type mice.  In addn., we found that mutant mice had impaired performance in the Y-maze test, which was reversed by SB-269970.  In the mutant mouse brain, 5-HT7 protein expression did not differ from wild-type mice.  In primary embryonic hippocampal neurons, the 5-HT7 agonist AS19 increased neurite length and no.  Furthermore, SB-269970 significantly inhibited the increase in neurite extension mediated by the 5-HT1A/7 agonist 8-OH-DPAT.  These results indicate that 5-HT7 receptor blockade ameliorates psychomotor and cognitive deficits in PACAP-deficient mice, providing addnl. evidence that the 5-HT7 receptor is a rational target for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWr0x9JOU047Vg90H21EOLACvtfcHk0lijEBa8jNNrrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKkurfF&md5=66af19c09cdfe3385a0d721fc45b6739</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs12031-012-9861-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-012-9861-y%26sid%3Dliteratum%253Aachs%26aulast%3DTajiri%26aufirst%3DM.%26aulast%3DHayata-Takano%26aufirst%3DA.%26aulast%3DSeiriki%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DK.%26aulast%3DHazama%26aufirst%3DK.%26aulast%3DShintani%26aufirst%3DN.%26aulast%3DBaba%26aufirst%3DA.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DSerotonin%25205-HT7%2520Receptor%2520Blockade%2520Reverses%2520Behavioral%2520Abnormalities%2520in%2520PACAP-Deficient%2520Mice%2520and%2520Receptor%2520Activation%2520Promotes%2520Neurite%2520Extension%2520in%2520Primary%2520Embryonic%2520Hippocampal%2520Neurons%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2012%26volume%3D48%26spage%3D473%26epage%3D481%26doi%3D10.1007%2Fs12031-012-9861-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rojas, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, J. L.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT) Regulates Neurite Outgrowth Through 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> Receptors in Cultured Hippocampal Neurons</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1002/jnr.23390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjnr.23390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24752854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVWhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=1000-1009&author=P.+S.+Rojasauthor=D.+Neiraauthor=M.+Mu%C3%B1ozauthor=S.+Lavanderoauthor=J.+L.+Fiedler&title=Serotonin+%285-HT%29+Regulates+Neurite+Outgrowth+Through+5-HT1A+and+5-HT7+Receptors+in+Cultured+Hippocampal+Neurons&doi=10.1002%2Fjnr.23390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons</span></div><div class="casAuthors">Rojas, Paulina S.; Neira, David; Munoz, Mauricio; Lavandero, Sergio; Fiedler, Jenny L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1000-1009</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Serotonin (5-HT) prodn. and expression of 5-HT receptors (5-HTRs) occur early during prenatal development.  Recent evidence suggests that, in addn. to its classical role as a neurotransmitter, 5-HT regulates neuronal connectivity during mammalian development by modulating cell migration and neuronal cytoarchitecture.  Given the variety of 5-HTRs, researchers have had difficulty clarifying the specific role of each receptor subtype in brain development.  Signaling mediated by the G-protein-coupled 5-HT1AR and 5-HT7R, however, has been assocd. with neuronal plasticity.  Thus, we hypothesized that 5-HT promotes neurite outgrowth through 5-HT1AR and 5-HT7R.  The involvement of 5-HT1AR and 5-HT7R in the morphol. of rat hippocampal neurons was evaluated by treating primary cultures at 2 days in vitro with 5-HT and specific antagonists for 5-HT1AR and 5-HT7R (WAY-100635 and SB 269970, resp.).  The stimulation of hippocampal neurons with 100 nM 5-HT for 24 h produced no effect on either the no. or the length of primary neurites.  Nonetheless, after 5-HT7R was blocked, the addn. of 5-HT increased the no. of primary neurites, suggesting that 5-HT7R could inhibit neuritogenesis.  In contrast, 5-HT induced secondary neurite outgrowth, an effect inhibited by 1 μM WAY-100635 or SB 269970.  These results suggest that both serotonergic receptors participate in secondary neurite outgrowth.  We conclude that 5-HT1AR and 5-HT7R regulate neuronal morphol. in primary hippocampal cultures by promoting secondary neurite outgrowth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLao8X2DXuH7Vg90H21EOLACvtfcHk0lijEBa8jNNrrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVWhtb8%253D&md5=0a28484dcab0e6a6516e6268e8d80805</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23390%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DP.%2BS.%26aulast%3DNeira%26aufirst%3DD.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DLavandero%26aufirst%3DS.%26aulast%3DFiedler%26aufirst%3DJ.%2BL.%26atitle%3DSerotonin%2520%25285-HT%2529%2520Regulates%2520Neurite%2520Outgrowth%2520Through%25205-HT1A%2520and%25205-HT7%2520Receptors%2520in%2520Cultured%2520Hippocampal%2520Neurons%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2014%26volume%3D92%26spage%3D1000%26epage%3D1009%26doi%3D10.1002%2Fjnr.23390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Canese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoratto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altabella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pasquale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span> </span><span class="NLM_article-title">Persistent Modification of Forebrain Networks and Metabolism in Rats Following Adolescent Exposure to a 5-HT7 Receptor Agonist</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="refDoi"> DOI: 10.1007/s00213-014-3639-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-014-3639-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24923983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVeisLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=75&author=R.+Caneseauthor=F.+Zorattoauthor=L.+Altabellaauthor=P.+Porcariauthor=L.+Mercurioauthor=F.+de+Pasqualeauthor=E.+Buttiauthor=G.+Martinoauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+Laviolaauthor=W.+Adriani&title=Persistent+Modification+of+Forebrain+Networks+and+Metabolism+in+Rats+Following+Adolescent+Exposure+to+a+5-HT7+Receptor+Agonist&doi=10.1007%2Fs00213-014-3639-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist</span></div><div class="casAuthors">Canese, Rossella; Zoratto, Francesca; Altabella, Luisa; Porcari, Paola; Mercurio, Laura; de Pasquale, Francesco; Butti, Erica; Martino, Gianvito; Lacivita, Enza; Leopoldo, Marcello; Laviola, Giovanni; Adriani, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The serotonin 7 receptor (5-HT7-R) is part of a neuro-transmission system with a proposed role in neural plasticity and in mood, cognitive or sleep regulation.  Objectives: We investigated long-term consequences of sub-chronic treatment, during adolescence (43-45 to 47-49 days old) in rats, with a novel 5-HT7-R agonist (LP-211, 0 or 0.250 mg/kg/day).  Methods: We evaluated behavioral changes as well as forebrain structural/functional modifications by in vivo magnetic resonance (MR) in a 4.7 T system, followed by ex vivo histol.  Results: Adult rats pre-treated during adolescence showed reduced anxiety-related behavior, in terms of reduced avoidance in the light/dark test and a less fragmented pattern of exploration in the novel object recognition test.  Diffusion tensor imaging (DTI) revealed decreased mean diffusivity (MD) in the amygdala, increased fractional anisotropy (FA) in the hippocampus (Hip) and reduced axial (D||) together with increased radial (D.perp.) diffusivity in the nucleus accumbens (NAcc).  An increased neural dendritic arborization was confirmed in the NAcc by ex vivo histol.  Seed-based functional MR imaging (fMRI) identified increased strength of connectivity within and between "limbic" and "cortical" loops, with affected cross-correlations between amygdala, NAcc and Hip.  The latter displayed enhanced connections through the dorsal striatum (dStr) to dorso-lateral prefrontal cortex (dl-PFC) and cerebellum.  Functional connection also increased between amygdala and limbic elements such as NAcc, orbito-frontal cortex (OFC) and hypothalamus.  MR spectroscopy (1H-MRS) indicated that adolescent LP-211 exposure increased glutamate and total creatine in the adult Hip.  Conclusions: Persistent MR-detectable modifications indicate a rearrangement within forebrain networks, accounting for long-lasting behavioral changes as a function of developmental 5-HT7-R stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Ai9hO1QTEbVg90H21EOLACvtfcHk0lijEBa8jNNrrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVeisLg%253D&md5=2b2215c5f311434f529753beef4631cf</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3639-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3639-6%26sid%3Dliteratum%253Aachs%26aulast%3DCanese%26aufirst%3DR.%26aulast%3DZoratto%26aufirst%3DF.%26aulast%3DAltabella%26aufirst%3DL.%26aulast%3DPorcari%26aufirst%3DP.%26aulast%3DMercurio%26aufirst%3DL.%26aulast%3Dde%2BPasquale%26aufirst%3DF.%26aulast%3DButti%26aufirst%3DE.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLaviola%26aufirst%3DG.%26aulast%3DAdriani%26aufirst%3DW.%26atitle%3DPersistent%2520Modification%2520of%2520Forebrain%2520Networks%2520and%2520Metabolism%2520in%2520Rats%2520Following%2520Adolescent%2520Exposure%2520to%2520a%25205-HT7%2520Receptor%2520Agonist%26jtitle%3DPsychopharmacology%26date%3D2015%26volume%3D232%26spage%3D75%26doi%3D10.1007%2Fs00213-014-3639-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhin, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinsworth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettys, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewal, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnovskaya, M. N.</span><span> </span><span class="NLM_article-title">Multiplicity of Mechanisms of Serotonin Receptor Signal Transduction</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><span class="refDoi"> DOI: 10.1016/S0163-7258(01)00169-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0163-7258%2801%2900169-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11916537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlejs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2001&pages=179-212&author=J.+R.+Raymondauthor=Y.+V.+Mukhinauthor=A.+Gelascoauthor=J.+Turnerauthor=G.+Collinsworthauthor=T.+W.+Gettysauthor=J.+S.+Grewalauthor=M.+N.+Garnovskaya&title=Multiplicity+of+Mechanisms+of+Serotonin+Receptor+Signal+Transduction&doi=10.1016%2FS0163-7258%2801%2900169-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Multiplicity of mechanisms of serotonin receptor signal transduction</span></div><div class="casAuthors">Raymond, John R.; Mukhin, Yurii V.; Gelasco, Andrew; Turner, Justin; Collinsworth, Georgiann; Gettys, Thomas W.; Grewal, Jasjit S.; Garnovskaya, Maria N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">179-212</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The serotonin (5-hydroxytryptamine, 5-HT) receptors have been divided into 7 subfamilies by convention, 6 of which include 13 different genes for G-protein-coupled receptors.  Those subfamilies have been characterized by overlapping pharmacol. properties, amino acid sequences, gene organization, and second messenger coupling pathways.  Post-genomic modifications, such as alternative mRNA splicing or mRNA editing, creates at least 20 more G-protein-coupled 5-HT receptors, such that there are at least 30 distinct 5-HT receptors that signal through G-proteins.  This review will focus on what is known about the signaling linkages of the G-protein-linked 5-HT receptors, and will highlight some fascinating new insights into 5-HT receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdBVczzTDd0LVg90H21EOLACvtfcHk0lilNv6K3cmVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlejs7s%253D&md5=e0782176f1e92603ada72bd50be86d7c</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2801%2900169-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252801%252900169-3%26sid%3Dliteratum%253Aachs%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DMukhin%26aufirst%3DY.%2BV.%26aulast%3DGelasco%26aufirst%3DA.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DCollinsworth%26aufirst%3DG.%26aulast%3DGettys%26aufirst%3DT.%2BW.%26aulast%3DGrewal%26aufirst%3DJ.%2BS.%26aulast%3DGarnovskaya%26aufirst%3DM.%2BN.%26atitle%3DMultiplicity%2520of%2520Mechanisms%2520of%2520Serotonin%2520Receptor%2520Signal%2520Transduction%26jtitle%3DPharmacol.%2520Ther.%26date%3D2001%26volume%3D92%26spage%3D179%26epage%3D212%26doi%3D10.1016%2FS0163-7258%2801%2900169-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span> </span><span class="NLM_article-title">Functional Characterization of Agonists at Human Recombinant 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> in CHO-K1 Cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0702751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0702751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10498829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=13-20&author=R.+H.+P.+Porterauthor=K.+R.+Benwellauthor=H.+Lambauthor=C.+S.+Malcolmauthor=N.+H.+Allenauthor=D.+F.+Revellauthor=D.+R.+Adamsauthor=M.+J.+Sheardown&title=Functional+Characterization+of+Agonists+at+Human+Recombinant+5-HT2A%2C+5-HT2B+and+5-HT2C+in+CHO-K1+Cells&doi=10.1038%2Fsj.bjp.0702751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span></div><div class="casAuthors">Porter, R. H. P.; Benwell, K. R.; Lamb, H.; Malcolm, C. S.; Allen, N. H.; Revell, D. F.; Adams, D. R.; Sheardown, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The goal of this study was to characterize the agonist pharmacol. of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells.  We used a fluorometric imaging plate reader (FLIPR) which allows rapid detection of rises in intracellular calcium levels upon the addn. of agonists.  Stimulation of all three receptors by 5-HT caused a robust concn. dependent increase in intracellular calcium levels.  No such effect was obsd. from non-transfected control CHO-K1 cells.  The rank order of potency of agonists at the different receptor subtypes varied.  Tryptamines, BW-723C86, d-norfenfluramine, Ro 60-0175 and LSD exhibited the following rank order of potency; 5-HT2B>5-HT2C>5-HT2A.  Piperazines such as m-chlorophenylpiperazine (mCPP), ORG-12962, MK-212 and also ORG-37684 exhibited a rank order of potency of 5-HT2C>5-HT2B>5-HT2A.  The phenylisopropylamines DOI and DOB had a rank order of 5-HT2A>5-HT2B>5-HT2C.  Many agonists tested had partial agonist actions when compared to 5-HT, and a wide range of relative efficacies were exhibited, which was cell line dependent.  For example, mCPP had a relative efficacy of 65% at 5-HT2C receptors but <25% at either 5-HT2A or 5-HT2B receptors.  Interpretation of literature values of functional assays using different cell lines, different receptor expression levels and different receptor isoforms, is complex.  Species differences and the previous use of antagonist radioligands to characterize agonist potency in binding assays emphasizes the importance of studying agonists in the same expt. using the same assay conditions and parental cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNDFqRrlEtbVg90H21EOLACvtfcHk0lilNv6K3cmVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D&md5=ff33f4122999f10960865e75161179ca</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702751%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DBenwell%26aufirst%3DK.%2BR.%26aulast%3DLamb%26aufirst%3DH.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DAllen%26aufirst%3DN.%2BH.%26aulast%3DRevell%26aufirst%3DD.%2BF.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26atitle%3DFunctional%2520Characterization%2520of%2520Agonists%2520at%2520Human%2520Recombinant%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520in%2520CHO-K1%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D13%26epage%3D20%26doi%3D10.1038%2Fsj.bjp.0702751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Nakaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, E.</span><span> </span><span class="NLM_article-title">Phasic and Tonic Components in 5-HT2 Receptor-Mediated Rat Aorta Contraction: Participation of Ca++ Channels and Phospholipase C</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=2410594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaL2MXltlGkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1985&pages=442-446&author=T.+Nakakiauthor=B.+L.+Rothauthor=D.+M.+Chuangauthor=E.+Costa&title=Phasic+and+Tonic+Components+in+5-HT2+Receptor-Mediated+Rat+Aorta+Contraction%3A+Participation+of+Ca%2B%2B+Channels+and+Phospholipase+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction:  participation of calcium channels and phospholipase C</span></div><div class="casAuthors">Nakaki, Toshio; Roth, Bryan L.; Chuang, De Maw; Costa, Erminio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">442-6</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The mechanisms of 5-HT  [50-67-9]-induced contraction of rat aorta were investigated in vitro.  The 5-HT-induced contraction could be analyzed into 2 distinct components (phasic and tonic) by the use of appropriate inhibitors; nifedipine, an inhibitor of voltage-dependent Ca2+ channels, inhibited only the phasic component of 5-HT-induced contraction while totally blocking the KCl-induced contraction.  2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate, an inhibitor of phospholipase C  [9001-86-9], inhibited the tonic components of 5-HT-induced contraction as well as the 5-HT-induced stimulation of phosphoinositide hydrolysis in rat aorta.  This component of contraction was mimicked by a protein kinase C activator 12-O-tetradecanoyl phorbol 13-acetate.  Apparently, 5-HT2 receptors differentially regulate a voltage-dependent Ca2+ channel and phospholipase C activity; the voltage-dependent Ca2+ channel is involved in the phasic component of contraction, whereas the phosphoinositide hydrolysis that results in the activation of protein kinase C and Ca mobilization by inositol triphosphate plays a physiol. important role in the tonic component of the aortic contraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99TAhU0CxBLVg90H21EOLACvtfcHk0lilNv6K3cmVBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlGkuro%253D&md5=86f3e65c19dbdf81124090344e6b0aab</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakaki%26aufirst%3DT.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BM.%26aulast%3DCosta%26aufirst%3DE.%26atitle%3DPhasic%2520and%2520Tonic%2520Components%2520in%25205-HT2%2520Receptor-Mediated%2520Rat%2520Aorta%2520Contraction%253A%2520Participation%2520of%2520Ca%252B%252B%2520Channels%2520and%2520Phospholipase%2520C%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1985%26volume%3D234%26spage%3D442%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malleron, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comte, M. – T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueremy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyronel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zundel, J. – L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viroulaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, J.</span><span> </span><span class="NLM_article-title">Naphthosultam Derivatives: A New class of Potent and Selective 5-HT<sub>2</sub> Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span><span class="refDoi"> DOI: 10.1021/jm00112a025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2477-2483&author=J.-L.+Malleronauthor=M.+%E2%80%93+T.+Comteauthor=C.+Gueremyauthor=J.+F.+Peyronelauthor=A.+Truchonauthor=J.+C.+Blanchardauthor=A.+Dobleauthor=O.+Piotauthor=J.+%E2%80%93+L.+Zundelauthor=C.+Huonauthor=B.+Martinauthor=P.+Moutonauthor=A.+Viroulaudauthor=D.+Allamauthor=J.+Betschart&title=Naphthosultam+Derivatives%3A+A+New+class+of+Potent+and+Selective+5-HT2+Antagonists&doi=10.1021%2Fjm00112a025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a025%26sid%3Dliteratum%253Aachs%26aulast%3DMalleron%26aufirst%3DJ.-L.%26aulast%3DComte%26aufirst%3DM.%2B%25E2%2580%2593%2BT.%26aulast%3DGueremy%26aufirst%3DC.%26aulast%3DPeyronel%26aufirst%3DJ.%2BF.%26aulast%3DTruchon%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DPiot%26aufirst%3DO.%26aulast%3DZundel%26aufirst%3DJ.%2B%25E2%2580%2593%2BL.%26aulast%3DHuon%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DMouton%26aufirst%3DP.%26aulast%3DViroulaud%26aufirst%3DA.%26aulast%3DAllam%26aufirst%3DD.%26aulast%3DBetschart%26aufirst%3DJ.%26atitle%3DNaphthosultam%2520Derivatives%253A%2520A%2520New%2520class%2520of%2520Potent%2520and%2520Selective%25205-HT2%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2477%26epage%3D2483%26doi%3D10.1021%2Fjm00112a025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girdlestone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boireau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guérémy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zundel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of RP 62203, a Novel 5-Hydroxytryptamine 5-HT<sub>2</sub> Receptor Antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1992.tb14206.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1476-5381.1992.tb14206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1596688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK38Xit1yjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1992&pages=27-36&author=A.+Dobleauthor=D.+Girdlestoneauthor=O.+Piotauthor=D.+Allamauthor=J.+Betschartauthor=A.+Boireauauthor=A.+Dupuyauthor=C.+Gu%C3%A9r%C3%A9myauthor=J.+M%C3%A9nagerauthor=J.+L.+Zundelauthor=J.+C.+Blanchard&title=Pharmacological+Characterization+of+RP+62203%2C+a+Novel+5-Hydroxytryptamine+5-HT2+Receptor+Antagonist&doi=10.1111%2Fj.1476-5381.1992.tb14206.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist</span></div><div class="casAuthors">Doble, A.; Girdlestone, D.; Piot, O.; Allam, D.; Betschart, J.; Boireau, A.; Dupuy, A.; Gueremy, C.; Menager, J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-36</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">RP 62203 (I) is a novel naphthosultam deriv. which shows very high affinity for 5-HT2 receptors in the rat cerebral cortex (Ki = 50.0 pM).  RP 62203 is relatively selective for this sub-type of 5-hydroxytryptamine (5-HT) receptor, having lower affinity for the 5-HT1A receptor and very low affinity for the 5-HT3 receptor.  RP 62203 displayed low to moderate affinity for α1-adrenoceptors, dopamine D2 receptors and histamine H1 receptors.  In vivo binding expts. demonstrated that oral administration of low doses of RP 62203 led to a long-lasting (>6 h) occupation of cortical 5-HT2 receptors (ID50 = 0.39 mg kg-1).  In cortical slices from the neonatal rat, RP 62203 potently inhibited inositol phosphate formation evoked by 5-HT, with an IC50 of 7.76 nM.  The activity of neurons in the raphe and their responses to microiontophoretically applied 5-HT were studied with extracellular recording electrodes in the anesthetized rat.  RP 62203 potently and dose-dependently blocked excitations evoked by 5-HT when administered at doses of 0.5-4.0 mg kg-1, i.p.  In contrast, neither 5-HT-evoked depressions nor glutamate-evoked excitations of raphe neuronal firing were blocked by RP 62203 at doses as high as 8.0 mg kg-1, i.p.  Head twitches induced by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) could be abolished by low doses of RP 62203 in mice (ED50 = 0.44 mg kg-1, p.o.) and in rats (ED50 = 1.54 p.o.).  Similar results were obtained with mescaline and 5-hydroxytryptophan (5-HTP).  The potency of RP 62203 was compared with that of three other 5-HT receptor antagonists, ritanserin, ICI 169,369 and ICI 170,809.  In all models, RP 62203 showed similar activity to ritanserin, whereas either ICI 169,369 or ICI 170,809 was several fold less active.  It is concluded that RP 62203 is a potent and selective antagonist at 5-HT2 receptors in the rodent central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVkPUhdZOMM7Vg90H21EOLACvtfcHk0lhcVL9PMqRg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xit1yjt70%253D&md5=b244fb288a4c321ee148b68bab7b2c53</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb14206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb14206.x%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DGirdlestone%26aufirst%3DD.%26aulast%3DPiot%26aufirst%3DO.%26aulast%3DAllam%26aufirst%3DD.%26aulast%3DBetschart%26aufirst%3DJ.%26aulast%3DBoireau%26aufirst%3DA.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DGu%25C3%25A9r%25C3%25A9my%26aufirst%3DC.%26aulast%3DM%25C3%25A9nager%26aufirst%3DJ.%26aulast%3DZundel%26aufirst%3DJ.%2BL.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26atitle%3DPharmacological%2520Characterization%2520of%2520RP%252062203%252C%2520a%2520Novel%25205-Hydroxytryptamine%25205-HT2%2520Receptor%2520Antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D105%26spage%3D27%26epage%3D36%26doi%3D10.1111%2Fj.1476-5381.1992.tb14206.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Heuillet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petitet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malleron, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavayre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Néliat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. – C.</span><span> </span><span class="NLM_article-title">The Naphthosultam Derivative RP 62203 (Fananserin) has High Affinity for the Dopamine D<sub>4</sub> Receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1016/S0014-2999(96)00554-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0014-2999%2896%2900554-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8957240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK28XnsFKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1996&pages=229-233&author=E.+Heuilletauthor=F.+Petitetauthor=S.+Mignaniauthor=J.-L.+Malleronauthor=J.+Lavayreauthor=G.+N%C3%A9liatauthor=A.+Dobleauthor=J.+%E2%80%93+C.+Blanchard&title=The+Naphthosultam+Derivative+RP+62203+%28Fananserin%29+has+High+Affinity+for+the+Dopamine+D4+Receptor&doi=10.1016%2FS0014-2999%2896%2900554-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">The naphthosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor</span></div><div class="casAuthors">Heuillet, Edith; Petitet, Francois; Mignani, Serge; Malleron, Jean-Luc; Lavayre, Jacques; Neliat, Gervais; Doble, Adam; Blanchard, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The dopamine D4 receptor is a potential target for novel antipsychotic drugs.  Most available compds. with affinity for the dopamine D4 receptor also bind to dopamine D4 receptors.  This report describes the affinity of the 5-HT2A receptor antagonist RP 62203 (fananserin) for the human dopamine D4 receptor.  Fananserin displaces [3H]spiperone binding to recombinant human dopamine D4 receptors with a Ki of 2.93 nM.  This compares with an affinity (Ki) of 0.37 nM for the rat 5-HT2A receptor and of 726 nM for the rat dopamine D2 receptor.  [3H]Fananserin can be used to label the recombinant dopamine D4 receptor expressed in Chinese hamster ovary cells with a KD of 0.725 nM.  Fananserin is, thus, the first compd. to be reported that distinguishes between dopamine D4 and D2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFk_yEIjx_prVg90H21EOLACvtfcHk0lhcVL9PMqRg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsFKms7Y%253D&md5=7d0f04c6f915e1c315ea52de33b4a482</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900554-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900554-7%26sid%3Dliteratum%253Aachs%26aulast%3DHeuillet%26aufirst%3DE.%26aulast%3DPetitet%26aufirst%3DF.%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DMalleron%26aufirst%3DJ.-L.%26aulast%3DLavayre%26aufirst%3DJ.%26aulast%3DN%25C3%25A9liat%26aufirst%3DG.%26aulast%3DDoble%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2B%25E2%2580%2593%2BC.%26atitle%3DThe%2520Naphthosultam%2520Derivative%2520RP%252062203%2520%2528Fananserin%2529%2520has%2520High%2520Affinity%2520for%2520the%2520Dopamine%2520D4%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D314%26spage%3D229%26epage%3D233%26doi%3D10.1016%2FS0014-2999%2896%2900554-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Herth, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Synthesis and In Vitro Affinities of Various MDL 100907 Derivatives as Potential <sup>18</sup>F-Radioligands for 5-HT<sub>2A</sub> Receptor Imaging with PET</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3002</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.03.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2009.03.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19329329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2989-3002&author=M.+M.+Herthauthor=V.+Kramerauthor=M.+Pielauthor=M.+Palnerauthor=P.+J.+Rissauthor=G.+M.+Knudsenauthor=F.+R%C3%B6sch&title=Synthesis+and+In+Vitro+Affinities+of+Various+MDL+100907+Derivatives+as+Potential+18F-Radioligands+for+5-HT2A+Receptor+Imaging+with+PET&doi=10.1016%2Fj.bmc.2009.03.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET</span></div><div class="casAuthors">Herth, Matthias M.; Kramer, Vasko; Piel, Markus; Palner, Mikael; Riss, Patrick J.; Knudsen, Gitte M.; Roesch, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2989-3002</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Radiolabeled piperidine derivs. such as [11C]MDL 100907 and [18F]altanserin have played an important role in diagnosing malfunction in the serotonergic neurotransmission.  A variety of novel piperidine MDL 100907 derivs., possible to label with 18F-fluorine, were synthesized to improve mol. imaging properties of [11C]MDL 100907.  Their in vitro affinities to a broad spectrum of neuroreceptors and their lipophilicities were detd. and compared to the clin. used ref. compds. MDL 100907 and altanserin.  The novel compds. MA-1 (53) and (R)-MH.MZ (56) show K i-values in the nanomolar range towards the 5-HT2A receptor and insignificant binding to other 5-HT receptor subtypes or receptors.  Interestingly, compds. MA-1 (53), MH.MZ (55) and (R)-MH.MZ (56) provide a receptor selectivity profile similar to MDL 100907.  These compds. could possibly be preferable antagonistic 18F-tracers for visualization of the 5-HT2A receptor status.  Medium affine compds. (VK-1 (32), (51), (52), (54)) were synthesized and have K i values between 30 and 120 nM.  All promising compds. show log P values between 2 and 3, i.e., within the range of those for the established radiotracers altanserin and MDL 100907.  The novel compds. MA-1 (53) and (R)-MH.MZ (56) thus appear to be promising high affine and selective tracers of 18F-labeled analogs for 5-HT2A imaging with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGuDhmyQor1bVg90H21EOLACvtfcHk0lhcVL9PMqRg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWlu7w%253D&md5=6af998051cfd6829df09eae91354ee8c</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.03.021%26sid%3Dliteratum%253Aachs%26aulast%3DHerth%26aufirst%3DM.%2BM.%26aulast%3DKramer%26aufirst%3DV.%26aulast%3DPiel%26aufirst%3DM.%26aulast%3DPalner%26aufirst%3DM.%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520In%2520Vitro%2520Affinities%2520of%2520Various%2520MDL%2520100907%2520Derivatives%2520as%2520Potential%252018F-Radioligands%2520for%25205-HT2A%2520Receptor%2520Imaging%2520with%2520PET%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2989%26epage%3D3002%26doi%3D10.1016%2Fj.bmc.2009.03.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Eison, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eison, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrente, J.R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span> </span><span class="NLM_article-title">Nefazodone: Preclinical Pharmacology of a New Anti-depressant</span> <span class="citation_source-journal">Psychopharmacol. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=2274630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK3MXisVSgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1990&pages=311-315&author=A.+S.+Eisonauthor=M.+S.+Eisonauthor=J.R.+Torrenteauthor=R.+N.+Wrightauthor=F.+D.+Yocca&title=Nefazodone%3A+Preclinical+Pharmacology+of+a+New+Anti-depressant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Nefazodone:  preclinical pharmacology of a new antidepressant</span></div><div class="casAuthors">Eison, Arlene S.; Eison, Michael S.; Torrente, John R.; Wright, Robert N.; Yocca, Frank D.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-15</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">Recent pharmacol. studies suggest that nefazodone (I) may possess antidepressant activity.  I is active in behavioral models predictive of antidepressant potential.  It is active in reversing learned helplessness, prevents reserpine-induced ptosis, and enhances response efficiency in the differential reinforcement for low rates of response paradigm.  In in vitro studies, I inhibits the binding of [3H]ketanserin to cortical serotonin2 (5-HT2) binding sites, whereas in vivo, it antagonizes the 5-HT2-mediated quipazine-induced head shake in rats.  In ex vivo studies, acute oral administration of I inhibits cortical seotonin uptake and occupies frontal cortical 5-HT2 receptor binding sites.  Chronic administration of I produces a redn. in 5-HT2-mediated behavior and decreases cortical 5-HT2 receptor binding site d.  Further, a chronic high-dose I regimen significantly potentiates 5-HT1A-mediated behavioral responses in rats.  I exhibits decreased anticholinergic, α-adrenolytic, and sedative actiivty relative to other antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp22B3vChlPeLVg90H21EOLACvtfcHk0liz-1ApIs9SpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVSgurs%253D&md5=08b2fb5fda095e4dc251b9ab37641c05</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEison%26aufirst%3DA.%2BS.%26aulast%3DEison%26aufirst%3DM.%2BS.%26aulast%3DTorrente%26aufirst%3DJ.R.%26aulast%3DWright%26aufirst%3DR.%2BN.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26atitle%3DNefazodone%253A%2520Preclinical%2520Pharmacology%2520of%2520a%2520New%2520Anti-depressant%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1990%26volume%3D26%26spage%3D311%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Armitage, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roffwarg, H. P.</span><span> </span><span class="NLM_article-title">The effects of Nefazodone on Sleep Architecture in Depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span><span class="refDoi"> DOI: 10.1038/npp.1994.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fnpp.1994.14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1994&pages=123-127&author=R.+Armitageauthor=A.+J.+Rushauthor=M.+Trivediauthor=J.+Cainauthor=H.+P.+Roffwarg&title=The+effects+of+Nefazodone+on+Sleep+Architecture+in+Depression&doi=10.1038%2Fnpp.1994.14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.1994.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.1994.14%26sid%3Dliteratum%253Aachs%26aulast%3DArmitage%26aufirst%3DR.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DCain%26aufirst%3DJ.%26aulast%3DRoffwarg%26aufirst%3DH.%2BP.%26atitle%3DThe%2520effects%2520of%2520Nefazodone%2520on%2520Sleep%2520Architecture%2520in%2520Depression%26jtitle%3DNeuropsychopharmacology%26date%3D1994%26volume%3D10%26spage%3D123%26epage%3D127%26doi%3D10.1038%2Fnpp.1994.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pullar, I.A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedley, S.</span><span> </span><span class="NLM_article-title">LY367265, an Inhibitor of the 5-Hydroxytryptamine Transporter and 5-Hydroxytryptamine 2A Receptor Antagonist: a Comparison with the Antidepressant, Nefazodone</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/S0014-2999(00)00728-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0014-2999%2800%2900728-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11050288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsFWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=39-46&author=I.A.+Pullarauthor=S.+L.+Carneyauthor=E.+M.+Colvinauthor=V.+L.+Lucaitesauthor=D.+L.+Nelsonauthor=S.+Wedley&title=LY367265%2C+an+Inhibitor+of+the+5-Hydroxytryptamine+Transporter+and+5-Hydroxytryptamine+2A+Receptor+Antagonist%3A+a+Comparison+with+the+Antidepressant%2C+Nefazodone&doi=10.1016%2FS0014-2999%2800%2900728-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone</span></div><div class="casAuthors">Pullar, I. A.; Carney, S. L.; Colvin, E. M.; Lucaites, V. L.; Nelson, D. L.; Wedley, S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The potential antidepressant, LY367265 (1-[2-[4-(6-fluoro-1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl]ethyl]-5,6-dihydro-1H,4H-[1,2,5]thiadiazolo[4.3.2-ij]quinoline-2,2,-dioxide) has been shown to have a higher affinity for the 5-hydroxytryptamine (5-HT) transporter (Ki=2.3 nM) and 5-HT2A (Ki=0.81 nM) receptor than the clin. effective antidepressant, nefazodone.  It is a potent inhibitor of [3H]5-HT uptake into rat cortical synaptosomes (IC50=3.1 nM) and shows selectivity over that for [3H]noradrenaline (IC50°1000 nM).  It potentiates potassium-induced [3H]5-HT outflow from prelabeled guinea pig cortical slices both in the presence (EC50=950 nM) and absence (EC50=250 nM) of a satg. concn. of the 5-HT transport inhibitor, paroxetine, indicating a low level of activity at the 5-HT1B/1D autoreceptor.  These studies indicate that LY367265 is a putative antidepressant which, because of its 5-HT2A receptor antagonist activity, has the potential to produce less sleep disturbance and sexual dysfunction than selective serotonin uptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCax7sIb7CuLVg90H21EOLACvtfcHk0liz-1ApIs9SpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsFWqt7o%253D&md5=f20cbf13b5c9d04cba0a86aeeed0eca2</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900728-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900728-7%26sid%3Dliteratum%253Aachs%26aulast%3DPullar%26aufirst%3DI.A.%26aulast%3DCarney%26aufirst%3DS.%2BL.%26aulast%3DColvin%26aufirst%3DE.%2BM.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DWedley%26aufirst%3DS.%26atitle%3DLY367265%252C%2520an%2520Inhibitor%2520of%2520the%25205-Hydroxytryptamine%2520Transporter%2520and%25205-Hydroxytryptamine%25202A%2520Receptor%2520Antagonist%253A%2520a%2520Comparison%2520with%2520the%2520Antidepressant%252C%2520Nefazodone%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D407%26spage%3D39%26epage%3D46%26doi%3D10.1016%2FS0014-2999%2800%2900728-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">For a comprehensive review on Nefazodone:</p></div><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, H. M.</span><span> </span><span class="NLM_article-title">Nefazodone. A Review of its Pharmacology and Clinical Efficacy in the Management of Major Depression</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span><span class="refDoi"> DOI: 10.2165/00003495-199753040-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2165%2F00003495-199753040-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=608-636&author=R.+Davisauthor=R.+Whittingtonauthor=H.+M.+Bryson&title=Nefazodone.+A+Review+of+its+Pharmacology+and+Clinical+Efficacy+in+the+Management+of+Major+Depression&doi=10.2165%2F00003495-199753040-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.2165%2F00003495-199753040-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199753040-00006%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DWhittington%26aufirst%3DR.%26aulast%3DBryson%26aufirst%3DH.%2BM.%26atitle%3DNefazodone.%2520A%2520Review%2520of%2520its%2520Pharmacology%2520and%2520Clinical%2520Efficacy%2520in%2520the%2520Management%2520of%2520Major%2520Depression%26jtitle%3DDrugs%26date%3D1997%26volume%3D53%26spage%3D608%26epage%3D636%26doi%3D10.2165%2F00003495-199753040-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Tol, H. H. M.</span><span> </span><span class="NLM_article-title">Atypical Neuroleptics Have Low Affinity for Dopamine D<sub>2</sub> Receptors or Are Selective for D<sub>4</sub> Receptors</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/S0893-133X(96)00187-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0893-133X%2896%2900187-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=93-110&author=P.+Seemanauthor=R.+Corbettauthor=H.+H.+M.+Van+Tol&title=Atypical+Neuroleptics+Have+Low+Affinity+for+Dopamine+D2+Receptors+or+Are+Selective+for+D4+Receptors&doi=10.1016%2FS0893-133X%2896%2900187-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2896%2900187-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252896%252900187-X%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DCorbett%26aufirst%3DR.%26aulast%3DVan%2BTol%26aufirst%3DH.%2BH.%2BM.%26atitle%3DAtypical%2520Neuroleptics%2520Have%2520Low%2520Affinity%2520for%2520Dopamine%2520D2%2520Receptors%2520or%2520Are%2520Selective%2520for%2520D4%2520Receptors%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D93%26epage%3D110%26doi%3D10.1016%2FS0893-133X%2896%2900187-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ichikawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span> </span><span class="NLM_article-title">Atypical Antipsychotic Drugs, Quetiapine, Iloperidone, and Melperone Preferentially Increase Dopamine and Acetylcholine Release in Rat Medial Prefrontal Cortex: Role of 5-HT<sub>1A</sub> Receptor Agonism</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">956</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.1016/S0006-8993(02)03570-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0006-8993%2802%2903570-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=12445705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xoslamtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=956&publication_year=2002&pages=349-357&author=J.+Ichikawaauthor=Z.+Liauthor=J.+Daiauthor=H.+Y.+Meltzer&title=Atypical+Antipsychotic+Drugs%2C+Quetiapine%2C+Iloperidone%2C+and+Melperone+Preferentially+Increase+Dopamine+and+Acetylcholine+Release+in+Rat+Medial+Prefrontal+Cortex%3A+Role+of+5-HT1A+Receptor+Agonism&doi=10.1016%2FS0006-8993%2802%2903570-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism</span></div><div class="casAuthors">Ichikawa, Junji; Li, Zhu; Dai, Jin; Meltzer, Herbert Y.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">956</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">349-357</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Preferential increases in both cortical dopamine (DA) and acetylcholine (ACh) release have been proposed to distinguish the atypical antipsychotic drugs (APDs) clozapine, olanzapine, risperidone and ziprasidone from typical APDs such as haloperidol.  Although only clozapine and ziprasidone are directly acting 5-HT1A agonists, WAY100635, a selective 5-HT1A antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT2A and D2 blockade.  However, WAY100635 does not attenuate clozapine-induced cortical ACh release.  The present study detd. whether quetiapine, iloperidone and melperone, 5-HT2A/D2 antagonist atypical APDs, also increase cortical DA and ACh release, and whether these effects are related to 5-HT1A agonism.  Quetiapine (30 mg/kg), iloperidone (1-10 mg/kg), and melperone (3-10 mg/kg) increased DA and ACh release in the medial prefrontal cortex (mPFC).  Iloperidone (10 mg/kg) and melperone (10 mg/kg), but not quetiapine (30 mg/kg), produced an equiv. or a smaller increase in DA release in the nucleus accumbens (NAC), resp., compared to the mPFC, whereas none of them increased ACh release in the NAC.  WAY100635 (0.2 mg/kg), which alone did not affect DA or ACh release, partially attenuated quetiapine (30 mg/kg)-, iloperidone (10 mg/kg)- and melperone (10 mg/kg)-induced DA release in the mPFC.  WAY100635 also partially attenuated quetiapine (30 mg/kg)-induced ACh release in the mPFC, but not that induced by iloperidone (10 mg/kg) or melperone (10 mg/kg).  These results indicate that quetiapine, iloperidone and melperone preferentially increase DA release in the mPFC, compared to the NAC via a 5-HT1A-related mechanism.  However, 5-HT1A agonism may be important only for quetiapine-induced ACh release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6oSrcameDX7Vg90H21EOLACvtfcHk0lihVmYYNW8zBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xoslamtrw%253D&md5=77244027fc93095506663826c32ee129</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903570-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903570-9%26sid%3Dliteratum%253Aachs%26aulast%3DIchikawa%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26atitle%3DAtypical%2520Antipsychotic%2520Drugs%252C%2520Quetiapine%252C%2520Iloperidone%252C%2520and%2520Melperone%2520Preferentially%2520Increase%2520Dopamine%2520and%2520Acetylcholine%2520Release%2520in%2520Rat%2520Medial%2520Prefrontal%2520Cortex%253A%2520Role%2520of%25205-HT1A%2520Receptor%2520Agonism%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D956%26spage%3D349%26epage%3D357%26doi%3D10.1016%2FS0006-8993%2802%2903570-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Uhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namendorf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenhagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebinger, M.</span><span> </span><span class="NLM_article-title">P-Glycoprotein is a Factor in the Uptake of Dextromethorphan, but not of Melperone, into the Mouse Brain: Evidence for an Overlap in Substrate Specificity Between P-gp and CYP2D6</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1177/0269881104047278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1177%2F0269881104047278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15582917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVWlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=509-515&author=M.+Uhrauthor=C.+Namendorfauthor=M.+T.+Grauerauthor=M.+Rosenhagenauthor=M.+Ebinger&title=P-Glycoprotein+is+a+Factor+in+the+Uptake+of+Dextromethorphan%2C+but+not+of+Melperone%2C+into+the+Mouse+Brain%3A+Evidence+for+an+Overlap+in+Substrate+Specificity+Between+P-gp+and+CYP2D6&doi=10.1177%2F0269881104047278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6</span></div><div class="casAuthors">Uhr, Manfred; Namendorf, Christian; Grauer, Markus T.; Rosenhagen, Markus; Ebinger, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">509-515</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">In this study, the role of P-glycoprotein (P-gp) for the pharmacokinetics of dextromethorphan, a CYP2D6 substrate, and of melperone, a CYP2D6 inhibitor, was investigated.  The substances were administered s.c. near the nape of the neck of wild-type mice and of abcb1ab (-/-) mice.  One hour after injection, concns. of the two drugs in cerebrum, plasma and in different organs were measured by high-performance liq. chromatog.  No significant differences between wild-type mice and abcb1ab (-/-) mice were obsd. for melperone, suggesting that P-gp is not involved in the uptake of melperone into the brain or other organs of mice.  The concn. of dextromethorphan in the brain was more than twice as high in abcb1ab (-/-) mice compared to wild-type mice.  Therefore, P-gp appears to be a factor in the uptake of dextromethorphan into the mouse brain, and abcb1-polymorphisms need to be considered for CYP2D6 phenotyping expts. with this drug.  There is an overlap in substrate specificity between P-gp and CYP2D6.  P-gp is a factor in the uptake of dextromethorphan, but not of melperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfB1y9TUnGC7Vg90H21EOLACvtfcHk0lihVmYYNW8zBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVWlsw%253D%253D&md5=28a2223aa6c1dda5933fdf30c751d691</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1177%2F0269881104047278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881104047278%26sid%3Dliteratum%253Aachs%26aulast%3DUhr%26aufirst%3DM.%26aulast%3DNamendorf%26aufirst%3DC.%26aulast%3DGrauer%26aufirst%3DM.%2BT.%26aulast%3DRosenhagen%26aufirst%3DM.%26aulast%3DEbinger%26aufirst%3DM.%26atitle%3DP-Glycoprotein%2520is%2520a%2520Factor%2520in%2520the%2520Uptake%2520of%2520Dextromethorphan%252C%2520but%2520not%2520of%2520Melperone%252C%2520into%2520the%2520Mouse%2520Brain%253A%2520Evidence%2520for%2520an%2520Overlap%2520in%2520Substrate%2520Specificity%2520Between%2520P-gp%2520and%2520CYP2D6%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2004%26volume%3D18%26spage%3D509%26epage%3D515%26doi%3D10.1177%2F0269881104047278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sorensen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehne, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadayel, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketteler, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Characterization of 5-HT2 Receptor Antagonist MDL 100907 as a Putative Atypical Antipsychotic: Behavioral, Electrophysiological and Neurochemical Studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8102646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2cXitlelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1993&pages=684-691&author=S.+M.+Sorensenauthor=J.+H.+Kehneauthor=G.+M.+Fadayelauthor=T.+M.+Humphreysauthor=H.+J.+Kettelerauthor=C.+K.+Sullivanauthor=V.+L.+Taylorauthor=C.+J.+Schmidt&title=Characterization+of+5-HT2+Receptor+Antagonist+MDL+100907+as+a+Putative+Atypical+Antipsychotic%3A+Behavioral%2C+Electrophysiological+and+Neurochemical+Studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies</span></div><div class="casAuthors">Sorensen, Stephen M.; Kehne, John H.; Fadayel, Gina M.; Humphreys, Teresa M.; Ketteler, Herbert J.; Sullivan, Christine K.; Taylor, Vicki L.; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">684-91</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Progress toward understanding the role of the 5-hydroxytryptamine (5-HT)2 receptor in the therapy for schizophrenia has been hampered by the lack of high selective antagonists.  The authors now report on the effects of MDL 100,907 [R(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol], a highly selective and potent 5-HT2 receptor antagonist, in behavioral, electrophysiol. and neurochem. models of antipsychotic activity and extrapyramidal side-effect liability.  In mice, MDL 100,907 blocked amphetamine-stimulated locomotion at doses that did not significantly affect apomorphine-stimulated climbing behavior.  Neither MDL 100,907 nor clozapine reduced apomorphine-induced stereotypies or produced catalepsy in rats.  MDL 100,907 blocked the slowing of ventral tegmental area (A10) dopaminergic neurons by amphetamine but, like clozapine, produced only small increases in the no. of active substantia nigra zona compacta (A9) and A10 dopamine neurons after acute administration.  When administered chronically, MDL 100,907 and clozapine selectively reduced the no. of spontaneously active A10 neurons, whereas haloperidol reduced activity in both the A9 and A10 regions.  Consistent with their acute effect on A9 and A10 activity, neither MDL 100,907 nor clozapine increased dopamine metab. in the striatum or nucleus accumbens, whereas acute haloperidol accelerated dopamine turnover in both regions.  The administration of the dopamine uptake blocker amfonelic acid with haloperidol produced a massive increase in DA metab. characteristic of typical antipsychotics.  In contrast, MDL 100,907 and clozapine were without effect on dopamine turnover when given in the presence of amfonelic acid.  These data indicate that MDL 100,907 has a clozapine-like profile of potential antipsychotic activity with low extrapyramidal side-effect liability.  The receptor selectivity of MDL 100,907 and the proposed regulation of dopaminergic function by 5-HT2 receptors support the conclusion that further clin. evaluation of selective 5-HT2 antagonists as antipsychotic agents is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwBFqMWvGTiLVg90H21EOLACvtfcHk0lhgBPJQwYKWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlelug%253D%253D&md5=5519667c5d7e79ee2132247738de91a7</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DS.%2BM.%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DFadayel%26aufirst%3DG.%2BM.%26aulast%3DHumphreys%26aufirst%3DT.%2BM.%26aulast%3DKetteler%26aufirst%3DH.%2BJ.%26aulast%3DSullivan%26aufirst%3DC.%2BK.%26aulast%3DTaylor%26aufirst%3DV.%2BL.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DCharacterization%2520of%25205-HT2%2520Receptor%2520Antagonist%2520MDL%2520100907%2520as%2520a%2520Putative%2520Atypical%2520Antipsychotic%253A%2520Behavioral%252C%2520Electrophysiological%2520and%2520Neurochemical%2520Studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D266%26spage%3D684%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kehne, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Giersbergen, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloskey, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senyah, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildmaier, C.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of the Potential of the Putative Atypical Antipsychotic MDL 100,907 as a Potent 5-HT2A Antagonist with a Favorable CNS Safety Profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8627580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK28XivFeht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=968-981&author=J.+H.+Kehneauthor=M.+M.+Baronauthor=A.+A.+Carrauthor=S.+F.+Chaneyauthor=J.+Elandsauthor=D.+J.+Feldmanauthor=R.+A.+Franckauthor=P.+L.+Van+Giersbergenauthor=T.+C.+McCloskeyauthor=M.+P.+Johnsonauthor=D.+R.+McCartyauthor=M.+Poirotauthor=Y.+Senyahauthor=B.+W.+Siegelauthor=C.+Wildmaier&title=Preclinical+Characterization+of+the+Potential+of+the+Putative+Atypical+Antipsychotic+MDL+100%2C907+as+a+Potent+5-HT2A+Antagonist+with+a+Favorable+CNS+Safety+Profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile</span></div><div class="casAuthors">Kehne, John H.; Baron, Bruce M.; Carr, Albert A.; Chaney, Stephen F.; Elands, Jack; Feldman, Daniel J.; Frank, Robert A.; Van Giersbergen, Paul L. M.; McCloskey, Timothy C.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">968-981</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In preclin. studies, [R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol] (MDL 100,907), a putative atypical antipsychotic, was characterized in vitro as a potent and selective ligand for the serotonin2A (5-HT2A) receptor and was evaluated in vitro and in vivo as a potent 5-HT2A receptor antagonist.  Furthermore, MDL 100,907's potential CNS safety profile and selectivity as a potential antipsychotic agent were evaluated and compared with benchmark compds.  MDL 100,907 demonstrated low nanomolar or subnanomolar binding in vitro at the 5-HT2A receptor and showed a > 100-fold sepn. from all other receptors measured.  MDL 100,907 has subnanomolar potency as a 5-HT2A antagonist in vitro in reversing 5-HT-stimulated inositol phosphate accumulation in NIH 3T3 cells transfected with the rat 5-HT2A receptor.  In vivo, MDL 100,907 potently inhibited 5-methoxy-N,N-dimethyltryptamine-induced head twitches in mice or 5-hydroxytrypophan-induced head twitched in rats.  In vivo functional tests in mice revealed a > 500-fold sepn. between doses that produced 5-HT2A antagonism and doses that produced α1-adrenergic or striatal D2 antagonism.  Using inhibition of D-amphetamine-stimulated locomotion in mice as a measure of potential antipsychotic efficacy, MDL 100,907 showed a superior CNS safety index relative to the ref. compds., haloperidol, clozapine, risperidone,ritanserin, and amperozide, in each of five tests for side effect potential, including measures of ataxia, general depressant effects, α1-adrenergic antagonism, striatal D2 receptor antagonism, and muscle relaxation.  MDL 100,907 did not antagonize apomorphine-induced stereotypies in rats, suggesting that it potentially lacks extrapyramidal side effect liability.  MDL 100,907 showed selectivity as a potential antipsychotic in that it lacked consistent activity in selected rodent models of anticonvulsant, anti-depressant, analgesic, or anxiolytic activity.  In summary, these preclin. data indicate that MDL 100,907 is a potent and selective ligand at the 5-HT2A receptor.  MDL 100,907's potent 5-HT2A antagonist activity might account for its activity in preclin. models of antipsychotic potential.  Ongoing clin. evaluation with MDL 100,907 will test the hypothesis that 5-HT2A receptor antagonism is sufficient for antipsychotic activity in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqravKtRD4ZLbVg90H21EOLACvtfcHk0lhgBPJQwYKWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFeht7s%253D&md5=01a7031bf3ef86ac47fe60ac14493a64</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKehne%26aufirst%3DJ.%2BH.%26aulast%3DBaron%26aufirst%3DM.%2BM.%26aulast%3DCarr%26aufirst%3DA.%2BA.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BJ.%26aulast%3DFranck%26aufirst%3DR.%2BA.%26aulast%3DVan%2BGiersbergen%26aufirst%3DP.%2BL.%26aulast%3DMcCloskey%26aufirst%3DT.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DPoirot%26aufirst%3DM.%26aulast%3DSenyah%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DB.%2BW.%26aulast%3DWildmaier%26aufirst%3DC.%26atitle%3DPreclinical%2520Characterization%2520of%2520the%2520Potential%2520of%2520the%2520Putative%2520Atypical%2520Antipsychotic%2520MDL%2520100%252C907%2520as%2520a%2520Potent%25205-HT2A%2520Antagonist%2520with%2520a%2520Favorable%2520CNS%2520Safety%2520Profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26spage%3D968%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ardayfio, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">The Hydroxytryptamine<sub>2A</sub> Receptor Antagonist <i>R</i>-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) Attenuates Impulsivity after Both Drug-Induced Disruption (Dizocilpine) and Enhancement (Antidepressant Drugs) of Differential-Reinforcement-of-Low-Rate 72-s Behavior in the Rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1124/jpet.108.143370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1124%2Fjpet.108.143370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=18772320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=891-897&author=P.+A.+Ardayfioauthor=M.+J.+Benvengaauthor=S.+F.+Chaneyauthor=P.+L.+Loveauthor=J.+Catlowauthor=S.+P.+Swansonauthor=G.+J.+Marek&title=The+Hydroxytryptamine2A+Receptor+Antagonist+R-%28%2B%29-%CE%B1-%282%2C3-Dimethoxyphenyl%29-1-%5B2-%284-fluorophenyl%29ethyl-4-piperidinemethanol+%28M100907%29+Attenuates+Impulsivity+after+Both+Drug-Induced+Disruption+%28Dizocilpine%29+and+Enhancement+%28Antidepressant+Drugs%29+of+Differential-Reinforcement-of-Low-Rate+72-s+Behavior+in+the+Rat&doi=10.1124%2Fjpet.108.143370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-hydroxytryptamine2A receptor antagonist R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat</span></div><div class="casAuthors">Ardayfio, Paul A.; Benvenga, Mark J.; Chaney, Stephen F.; Love, Patrick L.; Catlow, John; Swanson, Steven P.; Marek, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">891-897</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work has suggested that N-methyl-D-aspartate (NMDA) receptor antagonism and 5-hydroxytryptamine (5-HT)2A receptor blockade may enhance and attenuate, resp., certain types of impulsivity mediated by corticothalamostriatal circuits.  More specifically, past demonstrations of synergistic "antidepressant-like" effects of a 5-HT2A receptor antagonist and fluoxetine on differential-reinforcement-of-low-rate (DRL) 72-s schedule of operant reinforcement may speak to the role of 5-HT2A receptor blockade with respect to response inhibition as an important prefrontal cortical executive function relating to motor impulsivity.  To examine the dynamic range over which 5-HT2A receptor blockade may exert effects on impulsivity, M100907 was examd. both alone and in combination with the psychotomimetic NMDA receptor antagonist dizocilpine [e.g., (-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate; MK-801] and two different antidepressants, the tricyclic antidepressant desmethylimipramine (DMI) and the monoamine oxidase inhibitor tranylcypromine in rats performing under a DRL 72-s schedule.  MK-801 increased the response rate, decreased the no. of reinforcers obtained, and exerted a leftward shift in the inter-response time (IRT) distribution as expected.  A dose of M100907 that exerted minimal effect on DRL behavior by itself attenuated the psychotomimetic effects of MK-801.  Extending previous M100907-fluoxetine observations, addn. of a minimally active dose of M100907 to low doses of DMI and tranylcypromine enhanced the antidepressant-like effect of the antidepressants.  Therefore, it may be that a tonic excitation of 5-HT2A receptors modulates impulsivity and function of corticothalamostriatal circuits over an extensive dynamic range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgN9ZC1HG7tLVg90H21EOLACvtfcHk0liWDCs51GNDVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLjE&md5=af0ff38682682675835cccb955ce7314</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143370%26sid%3Dliteratum%253Aachs%26aulast%3DArdayfio%26aufirst%3DP.%2BA.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DLove%26aufirst%3DP.%2BL.%26aulast%3DCatlow%26aufirst%3DJ.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520Hydroxytryptamine2A%2520Receptor%2520Antagonist%2520R-%2528%252B%2529-%25CE%25B1-%25282%252C3-Dimethoxyphenyl%2529-1-%255B2-%25284-fluorophenyl%2529ethyl-4-piperidinemethanol%2520%2528M100907%2529%2520Attenuates%2520Impulsivity%2520after%2520Both%2520Drug-Induced%2520Disruption%2520%2528Dizocilpine%2529%2520and%2520Enhancement%2520%2528Antidepressant%2520Drugs%2529%2520of%2520Differential-Reinforcement-of-Low-Rate%252072-s%2520Behavior%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D891%26epage%3D897%26doi%3D10.1124%2Fjpet.108.143370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leysen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awouters, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laduron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A. J.</span><span> </span><span class="NLM_article-title">Receptor Binding Profile of R 41 468, a Novel Antagonist at 5-HT<sub>2</sub> Receptors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span><span class="refDoi"> DOI: 10.1016/0024-3205(81)90747-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0024-3205%2881%2990747-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1981&pages=1015-1022&author=J.+E.+Leysenauthor=F.+Awoutersauthor=L.+Kennisauthor=P.+M.+Laduronauthor=J.+Vandenberkauthor=P.+A.+J.+Janssen&title=Receptor+Binding+Profile+of+R+41+468%2C+a+Novel+Antagonist+at+5-HT2+Receptors&doi=10.1016%2F0024-3205%2881%2990747-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2881%2990747-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252881%252990747-5%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26aulast%3DAwouters%26aufirst%3DF.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DLaduron%26aufirst%3DP.%2BM.%26aulast%3DVandenberk%26aufirst%3DJ.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%2BJ.%26atitle%3DReceptor%2520Binding%2520Profile%2520of%2520R%252041%2520468%252C%2520a%2520Novel%2520Antagonist%2520at%25205-HT2%2520Receptors%26jtitle%3DLife%2520Sci.%26date%3D1981%26volume%3D28%26spage%3D1015%26epage%3D1022%26doi%3D10.1016%2F0024-3205%2881%2990747-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Nueten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Beek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xhonneux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeuren, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoutte, P. M.</span><span> </span><span class="NLM_article-title">Vascular Effects of Ketanserin (R 41468), a Novel Antagonist of 5-HT2 Serotonergic Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=6113280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaL3MXksFCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=1981&pages=217-230&author=J.+M.+Van+Nuetenauthor=P.+A.+Janssenauthor=J.+Van+Beekauthor=R.+Xhonneuxauthor=T.+J.+Verbeurenauthor=P.+M.+Vanhoutte&title=Vascular+Effects+of+Ketanserin+%28R+41468%29%2C+a+Novel+Antagonist+of+5-HT2+Serotonergic+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects of R 41468, a novel antagonist of 5-HT2 serotonergic receptors</span></div><div class="casAuthors">Van Nueten, J. M.; Janssen, P. A. J.; Van Beek, J.; Xhonneux, R.; Verbeuren, T. J.; Vanhoutte, P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-30</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The serotonergic receptor antagonist R 41468 (I)  [74050-98-9] dose-dependently inhibited the contractile responses to 5-hydroxytryptamine sulfate  [2906-14-1] of isolated rat caudal artery, canine basilar, carotid, coronary and gastrosplenic arteries, canine gastrosplenic veins (threshold 10-10-10-9 M) and canine saphenous veins (threshold 10-8 M).  In concns. up to 2.5 × 10-5 M, it did not have agonistic properties.  From 10-8 M on R 41468 inhibited the conjuctional α-adrenergic activation.  In the rat caudal artery, R 41468, in concns. which did not affect the contractile response to norepinephrine, abolished the amplifying effect of low concns. of 5-hydroxytryptamine during sympathetic nerve stimulation.  In the perfused guinea pig stomach, R 41468 depressed and in certain expts. reversed the vasoconstrictor response to 5-hydroxytryptamine.  In isolated perfused kidneys from both normotensive and spontaneously hypertensive rats, R 41468, in concns. which did not depress vasoconstrictor responses to exogenous norepinephrine, inhibited those to 5-hydroxytryptamine.  The compd. caused a dose-related redn. in aortic blood pressure in unanesthetized spontaneously hypertensive rats, which was larger and occurred at lower concns., than in control animals.  Thus, R 41468 is a potent antagonist of the vasoconstrictor effects of 5-hydroxytryptamine, in particular of its amplifying effect on threshold amts. of norepinephrine, which may help explain its antihypertensive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJVDLWABeurVg90H21EOLACvtfcHk0liWDCs51GNDVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXksFCrt7g%253D&md5=54ad01a31dff318c7dcfefcf72090138</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNueten%26aufirst%3DJ.%2BM.%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26aulast%3DVan%2BBeek%26aufirst%3DJ.%26aulast%3DXhonneux%26aufirst%3DR.%26aulast%3DVerbeuren%26aufirst%3DT.%2BJ.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26atitle%3DVascular%2520Effects%2520of%2520Ketanserin%2520%2528R%252041468%2529%252C%2520a%2520Novel%2520Antagonist%2520of%25205-HT2%2520Serotonergic%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1981%26volume%3D218%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Razzaque, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longmore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span> </span><span class="NLM_article-title">Differences in the Effects of Ketanserin and GR127935 on the 5-HT-Receptor Mediated Responses in Rabbit Saphenous Vein and Guinea-Pig jugular Vein</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/0014-2999(95)00349-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0014-2999%2895%2900349-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=7498311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1995&pages=199-206&author=Z.+Razzaqueauthor=J.+Longmoreauthor=R.+G.+Hill&title=Differences+in+the+Effects+of+Ketanserin+and+GR127935+on+the+5-HT-Receptor+Mediated+Responses+in+Rabbit+Saphenous+Vein+and+Guinea-Pig+jugular+Vein&doi=10.1016%2F0014-2999%2895%2900349-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein</span></div><div class="casAuthors">Razzaque, Zerin; Longmore, Jeanette; Hill, Raymond G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">199-206</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ketanserin has higher affinity for 5-HT1Dα receptors compared to 5-HT1Dβ receptors, whereas, GR127935 (N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2(methyl-4(-(5-methyl-1,2 ,4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide), a novel and selective 5-HT1D receptor antagonist, has higher affinity for 5-HT1Dβ receptors compared to 5-HT1Dα receptors.  In the present study, we compared the effects of ketanserin and GR127935 on sumatriptan-induced responses of rabbit saphenous vein and guinea-pig jugular vein.  In rabbit saphenous vein, contractile responses elicited by sumatriptan were antagonized by ketanserin (pA2 = 6.76) and GR127935 (apparent pA2 = 9.4).  In guinea-pig jugular vein, concn.-dependent relaxations evoked by sumatriptan were antagonized by ketanserin and GR127935 (apparent pA2 = 5.9 and 10, resp.).  Ketanserin but not GR127935, inhibited Ca2+-induced contraction of depolarized strips of guinea-pig ileum longitudinal muscle/myenteric plexus, however, in rabbit saphenous vein and guinea-pig jugular vein, 5-HT receptor mediated responses were insensitive to nifedipine (Ca2+ channel blocker), eliminating the possibility that the inhibitory effects of ketanserin and GR127935 were due to the blockade of voltage-operated Ca2+ channels.  Thus, antagonism by ketanserin and GR127935 confirms the presence of 5-HT1D receptors in rabbit saphenous vein and guinea-pig jugular vein.  The differential effects of ketanserin and GR127935 on responses elicited by sumatriptan in rabbit saphenous vein and guinea-pig jugular vein may reflect either species differences in 5-HT1D receptors or the involvement of 5-HT1Dα and 5-HT1Dβ receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoot0O7-tDemLVg90H21EOLACvtfcHk0li-sHjrJQQm5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFWhs7k%253D&md5=fad25e62b91c9f4e9a2839177f96a3ec</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2895%2900349-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252895%252900349-P%26sid%3Dliteratum%253Aachs%26aulast%3DRazzaque%26aufirst%3DZ.%26aulast%3DLongmore%26aufirst%3DJ.%26aulast%3DHill%26aufirst%3DR.%2BG.%26atitle%3DDifferences%2520in%2520the%2520Effects%2520of%2520Ketanserin%2520and%2520GR127935%2520on%2520the%25205-HT-Receptor%2520Mediated%2520Responses%2520in%2520Rabbit%2520Saphenous%2520Vein%2520and%2520Guinea-Pig%2520jugular%2520Vein%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D283%26spage%3D199%26epage%3D206%26doi%3D10.1016%2F0014-2999%2895%2900349-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zgombick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharewicz, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshank, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchek, T. A.</span><span> </span><span class="NLM_article-title">Ketanserin and Ritanserin Discriminate Between Recombinant Human 5-HT<sub>1Dα</sub> and 5-HT<sub>1Dβ</sub> Receptor Subtypes</span> <span class="citation_source-journal">Eur. J. Pharmacol., Mol. Pharmacol. Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/0922-4106(95)90183-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2F0922-4106%2895%2990183-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8549648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXotFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1995&pages=9-15&author=J.+M.+Zgombickauthor=L.+E.+Schechterauthor=S.+A.+Kucharewiczauthor=R.+L.+Weinshankauthor=T.+A.+Branchek&title=Ketanserin+and+Ritanserin+Discriminate+Between+Recombinant+Human+5-HT1D%CE%B1+and+5-HT1D%CE%B2+Receptor+Subtypes&doi=10.1016%2F0922-4106%2895%2990183-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Ketanserin and ritanserin discriminate between recombinant human 5-HT1Dα and 5-HT1Dβ receptor subtypes</span></div><div class="casAuthors">Zgombick, John M.; Schechter, Lee E.; Kucharewicz, Stefan A.; Weinshank, Richard L.; Branchek, Theresa A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Molecular Pharmacology Section</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">EJPPET</span>;
        ISSN:<span class="NLM_cas:issn">0922-4106</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Compds. able to discriminate functionally between the closely related cloned human 5-HT1Dα and 5-HT1Dβ receptor subtypes have not been reported previously.  In [3H]5-HT competition assays, the classical 5-HT2A receptor antagonists, ritanserin and ketanserin, displayed moderate affinity (pKi = 7.30 and 7.17, resp.) and marked selectivity (22-and 71-fold, resp.) for the recombinant human 5-HT1Dα subtype relative to the 5-HT1Dβ receptor.  In contrast, the nonselective 5-HT1/2 receptor antagonist, methiothepin, exhibited similar binding affinities (pKi = 7.64-8.01) for both recombinant 5-HT1D subtypes.  The antagonistic properties of these compds. were evaluated for their ability to block 5-HT-induced inhibition of forskolin-stimulated cAMP accumulation in intact cells stably expressing either 5-HT1Dα or 5-HT1Dβ receptors.  All 3 compds. behaved as antagonists devoid of intrinsic activity in the functional assays.  The apparent pKb values detd. in functional assays closely matched their pKi values obtained in binding assays.  Since ketanserin exhibits significant selectivity for the human 5-HT1Dα receptor, this antagonist can be used as a pharmacol. tool to discriminate between 5-HT1Dα and 5-HT1Dβ receptor-mediated responses in human tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSPHZ48iN1c7Vg90H21EOLACvtfcHk0li-sHjrJQQm5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFCls7g%253D&md5=3d848b04687b7b1df31c6e3314bfc429</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1016%2F0922-4106%2895%2990183-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0922-4106%252895%252990183-3%26sid%3Dliteratum%253Aachs%26aulast%3DZgombick%26aufirst%3DJ.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DKucharewicz%26aufirst%3DS.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26atitle%3DKetanserin%2520and%2520Ritanserin%2520Discriminate%2520Between%2520Recombinant%2520Human%25205-HT1D%25CE%25B1%2520and%25205-HT1D%25CE%25B2%2520Receptor%2520Subtypes%26jtitle%3DEur.%2520J.%2520Pharmacol.%252C%2520Mol.%2520Pharmacol.%2520Sect.%26date%3D1995%26volume%3D291%26spage%3D9%26epage%3D15%26doi%3D10.1016%2F0922-4106%2895%2990183-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucaites, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainscott, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Comparisons of Hallucinogenic Phenylisopropylamine Binding Affinities at Cloned Human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> Receptors</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span><span class="refDoi"> DOI: 10.1007/PL00005315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FPL00005315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=9933142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1999&pages=1-6&author=D.+L.+Nelsonauthor=V.+L.+Lucaitesauthor=D.+B.+Wainscottauthor=R.+A.+Glennon&title=Comparisons+of+Hallucinogenic+Phenylisopropylamine+Binding+Affinities+at+Cloned+Human+5-HT2A%2C+5-HT2B%2C+and+5-HT2C+Receptors&doi=10.1007%2FPL00005315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors</span></div><div class="casAuthors">Nelson, D. L.; Lucaites, V. L.; Wainscott, D. B.; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Since the classical hallucinogens were initially reported to produce their behavioral effects via a 5-HT2 agonist mechanism (i.e., the 5-HT2 hypothesis of hallucinogen action), 5-HT2 receptors have been demonstrated to represent a family of receptors that consists of three distinct subpopulations: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Today, there is greater support for 5-HT2A than for 5-HT2C receptor involvement in the behavioral effects evoked by these agents.  However, with the recent discovery of 5-HT2B receptors, a new question arises: do classical hallucinogens bind at 5-HT2B receptors.  In the present study, the authors examd. and compared the binding of 17 phenylisopropylamines at human 5-HT2A, 5-HT2B, and 5-HT2C receptors.  Although there was a notable pos. correlation (r>0.9) between the affinities of the agents at all three populations of 5-HT2 receptors, structural modification resulted only in small differences in 5-HT2B receptor affinity such that the range of affinities was only about 50-fold.  As with 5-HT2A and 5-HT2C receptor affinity, there is a significant correlation (r>0.9) between 5-HT2B receptor affinity and human hallucinogenic potency.  Nevertheless, given that 5-HT2A and 5-HT2A/2C antagonists - antagonists with low affinity for 5-HT2B receptors - have been previously shown to block the stimulus effects of phenylisopropylamine hallucinogens, it is likely that 5-HT2A receptors play a more prominent role than 5-HT2B and 5-HT2C receptors in mediating such effects despite the affinity of these agents for all three 5-HT2 receptor subpopulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvcUJ72-JQ2LVg90H21EOLACvtfcHk0li7L1T2XxIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFalu7k%253D&md5=0aa21959353f624601097271883a49de</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1007%2FPL00005315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005315%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DComparisons%2520of%2520Hallucinogenic%2520Phenylisopropylamine%2520Binding%2520Affinities%2520at%2520Cloned%2520Human%25205-HT2A%252C%25205-HT2B%252C%2520and%25205-HT2C%2520Receptors%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D359%26spage%3D1%26epage%3D6%26doi%3D10.1007%2FPL00005315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Effect of the Serotonin 5-HT<sub>2A/2C</sub> Receptor Agonist DOI and of the Selective 5-HT<sub>2A</sub> or 5-HT<sub>2C</sub> Receptor Antagonists EMD 281014 and SB-243213, Respectively, on Sleep and Waking in the Rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2006.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.ejphar.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=17059817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=163-170&author=J.+M.+Montiauthor=H.+Jantos&title=Effect+of+the+Serotonin+5-HT2A%2F2C+Receptor+Agonist+DOI+and+of+the+Selective+5-HT2A+or+5-HT2C+Receptor+Antagonists+EMD+281014+and+SB-243213%2C+Respectively%2C+on+Sleep+and+Waking+in+the+Rat&doi=10.1016%2Fj.ejphar.2006.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat</span></div><div class="casAuthors">Monti, Jaime M.; Jantos, Hector</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of the serotonin 5-HT2A/2C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and of the selective 5-HT2A or 5-HT2C receptor antagonists 7-{4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl}-1H-indole-3-carbonitrile HCl (EMD 281014) and 5-methyl-1-[[-2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline HCl (SB-243213), resp., on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings.  S.c. administration of DOI (0.35-0.7 mmol/kg) significantly increased waking and light sleep and reduced slow wave sleep, rapid-eye-movement (REM) sleep, and the no. of REM periods.  With s.c. EMD 281014 (1.2-4.8 mmol/kg) or SB-243213 (1.2-4.8 mmol/kg) a significant redn. in time spent in REM sleep was also seen.  Pretreatment with EMD 281014 prevented the DOI-induced increase of waking and light sleep and the redn. of slow wave sleep.  However, REM sleep remained suppressed.  SB-243213 failed to reverse the changes of sleep and waking induced by DOI.  Thus, on the basis of these results it appears that serotonin 5-HT2A receptor mechanisms might be responsible for the DOI-induced effects on waking and slow wave sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYNE3-PqoT7Vg90H21EOLACvtfcHk0li7L1T2XxIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM&md5=562384708b4da429f87b73286570f5de</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DEffect%2520of%2520the%2520Serotonin%25205-HT2A%252F2C%2520Receptor%2520Agonist%2520DOI%2520and%2520of%2520the%2520Selective%25205-HT2A%2520or%25205-HT2C%2520Receptor%2520Antagonists%2520EMD%2520281014%2520and%2520SB-243213%252C%2520Respectively%252C%2520on%2520Sleep%2520and%2520Waking%2520in%2520the%2520Rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D163%26epage%3D170%26doi%3D10.1016%2Fj.ejphar.2006.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. L.</span><span> </span><span class="NLM_article-title">Hallucinogen-Like Effects of 2-([2-(4-Cyano-2,5-dimethoxyphenyl)ethylamino] methyl)phenol (25CN-NBOH), a Novel <i>N</i>-Benzylphenethylamine with 100-Fold Selectivity for 5-HT<sub>2A</sub> Receptors, in Mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1007/s00213-014-3739-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-014-3739-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=1039-1047&author=W.+E.+Fantegrossiauthor=B.+W.+Grayauthor=J.+M.+Baileyauthor=D.+A.+Smithauthor=M.+Hansenauthor=J.+L.+Kristensen&title=Hallucinogen-Like+Effects+of+2-%28%5B2-%284-Cyano-2%2C5-dimethoxyphenyl%29ethylamino%5D+methyl%29phenol+%2825CN-NBOH%29%2C+a+Novel+N-Benzylphenethylamine+with+100-Fold+Selectivity+for+5-HT2A+Receptors%2C+in+Mice&doi=10.1007%2Fs00213-014-3739-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3739-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3739-3%26sid%3Dliteratum%253Aachs%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DGray%26aufirst%3DB.%2BW.%26aulast%3DBailey%26aufirst%3DJ.%2BM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DKristensen%26aufirst%3DJ.%2BL.%26atitle%3DHallucinogen-Like%2520Effects%2520of%25202-%2528%255B2-%25284-Cyano-2%252C5-dimethoxyphenyl%2529ethylamino%255D%2520methyl%2529phenol%2520%252825CN-NBOH%2529%252C%2520a%2520Novel%2520N-Benzylphenethylamine%2520with%2520100-Fold%2520Selectivity%2520for%25205-HT2A%2520Receptors%252C%2520in%2520Mice%26jtitle%3DPsychopharmacology%26date%3D2015%26volume%3D232%26spage%3D1039%26epage%3D1047%26doi%3D10.1007%2Fs00213-014-3739-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phonekeo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leth-Petersen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begtrup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristensen, J. L.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of <i>N</i>-Benzyl phenethylamines as 5-HT<sub>2A/2C</sub> Agonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1021/cn400216u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400216u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=243-249&author=M.+Hansenauthor=K.+Phonekeoauthor=J.+S.+Paineauthor=S.+Leth-Petersenauthor=M.+Begtrupauthor=H.+Br%C3%A4uner-Osborneauthor=J.+L.+Kristensen&title=Synthesis+and+Structure-Activity+Relationships+of+N-Benzyl+phenethylamines+as+5-HT2A%2F2C+Agonists&doi=10.1021%2Fcn400216u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists</span></div><div class="casAuthors">Hansen, Martin; Phonekeo, Karina; Paine, James S.; Leth-Petersen, Sebastian; Begtrup, Mikael; Brauner-Osborne, Hans; Kristensen, Jesper L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-249</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Benzyl substitution of 5-HT2A receptor agonists of the phenethylamine structural class of psychedelics (such as 4-bromo-2,5-dimethoxyphenethylamine, often referred to as 2C-B) confer a significant increase in binding affinity as well as functional activity of the receptor.  We have prepd. a series of 48 compds. with structural variations in both the phenethylamine and N-benzyl part of the mol. to det. the effects on receptor binding affinity and functional activity at 5-HT2A and 5-HT2C receptors.  The compds. generally had high affinity for the 5-HT2A receptor with 2-((4-Ethyl-2,5-dimethoxyphenethylamino)methyl)phenol HCl having the highest affinity at 0.29 nM but with several other compds. also exhibiting subnanomolar binding affinities.  The functional activity of the compds. was distributed over a wider range with (I) being the most potent at 0.074 nM.  Most of the compds. exhibited low to moderate selectivity (1- to 40-fold) for the 5-HT2A receptor in the binding assays, although one, 4-(2-(2-Hydroxybenzylamino)ethyl)-2,5-dimethoxybenzonitrile HCl, showed an impressive 100-fold selectivity for the 5-HT2A receptor.  In the functional assay, selectivity was generally higher with I being more than 400-fold selective for the 5-HT2A receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ZkfztjBttLVg90H21EOLACvtfcHk0li7L1T2XxIygQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVertQ%253D%253D&md5=665522d747c8a2fbc98ce960111bf3cb</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Fcn400216u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400216u%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DPhonekeo%26aufirst%3DK.%26aulast%3DPaine%26aufirst%3DJ.%2BS.%26aulast%3DLeth-Petersen%26aufirst%3DS.%26aulast%3DBegtrup%26aufirst%3DM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DKristensen%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520N-Benzyl%2520phenethylamines%2520as%25205-HT2A%252F2C%2520Agonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D243%26epage%3D249%26doi%3D10.1021%2Fcn400216u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, M. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isberg, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloriam, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogsgaard-Larsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frølund, B.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Pharmacological Characterization of <i>N</i>- and <i>O</i>-Substituted 5,6,7,8-Tetrahydro-4<i>H</i>-isoxazolo[4,5-<i>d</i>]azepin-3-ol Analogues: Novel 5-HT<sub>2A</sub>/5-HT<sub>2C</sub> Receptor Agonists with Pro-Cognitive Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1021/jm301656h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301656h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1yhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1211-1227&author=A.+A.+Jensenauthor=N.+Plathauthor=M.+H.+F.+Pedersenauthor=V.+Isbergauthor=J.+Krallauthor=P.+Wellendorphauthor=T.+B.+Stensb%C3%B8lauthor=D.+E.+Gloriamauthor=P.+Krogsgaard-Larsenauthor=B.+Fr%C3%B8lund&title=Design%2C+Synthesis%2C+and+Pharmacological+Characterization+of+N-+and+O-Substituted+5%2C6%2C7%2C8-Tetrahydro-4H-isoxazolo%5B4%2C5-d%5Dazepin-3-ol+Analogues%3A+Novel+5-HT2A%2F5-HT2C+Receptor+Agonists+with+Pro-Cognitive+Properties&doi=10.1021%2Fjm301656h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties</span></div><div class="casAuthors">Jensen, Anders A.; Plath, Niels; Pedersen, Martin H. F.; Isberg, Vignir; Krall, Jacob; Wellendorph, Petrine; Stensboel, Tine B.; Gloriam, David E.; Krogsgaard-Larsen, Povl; Froelund, Bente</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1211-1227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The isoxazol-3-one tautomer of the bicyclic isoxazole, 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol (THAZ), has previously been shown to be a weak GABAA and glycine receptor antagonist.  In the present study, the potential in this scaffold has been explored through the synthesis and pharmacol. characterization of a series of N- and O-substituted THAZ analogs.  The analogs N-Bn-THAZ (3d, I) and O-Bn-THAZ (4d, II) were found to be potent agonists of the human 5-HT2A and 5-HT2C receptors.  Judging from an elaborate pharmacol. profiling at numerous other CNS targets, the 3d analog appears to be selective for the two receptors.  Administration of 3d substantially improved the cognitive performance of mice in a place recognition Y-maze model, an effect fully reversible by coadministration of the selective 5-HT2C antagonist SB242084.  In conclusion, as novel bioavailable cognitive enhancers that most likely mediate their effects through 5-HT2A and/or 5-HT2C receptors, the isoxazoles 3d and 4d constitute interesting leads for further medicinal chem. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGnquX4JkP7rVg90H21EOLACvtfcHk0ljdLvhuvCz7wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1yhsg%253D%253D&md5=cdf977de75375930a0d10a060de840a4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301656h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301656h%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DPlath%26aufirst%3DN.%26aulast%3DPedersen%26aufirst%3DM.%2BH.%2BF.%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3DKrall%26aufirst%3DJ.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DKrogsgaard-Larsen%26aufirst%3DP.%26aulast%3DFr%25C3%25B8lund%26aufirst%3DB.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Pharmacological%2520Characterization%2520of%2520N-%2520and%2520O-Substituted%25205%252C6%252C7%252C8-Tetrahydro-4H-isoxazolo%255B4%252C5-d%255Dazepin-3-ol%2520Analogues%253A%2520Novel%25205-HT2A%252F5-HT2C%2520Receptor%2520Agonists%2520with%2520Pro-Cognitive%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1211%26epage%3D1227%26doi%3D10.1021%2Fjm301656h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McLean, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marona-Lewicka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT<sub>2A</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5794</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span><span class="refDoi"> DOI: 10.1021/jm060656o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060656o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVCitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5794-5803&author=T.+H.+McLeanauthor=J.+C.+Parrishauthor=M.+R.+Bradenauthor=D.+Marona-Lewickaauthor=A.+Gallardo-Godoyauthor=D.+E.+Nichols&title=1-Aminomethylbenzocycloalkanes%3A+Conformationally+Restricted+Hallucinogenic+Phenethylamine+Analogues+as+Functionally+Selective+5-HT2A+Receptor+Agonists&doi=10.1021%2Fjm060656o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists</span></div><div class="casAuthors">McLean, Thomas H.; Parrish, Jason C.; Braden, Michael R.; Marona-Lewicka, Danuta; Gallardo-Godoy, Alejandra; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5794-5803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of conformationally restricted analogs of the hallucinogenic phenethylamine 1 (2,5-dimethoxy-4-bromophenethylamine, 2C-B) was synthesized to test several hypotheses concerning the bioactive conformation of phenethylamine ligands upon binding to the 5-HT2A receptor.  These benzocycloalkane analogs were assayed for their receptor binding affinity and ability to activate downstream signaling pathways, and one exceptional compd. was selected for testing in an in vivo drug discrimination model of hallucinogenesis.  All compds. were examd. in silico by virtual docking into a homol. model of the 5-HT2A receptor.  On the basis of these docking expts., it was predicted that the R enantiomer of benzocyclobutene analog 2 would be the most potent.  Subsequent chem. resoln. and X-ray crystallog. confirmed this prediction, as (R)-2(I) proved to be equipotent to LSD in rats trained to discriminate LSD from saline.  Thus, we propose that the conformation of 2 mimics the active binding conformation of the more flexible phenethylamine type hallucinogens.  In addn., (R)-2 is one of the most potent and selective compds. yet discovered in the in vivo drug discrimination assay.  Further, 2 was found to be a functionally selective agonist at the 5-HT2A receptor, having 65-fold greater potency in stimulating phosphoinositide turnover than in producing arachidonic acid release.  If hallucinogenic effects are correlated with arachidonic acid prodn., such functionally selective 5-HT2A receptor agonists may lack the intoxicating properties of hallucinogens such as LSD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNv796JhOoSrVg90H21EOLACvtfcHk0ljdLvhuvCz7wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVCitbo%253D&md5=e6021aa27549a8c096d7b401d5859ee5</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm060656o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060656o%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DT.%2BH.%26aulast%3DParrish%26aufirst%3DJ.%2BC.%26aulast%3DBraden%26aufirst%3DM.%2BR.%26aulast%3DMarona-Lewicka%26aufirst%3DD.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3D1-Aminomethylbenzocycloalkanes%253A%2520Conformationally%2520Restricted%2520Hallucinogenic%2520Phenethylamine%2520Analogues%2520as%2520Functionally%2520Selective%25205-HT2A%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5794%26epage%3D5803%26doi%3D10.1021%2Fjm060656o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fox, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPorte, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackler, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. L.</span><span> </span><span class="NLM_article-title">The Serotonin 5-HT<sub>2A</sub> Receptor Agonist TCB-2: a Behavioral and Neurophysiological Analysis</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1007/s00213-009-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2Fs00213-009-1694-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=13-23&author=M.+A.+Foxauthor=H.+T.+Frenchauthor=J.+L.+LaPorteauthor=A.+R.+Blacklerauthor=D.+L.+Murphy&title=The+Serotonin+5-HT2A+Receptor+Agonist+TCB-2%3A+a+Behavioral+and+Neurophysiological+Analysis&doi=10.1007%2Fs00213-009-1694-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DM.%2BA.%26aulast%3DFrench%26aufirst%3DH.%2BT.%26aulast%3DLaPorte%26aufirst%3DJ.%2BL.%26aulast%3DBlackler%26aufirst%3DA.%2BR.%26aulast%3DMurphy%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Serotonin%25205-HT2A%2520Receptor%2520Agonist%2520TCB-2%253A%2520a%2520Behavioral%2520and%2520Neurophysiological%2520Analysis%26jtitle%3DPsychopharmacology%26date%3D2010%26volume%3D212%26spage%3D13%26epage%3D23%26doi%3D10.1007%2Fs00213-009-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgeirsdottir, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchow, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stackman, R. W.,  Jr.</span><span> </span><span class="NLM_article-title">Stimulation of Serotonin 2A Receptors facilitates Consolidation and Extinction of Fear Memory in C57BL/6J Mice</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neuropharm.2012.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=403-413&author=G.+Zhangauthor=H.+N.+Asgeirsdottirauthor=S.+J.+Cohenauthor=A.+H.+Munchowauthor=M.+P.+Barreraauthor=R.+W.+Stackman&title=Stimulation+of+Serotonin+2A+Receptors+facilitates+Consolidation+and+Extinction+of+Fear+Memory+in+C57BL%2F6J+Mice&doi=10.1016%2Fj.neuropharm.2012.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAsgeirsdottir%26aufirst%3DH.%2BN.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DMunchow%26aufirst%3DA.%2BH.%26aulast%3DBarrera%26aufirst%3DM.%2BP.%26aulast%3DStackman%26aufirst%3DR.%2BW.%26atitle%3DStimulation%2520of%2520Serotonin%25202A%2520Receptors%2520facilitates%2520Consolidation%2520and%2520Extinction%2520of%2520Fear%2520Memory%2520in%2520C57BL%252F6J%2520Mice%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D403%26epage%3D413%26doi%3D10.1016%2Fj.neuropharm.2012.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blasi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Virgilio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papazacharias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taurisano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ursini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinibaldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masellis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giorgio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Bianco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caforio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piva, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popolizio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellantuono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todarello, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolino, A.</span><span> </span><span class="NLM_article-title">Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene with Prefrontal function and Olanzapine Treatment</span> <span class="citation_source-journal">JAMA Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span><span class="refDoi"> DOI: 10.1001/jamapsychiatry.2013.1378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1001%2Fjamapsychiatry.2013.1378" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=921-930&author=G.+Blasiauthor=C.+De+Virgilioauthor=A.+Papazachariasauthor=P.+Taurisanoauthor=B.+Gelaoauthor=L.+Fazioauthor=G.+Ursiniauthor=L.+Sinibaldiauthor=I.+Andriolaauthor=R.+Masellisauthor=R.+Romanoauthor=A.+Rampinoauthor=A.+Di+Giorgioauthor=L.+Lo+Biancoauthor=G.+Caforioauthor=F.+Pivaauthor=T.+Popolizioauthor=C.+Bellantuonoauthor=O.+Todarelloauthor=J.+E.+Kleinmanauthor=G.+Gadaletaauthor=D.+R.+Weinbergerauthor=A.+Bertolino&title=Converging+Evidence+for+the+Association+of+Functional+Genetic+Variation+in+the+Serotonin+Receptor+2a+Gene+with+Prefrontal+function+and+Olanzapine+Treatment&doi=10.1001%2Fjamapsychiatry.2013.1378"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2013.1378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2013.1378%26sid%3Dliteratum%253Aachs%26aulast%3DBlasi%26aufirst%3DG.%26aulast%3DDe%2BVirgilio%26aufirst%3DC.%26aulast%3DPapazacharias%26aufirst%3DA.%26aulast%3DTaurisano%26aufirst%3DP.%26aulast%3DGelao%26aufirst%3DB.%26aulast%3DFazio%26aufirst%3DL.%26aulast%3DUrsini%26aufirst%3DG.%26aulast%3DSinibaldi%26aufirst%3DL.%26aulast%3DAndriola%26aufirst%3DI.%26aulast%3DMasellis%26aufirst%3DR.%26aulast%3DRomano%26aufirst%3DR.%26aulast%3DRampino%26aufirst%3DA.%26aulast%3DDi%2BGiorgio%26aufirst%3DA.%26aulast%3DLo%2BBianco%26aufirst%3DL.%26aulast%3DCaforio%26aufirst%3DG.%26aulast%3DPiva%26aufirst%3DF.%26aulast%3DPopolizio%26aufirst%3DT.%26aulast%3DBellantuono%26aufirst%3DC.%26aulast%3DTodarello%26aufirst%3DO.%26aulast%3DKleinman%26aufirst%3DJ.%2BE.%26aulast%3DGadaleta%26aufirst%3DG.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26aulast%3DBertolino%26aufirst%3DA.%26atitle%3DConverging%2520Evidence%2520for%2520the%2520Association%2520of%2520Functional%2520Genetic%2520Variation%2520in%2520the%2520Serotonin%2520Receptor%25202a%2520Gene%2520with%2520Prefrontal%2520function%2520and%2520Olanzapine%2520Treatment%26jtitle%3DJAMA%2520Psychiatry%26date%3D2013%26volume%3D70%26spage%3D921%26epage%3D930%26doi%3D10.1001%2Fjamapsychiatry.2013.1378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mestre, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2A Receptors Antagonists as Potential Treatment for Psychiatric Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.1517/13543784.2013.769957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1517%2F13543784.2013.769957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=411-421&author=T.+A.+Mestreauthor=M.+Zurowskiauthor=S.+H.+Fox&title=5-Hydroxytryptamine+2A+Receptors+Antagonists+as+Potential+Treatment+for+Psychiatric+Disorders&doi=10.1517%2F13543784.2013.769957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.769957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.769957%26sid%3Dliteratum%253Aachs%26aulast%3DMestre%26aufirst%3DT.%2BA.%26aulast%3DZurowski%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DS.%2BH.%26atitle%3D5-Hydroxytryptamine%25202A%2520Receptors%2520Antagonists%2520as%2520Potential%2520Treatment%2520for%2520Psychiatric%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D411%26epage%3D421%26doi%3D10.1517%2F13543784.2013.769957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, K.</span><span> </span><span class="NLM_article-title">Pimavanserin, a 5-HT2A Receptor Inverse Agonist, Reverses Psychosis-Like Behaviors in a Rodent Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span><span class="refDoi"> DOI: 10.1097/FBP.0b013e3283566082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1097%2FFBP.0b013e3283566082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=426-433&author=D.+L.+Priceauthor=D.+W.+Bonhausauthor=K.+McFarland&title=Pimavanserin%2C+a+5-HT2A+Receptor+Inverse+Agonist%2C+Reverses+Psychosis-Like+Behaviors+in+a+Rodent+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1097%2FFBP.0b013e3283566082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3283566082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3283566082%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DMcFarland%26aufirst%3DK.%26atitle%3DPimavanserin%252C%2520a%25205-HT2A%2520Receptor%2520Inverse%2520Agonist%252C%2520Reverses%2520Psychosis-Like%2520Behaviors%2520in%2520a%2520Rodent%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2012%26volume%3D23%26spage%3D426%26epage%3D433%26doi%3D10.1097%2FFBP.0b013e3283566082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Gong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span> </span><span class="NLM_article-title">Variations in 5-HT2A Influence Spatial Cognitive Abilities and Working Memory</span> <span class="citation_source-journal">Can. J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1017/S0317167100011513</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1017%2FS0317167100011513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=21320838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BC3M7pt1Krtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=303-308&author=P.+Gongauthor=J.+Liauthor=J.+Wangauthor=X.+Leiauthor=D.+Chenauthor=K.+Zhangauthor=W.+Zhangauthor=A.+Zhenauthor=X.+Gaoauthor=F.+Zhang&title=Variations+in+5-HT2A+Influence+Spatial+Cognitive+Abilities+and+Working+Memory&doi=10.1017%2FS0317167100011513"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28eR"><div class="casContent"><span class="casTitleNuber">28e</span><div class="casTitle"><span class="NLM_cas:atitle">Variations in 5-HT2A influence spatial cognitive abilities and working memory</span></div><div class="casAuthors">Gong Pingyuan; Li Jing; Wang Jian; Lei Xu; Chen Dongmei; Zhang Kejin; Zhang Wenjiang; Zhen Anyuan; Gao Xiaocai; Zhang Fuchang</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-8</span>
        ISSN:<span class="NLM_cas:issn">0317-1671</span>.
    </div><div class="casAbstract">BACKGROUND:  5-hydroxytryptamine receptor 2A (5-HT2A) participates in diverse psychiatric disorders by regulating the activity of serotonin.  Some previous studies have also suggested that the receptor is involved in cognitive abilities of disease groups.  We hypothesize that some functional genetic variants in 5-HT2A have certain specific influences on cognitive abilities in a normal population.  METHOD:  To confirm this hypothesis, two polymorphisms (rs6313 and rs4941573) in 5-HT2A were selected, and a population-based study was performed in a young healthy Chinese Han cohort.  RESULTS:  The results indicated that the rs6313 and rs4941573 were associated with touching blocks and mental rotation-3D error ratio in males, and the rs4941573 was associated with visuo-spatial working memory in the whole cohort.  CONCLUSION:  All the findings suggest that 5-HT2A participates in human spatial cognitive abilities and spatial working memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVc-Qq91xFSjToTC3aBaesfW6udTcc2eayXk51ma833bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7pt1Krtg%253D%253D&md5=ebd50eb87e2625edb06e1e3c78025d50</span></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=10.1017%2FS0317167100011513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0317167100011513%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhen%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26atitle%3DVariations%2520in%25205-HT2A%2520Influence%2520Spatial%2520Cognitive%2520Abilities%2520and%2520Working%2520Memory%26jtitle%3DCan.%2520J.%2520Neurol.%2520Sci.%26date%3D2011%26volume%3D38%26spage%3D303%26epage%3D308%26doi%3D10.1017%2FS0317167100011513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Hasselbalch, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svarer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinborg, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldemar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span> </span><span class="NLM_article-title">Reduced 5-HT2A Receptor Binding in Patients with Mild Cognitive Impairment</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1830</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2007.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.neurobiolaging.2007.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=17544547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KnsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=1830-1838&author=S.+G.+Hasselbalchauthor=K.+Madsenauthor=C.+Svarerauthor=L.+H.+Pinborgauthor=S.+Holmauthor=O.+B.+Paulsonauthor=G.+Waldemarauthor=G.+M.+Knudsen&title=Reduced+5-HT2A+Receptor+Binding+in+Patients+with+Mild+Cognitive+Impairment&doi=10.1016%2Fj.neurobiolaging.2007.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28fR"><div class="casContent"><span class="casTitleNuber">28f</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced 5-HT2A receptor binding in patients with mild cognitive impairment</span></div><div class="casAuthors">Hasselbalch, S. G.; Madsen, K.; Svarer, C.; Pinborg, L. H.; Holm, S.; Paulson, O. B.; Waldemar, G.; Knudsen, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1830-1838</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Previous studies of patients with Alzheimer's disease (AD) have described reduced brain serotonin 2A (5-HT2A) receptor d.  It is unclear whether this abnormality sets in early in the course of the disease and whether it is related to early cognitive and neuropsychiatric symptoms.  We assessed cerebral 5-HT2A receptor binding in patients with mild cognitive impairment (MCI) and related 5-HT2A receptor binding to clin. symptoms.  Sixteen patients with MCI of the amnestic type (mean age 73, mean MMSE 26.1) and 17 age and sex matched control subjects were studied with MRI and [18F]altanserin PET in a bolus-infusion approach.  A significant global redn. of 20-30% in 5-HT2A binding (atrophy cor.) was found in most neocortical areas.  Reduced 5-HT2A binding in the striatum correlated significantly with Neuropsychiatric Inventory depression and anxiety scores.  We conclude that widespread redns. in 5-HT2A receptor binding were found in amnestic MCI, pointing at the presence of serotonergic dysfunction in prodromal AD.  This may provide some of the pathophysiol. background for the neuropsychiatric symptoms found in early AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6JpJzo8viu7Vg90H21EOLACvtfcHk0lj_embGAoeHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KnsL7K&md5=f12d9f4c71b00f8da123777f76194530</span></div><a href="/servlet/linkout?suffix=cit28f&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DHasselbalch%26aufirst%3DS.%2BG.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DSvarer%26aufirst%3DC.%26aulast%3DPinborg%26aufirst%3DL.%2BH.%26aulast%3DHolm%26aufirst%3DS.%26aulast%3DPaulson%26aufirst%3DO.%2BB.%26aulast%3DWaldemar%26aufirst%3DG.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26atitle%3DReduced%25205-HT2A%2520Receptor%2520Binding%2520in%2520Patients%2520with%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DNeurobiol.%2520Aging%26date%3D2008%26volume%3D29%26spage%3D1830%26epage%3D1838%26doi%3D10.1016%2Fj.neurobiolaging.2007.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Celada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amargόs-Bosch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">The Therapeutic Role of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> Receptors in Depression</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15309042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD2cvgsV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=252-265&author=P.+Celadaauthor=M.+V.+Puigauthor=M.+Amarg%CF%8Cs-Boschauthor=A.+Adellauthor=F.+Artigas&title=The+Therapeutic+Role+of+5-HT1A+and+5-HT2A+Receptors+in+Depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28gR"><div class="casContent"><span class="casTitleNuber">28g</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic role of 5-HT1A and 5-HT2A receptors in depression</span></div><div class="casAuthors">Celada Pau; Puig M; Amargos-Bosch Merce; Adell Albert; Artigas Francesc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-65</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects.  They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic action requires weeks of treatment.  This delay is the result of presynaptic and postsynaptic adaptive mechanisms secondary to reuptake inhibition.  The prevention of a negative feedback mechanism operating at the 5-HT autoreceptor level enhances the neurochemical and clinical effects of SSRIs.  The blockade of 5-HT2A receptors also seems to improve the clinical effects of SSRIs.  These receptors are located postsynaptically to 5-HT axons, mainly in the neocortex.  Pyramidal neurons in the prefrontal cortex are particularly enriched in 5-HT2A receptors.  Their blockade may affect the function of prefrontal-subcortical circuits, an effect that probably underlies the beneficial effects of the addition of atypical antipsychotic drugs, which are 5-HT2A receptor antagonists, to SSRIs in treatment-resistant patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZfG1UEEH_MrqxQ2mb9Pu8fW6udTcc2ebuNCkecBGKtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvgsV2jsQ%253D%253D&md5=bbfa333672f3b963422fbf8e8893cec8</span></div><a href="/servlet/linkout?suffix=cit28g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelada%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DM.%2BV.%26aulast%3DAmarg%25CF%258Cs-Bosch%26aufirst%3DM.%26aulast%3DAdell%26aufirst%3DA.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DThe%2520Therapeutic%2520Role%2520of%25205-HT1A%2520and%25205-HT2A%2520Receptors%2520in%2520Depression%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2004%26volume%3D29%26spage%3D252%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ohuoha, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinman, J. E.</span><span> </span><span class="NLM_article-title">The role of Serotonin in Schizophrenia: an Overview of the Nomenclature, Distribution and Alterations of Serotonin Receptors in the Central Nervous System</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1007/BF02245003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FBF02245003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1993&pages=S5-15&author=D.+C.+Ohuohaauthor=T.+M.+Hydeauthor=J.+E.+Kleinman&title=The+role+of+Serotonin+in+Schizophrenia%3A+an+Overview+of+the+Nomenclature%2C+Distribution+and+Alterations+of+Serotonin+Receptors+in+the+Central+Nervous+System&doi=10.1007%2FBF02245003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28h&amp;dbid=16384&amp;doi=10.1007%2FBF02245003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245003%26sid%3Dliteratum%253Aachs%26aulast%3DOhuoha%26aufirst%3DD.%2BC.%26aulast%3DHyde%26aufirst%3DT.%2BM.%26aulast%3DKleinman%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520role%2520of%2520Serotonin%2520in%2520Schizophrenia%253A%2520an%2520Overview%2520of%2520the%2520Nomenclature%252C%2520Distribution%2520and%2520Alterations%2520of%2520Serotonin%2520Receptors%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D112%26spage%3DS5%26epage%3D15%26doi%3D10.1007%2FBF02245003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moritomo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akuzawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationships of New Carbonyl Guanidine Derivatives as Novel Dual 5-HT<sub>2B</sub> and 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7841</span><span class="NLM_x">–</span> <span class="NLM_lpage">7852</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2013.10.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=7841-7852&author=A.+Moritomoauthor=H.+Yamadaauthor=T.+Watanabeauthor=H.+Itahanaauthor=S.+Akuzawaauthor=M.+Okadaauthor=M.+Ohta&title=Synthesis+and+Structure-Activity+Relationships+of+New+Carbonyl+Guanidine+Derivatives+as+Novel+Dual+5-HT2B+and+5-HT7+Receptor+Antagonists&doi=10.1016%2Fj.bmc.2013.10.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DItahana%26aufirst%3DH.%26aulast%3DAkuzawa%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationships%2520of%2520New%2520Carbonyl%2520Guanidine%2520Derivatives%2520as%2520Novel%2520Dual%25205-HT2B%2520and%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D7841%26epage%3D7852%26doi%3D10.1016%2Fj.bmc.2013.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein</p></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a thorough review on 5-HT receptors, please see:</p></div><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span> </span><span class="NLM_article-title">A Review of Central 5-HT Receptors and their Function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/S0028-3908(99)00010-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FS0028-3908%2899%2900010-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10462127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXltVCgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1083-1152&author=N.+M.+Barnesauthor=T.+Sharp&title=A+Review+of+Central+5-HT+Receptors+and+their+Function&doi=10.1016%2FS0028-3908%2899%2900010-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">A review of central 5-HT receptors and their function</span></div><div class="casAuthors">Barnes, Nicholas M.; Sharp, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1152</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with ∼700 refs.  It is now nearly 5 yr since the last of the currently recognized 5-HT receptors was identified in terms of its cDNA sequence.  Over this period, much effort has been directed towards understanding the function attributable to individual 5-HT receptors in the brain.  This has been helped, in part, by the synthesis of a no. of compds. that selectively interact with individual 5-HT receptor subtypes-although some 5-HT receptors still lack any selective ligands (e.g., 5-ht1E, 5-ht5A and 5-ht5B receptors).  The present review provides background information for each 5-HT receptor subtype and subsequently reviews in more detail the functional responses attributed to each receptor in the brain.  Clearly this latter area has moved forward in recent years and this progression is likely to continue given the level of interest assocd. with the actions of 5-HT.  This interest is stimulated by the belief that pharmacol. manipulation of the central 5-HT system will have therapeutic potential.  In support of which, a no. of 5-HT receptor ligands are currently utilized, or are in clin. development, to reduce the symptoms of CNS dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2De_9ij4c_LVg90H21EOLACvtfcHk0lh-ByazF_HGJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVCgsrg%253D&md5=7e92e3b6586ce16c00a1afab5ae06e01</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900010-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DA%2520Review%2520of%2520Central%25205-HT%2520Receptors%2520and%2520their%2520Function%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1083%26epage%3D1152%26doi%3D10.1016%2FS0028-3908%2899%2900010-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Badarau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzenet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojarski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fînaru, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Benzimidazolone-Based Serotonin 5-HT<sub>1A</sub> or 5-HT<sub>7</sub>R Ligands: Synthesis and Biological Evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1600</span><span class="NLM_x">–</span> <span class="NLM_lpage">1603</span><div class="note"><p class="first last">5-HT<sub>2A</sub>R. Binding result on (<b>I</b>) is unpublished</p></div><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmcl.2009.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19237285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1600-1603&author=E.+Badarauauthor=F.+Suzenetauthor=A.+J.+Bojarskiauthor=A.-L.+F%C3%AEnaruauthor=G.+Guillaumet&title=Benzimidazolone-Based+Serotonin+5-HT1A+or+5-HT7R+Ligands%3A+Synthesis+and+Biological+Evaluation&doi=10.1016%2Fj.bmcl.2009.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: Synthesis and biological evaluation</span></div><div class="casAuthors">Badarau, Eduard; Suzenet, Franck; Bojarski, Andrzej J.; Finaru, Adriana-Luminita; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1600-1603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new group of serotoninergic 5-HT1A or 5-HT7 receptor ligands was identified.  These compds. were designed and synthesized on a benzimidazolone scaffold and they enrich the well-known arylpiperazine class of 5-HT ligands.  Diverse pharmacomodulations induced a shift in the affinity and selectivity profile with final identification of new potent hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwILwj8xQcfLVg90H21EOLACvtfcHk0lh-ByazF_HGJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsLs%253D&md5=399986c7c98b7cd4f499f074cf94659c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBadarau%26aufirst%3DE.%26aulast%3DSuzenet%26aufirst%3DF.%26aulast%3DBojarski%26aufirst%3DA.%2BJ.%26aulast%3DF%25C3%25AEnaru%26aufirst%3DA.-L.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DBenzimidazolone-Based%2520Serotonin%25205-HT1A%2520or%25205-HT7R%2520Ligands%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1600%26epage%3D1603%26doi%3D10.1016%2Fj.bmcl.2009.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sit, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, N.</span><span> </span><span class="NLM_article-title">Regiospecific Functionalization of 1,3-Dihydro-2<i>H</i>-benzimidazol-2-one and Structurally Related Cyclic Urea Derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1021/jo00111a014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00111a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2MXktlemurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=1565-1582&author=N.+A.+Meanwellauthor=S.+Y.+Sitauthor=J.+Gaoauthor=H.+S.+Wongauthor=Q.+Gaoauthor=D.+R.+St.+Laurentauthor=N.+Balasubramanian&title=Regiospecific+Functionalization+of+1%2C3-Dihydro-2H-benzimidazol-2-one+and+Structurally+Related+Cyclic+Urea+Derivatives&doi=10.1021%2Fjo00111a014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Regiospecific Functionalization of 1,3-Dihydro-2H-benzimidazol-2-one and Structurally Related Cyclic Urea Derivatives</span></div><div class="casAuthors">Meanwell, Nicholas A.; Sit, Sing Yuen; Gao, Jinnian; Wong, Henry S.; Gao, Qi; St. Laurent, Denis R.; Balasubramanian, Neelakantan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1565-82</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methods for selectively protecting one of the degenerate nitrogen atoms of the cyclic urea derivs. 1,3-dihydro-2H-benzimidazol-2-one (6a), 1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones, 1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one, and 1,3-dihydro-4-phenyl-2H-imidazol-2-one were developed.  Heating these cyclic ureas with Et 2-pyridyl carbonate in the presence of a base in CH3CN at reflux or DMF at 100 °C cleanly provided the mono(ethoxycarbonyl) derivs.  Alternatively, treatment of 6a with an excess of di-Et pyrocarbonate or di-tert-Bu dicarbonate afforded the bis(alkoxycarbonyl) derivs., which underwent disproportionation to mono(alkoxycarbonyl) deriv. upon heating with 1 mol equiv of 6a and K2CO3 in CH3CN at reflux.  The regiochem. of the introduction of alkoxycarbonyl groups to benzimidazol-2-one derivs. was not significantly influenced by an electron-withdrawing (CF3) or an electron-donating (OCH3) substituent at C-5 of the heterocyclic ring.  However, the reaction was found to be sensitive to steric factors since a chlorine substituent ortho to one of the urea N atoms completely directed the alkoxycarbonyl moiety to the less sterically encumbered N atom.  Alkylation or halogenation of the monoprotected derivs. occurred regiospecifically.  A protecting group interchange strategy that took advantage of the distinctive chem. reactivities of the EtO2C and t-BuO2C protecting groups toward isopropylamine was developed that provided access to the isomerically substituted series of monohalo, mono-N-alkylated benzimidazol-2-ones.  The efficient derivatization of the unprotected N atom of these monoprotected cyclic urea derivs. was accomplished by treating with activated and unactivated halides in the presence of K2CO3 or exposure to alcs. under Mitsunobu conditions.  In several cases, mixts. of O- and N-alkylated products were produced which were readily sepd. by chromatog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXJfNueaz6m7Vg90H21EOLACvtfcHk0lh-ByazF_HGJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktlemurY%253D&md5=5678fe70c56296b153b32a46274907c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo00111a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00111a014%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSit%26aufirst%3DS.%2BY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DBalasubramanian%26aufirst%3DN.%26atitle%3DRegiospecific%2520Functionalization%2520of%25201%252C3-Dihydro-2H-benzimidazol-2-one%2520and%2520Structurally%2520Related%2520Cyclic%2520Urea%2520Derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D1565%26epage%3D1582%26doi%3D10.1021%2Fjo00111a014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+Applications+of+Halogen+Bonding+in+Medicinal+Chemistry+and+Chemical+Biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0lhY6DQXx_SnGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520Applications%2520of%2520Halogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%2520and%2520Chemical%2520Biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Topliss, J. G.</span><span> </span><span class="NLM_article-title">Utilization of Operational Schemes for Analog Synthesis in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span><span class="refDoi"> DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+Operational+Schemes+for+Analog+Synthesis+in+Drug+Design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0lhY6DQXx_SnGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520Operational%2520Schemes%2520for%2520Analog%2520Synthesis%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5HT<sub>7</sub> Receptor Modulators: a Medicinal Chemistry Survey of Recent Patent Literature (2004–2009)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1517/13543776.2010.484802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1517%2F13543776.2010.484802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=20476847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=739-754&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perrone&title=5HT7+Receptor+Modulators%3A+a+Medicinal+Chemistry+Survey+of+Recent+Patent+Literature+%282004%E2%80%932009%29&doi=10.1517%2F13543776.2010.484802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009)</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-754</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT7 receptors are discretely localized within the CNS (thalamus, hypothalamus, limbic and cortical regions).  The 5-HT7 receptors are also present in smooth muscle cells from blood vessels and have been reported in gastrointestinal tract as well as in rat lumbar dorsal root and sympathetic ganglia.  The 5-HT7 receptors have been implicated in depression, disorders related to circadian rhythms, pain and migraine.  Thus, there is a great interest in developing potent and selective 5-HT7 receptor modulators.Areas covered in this review: This review article highlights the research advances published in the patent literature between Jan. 2004 and Dec. 2009, giving emphasis to the medicinal chemist's standpoint.What the reader will gain: Readers will rapidly gain an overview of the various 5-HT7 receptor modulators reported in the patent literature in the past 6 years.  Furthermore, the readers will learn which structure type can interact with 5-HT7 receptor and also the different companies that are the main players in the field.Take home message: Although no 5-HT7 modulator has entered clin. trials, the development and future use of different agonists and antagonists suitable for use in vivo seem very promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_eZylyhMWbVg90H21EOLACvtfcHk0lhY6DQXx_SnGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtro%253D&md5=9ee8b9f849c844b9d9cb65d1a48dd54d</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.484802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.484802%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5HT7%2520Receptor%2520Modulators%253A%2520a%2520Medicinal%2520Chemistry%2520Survey%2520of%2520Recent%2520Patent%2520Literature%2520%25282004%25E2%2580%25932009%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D739%26epage%3D754%26doi%3D10.1517%2F13543776.2010.484802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> Receptor Agents: Structure-Activity Relationships and Potential Therapeutic Applications in Central Nervous system Disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><div class="note"><p class="first last">and references cited therein</p></div><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.pharmthera.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=20923682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=120-148&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perroneauthor=P.+B.+Hedlund&title=Serotonin+5-HT7+Receptor+Agents%3A+Structure-Activity+Relationships+and+Potential+Therapeutic+Applications+in+Central+Nervous+system+Disorders&doi=10.1016%2Fj.pharmthera.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto; Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-148</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Since its discovery in the 1940s in serum, the mammalian intestinal mucosa, and in the central nervous system, serotonin (5-HT) has been shown to be involved in virtually all cognitive and behavioral human functions, and alterations in its neurochem. have been implicated in the etiol. of a plethora of neuropsychiatric disorders.  The cloning of 5-HT receptor subtypes has been of importance in enabling them to be classified as specific protein mols. encoded by specific genes.  The 5-HT7 receptor is the most recently classified member of the serotonin receptor family.  Since its identification, it has been the subject of intense research efforts driven by its presence in functionally relevant regions of the brain.  The availability of some selective antagonists and agonists, in combination with genetically modified mice lacking the 5-HT7 receptor, has allowed for a better understanding of the pathophysiol. role of this receptor.  This paper reviews data on localization and pharmacol. properties of the 5-HT7 receptor, and summarizes the results of structure-activity relationship studies aimed at the discovery of selective 5-HT7 receptor ligands.  Addnl., an overview of the potential therapeutic applications of 5-HT7 receptor agonists and antagonists in central nervous system disorders is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpaPQfXAkrVg90H21EOLACvtfcHk0li-tYP2bZbs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D&md5=060ef6a028b4f9a2b6f842a2accdae2c</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DSerotonin%25205-HT7%2520Receptor%2520Agents%253A%2520Structure-Activity%2520Relationships%2520and%2520Potential%2520Therapeutic%2520Applications%2520in%2520Central%2520Nervous%2520system%2520Disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D129%26spage%3D120%26epage%3D148%26doi%3D10.1016%2Fj.pharmthera.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morcillo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viso, A.</span><span> </span><span class="NLM_article-title">Arylpiperazine Derivatives Acting at 5-HT(1A) Receptors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span><span class="refDoi"> DOI: 10.2174/0929867023371030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2174%2F0929867023371030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=11945120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=443-469&author=M.+L.+L%C3%B3pez-Rodr%C3%ADguezauthor=D.+Ayalaauthor=B.+Benham%C3%BAauthor=M.+J.+Morcilloauthor=A.+Viso&title=Arylpiperazine+Derivatives+Acting+at+5-HT%281A%29+Receptors&doi=10.2174%2F0929867023371030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Arylpiperazine derivatives acting at 5-HT1A receptors</span></div><div class="casAuthors">Lopez-Rodriguez, M. L.; Ayala, D.; Benhamu, B.; Morcillo, M. J.; Viso, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists.  Among 5-HTRs, the 5-HT1A subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1AR sites.  Among these, arylpiperazine derivs. represent one of the most important classes of 5-HT1AR ligands.  This article will review the development of arylpiperazine derivs. acting at 5-HT1ARs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp08_YI2jco87Vg90H21EOLACvtfcHk0li-tYP2bZbs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7w%253D&md5=88125d9e44708938260bdadeb73c6efb</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.2174%2F0929867023371030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371030%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26aulast%3DAyala%26aufirst%3DD.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMorcillo%26aufirst%3DM.%2BJ.%26aulast%3DViso%26aufirst%3DA.%26atitle%3DArylpiperazine%2520Derivatives%2520Acting%2520at%25205-HT%25281A%2529%2520Receptors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D443%26epage%3D469%26doi%3D10.2174%2F0929867023371030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kołaczkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Śniecikowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawłowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siwek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jastrzębska-Więsek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesołowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierzejewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, P.</span><span> </span><span class="NLM_article-title">Novel 5-HT6 Receptor Antagonists/D2 Receptor Partial Agonists Targeting Behavioral and Psychological Symptoms of Dementia</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.ejmech.2014.12.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=221-235&author=M.+Ko%C5%82aczkowskiauthor=M.+Marcinkowskaauthor=A.+Buckiauthor=J.+%C5%9Aniecikowskaauthor=M.+Paw%C5%82owskiauthor=G.+Kazekauthor=A.+Siwekauthor=M.+Jastrz%C4%99bska-Wi%C4%99sekauthor=A.+Partykaauthor=A.+Wasikauthor=A.+Weso%C5%82owskaauthor=P.+Mierzejewskiauthor=P.+Bienkowski&title=Novel+5-HT6+Receptor+Antagonists%2FD2+Receptor+Partial+Agonists+Targeting+Behavioral+and+Psychological+Symptoms+of+Dementia&doi=10.1016%2Fj.ejmech.2014.12.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DKo%25C5%2582aczkowski%26aufirst%3DM.%26aulast%3DMarcinkowska%26aufirst%3DM.%26aulast%3DBucki%26aufirst%3DA.%26aulast%3D%25C5%259Aniecikowska%26aufirst%3DJ.%26aulast%3DPaw%25C5%2582owski%26aufirst%3DM.%26aulast%3DKazek%26aufirst%3DG.%26aulast%3DSiwek%26aufirst%3DA.%26aulast%3DJastrz%25C4%2599bska-Wi%25C4%2599sek%26aufirst%3DM.%26aulast%3DPartyka%26aufirst%3DA.%26aulast%3DWasik%26aufirst%3DA.%26aulast%3DWeso%25C5%2582owska%26aufirst%3DA.%26aulast%3DMierzejewski%26aufirst%3DP.%26aulast%3DBienkowski%26aufirst%3DP.%26atitle%3DNovel%25205-HT6%2520Receptor%2520Antagonists%252FD2%2520Receptor%2520Partial%2520Agonists%2520Targeting%2520Behavioral%2520and%2520Psychological%2520Symptoms%2520of%2520Dementia%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D221%26epage%3D235%26doi%3D10.1016%2Fj.ejmech.2014.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">The full binding profiles of the most active compounds were not evaluated.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+full+binding+profiles+of+the+most+active+compounds+were+not+evaluated."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkóczy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udvari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacsályi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kompagne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egyed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hársing, L. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">(Phenylpiperazinyl-butyl)oxindoles as Selective 5-HT<sub>7</sub> Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2532</span><span class="refDoi"> DOI: 10.1021/jm070279v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070279v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2522-2532&author=B.+Volkauthor=J.+Bark%C3%B3czyauthor=E.+Hegedusauthor=S.+Udvariauthor=I.+Gacs%C3%A1lyiauthor=T.+Mezeiauthor=K.+Pallagiauthor=H.+Kompagneauthor=G.+L%C3%A9vayauthor=A.+Egyedauthor=L.+G.+H%C3%A1rsingauthor=M.+Speddingauthor=G.+Simig&title=%28Phenylpiperazinyl-butyl%29oxindoles+as+Selective+5-HT7+Receptor+Antagonists&doi=10.1021%2Fjm070279v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">(Phenylpiperazinyl-butyl)oxindoles as Selective 5-HT7 Receptor Antagonists</span></div><div class="casAuthors">Volk, Balazs; Barkoczy, Jozsef; Hegedus, Endre; Udvari, Szabolcs; Gacsalyi, Istvan; Mezei, Tibor; Pallagi, Katalin; Kompagne, Hajnalka; Levay, Gyoergy; Egyed, Andras; Harsing, Laszlo G., Jr.; Spedding, Michael; Simig, Gyula</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2522-2532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent 5-hydroxytryptamine7 (5-HT7) ligands has been synthesized that contain a 1,3-dihydro-2H-indol-2-one (oxindole) skeleton.  The binding of these compds. to the 5-HT7 and 5-HT1A receptors was measured.  Despite the structural similarity of these two serotonin receptor subtypes, several derivs. exhibited a high selectivity to the 5-HT7 receptor.  According to the structure-activity relationship observations, compds. unsubstituted at the oxindole nitrogen atom and contg. a tetramethylene spacer between the oxindole skeleton and the basic nitrogen atom are the most potent ligands.  Concerning the basic group, besides the moieties of the 4-phenylpiperazine type, halophenyl-1,2,3,6-tetrahydropyridines also proved to be 5-HT7 receptor ligands.  Because of halogen substitution on the arom. rings, good metabolic stability could be achieved.  A representative of the family, 3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-6-fluoro-1,3-dihydro-2H-indol-2-one exhibited selective 5-HT7 antagonist activity (Ki = 0.79 nM).  The in vivo pharmacol. potencies of these 5-HT7 receptor-ligands were estd. by the conflict drinking (Vogel) and the light-dark anxiolytic tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogYXSXhs8zUbVg90H21EOLACvtfcHk0li-tYP2bZbs9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslahurc%253D&md5=c1f806b8a01a4842aee4c6986cf8c7db</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fjm070279v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070279v%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DBark%25C3%25B3czy%26aufirst%3DJ.%26aulast%3DHegedus%26aufirst%3DE.%26aulast%3DUdvari%26aufirst%3DS.%26aulast%3DGacs%25C3%25A1lyi%26aufirst%3DI.%26aulast%3DMezei%26aufirst%3DT.%26aulast%3DPallagi%26aufirst%3DK.%26aulast%3DKompagne%26aufirst%3DH.%26aulast%3DL%25C3%25A9vay%26aufirst%3DG.%26aulast%3DEgyed%26aufirst%3DA.%26aulast%3DH%25C3%25A1rsing%26aufirst%3DL.%2BG.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D%2528Phenylpiperazinyl-butyl%2529oxindoles%2520as%2520Selective%25205-HT7%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2522%26epage%3D2532%26doi%3D10.1021%2Fjm070279v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacsalyi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poszavacz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyonos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bako, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szenasi, G.</span><span> </span><span class="NLM_article-title">Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT7 Receptor Antagonist Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6657</span><span class="NLM_x">–</span> <span class="NLM_lpage">6669</span><span class="refDoi"> DOI: 10.1021/jm200547z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200547z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6657-6669&author=B.+Volkauthor=I.+Gacsalyiauthor=K.+Pallagiauthor=L.+Poszavaczauthor=I.+Gyonosauthor=E.+Szaboauthor=T.+Bakoauthor=M.+Speddingauthor=G.+Simigauthor=G.+Szenasi&title=Optimization+of+%28Arylpiperazinylbutyl%29oxindoles+Exhibiting+Selective+5-HT7+Receptor+Antagonist+Activity&doi=10.1021%2Fjm200547z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of (Arylpiperazinylbutyl)oxindoles Exhibiting Selective 5-HT7 Receptor Antagonist Activity</span></div><div class="casAuthors">Volk, Balazs; Gacsalyi, Istvan; Pallagi, Katalin; Poszavacz, Laszlo; Gyonos, Ildiko; Szabo, Eva; Bako, Tibor; Spedding, Michael; Simig, Gyula; Szenasi, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6657-6669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of (arylpiperazinylbutyl)oxindoles I (R1 = H, Et; R2 = H, Cl, F; R3 = H, F; R4 = H, Cl; R5 = Ph, 2-MeOC6H4, 4-ClC6H4, 2,4-Cl2C6H3, etc.) and their (aryltetrahydropyridinyl)butyl analogs has been synthesized and studied as highly potent 5-HT7 receptor antagonists for their selectivity toward the 5-HT1A receptor and α1-adrenoceptor.  Several derivs. exhibited high 5-HT7/5-HT1A selectivity, and the key structural factors for reducing undesired α1-adrenergic receptor binding have also been identified.  Rapid metab., a common problem within this family of compds., could be circumvented with appropriate substitution patterns on the oxindole carbocycle.  Contrary to expectations, none of the compds. produced an antidepressant-like action in the forced swimming test in mice despite sufficiently high brain concns.  On the other hand, certain analogs showed significant anxiolytic activity in two different animal models: the Vogel conflict drinking test in rats and the light-dark test in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonMPKyKUteS7Vg90H21EOLACvtfcHk0lgkDlAUgdMWsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7rK&md5=d1f46d3725b029ec92a88bd1944c8a95</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm200547z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200547z%26sid%3Dliteratum%253Aachs%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DGacsalyi%26aufirst%3DI.%26aulast%3DPallagi%26aufirst%3DK.%26aulast%3DPoszavacz%26aufirst%3DL.%26aulast%3DGyonos%26aufirst%3DI.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DBako%26aufirst%3DT.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26aulast%3DSzenasi%26aufirst%3DG.%26atitle%3DOptimization%2520of%2520%2528Arylpiperazinylbutyl%2529oxindoles%2520Exhibiting%2520Selective%25205-HT7%2520Receptor%2520Antagonist%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6657%26epage%3D6669%26doi%3D10.1021%2Fjm200547z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships Between Radiotracer Properties and Image Quality in Molecular Imaging of the Brain with Positron Emission Tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+Between+Radiotracer+Properties+and+Image+Quality+in+Molecular+Imaging+of+the+Brain+with+Positron+Emission+Tomography&doi=10.1016%2Fj.mibio.2003.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eZnqGjGO2fsWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520Between%2520Radiotracer%2520Properties%2520and%2520Image%2520Quality%2520in%2520Molecular%2520Imaging%2520of%2520the%2520Brain%2520with%2520Positron%2520Emission%2520Tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375%26doi%3D10.1016%2Fj.mibio.2003.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of Lipophilicity and its Use as a Predictor of Blood-Brain Barrier Penetration of Molecular Imaging Agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+Lipophilicity+and+its+Use+as+a+Predictor+of+Blood-Brain+Barrier+Penetration+of+Molecular+Imaging+Agents&doi=10.1016%2Fj.mibio.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eZnqGjGO2fsWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520Lipophilicity%2520and%2520its%2520Use%2520as%2520a%2520Predictor%2520of%2520Blood-Brain%2520Barrier%2520Penetration%2520of%2520Molecular%2520Imaging%2520Agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389%26doi%3D10.1016%2Fj.mibio.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For a comprehensive review on drugs’ physicochemical properties and CNS penetration see:</p></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal Chemical Properties of Successful Central Nervous System Drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+Chemical+Properties+of+Successful+Central+Nervous+System+Drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36cR"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYVZbl1zKDIr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520Chemical%2520Properties%2520of%2520Successful%2520Central%2520Nervous%2520System%2520Drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span><span class="refDoi"> DOI: 10.1021/jm000942e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+Calculation+of+Molecular+Polar+Surface+Area+as+a+Sum+of+Fragment-Based+Contributions+and+Its+Application+to+the+Prediction+of+Drug+Transport+Properties&doi=10.1021%2Fjm000942e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lhJBM0nVhgxgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520Calculation%2520of%2520Molecular%2520Polar%2520Surface%2520Area%2520as%2520a%2520Sum%2520of%2520Fragment-Based%2520Contributions%2520and%2520Its%2520Application%2520to%2520the%2520Prediction%2520of%2520Drug%2520Transport%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717%26doi%3D10.1021%2Fjm000942e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kelder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayada, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbressine, L. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploemen, J. – P.</span><span> </span><span class="NLM_article-title">Polar Molecular Surface as a dominating Determinant for Oral Absorption and Brain Penetration of Drugs</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span><span class="refDoi"> DOI: 10.1023/A:1015040217741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1023%2FA%3A1015040217741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10554091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=1514-1519&author=J.+Kelderauthor=P+D.+J.+Grootenhuisauthor=D.+M.+Bayadaauthor=L.+P.+C.+Delbressineauthor=J.+%E2%80%93+P.+Ploemen&title=Polar+Molecular+Surface+as+a+dominating+Determinant+for+Oral+Absorption+and+Brain+Penetration+of+Drugs&doi=10.1023%2FA%3A1015040217741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span></div><div class="casAuthors">Kelder, Jan; Grootenhuis, Peter D. J.; Bayada, Denis M.; Delbressine, Leon P. C.; Ploemen, Jan-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1514-1519</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Purpose: To study oral absorption and brain penetration as a function of polar mol. surface area.  Methods: Measured brain penetration data of 45 drug mols. were investigated.  The dynamic polar surface areas were calcd. and correlated with the brain penetration data.  Also the static polar surface areas of 776 orally administered CNS drugs that have reached at least Phase II efficacy studies were calcd.  The same was done for a series of 1590 orally administered non-CNS drugs that have reached at least Phase II efficacy studies.  Results: A linear relationship between brain penetration and dynamic polar surface area (A2) was found (n = 45, R = 0.917, F1,43 = 229).  Brain penetration decreases with increasing polar surface area.  A clear difference between the distribution of the polar surface area of the 776 CNS and 1590 non-CNS drugs was found.  It was deduced that orally active drugs that are transported passively by the transcellular route should not exceed a polar surface area of about 120 A2.  They can be tailored to brain penetration by decreasing the polar surface to <60-70 A2.  This conclusion is supported by the inverse linear relationship between exptl. brain penetration data and the dynamic polar surface area of 45 drug mols.  Conclusions: The polar mol. surface area is a dominating determinant for oral absorption and brain penetration of drugs that are transported by the transcellular route.  This property should be considered in the early phase of drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmc3v7TzWM4LVg90H21EOLACvtfcHk0lhJBM0nVhgxgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVOhtb8%253D&md5=868fe1e9491dd3b8b92b326d28ee48f9</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015040217741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015040217741%26sid%3Dliteratum%253Aachs%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DGrootenhuis%26aufirst%3DP%2BD.%2BJ.%26aulast%3DBayada%26aufirst%3DD.%2BM.%26aulast%3DDelbressine%26aufirst%3DL.%2BP.%2BC.%26aulast%3DPloemen%26aufirst%3DJ.%2B%25E2%2580%2593%2BP.%26atitle%3DPolar%2520Molecular%2520Surface%2520as%2520a%2520dominating%2520Determinant%2520for%2520Oral%2520Absorption%2520and%2520Brain%2520Penetration%2520of%2520Drugs%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D1514%26epage%3D1519%26doi%3D10.1023%2FA%3A1015040217741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span> </span><span class="NLM_article-title">A Novel, Potent, and Selective 5-HT<sub>7</sub> Antagonist: (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.1021/jm991151j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991151j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=342-345&author=P.+J.+Lovellauthor=S.+M.+Bromidgeauthor=S.+Dabbsauthor=D.+M.+Duckworthauthor=I.+T.+Forbesauthor=A.+J.+Jenningsauthor=F.+D.+Kingauthor=D.+N.+Middlemissauthor=S.+K.+Rahmanauthor=D.+V.+Saundersauthor=L.+L.+Collinauthor=J.+J.+Haganauthor=G.+J.+Rileyauthor=D.+R.+Thomas&title=A+Novel%2C+Potent%2C+and+Selective+5-HT7+Antagonist%3A+%28R%29-3-%282-%282-%284-Methylpiperidin-1-yl%29-ethyl%29pyrrolidine-1-sulfonyl%29phenol+%28SB-269970%29&doi=10.1021%2Fjm991151j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm991151j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991151j%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDabbs%26aufirst%3DS.%26aulast%3DDuckworth%26aufirst%3DD.%2BM.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DRahman%26aufirst%3DS.%2BK.%26aulast%3DSaunders%26aufirst%3DD.%2BV.%26aulast%3DCollin%26aufirst%3DL.%2BL.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26atitle%3DA%2520Novel%252C%2520Potent%252C%2520and%2520Selective%25205-HT7%2520Antagonist%253A%2520%2528R%2529-3-%25282-%25282-%25284-Methylpiperidin-1-yl%2529-ethyl%2529pyrrolidine-1-sulfonyl%2529phenol%2520%2528SB-269970%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D342%26epage%3D345%26doi%3D10.1021%2Fjm991151j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lazareno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birdsall, N. J.</span><span> </span><span class="NLM_article-title">Estimation of Competitive Antagonist Affinity from Functional Inhibition Curves Using the Gaddum, Schild and Cheng-Prusoff Equations</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1993.tb13737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1476-5381.1993.tb13737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8401922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1993&pages=1110-1119&author=S.+Lazarenoauthor=N.+J.+Birdsall&title=Estimation+of+Competitive+Antagonist+Affinity+from+Functional+Inhibition+Curves+Using+the+Gaddum%2C+Schild+and+Cheng-Prusoff+Equations&doi=10.1111%2Fj.1476-5381.1993.tb13737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations</span></div><div class="casAuthors">Lazareno, S.; Birdsall, N. J. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1110-19</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The estn. of antagonist affinity from functional expts. in which the effect of a fixed agonist concn. is reduced by a range of antagonist concns. ('functional inhibition curves') has been considered from both a theor. and exptl. viewpoint.  Theor. predictions are compared with results obtained from the stimulation of [35S]-GTPγS binding by acetylcholine to membranes of Chinese hamster ovary (CHO) cells stably transfected with human m1-m4 muscarinic receptors, and inhibition of the stimulated binding by pirenzepine and AQ-RA 741.  The usual procedure of applying the Cheng-Prusoff correction is shown to be theor. invalid, and predictions are made of the size and distribution of errors assocd. with this procedure.  A different procedure for estg. antagonist affinity, using the principles of dose-ratio anal. and analogous to use of the Gaddum equation, is found to be accurate and theor. valid.  A novel method of anal. allows accurate estn. of both antagonist affinity and Schild slope, by fitting the combined data from an antagonist inhibition curve and an agonist activation curve directly to a form of the Schild equation (derived by Waud) using non-linear regression anal.  It is shown that the conventional Schild anal. can be enhanced by treating part of the data as a family of inhibition curves and including in the Schild plot dose-ratios estd. from the inhibition curves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwkiSVn8LIPLVg90H21EOLACvtfcHk0ljjEOCqZc7HhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGjtrs%253D&md5=1eb880b7a282a8de7c3f17ba95a11501</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13737.x%26sid%3Dliteratum%253Aachs%26aulast%3DLazareno%26aufirst%3DS.%26aulast%3DBirdsall%26aufirst%3DN.%2BJ.%26atitle%3DEstimation%2520of%2520Competitive%2520Antagonist%2520Affinity%2520from%2520Functional%2520Inhibition%2520Curves%2520Using%2520the%2520Gaddum%252C%2520Schild%2520and%2520Cheng-Prusoff%2520Equations%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D109%26spage%3D1110%26epage%3D1119%26doi%3D10.1111%2Fj.1476-5381.1993.tb13737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET Radiotracers: Crossing the Blood-Brain Barrier and Surviving Metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1016/j.tips.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+Radiotracers%3A+Crossing+the+Blood-Brain+Barrier+and+Surviving+Metabolism&doi=10.1016%2Fj.tips.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0ljjEOCqZc7HhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520Radiotracers%253A%2520Crossing%2520the%2520Blood-Brain%2520Barrier%2520and%2520Surviving%2520Metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440%26doi%3D10.1016%2Fj.tips.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efange, S. M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and in Vitro and in Vivo Evaluation of <sup>18</sup>F-Labeled Positron Emission Tomography (PET) Ligands for Imaging the Vesicular Acetylcholine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1369</span><span class="refDoi"> DOI: 10.1021/jm8012344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8012344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1358-1369&author=Z.+Tuauthor=S.+M.+N.+Efangeauthor=J.+Xuauthor=S.+Liauthor=L.+A.+Jonesauthor=S.+M.+Parsonsauthor=R.+H.+Mach&title=Synthesis+and+in+Vitro+and+in+Vivo+Evaluation+of+18F-Labeled+Positron+Emission+Tomography+%28PET%29+Ligands+for+Imaging+the+Vesicular+Acetylcholine+Transporter&doi=10.1021%2Fjm8012344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm8012344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8012344%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DEfange%26aufirst%3DS.%2BM.%2BN.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DParsons%26aufirst%3DS.%2BM.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%252018F-Labeled%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Ligands%2520for%2520Imaging%2520the%2520Vesicular%2520Acetylcholine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1358%26epage%3D1369%26doi%3D10.1021%2Fjm8012344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mengod, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilaro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raurich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Gimenez, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span> </span><span class="NLM_article-title">5-HT Receptors in Mammalian Brain: Receptor Autoradiography and In Situ Hybridization Studies of New Ligands and Newly Identified Receptors</span> <span class="citation_source-journal">Histochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span><span class="refDoi"> DOI: 10.1007/BF02272148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1007%2FBF02272148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=8968727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADyaK2sXkvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=747-758&author=G.+Mengodauthor=M.+T.+Vilaroauthor=A.+Raurichauthor=J.+F.+Lopez-Gimenezauthor=R.+Cortesauthor=J.+M.+Palacios&title=5-HT+Receptors+in+Mammalian+Brain%3A+Receptor+Autoradiography+and+In+Situ+Hybridization+Studies+of+New+Ligands+and+Newly+Identified+Receptors&doi=10.1007%2FBF02272148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT receptors in mammalian brain: Receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors</span></div><div class="casAuthors">Mengod, G.; Vilaro, M. T.; Raurich, A.; Lopez-gimenez, J. F.; Cortes, R.; Palacios, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Histochemical Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">747-758</span>CODEN:
                <span class="NLM_cas:coden">HISJAE</span>;
        ISSN:<span class="NLM_cas:issn">0018-2214</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">In recent years the family of mammalian serotonin receptors has grown to 14 different subtypes, characterized by pharmacol. or mol. biol. techniques.  In parallel, new ligand mols. have been developed for their study.  However, selective ligands are not yet available to study every one of them.  In addn. the degree of selectivity of ligands, hitherto regarded as specific for a particular receptor subtype has been called in question by their affinities for newly discovered receptors.  Consequently, a re-evaluation of past ligand receptor autoradiog. work is necessary in view of the redefined receptor profiles of these ligands, and the introduction of newly developed ligands.  A further difficulty for the characterization of these receptors is the absence of selective antagonist ligands which, for some of the subtypes, have become available only recently.  To overcome these difficulties we have combined in situ hybridization histochem. and receptor ligand autoradiog. to study the regional and cellular localization of several serotonin receptors in the rodent brain.  In addn., for some receptors, we have expanded these studies to primates, including humans.  We have found that the distribution of 5-HT1A receptors in monkey brain, labeled with the agonist 3H-8-OH-DPAT and the antagonist 3H-WAY 100635 was very similar at the levels examd., and corresponded well with that obsd. for the cells contg. mRNA coding for this receptor, confirming the somatodendritic localization of 5-HT1A receptors in monkey brain.  The labeling conditions to visualize 5-HT1F receptors in guinea pig brain, namely 3H-sumatriptan in the presence of 10-8 M 5-CT to block 5-HT1D receptors, are suitable for visualizing this receptor, since the results agreed with those obsd. by in situ hybridization.  By using 3H-ketanserin and 3H-mesulergine in parallel with in situ hybridization using the corresponding oligonucleotides, we were able to show that these ligands label resp. 5-HT2A and 5-HT2C binding sites in monkey brain.  5-HT4 receptors were localized in the brain of several species including humans by using 125I-SB 207710.  In situ hybridization expts. performed in guinea pig confirmed that 5-HT4 receptors are localized on the terminals of the striatopallidal and striatonigral projections.  5-HT7 binding sites were labeled in rat and guinea pig brains by incubating with 3H-5-CT in the presence of 100 μM WAY 100135 and 250 μM GR 127935; the distribution obtained in both species agreed, in general, with that of the corresponding mRNA coding for them.  These results are an illustration of the understanding of our current knowledge of the chem. neuroanatomy of the mammalian 5-HT system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog9URQGz8DGLVg90H21EOLACvtfcHk0ljjEOCqZc7HhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvVeitQ%253D%253D&md5=ca1be9db68453b5bca425ad9afc817ae</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1007%2FBF02272148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02272148%26sid%3Dliteratum%253Aachs%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DVilaro%26aufirst%3DM.%2BT.%26aulast%3DRaurich%26aufirst%3DA.%26aulast%3DLopez-Gimenez%26aufirst%3DJ.%2BF.%26aulast%3DCortes%26aufirst%3DR.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26atitle%3D5-HT%2520Receptors%2520in%2520Mammalian%2520Brain%253A%2520Receptor%2520Autoradiography%2520and%2520In%2520Situ%2520Hybridization%2520Studies%2520of%2520New%2520Ligands%2520and%2520Newly%2520Identified%2520Receptors%26jtitle%3DHistochem.%2520J.%26date%3D1996%26volume%3D28%26spage%3D747%26epage%3D758%26doi%3D10.1007%2FBF02272148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Martin-Cora, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, A.</span><span> </span><span class="NLM_article-title">Autoradiographic Distribution of 5-HT7 Receptors in the Human Brain Using [3H]Mesulergine: Comparison to Other Mammalian Species</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1038%2Fsj.bjp.0705576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=14656806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFalurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=92-104&author=F.+J.+Martin-Coraauthor=A.+Pazos&title=Autoradiographic+Distribution+of+5-HT7+Receptors+in+the+Human+Brain+Using+%5B3H%5DMesulergine%3A+Comparison+to+Other+Mammalian+Species&doi=10.1038%2Fsj.bjp.0705576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: Comparison to other mammalian species</span></div><div class="casAuthors">Martin-Cora, Francisco J.; Pazos, Angel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-104</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The main aim of this investigation was to delineate the distribution of the 5-HT7 receptor in human brain.  Autoradiog. studies in guinea-pig and rat brain were also carried out to revisit and compare the anatomical distribution of 5-HT7 receptors in different mammalian species.  Binding studies were performed in rat frontal cortex membranes using 10 nM [3H]mesulergine in the presence of raclopride (10 μM) and DOI (0.8 μM).  Under these conditions, a binding site with pharmacol. characteristics consistent with those of the 5-HT7 receptors was identified (rank order of binding affinity values: 5-CT>5-HT>5-MeOT> mesulergine ≈ methiothepin>8-OH-DPAT = spiperone ≈ (+)-butaclamol» imipramine ≈ (±)-pindolol» ondansetron ≈ clonidine ≈ prazosin).  The autoradiog. studies revealed that the anatomical distribution of 5-HT7 receptors throughout the human brain was heterogeneous.  High densities were found over the caudate and putamen nuclei, the pyramidal layer of the CA2 field of the hippocampus, the centromedial thalamic nucleus, and the dorsal raphe nucleus.  The inner layer of the frontal cortex, the dentate gyrus of the hippocampus, the subthalamic nucleus and superior colliculus, among others, presented intermediate concns. of 5-HT7 receptors.  A similar brain anatomical distribution of 5-HT7 receptors was obsd. in all three mammalian species studied.  By using [3H]mesulergine, the authors have mapped for the first time the anatomical distribution of 5-HT7 receptors in the human brain, overcoming the limitations previously found in radiometric studies with other radioligands, and also revisiting the distribution in guinea-pig and rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4iWtlqH5OPLVg90H21EOLACvtfcHk0ljU3SqBtz3ouw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFalurY%253D&md5=889fa47ca634f6f6c787f2cbbfdc71c4</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705576%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Cora%26aufirst%3DF.%2BJ.%26aulast%3DPazos%26aufirst%3DA.%26atitle%3DAutoradiographic%2520Distribution%2520of%25205-HT7%2520Receptors%2520in%2520the%2520Human%2520Brain%2520Using%2520%255B3H%255DMesulergine%253A%2520Comparison%2520to%2520Other%2520Mammalian%2520Species%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D92%26epage%3D104%26doi%3D10.1038%2Fsj.bjp.0705576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pilato, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herth, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettrup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Radiolabeling and In Vivo Evaluation of Potential Positron Emission Tomography (PET) Radioligands for Brain Imaging of the 5-HT<sub>7</sub> Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1736</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2Fj.bmc.2014.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=24508140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1736-1750&author=E.+Lacivitaauthor=M.+Nisoauthor=H.+D.+Hansenauthor=P.+Di+Pilatoauthor=M.+M.+Herthauthor=S.+Lehelauthor=A.+Ettrupauthor=L.+Montenegroauthor=R.+Perroneauthor=F.+Berardiauthor=N.+A.+Colabufoauthor=M.+Leopoldoauthor=G.+M.+Knudsen&title=Design%2C+Synthesis%2C+Radiolabeling+and+In+Vivo+Evaluation+of+Potential+Positron+Emission+Tomography+%28PET%29+Radioligands+for+Brain+Imaging+of+the+5-HT7+Receptor&doi=10.1016%2Fj.bmc.2014.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor</span></div><div class="casAuthors">Lacivita, Enza; Niso, Mauro; Hansen, Hanne D.; Di Pilato, Pantaleo; Herth, Matthias M.; Lehel, Szabolcs; Ettrup, Anders; Montenegro, Lisa; Perrone, Roberto; Berardi, Francesco; Colabufo, Nicola A.; Leopoldo, Marcello; Knudsen, Gitte M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1736-1750</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the design, synthesis, and pharmacol. evaluation of a set of compds. structurally related to the high affinity serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (6, LP-211).  Specific structural modifications were performed in order to maintain affinity for the target receptor and to improve the selectivity over 5-HT1A and adrenergic α1 receptors.  The synthesized compds. have chem. features that could enable labeling with a positron emitter radioisotope (carbon-11 or fluorine-18) and lipophilicity within the range considered optimal for brain penetration and low non-specific binding. 4-[2-(4-Methoxyphenyl)phenyl]-N-(pyridin-4-ylmethyl)piperazinehexanamide (23a) and N-pyridin-4-ylmethyl-[3-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]propanamide (26a) were radiolabeled on the methoxy group with carbon-11.  Positron emission tomog. (PET) anal. revealed that [11C]-23a and [11C]-26a were P-glycoprotein (P-gp) substrates and rapidly metabolized, resulting in poor brain uptake.  These features were not predicted by in vitro tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYULxFqd_ijbVg90H21EOLACvtfcHk0ljU3SqBtz3ouw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGrtrw%253D&md5=0a2a8df8298e279a5676c8b8c6d1eca6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%2BD.%26aulast%3DDi%2BPilato%26aufirst%3DP.%26aulast%3DHerth%26aufirst%3DM.%2BM.%26aulast%3DLehel%26aufirst%3DS.%26aulast%3DEttrup%26aufirst%3DA.%26aulast%3DMontenegro%26aufirst%3DL.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Radiolabeling%2520and%2520In%2520Vivo%2520Evaluation%2520of%2520Potential%2520Positron%2520Emission%2520Tomography%2520%2528PET%2529%2520Radioligands%2520for%2520Brain%2520Imaging%2520of%2520the%25205-HT7%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1736%26epage%3D1750%26doi%3D10.1016%2Fj.bmc.2014.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrikse, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waarde, A.</span><span> </span><span class="NLM_article-title">PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span><span class="refDoi"> DOI: 10.2174/1381612043384736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.2174%2F1381612043384736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15134571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVykurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1493-1503&author=P.+H.+Elsingaauthor=N.+H.+Hendrikseauthor=J.+Bartauthor=W.+Vaalburgauthor=A.+Van+Waarde&title=PET+Studies+on+P-Glycoprotein+Function+in+the+Blood-Brain+Barrier%3A+How+it+Affects+Uptake+and+Binding+of+Drugs+within+the+CNS&doi=10.2174%2F1381612043384736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS</span></div><div class="casAuthors">Elsinga, Philip H.; Hendrikse, N. Harry; Bart, Joost; Vaalburg, Willem; Van Waarde, Aren</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1493-1503</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Permeability of the blood-brain barrier (BBB) is one of the factors detg. the bioavailability of therapeutic drugs.  The BBB only allows entry of lipophilic compds. with low mol. wts. by passive diffusion.  However, many lipophilic drugs show negligible brain uptake.  They are substrates for transporters such as P-glycoprotein (P-gp), multidrug-resistance assocd. protein (MRP) and org. anion transporting polypeptides (OATPs).  The action of these carrier systems results in rapid efflux of xenobiotics from the central nervous system (CNS).  Classification of candidate drugs as substrates or inhibitors of such carrier proteins is of crucial importance in drug development.  Positron emission tomog. (PET) can play an important role in the screening process by providing in vivo information, after the putative drug has passed in vitro tests.  Although radiolabeled probes for MRP and OATP function are not yet available, many radiotracers have been prepd. to study P-glycoprotein function in vivo with PET.  These include alkaloids (11C-colchicine), antineoplastic agents (11C-daunorubicin, 18F-paclitaxel), modulators of L-type calcium channels (11C-(±)verapamil, 11C-R(+)-verapamil), β-adrenoceptor antagonists (11C-(S)-carazolol, 18F-(S)-1'-fluorocarazolol, 11C-carvedilol), serotonin 5-HT1A receptor antagonists (18F-MPPF), opioid receptor antagonists (11C-loperamide, 11C-carfentanyl), and various 64Cu-labeled copper complexes.  Studies in exptl. animals have indicated that it is possible to assess P-glycoprotein function in the BBB and its effect on the uptake and binding of drugs within the intact CNS, using suitable P-gp modulators labeled with positron emitters.  Provided that radiopharmaceuticals (and P-gp modulators) can be developed for human use, several exciting fields of study may be explored, viz. (i) direct evaluation of the effect of modulators on the cerebral uptake of therapeutic drugs; (ii) assessment of mechanisms underlying drug resistance in epilepsy; (iii) examn. of the role of the BBB in the pathophysiol. of neurodegenerative and affective disorders; and (iv) exploration of the relationship between polymorphisms of transporter genes and the pharmacokinetics of test compds. within the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAxP1udd9dx7Vg90H21EOLACvtfcHk0ljU3SqBtz3ouw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVykurc%253D&md5=ceb0e638fcae7d5180a7c4a2f353f200</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.2174%2F1381612043384736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384736%26sid%3Dliteratum%253Aachs%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26aulast%3DBart%26aufirst%3DJ.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3DVan%2BWaarde%26aufirst%3DA.%26atitle%3DPET%2520Studies%2520on%2520P-Glycoprotein%2520Function%2520in%2520the%2520Blood-Brain%2520Barrier%253A%2520How%2520it%2520Affects%2520Uptake%2520and%2520Binding%2520of%2520Drugs%2520within%2520the%2520CNS%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1493%26epage%3D1503%26doi%3D10.2174%2F1381612043384736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrikse, N. H.</span><span> </span><span class="NLM_article-title">In Vivo Evaluation of P-Glycoproteins Modulation of 8 PET Radioligands Used Clinically</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=81-87&author=K.+Ishiwataauthor=K.+Kawamuraauthor=K.+Yanaiauthor=N.+H.+Hendrikse&title=In+Vivo+Evaluation+of+P-Glycoproteins+Modulation+of+8+PET+Radioligands+Used+Clinically"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DHendrikse%26aufirst%3DN.%2BH.%26atitle%3DIn%2520Vivo%2520Evaluation%2520of%2520P-Glycoproteins%2520Modulation%2520of%25208%2520PET%2520Radioligands%2520Used%2520Clinically%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D81%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Armarego, W. L. F.; Chai, C. L. L.</span> <span class="citation_source-book">Purification of Laboratory Chemicals</span>, <span class="NLM_edition">6th</span> ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1016%2FB978-1-85617-567-8.50011-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=W.+L.+F.+Armarego&author=C.+L.+L.+Chai&title=Purification+of+Laboratory+Chemicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FB978-1-85617-567-8.50011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-85617-567-8.50011-1%26sid%3Dliteratum%253Aachs%26aulast%3DArmarego%26aufirst%3DW.%2BL.%2BF.%26btitle%3DPurification%2520of%2520Laboratory%2520Chemicals%26pub%3DElsevier%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Ding, Y. – S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K. – S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span> </span><span class="NLM_article-title">Comparative Evaluation of Positron Emission Tomography Radiotracers for Imaging the Norepinephrine Transporter: (<i>S</i>,<i>S</i>) and (<i>R</i>,<i>R</i>) Enantiomers of Reboxetine Analogs ([<sup>11</sup>C]Methylreboxetine, 3-Cl-[<sup>11</sup>C]Methylreboxetine and [<sup>18</sup>F]Fluororeboxetine), (<i>R</i>)-[<sup>11</sup>C]Nisoxetine, [<sup>11</sup>C]Oxaprotiline and [<sup>11</sup>C]Lortalamine</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2005.03202.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1111%2Fj.1471-4159.2005.03202.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=15998285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVarsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=337-351&author=Y.+%E2%80%93+S.+Dingauthor=K.+%E2%80%93+S.+Linauthor=J.+Loganauthor=H.+Benvenisteauthor=P.+Carter&title=Comparative+Evaluation+of+Positron+Emission+Tomography+Radiotracers+for+Imaging+the+Norepinephrine+Transporter%3A+%28S%2CS%29+and+%28R%2CR%29+Enantiomers+of+Reboxetine+Analogs+%28%5B11C%5DMethylreboxetine%2C+3-Cl-%5B11C%5DMethylreboxetine+and+%5B18F%5DFluororeboxetine%29%2C+%28R%29-%5B11C%5DNisoxetine%2C+%5B11C%5DOxaprotiline+and+%5B11C%5DLortalamine&doi=10.1111%2Fj.1471-4159.2005.03202.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine</span></div><div class="casAuthors">Ding, Yu-Shin; Lin, Kuo-Shyan; Logan, Jean; Benveniste, Helene; Carter, Pauline</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-351</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">We have synthesized and evaluated several new ligands for imaging the norepinephrine transporter (NET) system in baboons with positron emission tomog. (PET).  Ligands possessing high brain penetration, high affinity and selectivity, appropriate lipophilicity (log P = 1.0-3.5), high plasma free fraction and reasonable stability in plasma were selected for further studies.  Based on our characterization studies in baboons, including 11C-labeled (R)-nisoxetine (Nis), oxaprotiline (Oxap), lortalamine (Lort) and new analogs of methylreboxetine (MRB), in conjunction with our earlier evaluation of 11C and 18F derivs. of reboxetine, MRB and their individual (R,R) and (S,S) enantiomers, we have identified the superiority of (S,S)-[11C]MRB and the suitability of MRB analogs [(S,S)-[11C]MRB > (S,S)-[11C]3-Cl-MRB > (S,S)-[18F]fluororeboxetine] as potential NET ligands for PET.  In contrast, Nis, Oxap and Lort displayed high uptake in striatum (higher than in thalamus).  The use of these ligands is further limited by high non-specific binding and relatively low specific signal, as is characteristic of many earlier NET ligands.  Thus, to our knowledge (S,S)-[11C]MRB remains by far the most promising NET ligand for PET studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPC3UwcybIbVg90H21EOLACvtfcHk0ljXE5pkmfv4Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVarsLg%253D&md5=b9762414ff6e1ff795d20b10df23c851</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03202.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03202.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%2B%25E2%2580%2593%2BS.%26aulast%3DLin%26aufirst%3DK.%2B%25E2%2580%2593%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DBenveniste%26aufirst%3DH.%26aulast%3DCarter%26aufirst%3DP.%26atitle%3DComparative%2520Evaluation%2520of%2520Positron%2520Emission%2520Tomography%2520Radiotracers%2520for%2520Imaging%2520the%2520Norepinephrine%2520Transporter%253A%2520%2528S%252CS%2529%2520and%2520%2528R%252CR%2529%2520Enantiomers%2520of%2520Reboxetine%2520Analogs%2520%2528%255B11C%255DMethylreboxetine%252C%25203-Cl-%255B11C%255DMethylreboxetine%2520and%2520%255B18F%255DFluororeboxetine%2529%252C%2520%2528R%2529-%255B11C%255DNisoxetine%252C%2520%255B11C%255DOxaprotiline%2520and%2520%255B11C%255DLortalamine%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D94%26spage%3D337%26epage%3D351%26doi%3D10.1111%2Fj.1471-4159.2005.03202.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonoda, N.</span><span> </span><span class="NLM_article-title">A New Synthesis of Cyclic Ureas, Cyclic Urethanes, and a Quinozolinedione. Selenium-Assisted Carbonylation of Aromatic Amines with Carbon Monoxide</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span><span class="refDoi"> DOI: 10.1246/bcsj.60.1793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1246%2Fbcsj.60.1793" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=1793-1799&author=T.+Yoshidaauthor=N.+Kambeauthor=S.+Muraiauthor=N.+Sonoda&title=A+New+Synthesis+of+Cyclic+Ureas%2C+Cyclic+Urethanes%2C+and+a+Quinozolinedione.+Selenium-Assisted+Carbonylation+of+Aromatic+Amines+with+Carbon+Monoxide&doi=10.1246%2Fbcsj.60.1793"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1246%2Fbcsj.60.1793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fbcsj.60.1793%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKambe%26aufirst%3DN.%26aulast%3DMurai%26aufirst%3DS.%26aulast%3DSonoda%26aufirst%3DN.%26atitle%3DA%2520New%2520Synthesis%2520of%2520Cyclic%2520Ureas%252C%2520Cyclic%2520Urethanes%252C%2520and%2520a%2520Quinozolinedione.%2520Selenium-Assisted%2520Carbonylation%2520of%2520Aromatic%2520Amines%2520with%2520Carbon%2520Monoxide%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1987%26volume%3D60%26spage%3D1793%26epage%3D1799%26doi%3D10.1246%2Fbcsj.60.1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Pagani Zecchini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradisi, P.</span><span> </span><span class="NLM_article-title">The Reactivity of 2,3-Diaminopyridine toward Alkyl Chloroformates and Dicarbonates</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span><span class="refDoi"> DOI: 10.1002/jhet.5570220427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjhet.5570220427" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1985&pages=1061-1064&author=G.+Pagani+Zecchiniauthor=I.+Torriniauthor=P.+Paradisi&title=The+Reactivity+of+2%2C3-Diaminopyridine+toward+Alkyl+Chloroformates+and+Dicarbonates&doi=10.1002%2Fjhet.5570220427"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570220427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570220427%26sid%3Dliteratum%253Aachs%26aulast%3DPagani%2BZecchini%26aufirst%3DG.%26aulast%3DTorrini%26aufirst%3DI.%26aulast%3DParadisi%26aufirst%3DP.%26atitle%3DThe%2520Reactivity%2520of%25202%252C3-Diaminopyridine%2520toward%2520Alkyl%2520Chloroformates%2520and%2520Dicarbonates%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1985%26volume%3D22%26spage%3D1061%26epage%3D1064%26doi%3D10.1002%2Fjhet.5570220427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49c"><span><span class="NLM_contrib-group">Borgens, R. B.; Shi, R.; Stephen, R.; Daniel, T.</span><span> </span><span class="NLM_article-title">Pyridines for Treating Injured Mammalian Nerve Tissue</span>. WO2004/052291, Chem. Abstr.<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">47362</span>. <div class="note"><p class="first last">For alternative syntheses of 1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-2(3<i>H</i>)-one, please see:</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+B.+Borgens&author=R.+Shi&author=R.+Stephen&author=T.+Daniel&title=Pyridines+for+Treating+Injured+Mammalian+Nerve+Tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorgens%26aufirst%3DR.%2BB.%26atitle%3DPyridines%2520for%2520Treating%2520Injured%2520Mammalian%2520Nerve%2520Tissue%26jtitle%3DChem.%2520Abstr.%26date%3D2004%26volume%3D141%26spage%3D47362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Debeljak-Šuštar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zrimšek, Z.</span><span> </span><span class="NLM_article-title">Neighboring Group Interaction in Ortho-Substituted Aminopyridines. Pyridopyrimidines and Related Systems</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1021/jo00397a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00397a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=393-397&author=M.+Debeljak-%C5%A0u%C5%A1tarauthor=B.+Stanovnikauthor=M.+Ti%C5%A1lerauthor=Z.+Zrim%C5%A1ek&title=Neighboring+Group+Interaction+in+Ortho-Substituted+Aminopyridines.+Pyridopyrimidines+and+Related+Systems&doi=10.1021%2Fjo00397a003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Fjo00397a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00397a003%26sid%3Dliteratum%253Aachs%26aulast%3DDebeljak-%25C5%25A0u%25C5%25A1tar%26aufirst%3DM.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26aulast%3DZrim%25C5%25A1ek%26aufirst%3DZ.%26atitle%3DNeighboring%2520Group%2520Interaction%2520in%2520Ortho-Substituted%2520Aminopyridines.%2520Pyridopyrimidines%2520and%2520Related%2520Systems%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26spage%3D393%26epage%3D397%26doi%3D10.1021%2Fjo00397a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tomažič, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span> </span><span class="NLM_article-title">Syntheses of Some Azinylhydroxylamines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">864</span><span class="refDoi"> DOI: 10.1002/jhet.5570160507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;key=10.1002%2Fjhet.5570160507" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=861-864&author=A.+Toma%C5%BEi%C4%8Dauthor=M.+Ti%C5%A1lerauthor=B.+Stanovnik&title=Syntheses+of+Some+Azinylhydroxylamines&doi=10.1002%2Fjhet.5570160507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570160507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570160507%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25BEi%25C4%258D%26aufirst%3DA.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26aulast%3DStanovnik%26aufirst%3DB.%26atitle%3DSyntheses%2520of%2520Some%2520Azinylhydroxylamines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26spage%3D861%26epage%3D864%26doi%3D10.1002%2Fjhet.5570160507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i147"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00874">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72671"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00874">10.1021/acs.jmedchem.5b00874</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR of synthetic intermediates and final products, HPLC chromatograms of products tested in vitro and in vivo, reference and negative controls of 5-CT, SB-26970, and ligands <b>I</b>, <b>62</b>, <b>63</b>, <b>79</b>, and <b>81</b> for cAMP accumulation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_001.pdf">jm5b00874_si_001.pdf (26.82 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00874/suppl_file/jm5b00874_si_002.csv">jm5b00874_si_002.csv (6.38 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00874&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-20%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00874" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00874" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799cbb53d533c82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
